CUMULATIVE SUPPLEMENT 9 SEPTEMBER 2020

APPROVED DRUG PRODUCTS

WITH THERAPEUTIC EQUIVALENCE EVALUATIONS

40th EDITION

Department of Health and Human Services Food and Drug Administration Office of Medical Products and Tobacco Center for Drug Evaluation and Research Office of Generic Drugs Office of Generic Drug Policy

2020

Prepared By Food and Drug Administration Office of Medical Products and Tobacco Center for Drug Evaluation and Research Office of Generic Drugs Office of Generic Drug Policy

APPROVED DRUG PRODUCTS with THERAPEUTIC EQUIVALENCE EVALUATIONS

40th EDITION

Cumulative Supplement 9 September 2020

CONTENTS

PAGE

Contents 1.0 INTRODUCTION ...... v 1.1 HOW TO USE THE CUMULATIVE SUPPLEMENT ...... vi 1.2 CUMULATIVE SUPPLEMENT CONTENT ...... vi 1.3 APPLICANT NAME CHANGES ...... vii 1.4 LEVOTHYROXINE SODIUM ...... viii 1.5 AVAILABILITY OF THE EDITION ...... ix 1.6 REPORT OF COUNTS FOR THE PRESCRIPTION DRUG PRODUCT LIST ...... x 1.7 CUMULATIVE SUPPLEMENT LEGEND ...... xi

DRUG PRODUCT LISTS Prescription Drug Product List …………………………………………………………………….. 1-1 OTC Drug Product List ...... 2-1 Drug Products with Approval under Section 505 of the Act Administered by the Center for Biologics Evaluation and Research List ……………………………………………………… 3-1 Orphan Product Designations and Approvals List ……………………………………………… 4-1 Drug Products Which Must Demonstrate in vivo Bioavailability Only if Product Fails to Achieve Adequate Dissolution …………………………………………………………………. 5-1

PATENT AND EXCLUSIVITY INFORMATION ADDENDUM A. Patent and Exclusivity Lists ...... A-1 B. Patent and Exclusivity Terms …………………………………………………………………. B-1

iv

APPROVED DRUG PRODUCTS with THERAPEUTIC EQUIVALENCE EVALUATIONS

40th EDITION

CUMULATIVE SUPPLEMENT 9 SEPTEMBER 2020

1.0 INTRODUCTION

This Cumulative Supplement is one of a series of monthly updates to the Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book). The List is composed of four parts: approved prescription drug products with therapeutic equivalence evaluations; approved over-the-counter (OTC) drug products for those drugs that may not be marketed without NDAs or ANDAs because they are not covered under existing OTC monographs; drug products with approval under Section 505 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) administered by the Center for Biologics Evaluation and Research; and approved products that have never been marketed, are for exportation, are for military use, have been discontinued from marketing and we have not determined that they were withdrawn for safety or effectiveness reasons, or that have had their approvals withdrawn for other than safety or efficacy reasons. The Cumulative Supplement provides, among other things, information on newly approved drugs and, if necessary, revised therapeutic equivalence evaluations and updated patent and exclusivity data. The Addendum contains appropriate drug patent and exclusivity information required of the Agency by the "Drug Price Competition and Patent Term Restoration Act of 1984" for the Prescription, OTC, Discontinued Drug Product, and Drug Products with Approval under Section 505 of the Act Administered by the Center for Biologics Evaluation and Research Lists. Because all parts of the publication are subject to changes, additions, or deletions, the List must be used in conjunction with the most current Cumulative Supplement. Users may wish to mark to the left of the ingredient(s) in the List to indicate that changes to that entry appear in the Cumulative Supplement. Drug product information is provided in each Cumulative Supplement for completeness to assist in locating the proper place in the List for the revision. The presence of any therapeutic equivalence code indicates that the drug product is multisource; the deletion of a therapeutic equivalence code indicates that the drug product has become single source. (An infrequent exception exists when a therapeutic equivalence code is revised. In that case, the deletion of the therapeutic equivalence code is followed immediately by the addition of the revised one.) v

Products that have never been marketed, are for exportation, are for military use, have been discontinued from marketing and we have not determined that they were withdrawn for safety or effectiveness reasons or that have had their approvals withdrawn for other than safety or efficacy reasons, will be flagged in this Cumulative Supplement with the "@" symbol to designate their non-marketed status. All products having a "@" symbol in the 12th Cumulative Supplement of this Edition List will then be added to the "Discontinued Drug Product List" appearing in the next Edition. The current Annual Edition Section 2., How To Use The Drug Product Lists, describes the layout and usage of the List.

1.1 HOW TO USE THE CUMULATIVE SUPPLEMENT

New additions to the Prescription Drug Product List and OTC Drug Product List are indicated by the symbol >A>. The Patent and Exclusivity List new additions are indicated by the symbol >A> to the left of Patent Number or Exclusivity Code. The >A> symbol is then dropped in subsequent Cumulative Supplements for that item. New deletions to the Prescription Drug Product List and OTC Drug Product List are indicated by the symbol >D> (DELETE) to the left of the line. The information line with the >D> symbol is dropped in subsequent Cumulative Supplements for that item. The Patent and Exclusivity List is arranged in alphabetical order by active ingredient name(s) and trade name. The trade name will follow the active ingredient name separated by a dash symbol. Also shown is the application number and product number (FDA's internal file number) for reference purposes. All patents with their expiration dates are displayed for each application number. Drug substance and drug product patents are indicated as such with DS or DP in the Patent codes column. Use patents are indicated with the symbol "U" followed by a number representing a specific use. Exclusivity information for a specific drug is indicated by an abbreviation followed by the date upon which the exclusivity expires. Refer to the Exclusivity Terms, Section B, in the Patent and Exclusivity Information Addendum for an explanation of all codes and abbreviations. Refer to Section 1.3 for internet access to the most current list of Patent and Exclusivity terms.

1.2 CUMULATIVE SUPPLEMENT CONTENT

Since February 2005, we have been providing daily Electronic Orange Book (EOB) product information for new generic drug approvals. Daily generic updates provide the consumer with the current list of approved generic products which is important for substitution purposes. Previously, a first-time-generic product approved early in the month would not be published in the Cumulative Supplement (CS) for several weeks.

The CS monthly update publish goal is by the end of the following month’s second work week (e.g., November’s supplement will be updated by the end of the second full work week in December).

Currently, the monthly PDF CS includes:

• Generic product ANDA (Abbreviated New Drug Approval) approvals as of the date of publication.

vi

• All product changes received and processed as of the date of publication. o Refer to CS Section 1.7 Cumulative Supplement Legend for types of changes

• New Drug Application (NDA) approvals appear in the CS month they were approved.

• Patent information, also updated daily in the EOB, is current to the date of publication.

• Exclusivity information is updated monthly and is current as of the date of publication.

Every effort is made to ensure the Cumulative Supplement is accurate. Applicant holders are requested to inform the FDA Orange Book Staff (OBS) of any changes or corrections. The OBS can be contacted by email at [email protected].

1.3 APPLICANT NAME CHANGES

It is not practical to identify in the Cumulative Supplement each product involved when an applicant transfers its entire line of approved drug products to another applicant, or when an applicant changes its name. Therefore, the cumulation of these transfers and name changes will be identified in this section only. Where only partial lines of approved products are transferred between applicants, each approved product involved will appear as an applicant name change entry in the Cumulative Supplement.

It is also not practical to identify each, and every product involved when an applicant name is changed to meet internal publication standards (e.g., MSD or Zenith [Former Abbreviated Names] are changed, respectively to Merck Sharp Dohme or Zenith Labs [New Abbreviated Names]). When this occurs, each product involved (either currently in the Cumulative Supplement or in the following year's edition) will reflect the new abbreviated name. Consequently, it will not appear as an applicant name change entry in the Cumulative Supplement nor will the cumulation of these name changes appear in this section. The Electronic Orange Book Query, updated monthly, will contain the most current applicant holder name.

FORMER APPLICANT NAME NEW APPLICANT NAME (FORMER ABBREVIATED NAME) (NEW ABBREVIATED NAME)

ACP NIMBLE BUYER INC COSETTE PHARMACEUTICALS INC (ACP NIMBLE) (COSETTE)

AMNEAL PHARMACEUTICALS CO GMBH AMNEAL EU LTD (AMNEAL PHARMS CO) (AMNEAL EU)

AMERICAN ANTIBIOTICS INC BELCHER PHARMACEUTICALS INC (AM ANTIBIOTICS) (BELCHER PHARMS)

vii

AMERICAN ANTIBIOTICS LLC BELCHER PHARMACEUTICALS INC (AM ANTIBIOTICS) (BELCHER PHARMS)

ANDA REPOSITORY LLC PHARMACEUTICS INTERNATIONAL INC (ANDA REPOSITORY) (PII)

LUITPOLD PHARMACEUTICALS INC AMERICAN REGENT INC (LUITPOLD) (AM REGENT)

LUPIN ATLANTIS HOLDINGS SA LUPIN INC (LUPIN ATLANTIS) (LUPIN)

SHIRE DEVELOPMENT INC TAKEDA PHARMACEUTICALS USA INC (SHIRE) (TAKEDA PHARMS USA)

SHIRE DEVELOPMENT LLC TAKEDA PHARMACEUTICALS USA INC (SHIRE DEV LLC) (TAKEDA PHARMS USA)

SHIRE DEVELOPMENT LLC TAKEDA PHARMACEUTICALS USA INC (SHIRE LLC) (TAKEDA PHARMS USA)

SUVEN LIFE SCIENCES LTD SUVEN PHARMACEUTICALS LTD (SUVEN LIFE) (SUVEN PHARMS)

1.4 LEVOTHYROXINE SODIUM1

Because there are multiple reference listed drugs for levothyroxine sodium tablets and some reference listed drugs' sponsors have conducted studies to establish their drugs' therapeutic equivalence to other reference listed drugs, FDA has determined that its usual practice of assigning two or three character therapeutic equivalence codes may be potentially confusing and inadequate for these drug products. Looking at the Orange Book listing alone for a product identified as a reference listed drug or reference standard, it may be difficult to determine to which therapeutic equivalence code the reference listed drugs and/or reference standard designation corresponds. For example, Unithroid 0.3 mg strength has been assigned the therapeutic equivalence codes AB1, AB2, and AB3 and it is identified as the reference listed drug and reference standard, but it is unclear that the reference listed drug and reference standard designations are associated with the AB1 therapeutic equivalence code.

Accordingly, FDA provides the following chart, which identifies (1) a reference listed drug for each therapeutic equivalence code in the Orange Book and (2) and the reference standard products in the Active Section of the Orange Book.2

• Therapeutic equivalence has been established between products that have the same AB+number therapeutic equivalence code (i.e. AB1, AB2, AB3 or AB4).

1 In previous editions of the Orange Book, FDA provided a chart outlining therapeutic equivalence codes for all .025 mg levothyroxine sodium drug products in the Active Section of the Orange Book. FDA has decided, for ease of review, to revise the chart to identify the NDAs for the reference listed drugs for each therapeutic equivalence code (i.e., AB1, AB2, AB3, and AB4), and their corresponding reference standards, which are identified in 0.2 and 0.3 mg strengths. 2 Please consult the Active Section of the Orange Book for information on other strengths.

viii

• More than one therapeutic equivalence code may apply to some products. One common therapeutic equivalence code indicates therapeutic equivalence between products. For example, Unithroid has been assigned therapeutic equivalence codes AB1, AB2, and AB3 therefore Unithroid tablets are considered therapeutically equivalent to other levothyroxine sodium products of the same strength with these therapeutic equivalence codes.

Appl TE Code Proprietary Name Applicant Strength RLD RS No AB1 UNITHROID STEVENS J 0.3MG N021210 RLD RS

AB2 SYNTHROID ABBVIE 0.3MG N021402 RLD RS

KING AB3 LEVOXYL 0.2MG N021301 RLD RS PHARMS

ALVOGEN GROUP AB4 THYRO-TABS 0.3MG N021116 RLD − HOLDINGS 4 LLC AB4 LEVOTHYROXINE SODIUM3 MYLAN 0.3MG A076187 − RS

1.5 AVAILABILITY OF THE EDITION

Since 1997, the Electronic Orange Book Query (EOBQ) http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm, has been available on the internet and has become the updated-every-month Orange Book. The Query provides searching of the approved drug list by active ingredient, proprietary name, applicant holder, applicant number or patent number. Product search categories are: prescription, over-the-counter, discontinued drugs. There are links to patent and exclusivity information that may be applicable to each product.

Commencing with the 25th edition, the Annual Edition and monthly Cumulative Supplements have been provided in downloadable Portable Document Format (PDF) at the EOB home page by clicking on Publications. The PDF annual and cumulative supplements duplicate previous paper

3 Lloyd’s Thyro-Tabs tablets (NDA 021116) (previously known as Levothroid) previously was listed in the Discontinued Drug Product List section of the Orange Book. It is the RLD for therapeutic equivalents identified with the AB4 code. During this time, Mylan’s levothyroxine product (ANDA 076187) was selected as the reference standard for ANDA applicants to use to establish bioequivalence to Thyro-Tabs. It remains the reference standard for ANDA applicants to use to establish bioequivalence to Thyro-Tabs. If an ANDA that uses Mylan’s levothyroxine product as its reference standard is approved, the ANDA will receive an AB4 rating. The ANDA applicant also may obtain an AB rating for its product to the other reference listed drugs (i.e., Unithroid, Synthroid, and Levoxyl) by submitting supplements that demonstrate that the generic product is bioequivalent to these other reference listed drugs and satisfies all other therapeutic equivalence criteria with respect to these reference listed drugs. See Letter from Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research, FDA to Teri Nataline, Principal Consultant, Lachman Consultant Services, Inc., Docket No. FDA-2015-P-0403 (May 27, 2016). ix

versions. Over time, there will be an archive for the annuals and each year's December Cumulative Supplement.

The downloaded Annual Edition and Cumulative Supplements are also available in a paper version (Approved Drug Products with Therapeutic Equivalence Evaluations, ADP) from the U.S. Government Printing Office: http://bookstore.gpo.gov; toll free 866-512-1800.

There are historical lists of Orange Book cumulative supplement product monthly changes at http://www.fda.gov/Drugs/InformationOnDrugs/ucm086229.htm. There are ASCII text files of the Orange Book drug product, patent, and exclusivity data at http://www.fda.gov/Drugs/InformationOnDrugs/ucm129689.htm. The drug product text files are provided in eobzip.zip format. The files are updated concurrently with the monthly cumulative supplements. The annual Orange Book Edition Appendices A, B, and C in PDF format are updated quarterly.

Effective August 18, 2003, patent submissions for publication in the Orange Book and Docket *95S-0117 need to be submitted on form FDA-3542 which may be downloaded from the FDA Forms List, Effective August 18, 2003, patent submissions for publication in the Orange Book and Docket *95S-0117 need to be submitted on form FDA-3542 which may be downloaded from the FDA Forms List, https://www.fda.gov/about-fda/reports-manuals-forms/forms.

The current listing of the Orphan Product Designations and Approvals is available at https://www.fda.gov/industry/developing-products-rare- diseases-conditions/designating-orphan-product-drugs-and-biological- products.

1.6 REPORT OF COUNTS FOR THE PRESCRIPTION DRUG PRODUCT LIST

DESCRIPTION OF REPORT

This report provides summary counts derived from the product information in the Prescription Drug Product List and the current Cumulative Supplement. Products included in the counts are domestically marketed drug products approved for both safety and effectiveness under section 505 of the Federal Food, Drug, and Cosmetic Act. Excluded are approved drug products marketed by distributors; those marketed solely abroad; and those now regarded as medical devices, biologics or foods.

The baseline column (December of the previous Annual Edition) refers to the products in the Prescription Drug Product List. For each three-month period, a column of quarterly data is added which incorporates counts of product activity from the previous quarter(s) with those in the baseline count.

DEFINITIONS

Drug Product

For this report, a drug product is the representation in the Prescription Drug Product List of an active moiety (molecular entity and its salts, esters and derivatives) either as a single ingredient or as a combination product provided in a specific dosage form and strength for a given route x

of administration with approval for marketing by a firm under a particular generic or trade name.

New Molecular Entity

A new molecular entity is considered an active moiety that has not previously been approved (either as the parent compound or as a salt, ester or derivative of the parent compound) in the United States for use in a drug product either as a single ingredient or as part of a combination.

REPORT OF COUNTS FOR THE PRESCRIPTION DRUG PRODUCT LIST COUNTS CUMULATIVE BY QUARTER

CATEGORIES DEC MAR JUN SEP DEC COUNTED 2019 2020 2020 2020 2020

DRUG PRODUCTS 20567 20367 20382 20495 LISTED SINGLE 2743 2635 2660 2652 SOURCE (13.3%) (12.9%) (13.1%) (12.9%)

MULTISOURCE 17824 17732 17722 17843

(86.7%) (87.1%) (86.9%) (87.1%)

THERAPEUTICALLY 17740 17659 17649 17770 EQUIVALENT (86.3%) (86.7%) (86.6%) (86.7%) NOT 84 73 73 73 THERAPEUTICALLY (0.4%) (0.4%) (0.4%) (0.4%) EQUIVALENT EXCEPTIONS4 54 54 54 54 (0.3%) (0.3%) (0.3%) (0.3%) NEW MOLECULAR ENTITIES 17 24 25 12 APPROVED NUMBER OF 1162 1166 1189 1175 APPLICANTS

1.7 CUMULATIVE SUPPLEMENT LEGEND

The List is sorted by Ingredient(s) and, within each grouping, by the Dosage Form; Route of Administration and then by trade name (or established name of the active ingredient, if no trade name exists).

The individual product record contains the Therapeutic Equivalence Code, Reference Listed Drug symbol, Reference Standard symbol, applicant holder, strength(s), New Drug Application number, product number, and approval date. The application number preceded by “N” is a New Drug Application (NDA or innovator). The application number preceded by an “A” is an Abbreviated New Drug Application (ANDA or generic). The last two columns describe the action. The Action Month is the CS month the action occurred. The OB Action is the type of change that has occurred.

New ingredient(s), new dosage form, new route(s) of administration, new trade names, and new product additions are preceded by >A> during the action month. The change month is the current CS month; the change code

4 Amino acid containing products of varying composition (see Introduction, page xx of the List). xi

for new approvals is NEWA. Following months will display the same information without the >A>.

Changes to currently listed products will list two records. The deleted product record will be proceeded by >D>. The product record change addition being made will be preceded by >A>. Following months will display only the >A> record without the >A>. All changes that occur to the product through the Annual year will be listed. The change month and change code will document the change.

The change code and description: NEWA New drug product approval NFTG New first-time generic approval CAHN5 Applicant holder firm name has changed CAIN Change. There has been a change in the Ingredient(s) name. All products will be deleted under the old name and all products will be added under the changed ingredient(s) name. CDFR Change. Dosage Form; Route of Administration CFTG Change. A TE Code is added when a first time generic for an innovator is approved. CMFD Change. The product is moved from the Discontinued Section due to a change in marketing status. CMS1 Change. Miscellaneous addition to list. CMS2 Change. Miscellaneous deletion from list. CPOT Change. Potency amount/unit. CRLD Change. Reference Listed Drug CHRS Change. Reference Standard CTEC Change. Therapeutic Equivalence Code CTNA Change. Trade Name DISC Discontinued. The Rx or OTC listed product is not being marketed and will appear in the discontinued section in the next edition.

5 The Cumulative Supplement (CS) currently displays a condensed 20 character collapsed applicant holder firm name and the Electronic Orange Book (EOB) query may display up to a 250-character full applicant holder firm name. An applicant holder firm name change usually changes both the collapsed name and long name. On occasion, only the long name is changed resulting in the CS displaying only the collapsed name for the >D> and >A> action. The new firm long name will display in the EOB query.

xii

PRESCRIPTION DRUG PRODUCT LIST - 40TH EDITION RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -1

ABACAVIR SULFATE TABLET;ORAL ABACAVIR SULFATE @ APOTEX INC EQ 300MG BASE A 201570 001 Dec 17, 2012 Aug DISC

ABAMETAPIR LOTION;TOPICAL XEGLYZE +! DR REDDYS LABS SA 0.74% N 206966 001 Jul 24, 2020 Jul NEWA

ABIRATERONE ACETATE TABLET;ORAL ABIRATERONE ACETATE AB DR REDDYS LABS LTD 250MG A 208416 001 May 18, 2020 May NEWA

ACARBOSE TABLET;ORAL ACARBOSE @ EMCURE PHARMS LTD 25MG A 202271 001 Feb 07, 2012 Mar DISC @ 50MG A 202271 002 Feb 07, 2012 Mar DISC @ 100MG A 202271 003 Feb 07, 2012 Mar DISC AB HANGZHOU ZHONGMEI 25MG A 213821 001 Aug 18, 2020 Aug NEWA AB 50MG A 213821 002 Aug 18, 2020 Aug NEWA AB 100MG A 213821 003 Aug 18, 2020 Aug NEWA

ACETAMINOPHEN SOLUTION;INTRAVENOUS ACETAMINOPHEN AP MYLAN 1GM/100ML (10MG/ML) A 213255 001 Aug 07, 2020 Jul NEWA

ACETAMINOPHEN; BUTALBITAL TABLET;ORAL BUTALBITAL AND ACETAMINOPHEN AA ! LGM PHARMA 300MG;50MG A 090956 001 Aug 23, 2011 Aug CAHN

ACETAMINOPHEN; BUTALBITAL; CAFFEINE CAPSULE;ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE AA ! LGM PHARMA 300MG;50MG;40MG A 040885 001 Nov 16, 2009 Aug CAHN AA TARO PHARM INDS LTD 300MG;50MG;40MG A 213046 001 Jul 01, 2020 Jun NEWA TABLET;ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE @ HIKMA PHARMS 325MG;50MG;40MG A 089718 001 Jun 12, 1995 Feb DISC AA LGM PHARMA 325MG;50MG;40MG A 209587 001 Oct 31, 2018 Aug CAHN AA NESHER PHARMS 325MG;50MG;40MG A 211543 001 Jul 17, 2020 Jul NEWA @ SPECGX LLC 325MG;50MG;40MG A 087804 001 Jan 24, 1985 May DISC >A> AA STRIDES PHARMA 325MG;50MG;40MG A 203647 001 Sep 21, 2020 Sep NEWA

ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE;ORAL BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE LGM PHARMA 300MG;50MG;40MG;30MG A 076560 002 Jul 19, 2012 Aug CAHN AB 325MG;50MG;40MG;30MG A 076560 001 Jun 10, 2004 Aug CAHN AB STRIDES PHARMA 325MG;50MG;40MG;30MG A 204649 001 Jul 08, 2020 Jul NEWA

ACETAMINOPHEN; CODEINE PHOSPHATE SOLUTION;ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE >D> AA WOCKHARDT BIO AG 120MG/5ML;12MG/5ML A 087006 001 Sep DISC >A> @ 120MG/5ML;12MG/5ML A 087006 001 Sep DISC TABLET;ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE >A> AA NOSTRUM LABS INC 300MG;15MG A 088627 001 Mar 06, 1985 Sep CAHN >A> AA 300MG;30MG A 088628 001 Mar 06, 1985 Sep CAHN >A> AA ! 300MG;60MG A 088629 001 Mar 06, 1985 Sep CAHN >D> AA TEVA 300MG;15MG A 088627 001 Mar 06, 1985 Sep CAHN >D> AA 300MG;30MG A 088628 001 Mar 06, 1985 Sep CAHN >D> AA ! 300MG;60MG A 088629 001 Mar 06, 1985 Sep CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -2

ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET;ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN @ ACTAVIS LABS FL INC 300MG;5MG A 206470 001 Jun 02, 2016 Feb DISC @ 300MG;7.5MG A 206470 002 Jun 02, 2016 Feb DISC @ 300MG;10MG A 206470 003 Jun 02, 2016 Feb DISC >A> @ CEROVENE INC 325MG;5MG A 211690 001 Feb 07, 2020 Sep CAHN >A> @ 325MG;7.5MG A 211690 002 Feb 07, 2020 Sep CAHN >A> @ 325MG;10MG A 211690 003 Feb 07, 2020 Sep CAHN @ GRANULES PHARMS 325MG;5MG A 211729 001 Jan 03, 2020 Jun DISC @ 325MG;7.5MG A 211729 002 Jan 03, 2020 Jun DISC @ 325MG;10MG A 211729 003 Jan 03, 2020 Jun DISC @ PAR PHARM 300MG;5MG A 205001 001 Jul 05, 2016 May DISC @ 300MG;7.5MG A 205001 002 Jul 05, 2016 May DISC @ 300MG;10MG A 205001 003 Jul 05, 2016 May DISC >D> AA VINTAGE PHARMS 300MG;5MG A 090415 001 Jan 24, 2011 Sep DISC >A> @ 300MG;5MG A 090415 001 Jan 24, 2011 Sep DISC >D> AA 300MG;7.5MG A 090415 002 Jan 24, 2011 Sep DISC >A> @ 300MG;7.5MG A 090415 002 Jan 24, 2011 Sep DISC >D> AA 300MG;10MG A 090415 003 Jan 24, 2011 Sep DISC >A> @ 300MG;10MG A 090415 003 Jan 24, 2011 Sep DISC >D> @ XIROMED 325MG;5MG A 211690 001 Feb 07, 2020 Sep CAHN @ 325MG;5MG A 211690 001 Feb 07, 2020 Mar DISC AA 325MG;5MG A 211690 001 Feb 07, 2020 Feb CAHN AA 325MG;5MG A 211690 001 Feb 07, 2020 Jan NEWA >D> @ 325MG;7.5MG A 211690 002 Feb 07, 2020 Sep CAHN @ 325MG;7.5MG A 211690 002 Feb 07, 2020 Mar DISC AA 325MG;7.5MG A 211690 002 Feb 07, 2020 Feb CAHN AA 325MG;7.5MG A 211690 002 Feb 07, 2020 Jan NEWA >D> @ 325MG;10MG A 211690 003 Feb 07, 2020 Sep CAHN @ 325MG;10MG A 211690 003 Feb 07, 2020 Mar DISC AA 325MG;10MG A 211690 003 Feb 07, 2020 Feb CAHN AA 325MG;10MG A 211690 003 Feb 07, 2020 Jan NEWA

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE SOLUTION;ORAL OXYCODONE AND ACETAMINOPHEN MIKART INC 300MG/5ML;10MG/5ML A 202142 001 Nov 27, 2018 Feb CMFD TABLET;ORAL OXYCODONE AND ACETAMINOPHEN >A> @ CEROVENE INC 325MG;5MG A 207574 001 Dec 13, 2016 Sep CAHN @ GRANULES PHARMS 325MG;2.5MG A 211708 001 Oct 31, 2019 May DISC @ 325MG;5MG A 211708 002 Oct 31, 2019 May DISC @ 325MG;7.5MG A 211708 003 Oct 31, 2019 May DISC @ 325MG;10MG A 211708 004 Oct 31, 2019 May DISC @ WATSON LABS 325MG;5MG A 040171 001 Oct 30, 1997 Apr DISC @ 325MG;7.5MG A 040535 001 Sep 05, 2003 Apr DISC @ 325MG;10MG A 040535 002 Sep 05, 2003 Apr DISC >D> @ XIROMED 325MG;5MG A 207574 001 Dec 13, 2016 Sep CAHN @ 325MG;5MG A 207574 001 Dec 13, 2016 Mar DISC

ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE TABLET;ORAL TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN @ APOTEX 325MG;37.5MG A 078778 001 Apr 07, 2014 Feb DISC @ GRAVITI PHARMS 325MG;37.5MG A 076914 001 Jul 26, 2006 Apr CAHN @ MACLEODS PHARMS LTD 325MG;37.5MG A 206885 001 May 02, 2017 May DISC @ NOSTRUM LABS INC 325MG;37.5MG A 078778 001 Apr 07, 2014 Apr CAHN @ RISING 325MG;37.5MG A 076914 001 Jul 26, 2006 Aug CAHN

ACETAZOLAMIDE CAPSULE, EXTENDED RELEASE;ORAL ACETAZOLAMIDE >A> AB MICRO LABS LTD INDIA 500MG A 207401 001 Oct 01, 2020 Sep NEWA TABLET;ORAL ACETAZOLAMIDE AB BRECKENRIDGE 125MG A 207503 001 Apr 30, 2020 Apr NEWA AB 250MG A 207503 002 Apr 30, 2020 Apr NEWA >A> MANKIND PHARMA 125MG A 214282 001 Oct 07, 2020 Sep NEWA >A> 250MG A 214282 002 Oct 07, 2020 Sep NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -3

ACETAZOLAMIDE SODIUM INJECTABLE;INJECTION ACETAZOLAMIDE SODIUM AP ! XGEN PHARMS EQ 500MG BASE/VIAL A 040784 001 Dec 10, 2008 Feb CAHN

ACETIC ACID, GLACIAL SOLUTION/DROPS;OTIC ACETIC ACID AT SAPTALIS PHARMS 2% A 040607 001 Feb 24, 2005 Mar CAHN

ACETIC ACID, GLACIAL; HYDROCORTISONE SOLUTION/DROPS;OTIC HYDROCORTISONE AND ACETIC ACID AT COSETTE 2%;1% A 040609 001 Feb 06, 2006 May CAHN

ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE CAPSULE;ORAL SEMPREX-D + @ AUXILIUM PHARMS LLC 8MG;60MG N 019806 001 Mar 25, 1994 Aug DISC

ACYCLOVIR CAPSULE;ORAL ACYCLOVIR @ DAVA PHARMS INC 200MG A 074833 001 Apr 22, 1997 May DISC >A> AB YILING 200MG A 212173 001 Sep 14, 2020 Sep NEWA CREAM;TOPICAL ACYCLOVIR AB ! PERRIGO UK FINCO 5% A 208702 001 Feb 04, 2019 Jan CHRS ZOVIRAX AB + BAUSCH 5% N 021478 001 Dec 30, 2002 Jan CHRS OINTMENT;TOPICAL ACYCLOVIR >A> AB ANDA REPOSITORY 5% A 206437 001 Jul 31, 2017 Sep CAHN AB SOLARIS PHARMA CORP 5% A 212495 001 Apr 07, 2020 Mar NEWA >D> AB TOLMAR 5% A 206437 001 Jul 31, 2017 Sep CAHN AB XIROMED 5% A 201501 001 Jan 29, 2020 Jan NEWA SUSPENSION;ORAL ACYCLOVIR AB HERITAGE PHARMS INC 200MG/5ML A 212718 001 Apr 23, 2020 Apr NEWA AB NOVITIUM PHARMA 200MG/5ML A 212252 001 Jul 10, 2020 Jul NEWA TABLET;ORAL ACYCLOVIR AB ! HETERO LABS LTD V 800MG A 203834 002 Oct 29, 2013 Jan CHRS ZOVIRAX + MYLAN@ 400MG N 020089 001 Apr 30, 1991 Jan DISC + @ 800MG N 020089 002 Apr 30, 1991 Jan DISC

ACYCLOVIR SODIUM INJECTABLE;INJECTION ACYCLOVIR SODIUM AP EXELA PHARMA EQ 50MG BASE/ML A 207919 001 Jun 17, 2020 Jun NEWA

ADAPALENE GEL;TOPICAL ADAPALENE AB ALEOR DERMACEUTICALS 0.3% A 213508 001 Jun 18, 2020 Jun NEWA

ADENOSINE INJECTABLE;INJECTION ADENOSINE @ MYLAN LABS LTD 3MG/ML A 078640 001 Mar 21, 2014 Apr DISC

AIR POLYMER-TYPE A FOAM;INTRAUTERINE EXEM FOAM KIT + @ GISKIT 10ML N 212279 001 Nov 07, 2019 Jul CAHN + @ 10ML N 212279 001 Nov 07, 2019 Jul CAHN + @ 10ML N 212279 001 Nov 07, 2019 Jun DISC

RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -4

ALBENDAZOLE TABLET;ORAL ALBENDAZOLE AB LUPIN LTD 200MG A 211636 001 Jun 10, 2020 Jun NEWA

ALBUTEROL SULFATE AEROSOL, METERED;INHALATION ALBUTEROL SULFATE AB1 CIPLA EQ 0.09MG BASE/INH A 209959 001 Apr 08, 2020 Mar NFTG >A> AB2 LUPIN EQ 0.09MG BASE/INH A 209954 001 Aug 24, 2020 Sep CAHN >D> AB2 LUPIN ATLANTIS EQ 0.09MG BASE/INH A 209954 001 Aug 24, 2020 Sep CAHN AB2 EQ 0.09MG BASE/INH A 209954 001 Aug 24, 2020 Aug NEWA AB2 PERRIGO PHARMS CO EQ 0.09MG BASE/INH A 203760 001 Feb 24, 2020 Mar CTEC AB EQ 0.09MG BASE/INH A 203760 001 Feb 24, 2020 Feb NFTG PROAIR HFA AB2 +! TEVA BRANDED PHARM EQ 0.09MG BASE/INH N 021457 001 Oct 29, 2004 Mar CTEC AB +! EQ 0.09MG BASE/INH N 021457 001 Oct 29, 2004 Feb CFTG PROVENTIL-HFA AB1 +! 3M DRUG DELIVERY EQ 0.09MG BASE/INH N 020503 001 Aug 15, 1996 Mar CFTG AB1 +! KINDEVA EQ 0.09MG BASE/INH N 020503 001 Aug 15, 1996 May CAHN SOLUTION;INHALATION ALBUTEROL SULFATE AN AUROBINDO PHARMA LTD EQ 0.021% BASE A 211888 001 Apr 20, 2020 Apr NEWA AN EQ 0.042% BASE A 211888 002 Apr 20, 2020 Apr NEWA @ BAUSCH AND LOMB EQ 0.5% BASE A 075050 001 Jun 18, 1998 Feb DISC AN ! NEPHRON EQ 0.5% BASE A 075664 001 Jun 26, 2001 Feb CHRS SYRUP;ORAL ALBUTEROL SULFATE @ VISTAPHARM EQ 2MG BASE/5ML A 077788 001 Jun 26, 2007 Jul DISC TABLET;ORAL ALBUTEROL SULFATE @ ARISE EQ 2MG BASE A 210948 001 Mar 15, 2019 Jul DISC @ EQ 4MG BASE A 210948 002 Mar 15, 2019 Jul DISC AB AUROBINDO PHARMA LTD EQ 2MG BASE A 213657 001 May 14, 2020 May NEWA AB EQ 4MG BASE A 213657 002 May 14, 2020 May NEWA AB RISING EQ 2MG BASE A 207046 001 Jun 29, 2018 Jul CAHN AB EQ 4MG BASE A 207046 002 Jun 29, 2018 Jul CAHN TABLET, EXTENDED RELEASE;ORAL VOLMAX + @ MURO EQ 4MG BASE N 019604 002 Dec 23, 1992 Mar CRLD + @ EQ 8MG BASE N 019604 001 Dec 23, 1992 Mar CRLD

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE SOLUTION;INHALATION ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE AN AUROBINDO PHARMA LTD EQ 0.083% BASE;0.017% A 206532 001 Jul 08, 2020 Jul NEWA @ WATSON LABS TEVA EQ 0.083% BASE;0.017% A 077063 001 Dec 31, 2007 Apr DISC

ALOSETRON HYDROCHLORIDE TABLET;ORAL ALOSETRON HYDROCHLORIDE @ EYWA PHARMA EQ 0.5MG BASE A 211621 001 Sep 16, 2019 Apr DISC @ EQ 1MG BASE A 211621 002 Sep 16, 2019 Apr DISC AB MANKIND PHARMA EQ 0.5MG BASE A 213614 001 Sep 09, 2020 Aug NEWA AB EQ 1MG BASE A 213614 002 Sep 09, 2020 Aug NEWA

ALPRAZOLAM TABLET;ORAL ALPRAZOLAM @ DAVA INTL INC 0.25MG A 074174 001 Oct 19, 1993 Feb DISC @ 0.5MG A 074174 002 Oct 19, 1993 Feb DISC @ 1MG A 074174 003 Oct 19, 1993 Feb DISC @ 2MG A 074174 004 Oct 19, 1993 Feb DISC @ OXFORD PHARMS 0.25MG A 078491 001 Sep 25, 2008 Jun DISC @ 0.5MG A 078491 002 Sep 25, 2008 Jun DISC @ 1MG A 078491 003 Sep 25, 2008 Jun DISC @ 2MG A 078491 004 Dec 12, 2008 Jun DISC XANAX AB + UPJOHN 0.25MG N 018276 001 Apr CAHN AB + 0.5MG N 018276 002 Apr CAHN AB +! 1MG N 018276 003 Apr CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -5

TABLET;ORAL XANAX AB + 2MG N 018276 004 Nov 27, 1985 Apr CAHN TABLET, EXTENDED RELEASE;ORAL XANAX XR AB + UPJOHN 0.5MG N 021434 001 Jan 17, 2003 Apr CAHN AB + 1MG N 021434 002 Jan 17, 2003 Apr CAHN AB + 2MG N 021434 003 Jan 17, 2003 Apr CAHN AB +! 3MG N 021434 004 Jan 17, 2003 Apr CAHN

ALVIMOPAN CAPSULE;ORAL ALVIMOPAN @ WATSON LABS TEVA 12MG A 208295 001 Dec 19, 2019 Jun DISC ENTEREG +! CUBIST PHARMS 12MG N 021775 001 May 20, 2008 Jun CTEC

AMANTADINE HYDROCHLORIDE CAPSULE;ORAL AMANTADINE HYDROCHLORIDE AB ! BIONPHARMA INC 100MG A 078720 001 May 29, 2008 Jun CHRS >D> AB INVATECH 100MG A 210129 001 Mar 02, 2020 Sep CAHN AB 100MG A 210129 001 Mar 02, 2020 Feb NEWA >A> AB NOVELGENIX THERAPS 100MG A 210129 001 Mar 02, 2020 Sep CAHN AB RUBICON 100MG A 212044 001 May 21, 2020 May NEWA AB SANDOZ 100MG A 071293 001 Feb 18, 1987 Jun CHRS TABLET;ORAL AMANTADINE HYDROCHLORIDE >D> AB INVATECH 100MG A 210215 001 Mar 10, 2020 Sep CAHN AB 100MG A 210215 001 Mar 10, 2020 Feb NEWA >A> AB NOVELGENIX THERAPS 100MG A 210215 001 Mar 10, 2020 Sep CAHN TABLET, EXTENDED RELEASE;ORAL OSMOLEX ER >D> + OSMOTICA PHARM EQ 161MG BASE N 209410 004 Apr 22, 2020 Sep DISC >A> + @ EQ 161MG BASE N 209410 004 Apr 22, 2020 Sep DISC + EQ 161MG BASE N 209410 004 Apr 22, 2020 Apr NEWA

AMIKACIN SULFATE INJECTABLE;INJECTION AMIKACIN SULFATE AP TEVA PHARMS USA EQ 250MG BASE/ML A 064045 002 Sep 28, 1993 Mar CMFD

AMILORIDE HYDROCHLORIDE TABLET;ORAL AMILORIDE HYDROCHLORIDE >A> AB ANDA REPOSITORY 5MG A 204180 001 Aug 07, 2015 Sep CAHN >D> AB WINDLAS HLTHCARE 5MG A 204180 001 Aug 07, 2015 Sep CAHN

AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL EMULSION;INTRAVENOUS PERIKABIVEN IN PLASTIC CONTAINER +! FRESENIUS KABI USA 2.4%;20MG/100ML;6.8GM/100ML;68MG/1 N 200656 003 Aug 25, 2014 Jan CHRS 00ML;124MG/100ML;170MG/100ML ;105MG/100ML;3.5GM/100ML (2400ML)

AMINOCAPROIC ACID SYRUP;ORAL AMINOCAPROIC ACID AA TULEX PHARMS INC 1.25GM/5ML A 212494 001 Aug 11, 2020 Jul NEWA AA VISTAPHARM 1.25GM/5ML A 212814 001 Feb 26, 2020 Feb NEWA

AMIODARONE HYDROCHLORIDE TABLET;ORAL AMIODARONE HYDROCHLORIDE AB UNICHEM 200MG A 213446 001 Jul 21, 2020 Jul NEWA AB ! UPSHER SMITH LABS 200MG A 075315 001 Dec 23, 1998 Aug CAHN AB 400MG A 075315 002 Jun 30, 2000 Aug CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -6

AMISULPRIDE SOLUTION;INTRAVENOUS BARHEMSYS +! ACACIA 5MG/2ML (2.5MG/ML) N 209510 001 Feb 26, 2020 Feb NEWA >A> +! 10MG/4ML (2.5MG/ML) N 209510 002 Sep 01, 2020 Sep NEWA

AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL AMITRIPTYLINE HYDROCHLORIDE AB SANDOZ 10MG A 085968 004 Jan CMS1 AB ! 25MG A 085968 002 Jan CMS1 AB 75MG A 085968 006 Jan CMS1 AB 100MG A 085968 003 Jan CMS1 AB 150MG A 085968 005 Jan CMS1 @ UPSHER SMITH LABS 25MG A 212654 001 Apr 07, 2020 May DISC AB 25MG A 212654 001 Apr 07, 2020 Mar NEWA

AMLODIPINE BENZOATE SUSPENSION;ORAL KATERZIA +! AZURITY EQ 1MG BASE/ML N 211340 001 Jul 08, 2019 May CAHN

AMLODIPINE BESYLATE TABLET;ORAL AMLODIPINE BESYLATE >D> AB HEBEI CHANGSHAN EQ 2.5MG BASE A 076692 001 Jul 20, 2007 Sep CAHN >D> AB EQ 5MG BASE A 076692 002 Jul 20, 2007 Sep CAHN >D> AB EQ 10MG BASE A 076692 003 Jul 20, 2007 Sep CAHN HI KMA@ HIKMA@ EQ 2.5MG BASE A 077262 001 Jul 09, 2007 Feb DISC @ EQ 5MG BASE A 077262 002 Jul 09, 2007 Feb DISC @ EQ 10MG BASE A 077262 003 Jul 09, 2007 Feb DISC >D> AB HIKMA PHARMS EQ 2.5MG BASE A 077771 001 Apr 12, 2011 Sep DISC >A> @ EQ 2.5MG BASE A 077771 001 Apr 12, 2011 Sep DISC >D> AB EQ 5MG BASE A 077771 002 Apr 12, 2011 Sep DISC >A> @ EQ 5MG BASE A 077771 002 Apr 12, 2011 Sep DISC >D> AB EQ 10MG BASE A 077771 003 Apr 12, 2011 Sep DISC >A> @ EQ 10MG BASE A 077771 003 Apr 12, 2011 Sep DISC @ MACLEODS PHARMS LTD EQ 5MG BASE A 201380 001 Apr 13, 2012 May DISC @ EQ 10MG BASE A 201380 002 Apr 13, 2012 May DISC MY LAN@ MYLAN@ EQ 2.5MG BASE A 076418 001 Oct 03, 2005 Jul DISC @ EQ 5MG BASE A 076418 002 Oct 03, 2005 Jul DISC @ EQ 10MG BASE A 076418 003 Oct 03, 2005 Jul DISC @ WATSON LABS EQ 2.5MG BASE A 077671 001 Jul 19, 2007 Apr DISC @ EQ 5MG BASE A 077671 002 Jul 19, 2007 Apr DISC @ EQ 10MG BASE A 077671 003 Jul 19, 2007 Apr DISC >A> AB YILING EQ 2.5MG BASE A 076692 001 Jul 20, 2007 Sep CAHN >A> AB EQ 5MG BASE A 076692 002 Jul 20, 2007 Sep CAHN >A> AB EQ 10MG BASE A 076692 003 Jul 20, 2007 Sep CAHN NORVASC AB + UPJOHN EQ 2.5MG BASE N 019787 001 Jul 31, 1992 Jun CAHN AB + EQ 5MG BASE N 019787 002 Jul 31, 1992 Jun CAHN AB +! EQ 10MG BASE N 019787 003 Jul 31, 1992 Jun CAHN

AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TABLET;ORAL AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AB ZYDUS PHARMS EQ 2.5MG BASE;EQ 10MG BASE A 207762 001 Jan 11, 2019 Feb CMFD AB EQ 2.5MG BASE;EQ 20MG BASE A 207762 002 Jan 11, 2019 Feb CMFD AB EQ 2.5MG BASE;EQ 40MG BASE A 207762 003 Jan 11, 2019 Feb CMFD AB EQ 5MG BASE;EQ 10MG BASE A 207762 004 Jan 11, 2019 Feb CMFD AB EQ 5MG BASE;EQ 20MG BASE A 207762 005 Jan 11, 2019 Feb CMFD AB EQ 5MG BASE;EQ 40MG BASE A 207762 006 Jan 11, 2019 Feb CMFD AB EQ 5MG BASE;EQ 80MG BASE A 207762 007 Jan 11, 2019 Feb CMFD AB EQ 10MG BASE;EQ 10MG BASE A 207762 008 Jan 11, 2019 Feb CMFD AB EQ 10MG BASE;EQ 20MG BASE A 207762 009 Jan 11, 2019 Feb CMFD AB EQ 10MG BASE;EQ 40MG BASE A 207762 010 Jan 11, 2019 Feb CMFD AB EQ 10MG BASE;EQ 80MG BASE A 207762 011 Jan 11, 2019 Feb CMFD CADUET AB + PFIZER EQ 2.5MG BASE;EQ 10MG BASE N 021540 009 Jul 29, 2004 May CAHN AB + EQ 2.5MG BASE;EQ 20MG BASE N 021540 010 Jul 29, 2004 May CAHN AB + EQ 2.5MG BASE;EQ 40MG BASE N 021540 011 Jul 29, 2004 May CAHN AB + EQ 5MG BASE;EQ 10MG BASE N 021540 001 Jan 30, 2004 May CAHN

RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -7

TABLET;ORAL CADUET AB + EQ 5MG BASE;EQ 20MG BASE N 021540 002 Jan 30, 2004 May CAHN AB + EQ 5MG BASE;EQ 40MG BASE N 021540 003 Jan 30, 2004 May CAHN AB + EQ 5MG BASE;EQ 80MG BASE N 021540 004 Jan 30, 2004 May CAHN AB + EQ 10MG BASE;EQ 10MG BASE N 021540 005 Jan 30, 2004 May CAHN AB + EQ 10MG BASE;EQ 20MG BASE N 021540 006 Jan 30, 2004 May CAHN AB + EQ 10MG BASE;EQ 40MG BASE N 021540 007 Jan 30, 2004 May CAHN AB +! EQ 10MG BASE;EQ 80MG BASE N 021540 008 Jan 30, 2004 May CAHN AB + PHARMACIA EQ 2.5MG BASE;EQ 10MG BASE N 021540 009 Jul 29, 2004 Aug CAHN AB + EQ 2.5MG BASE;EQ 20MG BASE N 021540 010 Jul 29, 2004 Aug CAHN AB + EQ 2.5MG BASE;EQ 40MG BASE N 021540 011 Jul 29, 2004 Aug CAHN AB + EQ 5MG BASE;EQ 10MG BASE N 021540 001 Jan 30, 2004 Aug CAHN AB + EQ 5MG BASE;EQ 20MG BASE N 021540 002 Jan 30, 2004 Aug CAHN AB + EQ 5MG BASE;EQ 40MG BASE N 021540 003 Jan 30, 2004 Aug CAHN AB + EQ 5MG BASE;EQ 80MG BASE N 021540 004 Jan 30, 2004 Aug CAHN AB + EQ 10MG BASE;EQ 10MG BASE N 021540 005 Jan 30, 2004 Aug CAHN AB + EQ 10MG BASE;EQ 20MG BASE N 021540 006 Jan 30, 2004 Aug CAHN AB + EQ 10MG BASE;EQ 40MG BASE N 021540 007 Jan 30, 2004 Aug CAHN AB +! EQ 10MG BASE;EQ 80MG BASE N 021540 008 Jan 30, 2004 Aug CAHN

AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE CAPSULE;ORAL AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE @ PAR PHARM EQ 2.5MG BASE;10MG A 078381 001 Jul 29, 2010 May DISC @ EQ 5MG BASE;10MG A 078381 002 Jul 29, 2010 May DISC @ EQ 5MG BASE;20MG A 078381 003 Jul 29, 2010 May DISC @ EQ 5MG BASE;40MG A 078381 005 Jul 29, 2010 May DISC @ EQ 10MG BASE;20MG A 078381 004 Jul 29, 2010 May DISC @ EQ 10MG BASE;40MG A 078381 006 Jul 29, 2010 May DISC

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL TABLET;ORAL OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE AB TEVA PHARMS USA EQ 5MG BASE;12.5MG;20MG A 202491 001 Nov 03, 2016 Jul CMFD AB EQ 5MG BASE;12.5MG;40MG A 202491 002 Nov 03, 2016 Jul CMFD AB EQ 5MG BASE;25MG;40MG A 202491 003 Nov 03, 2016 Jul CMFD AB EQ 10MG BASE;12.5MG;40MG A 202491 004 Nov 03, 2016 Jul CMFD AB EQ 10MG BASE;25MG;40MG A 202491 005 Nov 03, 2016 Jul CMFD

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN TABLET;ORAL AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE AB AUROBINDO PHARMA LTD EQ 5MG BASE;12.5MG;160MG A 206180 001 Dec 19, 2017 Mar CPOT AB EQ 5MG BASE;25MG;160MG A 206180 002 Dec 19, 2017 Mar CPOT AB EQ 10MG BASE;12.5MG;160MG A 206180 003 Dec 19, 2017 Mar CPOT AB EQ 10MG BASE;25MG;160MG A 206180 004 Dec 19, 2017 Mar CPOT AB EQ 10MG BASE;25MG;320MG A 206180 005 Dec 19, 2017 Mar CPOT AB LUPIN LTD EQ 5MG BASE;12.5MG;160MG A 200797 001 Jun 03, 2015 Mar CPOT AB EQ 5MG BASE;25MG;160MG A 200797 002 Jun 03, 2015 Mar CPOT AB EQ 10MG BASE;12.5MG;160MG A 200797 003 Jun 03, 2015 Mar CPOT AB EQ 10MG BASE;25MG;160MG A 200797 004 Jun 03, 2015 Mar CPOT AB EQ 10MG BASE;25MG;320MG A 200797 005 Jun 03, 2015 Mar CPOT @ PAR PHARM EQ 5MG BASE;12.5MG;160MG A 201087 001 Jun 01, 2015 May DISC AB EQ 5MG BASE;12.5MG;160MG A 201087 001 Jun 01, 2015 Mar CPOT @ EQ 5MG BASE;25MG;160MG A 201087 002 Jun 01, 2015 May DISC AB EQ 5MG BASE;25MG;160MG A 201087 002 Jun 01, 2015 Mar CPOT @ EQ 10MG BASE;12.5MG;160MG A 201087 003 Jun 01, 2015 May DISC AB EQ 10MG BASE;12.5MG;160MG A 201087 003 Jun 01, 2015 Mar CPOT @ EQ 10MG BASE;25MG;160MG A 201087 004 Jun 01, 2015 May DISC AB EQ 10MG BASE;25MG;160MG A 201087 004 Jun 01, 2015 Mar CPOT @ EQ 10MG BASE;25MG;320MG A 201087 005 Jun 01, 2015 May DISC AB EQ 10MG BASE;25MG;320MG A 201087 005 Jun 01, 2015 Mar CPOT @ TEVA PHARMS EQ 5MG BASE;12.5MG;160MG A 200435 001 Sep 25, 2012 Mar CPOT @ EQ 5MG BASE;25MG;160MG A 200435 002 Sep 25, 2012 Mar CPOT @ EQ 10MG BASE;12.5MG;160MG A 200435 005 Sep 25, 2012 Mar CPOT @ EQ 10MG BASE;25MG;160MG A 200435 003 Sep 25, 2012 Mar CPOT @ EQ 10MG BASE;25MG;320MG A 200435 004 Sep 25, 2012 Mar CPOT @ TORRENT EQ 5MG BASE;12.5MG;160MG A 201593 001 Jun 03, 2015 Mar CPOT @ EQ 5MG BASE;25MG;160MG A 201593 002 Jun 03, 2015 Mar CPOT @ EQ 10MG BASE;12.5MG;160MG A 201593 003 Jun 03, 2015 Mar CPOT @ EQ 10MG BASE;25MG;160MG A 201593 004 Jun 03, 2015 Mar CPOT @ EQ 10MG BASE;25MG;320MG A 201593 005 Jun 03, 2015 Mar CPOT

RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -8

TABLET;ORAL EXFORGE HCT AB + NOVARTIS EQ 5MG BASE;12.5MG;160MG N 022314 001 Apr 30, 2009 Mar CPOT AB + EQ 5MG BASE;25MG;160MG N 022314 002 Apr 30, 2009 Mar CPOT AB + EQ 10MG BASE;12.5MG;160MG N 022314 003 Apr 30, 2009 Mar CPOT AB + EQ 10MG BASE;25MG;160MG N 022314 004 Apr 30, 2009 Mar CPOT AB +! EQ 10MG BASE;25MG;320MG N 022314 005 Apr 30, 2009 Mar CPOT

AMLODIPINE BESYLATE; VALSARTAN TABLET;ORAL AMLODIPINE BESYLATE AND VALSARTAN @ PAR PHARM INC EQ 5MG BASE;160MG A 090011 001 Mar 28, 2013 Jun DISC @ EQ 5MG BASE;320MG A 090011 003 Mar 28, 2013 Jun DISC @ EQ 10MG BASE;160MG A 090011 002 Mar 28, 2013 Jun DISC @ EQ 10MG BASE;320MG A 090011 004 Mar 28, 2013 Jun DISC

AMMONIA N-13 INJECTABLE;INTRAVENOUS AMMONIA N 13 AP CARDINAL HLTH 414 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A 203700 001 Feb 25, 2013 May CAHN AP UNIV WISCONSIN 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A 211740 001 Sep 09, 2020 Aug NEWA

AMMONIUM LACTATE CREAM;TOPICAL AMMONIUM LACTATE @ WATSON LABS INC EQ 12% BASE A 076829 001 Feb 07, 2006 Apr DISC LOTION;TOPICAL AMMONIUM LACTATE @ WATSON LABS INC EQ 12% BASE A 075575 001 Jun 11, 2002 Apr DISC

AMOXAPINE TABLET;ORAL AMOXAPINE @ WATSON PHARMS TEVA 25MG A 072418 001 Aug 01, 1989 Jan CMS1 @ 50MG A 072419 001 Aug 01, 1989 Jan CMS1

AMOXICILLIN CAPSULE;ORAL AMOXICILLIN @ DAVA PHARMS INC 250MG A 062884 001 Feb 25, 1988 Jul DISC @ 500MG A 062881 001 Feb 25, 1988 Jul DISC TABLET, CHEWABLE;ORAL AMOXICILLIN AB HIKMA 125MG A 205274 001 Jun 25, 2020 Jun NEWA AB 250MG A 205274 002 Jun 25, 2020 Jun NEWA AB TEVA 125MG A 064013 002 Sep 11, 1995 Jun CTEC AB ! 250MG A 064013 001 Dec 22, 1992 Jun CTEC

AMOXICILLIN; CLAVULANATE POTASSIUM FOR SUSPENSION;ORAL AUGMENTIN ES-600 AB + NEOPHARMA 600MG/5ML;EQ 42.9MG BASE/5ML N 050755 001 Jun 22, 2001 Jul CMFD TABLET, EXTENDED RELEASE;ORAL AMOXICILLIN AND CLAVULANATE POTASSIUM >D> AB SANDOZ 1GM;EQ 62.5MG BASE A 090227 001 Apr 21, 2010 Sep CHRS >A> ! 1GM;EQ 62.5MG BASE A 090227 001 Apr 21, 2010 Sep CTEC >A> AB ! 1GM;EQ 62.5MG BASE A 090227 001 Apr 21, 2010 Sep CHRS >D> AUGMENTIN XR >D> AB +! NEOPHARMA 1GM;EQ 62.5MG BASE N 050785 001 Sep 25, 2002 Sep DISC >A> + @ 1GM;EQ 62.5MG BASE N 050785 001 Sep 25, 2002 Sep DISC

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE AB ANI PHARMS INC 1.25MG;1.25MG;1.25MG;1.25MG A 205401 001 Jan 22, 2019 Jan CAHN AB 2.5MG;2.5MG;2.5MG;2.5MG A 205401 002 Jan 22, 2019 Jan CAHN AB 3.75MG;3.75MG;3.75MG;3.75MG A 205401 003 Jan 22, 2019 Jan CAHN AB 5MG;5MG;5MG;5MG A 205401 004 Jan 22, 2019 Jan CAHN AB 6.25MG;6.25MG;6.25MG;6.25MG A 205401 005 Jan 22, 2019 Jan CAHN AB 7.5MG;7.5MG;7.5MG;7.5MG A 205401 006 Jan 22, 2019 Jan CAHN AB ELITE LABS INC 1.25MG;1.25MG;1.25MG;1.25MG A 212037 001 Dec 11, 2019 May CAHN AB 2.5MG;2.5MG;2.5MG;2.5MG A 212037 002 Dec 11, 2019 May CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -9

CAPSULE, EXTENDED RELEASE;ORAL DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE AB 3.75MG;3.75MG;3.75MG;3.75MG A 212037 003 Dec 11, 2019 May CAHN AB 5MG;5MG;5MG;5MG A 212037 004 Dec 11, 2019 May CAHN AB 6.25MG;6.25MG;6.25MG;6.25MG A 212037 005 Dec 11, 2019 May CAHN AB 7.5MG;7.5MG;7.5MG;7.5MG A 212037 006 Dec 11, 2019 May CAHN AB MYLAN 1.25MG;1.25MG;1.25MG;1.25MG A 211876 001 Jun 24, 2020 Jun NEWA AB 2.5MG;2.5MG;2.5MG;2.5MG A 211876 002 Jun 24, 2020 Jun NEWA AB 3.75MG;3.75MG;3.75MG;3.75MG A 211876 003 Jun 24, 2020 Jun NEWA AB 5MG;5MG;5MG;5MG A 211876 004 Jun 24, 2020 Jun NEWA AB 6.25MG;6.25MG;6.25MG;6.25MG A 211876 005 Jun 24, 2020 Jun NEWA AB 7.5MG;7.5MG;7.5MG;7.5MG A 211876 006 Jun 24, 2020 Jun NEWA @ NESHER PHARMS 1.25MG;1.25MG;1.25MG;1.25MG A 210080 001 Jul 17, 2019 Jan DISC @ 2.5MG;2.5MG;2.5MG;2.5MG A 210080 002 Jul 17, 2019 Jan DISC @ 3.75MG;3.75MG;3.75MG;3.75MG A 210080 003 Jul 17, 2019 Jan DISC @ 5MG;5MG;5MG;5MG A 210080 004 Jul 17, 2019 Jan DISC @ 6.25MG;6.25MG;6.25MG;6.25MG A 210080 005 Jul 17, 2019 Jan DISC @ 7.5MG;7.5MG;7.5MG;7.5MG A 210080 006 Jul 17, 2019 Jan DISC AB SUN PHARM INDUSTRIES 1.25MG;1.25MG;1.25MG;1.25MG A 211715 001 May 17, 2019 Apr CMFD AB 2.5MG;2.5MG;2.5MG;2.5MG A 211715 002 May 17, 2019 Apr CMFD AB 3.75MG;3.75MG;3.75MG;3.75MG A 211715 003 May 17, 2019 Apr CMFD AB 5MG;5MG;5MG;5MG A 211715 004 May 17, 2019 Apr CMFD AB 6.25MG;6.25MG;6.25MG;6.25MG A 211715 005 May 17, 2019 Apr CMFD AB 7.5MG;7.5MG;7.5MG;7.5MG A 211715 006 May 17, 2019 Apr CMFD @ TEVA 1.25MG;1.25MG;1.25MG;1.25MG A 077488 001 Apr 29, 2013 Apr DISC @ 2.5MG;2.5MG;2.5MG;2.5MG A 077488 002 Apr 29, 2013 Apr DISC @ 3.75MG;3.75MG;3.75MG;3.75MG A 077488 003 Apr 29, 2013 Apr DISC @ 5MG;5MG;5MG;5MG A 077488 004 Apr 29, 2013 Apr DISC @ 6.25MG;6.25MG;6.25MG;6.25MG A 077488 005 Apr 29, 2013 Apr DISC @ 7.5MG;7.5MG;7.5MG;7.5MG A 077488 006 Apr 29, 2013 Apr DISC DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE @ BARR LABS INC 1.25MG;1.25MG;1.25MG;1.25MG A 076536 001 Feb 12, 2013 Apr DISC @ 2.5MG;2.5MG;2.5MG;2.5MG A 076536 002 Feb 12, 2013 Apr DISC @ 3.75MG;3.75MG;3.75MG;3.75MG A 076536 003 Feb 12, 2013 Apr DISC @ 5MG;5MG;5MG;5MG A 076536 004 Feb 12, 2013 Apr DISC @ 6.25MG;6.25MG;6.25MG;6.25MG A 076536 005 Feb 12, 2013 Apr DISC @ 7.5MG;7.5MG;7.5MG;7.5MG A 076536 006 Feb 12, 2013 Apr DISC TABLET;ORAL DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE AB BIONPHARMA INC 1.25MG;1.25MG;1.25MG;1.25MG A 210293 001 Apr 03, 2020 Mar NEWA AB 1.875MG;1.875MG;1.875MG;1.875MG A 210293 002 Apr 03, 2020 Mar NEWA AB 2.5MG;2.5MG;2.5MG;2.5MG A 210293 003 Apr 03, 2020 Mar NEWA AB 3.75MG;3.75MG;3.75MG;3.75MG A 210293 004 Apr 03, 2020 Mar NEWA AB 5MG;5MG;5MG;5MG A 210293 005 Apr 03, 2020 Mar NEWA AB 7.5MG;7.5MG;7.5MG;7.5MG A 210293 006 Apr 03, 2020 Mar NEWA AB ELITE LABS INC 1.25MG;1.25MG;1.25MG;1.25MG A 211352 001 Dec 07, 2018 May CAHN AB 1.875MG;1.875MG;1.875MG;1.875MG A 211352 002 Dec 07, 2018 May CAHN AB 2.5MG;2.5MG;2.5MG;2.5MG A 211352 003 Dec 07, 2018 May CAHN AB 3.125MG;3.125MG;3.125MG;3.125MG A 211352 004 Dec 07, 2018 May CAHN AB 3.75MG;3.75MG;3.75MG;3.75MG A 211352 005 Dec 07, 2018 May CAHN AB 5MG;5MG;5MG;5MG A 211352 006 Dec 07, 2018 May CAHN AB 7.5MG;7.5MG;7.5MG;7.5MG A 211352 007 Dec 07, 2018 May CAHN

AMPHETAMINE SULFATE TABLET;ORAL AMPHETAMINE SULFATE AA CEROVENE INC 5MG A 212582 001 Feb 04, 2020 Jan NEWA AA 10MG A 212582 002 Feb 04, 2020 Jan NEWA AA HAVIX 5MG A 212901 001 May 22, 2020 May NEWA AA 10MG A 212901 002 May 22, 2020 May NEWA AA MAYNE PHARMA 5MG A 213898 001 Jul 14, 2020 Jul NEWA AA 10MG A 213898 002 Jul 14, 2020 Jul NEWA >A> AA NOVAST LABS 5MG A 213763 001 Aug 24, 2020 Sep CAHN >A> AA 10MG A 213763 002 Aug 24, 2020 Sep CAHN AA PRINSTON INC 5MG A 211861 001 Mar 11, 2020 Feb NEWA AA 10MG A 211861 002 Mar 11, 2020 Feb NEWA >D> AA RICONPHARMA LLC 5MG A 213763 001 Aug 24, 2020 Sep CAHN AA 5MG A 213763 001 Aug 24, 2020 Aug NEWA >D> AA 10MG A 213763 002 Aug 24, 2020 Sep CAHN AA 10MG A 213763 002 Aug 24, 2020 Aug NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -10

AMPHOTERICIN B INJECTABLE;INJECTION AMPHOTERICIN B ! XGEN PHARMS 50MG/VIAL A 063206 001 Apr 29, 1992 Feb CAHN

AMPICILLIN SODIUM; SULBACTAM SODIUM INJECTABLE;INJECTION AMPICILLIN AND SULBACTAM @ PHARM ASSOC EQ 1GM BASE/VIAL;EQ 500MG A 065316 001 Jun 29, 2007 Jan CAHN BASE/VIAL @ EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL A 065316 002 Jun 29, 2007 Jan CAHN

AMPICILLIN/AMPICILLIN TRIHYDRATE CAPSULE;ORAL AMPICILLIN TRIHYDRATE @ DAVA PHARMS INC EQ 250MG BASE A 062883 001 Feb 25, 1988 Aug DISC @ EQ 500MG BASE A 062882 001 Feb 25, 1988 Mar DISC SANDOZ EQ 250MG BASE A 064082 001 Aug 29, 1995 Aug CTEC ! EQ 500MG BASE A 064082 002 Aug 29, 1995 Mar CHRS FOR SUSPENSION;ORAL AMPICILLIN TRIHYDRATE @ DAVA PHARMS INC EQ 125MG BASE/5ML A 062982 001 Feb 10, 1989 Jul DISC @ EQ 250MG BASE/5ML A 062982 002 Feb 10, 1989 Jul DISC

ANAGRELIDE HYDROCHLORIDE CAPSULE;ORAL ANAGRELIDE HYDROCHLORIDE @ BARR EQ 0.5MG BASE A 076530 001 Apr 18, 2005 Apr DISC @ EQ 1MG BASE A 076530 002 Apr 18, 2005 Apr DISC

ANASTROZOLE TABLET;ORAL ANASTROZOLE @ APOTEX INC 1MG A 200654 001 May 11, 2012 Feb DISC AB EUGIA PHARMA 1MG A 212434 001 Jul 24, 2020 Jul NEWA >D> AB HIKMA 1MG A 078485 001 Jun 28, 2010 Sep DISC >A> @ 1MG A 078485 001 Jun 28, 2010 Sep DISC @ MYLAN 1MG A 091051 001 Jun 28, 2010 Jan DISC

APIXABAN TABLET;ORAL APIXABAN AB ACCORD HLTHCARE 2.5MG A 210180 001 Jul 28, 2020 Jul NEWA AB 5MG A 210180 002 Jul 28, 2020 Jul NEWA @ BIONPHARMA INC 2.5MG A 210152 001 Apr 08, 2020 Jul DISC AB 2.5MG A 210152 001 Apr 08, 2020 Mar NEWA @ 5MG A 210152 002 Apr 08, 2020 Jul DISC AB 5MG A 210152 002 Apr 08, 2020 Mar NEWA >A> AB INDOCO 2.5MG A 209898 001 Sep 11, 2020 Sep NEWA >A> AB 5MG A 209898 002 Sep 11, 2020 Sep NEWA @ MICRO LABS 2.5MG A 210013 001 Dec 23, 2019 Jun DISC @ 5MG A 210013 002 Dec 23, 2019 Jun DISC MY LAN@ MYLAN@ 2.5MG A 210128 001 Dec 23, 2019 Jan DISC @ 5MG A 210128 002 Dec 23, 2019 Jan DISC ELIQUIS >D> + BRISTOL MYERS SQUIBB 2.5MG N 202155 001 Dec 28, 2012 Sep CTEC >A> AB + 2.5MG N 202155 001 Dec 28, 2012 Sep CTEC + 2.5MG N 202155 001 Dec 28, 2012 Jul CTEC >D> +! 5MG N 202155 002 Dec 28, 2012 Sep CTEC >A> AB +! 5MG N 202155 002 Dec 28, 2012 Sep CTEC +! 5MG N 202155 002 Dec 28, 2012 Jul CTEC

APOMORPHINE HYDROCHLORIDE FILM;SUBLINGUAL KYNMOBI + SUNOVION PHARMS INC 10MG N 210875 001 May 21, 2020 May NEWA + 15MG N 210875 002 May 21, 2020 May NEWA + 20MG N 210875 003 May 21, 2020 May NEWA + 25MG N 210875 004 May 21, 2020 May NEWA +! 30MG N 210875 005 May 21, 2020 May NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -11

INJECTABLE;SUBCUTANEOUS APOKYN @ MDD US 20MG/2ML (10MG/ML) N 021264 001 Apr 20, 2004 Jul CAHN +! 30MG/3ML (10MG/ML) N 021264 002 Apr 20, 2004 Jul CAHN

ARGATROBAN INJECTABLE;INJECTION ARGATROBAN AP +! HIKMA PHARM CO LTD 250MG/2.5ML (100MG/ML) N 203049 001 Jan 05, 2012 Mar CHRS AP + 250MG/2.5ML (100MG/ML) N 203049 001 Jan 05, 2012 Mar CRLD INJECTABLE;INTRAVENOUS ARGATROBAN IN 0.9% SODIUM CHLORIDE @ TEVA PHARMS USA 250MG/250ML (1MG/ML) N 206769 001 Dec 15, 2014 Mar DISC

ARTESUNATE POWDER;INTRAVENOUS ARTESUNATE +! AMIVAS 110MG/VIAL N 213036 001 May 26, 2020 May NEWA

ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE INJECTABLE;INJECTION SEPTOCAINE +! DEPROCO 4%; EQ 0.0085MG BASE/1.7ML (4%; EQ N 020971 002 Mar 30, 2006 Aug CMS1 0.005MG BASE/ML) +! 4%;EQ 0.017MG BASE/1.7ML (4%;EQ N 020971 001 Apr 03, 2000 Feb CTEC 0.01MG BASE/ML)

ASENAPINE MALEATE TABLET;SUBLINGUAL SAPHRIS + ALLERGAN EQ 2.5MG BASE N 022117 003 Mar 12, 2015 Jan CMS1

ASPIRIN; BUTALBITAL; CAFFEINE TABLET;ORAL BUTALBITAL, ASPIRIN AND CAFFEINE >D> AA ! HIKMA INTL PHARMS 325MG;50MG;40MG A 086162 002 Feb 16, 1984 Sep DISC >A> @ 325MG;50MG;40MG A 086162 002 Feb 16, 1984 Sep DISC >D> AA STRIDES PHARMA 325MG;50MG;40MG A 204195 001 Sep 22, 2016 Sep CHRS >A> ! 325MG;50MG;40MG A 204195 001 Sep 22, 2016 Sep CTEC >A> AA ! 325MG;50MG;40MG A 204195 001 Sep 22, 2016 Sep CHRS AA 325MG;50MG;40MG A 204195 001 Sep 22, 2016 Mar CAHN

ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE;ORAL BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE AB LGM PHARMA 325MG;50MG;40MG;30MG A 075231 001 Nov 30, 2001 Aug CAHN

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE TABLET;ORAL ORPHENGESIC FORTE ! GALT PHARMS 770MG;60MG;50MG A 075141 002 May 29, 1998 Jul CMFD

ASPIRIN; CARISOPRODOL TABLET;ORAL CARISOPRODOL AND ASPIRIN @ HERITAGE PHARMS INC 325MG;200MG A 089594 001 Mar 31, 1989 May DISC @ NOVAST LABS 325MG;200MG A 040832 001 Jan 07, 2010 May DISC @ SANDOZ 325MG;200MG A 040116 001 Apr 25, 1996 May DISC

ASPIRIN; METHOCARBAMOL TABLET;ORAL METHOCARBAMOL AND ASPIRIN @ STEVENS J 325MG;400MG A 081145 001 Jan 31, 1995 Jul DISC

ASPIRIN; OXYCODONE HYDROCHLORIDE TABLET;ORAL OXYCODONE AND ASPIRIN @ ACTAVIS LABS FL INC 325MG;4.8355MG A 090084 001 Mar 22, 2011 Jun DISC AA EPIC PHARMA LLC 325MG;4.8355MG A 040910 001 Jul 16, 2020 Jul NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -12

ASPIRIN; PRAVASTATIN SODIUM TABLET;ORAL PRAVIGARD PAC (COPACKAGED) @ BRISTOL MYERS SQUIBB 81MG;20MG N 021387 001 Jun 24, 2003 May CPOT @ 81MG,N/A;N/A,20MG N 021387 001 Jun 24, 2003 May CDFR @ 81MG;40MG N 021387 002 Jun 24, 2003 May CPOT @ 81MG,N/A;N/A,40MG N 021387 002 Jun 24, 2003 May CDFR @ 81MG;80MG N 021387 003 Jun 24, 2003 May CPOT @ 81MG,N/A;N/A,80MG N 021387 003 Jun 24, 2003 May CDFR @ 325MG;20MG N 021387 004 Jun 24, 2003 May CPOT @ 325MG,N/A;N/A,20MG N 021387 004 Jun 24, 2003 May CDFR @ 325MG;40MG N 021387 005 Jun 24, 2003 May CPOT @ 325MG,N/A;N/A,40MG N 021387 005 Jun 24, 2003 May CDFR @ 325MG;80MG N 021387 006 Jun 24, 2003 May CPOT @ 325MG,N/A;N/A,80MG N 021387 006 Jun 24, 2003 May CDFR

ATAZANAVIR SULFATE CAPSULE;ORAL ATAZANAVIR SULFATE @ AMNEAL EQ 100MG BASE A 209717 001 Jun 01, 2020 Aug DISC AB EQ 100MG BASE A 209717 001 Jun 01, 2020 May NEWA AB EQ 150MG BASE A 209717 002 Jun 01, 2020 May NEWA AB EQ 200MG BASE A 209717 003 Jun 01, 2020 May NEWA AB EQ 300MG BASE A 209717 004 Jun 01, 2020 May NEWA @ MYLAN EQ 150MG BASE A 208177 001 Sep 24, 2018 Feb DISC @ EQ 200MG BASE A 208177 002 Sep 24, 2018 Feb DISC @ EQ 300MG BASE A 208177 003 Sep 24, 2018 Feb DISC AB ZYDUS PHARMS EQ 150MG BASE A 210575 001 Jun 04, 2020 Jun NEWA AB EQ 200MG BASE A 210575 002 Jun 04, 2020 Jun NEWA AB EQ 300MG BASE A 210575 003 Jun 04, 2020 Jun NEWA

ATENOLOL TABLET;ORAL ATENOLOL AB HLTHCARE 25MG A 073026 002 May 01, 1992 Jun CMS1 AB 50MG A 073026 003 Sep 17, 1991 Jun CMS1

ATENOLOL; CHLORTHALIDONE TABLET;ORAL ATENOLOL AND CHLORTHALIDONE @ MYLAN 50MG;25MG A 074203 001 Oct 31, 1993 May DISC @ 100MG;25MG A 074203 002 Oct 31, 1993 May DISC

ATORVASTATIN CALCIUM TABLET;ORAL ATORVASTATIN CALCIUM AB LUPIN LTD EQ 10MG BASE A 204991 001 Mar 06, 2019 Jan CMFD AB EQ 20MG BASE A 204991 002 Mar 06, 2019 Jan CMFD AB EQ 40MG BASE A 204991 003 Mar 06, 2019 Jan CMFD AB EQ 80MG BASE A 204991 004 Mar 06, 2019 Jan CMFD @ PERRIGO R AND D EQ 10MG BASE A 208478 001 Jun 23, 2020 Jul DISC AB EQ 10MG BASE A 208478 001 Jun 23, 2020 Jun NEWA @ EQ 20MG BASE A 208478 002 Jun 23, 2020 Jul DISC AB EQ 20MG BASE A 208478 002 Jun 23, 2020 Jun NEWA AB UMEDICA LABS PVT LTD EQ 10MG BASE A 213853 001 Aug 19, 2020 Aug NEWA AB EQ 20MG BASE A 213853 002 Aug 19, 2020 Aug NEWA AB EQ 40MG BASE A 213853 003 Aug 19, 2020 Aug NEWA AB EQ 80MG BASE A 213853 004 Aug 19, 2020 Aug NEWA LIPITOR AB + UPJOHN EQ 10MG BASE N 020702 001 Dec 17, 1996 Jun CAHN AB + EQ 20MG BASE N 020702 002 Dec 17, 1996 Jun CAHN AB + EQ 40MG BASE N 020702 003 Dec 17, 1996 Jun CAHN AB +! EQ 80MG BASE N 020702 004 Apr 07, 2000 Jun CAHN

ATORVASTATIN CALCIUM; EZETIMIBE TABLET;ORAL EZETIMIBE AND ATORVASTATIN CALCIUM @ SCOV3 EQ 10MG BASE;10MG A 206084 001 Apr 26, 2017 Apr DISC EQ 10MG BASE;10MG A 206084 001 Apr 26, 2017 Mar CAHN @ EQ 20MG BASE;10MG A 206084 002 Apr 26, 2017 Apr DISC EQ 20MG BASE;10MG A 206084 002 Apr 26, 2017 Mar CAHN @ EQ 40MG BASE;10MG A 206084 003 Apr 26, 2017 Apr DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -13

TABLET;ORAL EZETIMIBE AND ATORVASTATIN CALCIUM EQ 40MG BASE;10MG A 206084 003 Apr 26, 2017 Mar CAHN @ EQ 80MG BASE;10MG A 206084 004 Apr 26, 2017 Apr DISC ! EQ 80MG BASE;10MG A 206084 004 Apr 26, 2017 Mar CAHN

ATROPINE SULFATE SOLUTION;INTRAVENOUS ATROPINE SULFATE >A> +! ACCORD HLTHCARE 0.4MG/ML (0.4MG/ML) N 214652 001 Sep 29, 2020 Sep NEWA >A> +! 1MG/ML (1MG/ML) N 214652 002 Sep 29, 2020 Sep NEWA +! HOSPIRA 0.25MG/5ML (0.05MG/ML) N 021146 002 Jul 09, 2001 Aug CTNA +! 0.25MG/5ML (0.05MG/ML) N 021146 002 Jul 09, 2001 Aug CDFR + @ 0.5MG/5ML (0.1MG/ML) N 021146 001 Jul 09, 2001 Aug CTNA + @ 0.5MG/5ML (0.1MG/ML) N 021146 001 Jul 09, 2001 Aug CDFR +! 0.5MG/5ML (0.1MG/ML) N 021146 004 Aug 17, 2017 Aug CTNA +! 1MG/10ML (0.1MG/ML) N 021146 003 Jul 09, 2001 Aug CTNA +! 1MG/10ML (0.1MG/ML) N 021146 003 Jul 09, 2001 Aug CDFR >D> +! 1MG/10ML (0.1MG/ML) N 021146 005 Aug 17, 2017 Sep CFTG >A> AA +! 1MG/10ML (0.1MG/ML) N 021146 005 Aug 17, 2017 Sep CFTG +! 1MG/10ML (0.1MG/ML) N 021146 005 Aug 17, 2017 Aug CTNA >A> AA INTL MEDICATION SYS 1MG/10ML (0.1MG/ML) A 212461 001 Oct 05, 2020 Sep NEWA SOLUTION/DROPS;OPHTHALMIC ISOPTO ATROPINE +! ALCON LABS INC 1% N 208151 001 Dec 01, 2016 Feb CRLD ! 1% N 208151 001 Dec 01, 2016 Feb CHRS

ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE TABLET;ORAL DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE AA LEADING PHARMA LLC 0.025MG;2.5MG A 213413 001 Feb 20, 2020 Feb NEWA AA MAYNE PHARMA INC 0.025MG;2.5MG A 210789 001 Jun 03, 2020 May NEWA @ PAR PHARM 0.025MG;2.5MG A 040357 001 May 02, 2000 May DISC >A> AA SPECGX LLC 2.5MG;0.025MG A 213335 001 Oct 06, 2020 Sep NEWA LOMOTIL >D> AA +! GD SEARLE LLC 0.025MG;2.5MG N 012462 001 Sep CAHN >A> AA +! PFIZER 0.025MG;2.5MG N 012462 001 Sep CAHN

AVAPRITINIB TABLET;ORAL AYVAKIT + BLUEPRINT MEDICINES 100MG N 212608 001 Jan 09, 2020 Jan NEWA + 200MG N 212608 002 Jan 09, 2020 Jan NEWA +! 300MG N 212608 003 Jan 09, 2020 Jan NEWA

AZACITIDINE POWDER;INTRAVENOUS, SUBCUTANEOUS AZACITIDINE AP EUROHLTH INTL SARL 100MG/VIAL A 209337 001 Jun 08, 2020 Jun NEWA >A> TABLET;ORAL >A> ONUREG >A> + CELGENE CORP 200MG N 214120 001 Sep 01, 2020 Sep NEWA >A> +! 300MG N 214120 002 Sep 01, 2020 Sep NEWA

AZATHIOPRINE TABLET;ORAL AZATHIOPRINE AB ALKEM LABS LTD 25MG A 208687 001 Mar 27, 2020 Mar NEWA AB 50MG A 208687 002 Mar 27, 2020 Mar NEWA AB 75MG A 208687 003 Mar 27, 2020 Mar NEWA AB 100MG A 208687 004 Mar 27, 2020 Mar NEWA AB RISING 50MG A 075568 001 Dec 13, 1999 May CAHN

AZELAIC ACID AEROSOL, FOAM;TOPICAL >A> AZELAIC ACID >A> AB TEVA PHARMS USA 15% A 210928 001 Oct 07, 2020 Sep NFTG FINACEA >D> +! LEO PHARMA AS 15% N 207071 001 Jul 29, 2015 Sep CFTG >A> AB +! 15% N 207071 001 Jul 29, 2015 Sep CFTG RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -14

AZELASTINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC AZELASTINE HYDROCHLORIDE AT GLAND PHARMA LTD 0.05% A 210092 001 Feb 25, 2020 Feb NEWA SPRAY, METERED;NASAL AZELASTINE HYDROCHLORIDE AB AUROBINDO PHARMA LTD EQ 0.125MG BASE/SPRAY A 212289 001 May 08, 2020 Apr NEWA

AZITHROMYCIN FOR SUSPENSION;ORAL AZITHROMYCIN TA RO@ TARO@ EQ 200MG BASE/5ML A 211521 001 Dec 11, 2019 May DISC @ TEVA PHARMS EQ 100MG BASE/5ML A 065419 001 Jun 24, 2008 Apr DISC @ EQ 200MG BASE/5ML A 065419 002 Jun 24, 2008 Apr DISC INJECTABLE;INJECTION AZITHROMYCIN HI KMA@ HIKMA@ EQ 500MG BASE/VIAL A 065265 001 Jan 18, 2007 Mar CAHN @ MYLAN LABS LTD EQ 500MG BASE/VIAL A 204732 001 Jan 26, 2017 Mar DISC TABLET;ORAL AZITHROMYCIN AB ALEMBIC PHARMS LTD EQ 250MG BASE A 211791 001 Jan 28, 2020 Jan NEWA AB EQ 500MG BASE A 211792 001 Jan 28, 2020 Jan NEWA AB EQ 600MG BASE A 211793 001 Jan 27, 2020 Jan NEWA MY LAN@ MYLAN@ EQ 600MG BASE A 065360 001 Jan 08, 2007 Jan DISC @ YUNG SHIN PHARM EQ 600MG BASE A 211068 001 May 08, 2020 Jun DISC AB EQ 600MG BASE A 211068 001 May 08, 2020 Apr NEWA

BACITRACIN INJECTABLE;INJECTION BACIIM @ X GEN PHARMS 50,000 UNITS/VIAL A 064153 001 May 09, 1997 Mar DISC BACITRACIN AK ORN@ AKORN@ 50,000 UNITS/VIAL A 206719 001 Oct 20, 2017 Mar DISC @ FRESENIUS KABI USA 50,000 UNITS/VIAL A 065116 001 Dec 03, 2002 Mar DISC @ PHARMACIA AND UPJOHN 50,000 UNITS/VIAL A 060733 002 Aug DISC ! XELLIA PHARMS APS 50,000 UNITS/VIAL A 203177 001 Aug 25, 2014 Aug CHRS 50,000 UNITS/VIAL A 203177 001 Aug 25, 2014 Aug CTEC

BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE OINTMENT;OPHTHALMIC LUMI-SPORYN AT + CASPER PHARMA LLC EQ 400 UNITS/GM;EQ 3.5MG N 050417 001 May CTNA BASE/GM;EQ 10,000 UNITS/GM

BACLOFEN INJECTABLE;INTRATHECAL BACLOFEN @ MAIA PHARMS INC 0.5MG/ML A 210048 001 Sep 11, 2019 Mar DISC @ 2MG/ML A 210048 002 Sep 11, 2019 Mar DISC TABLET;ORAL BACLOFEN MY LAN@ MYLAN@ 20MG A 077121 002 Jul 29, 2005 Jan DISC @ MYLAN PHARMS INC 10MG A 090334 001 Feb 18, 2010 Apr DISC @ 20MG A 090334 002 Feb 18, 2010 Apr DISC AB RUBICON 5MG A 209102 001 Nov 28, 2017 Apr CTEC AB UNICHEM 10MG A 212067 001 Jul 09, 2020 Jul NEWA AB 20MG A 212067 002 Jul 09, 2020 Jul NEWA AB ZYDUS 5MG A 211659 003 Apr 17, 2020 Apr NEWA

BARIUM SULFATE SUSPENSION;ORAL ENTERO VU 24% +! BRACCO 24% (144GM/600ML) N 208143 008 May 29, 2020 Jun NEWA

BEDAQUILINE FUMARATE TABLET;ORAL SIRTURO + JANSSEN THERAP EQ 20MG BASE N 204384 002 May 27, 2020 May NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -15

BEMPEDOIC ACID TABLET;ORAL NEXLETOL +! ESPERION THERAPS INC 180MG N 211616 001 Feb 21, 2020 Feb NEWA

BEMPEDOIC ACID; EZETIMIBE TABLET;ORAL NEXLIZET +! ESPERION THERAPS INC 180MG;10MG N 211617 001 Feb 26, 2020 Feb NEWA

BENAZEPRIL HYDROCHLORIDE TABLET;ORAL BENAZEPRIL HYDROCHLORIDE >A> AB ANNORA PHARMA 5MG A 077128 001 Mar 08, 2006 Sep CAHN >A> AB 10MG A 077128 002 Mar 08, 2006 Sep CAHN >A> AB 20MG A 077128 003 Mar 08, 2006 Sep CAHN >A> AB 40MG A 077128 004 Mar 08, 2006 Sep CAHN >D> AB COREPHARMA 5MG A 077128 001 Mar 08, 2006 Sep CAHN AB 5MG A 077128 001 Mar 08, 2006 Feb CAHN >D> AB 10MG A 077128 002 Mar 08, 2006 Sep CAHN AB 10MG A 077128 002 Mar 08, 2006 Feb CAHN >D> AB 20MG A 077128 003 Mar 08, 2006 Sep CAHN AB 20MG A 077128 003 Mar 08, 2006 Feb CAHN >D> AB 40MG A 077128 004 Mar 08, 2006 Sep CAHN AB 40MG A 077128 004 Mar 08, 2006 Feb CAHN @ MYLAN 5MG A 076430 001 Feb 11, 2004 Jul DISC @ 10MG A 076430 002 Feb 11, 2004 Jul DISC @ 20MG A 076430 003 Feb 11, 2004 Jul DISC @ 40MG A 076430 004 Feb 11, 2004 Jul DISC

BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE TABLET;ORAL BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE @ APOTEX 5MG;6.25MG A 078794 001 Aug 21, 2014 Jun DISC @ 10MG;12.5MG A 078794 002 Aug 21, 2014 Jun DISC @ 20MG;12.5MG A 078794 003 Aug 21, 2014 Jun DISC @ 20MG;25MG A 078794 004 Aug 21, 2014 Jun DISC

BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM SOLUTION/DROPS;OPHTHALMIC FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE +! BAUSCH 0.4%;0.3% N 211039 001 Mar 09, 2020 Mar NEWA

BENZPHETAMINE HYDROCHLORIDE TABLET;ORAL BENZPHETAMINE HYDROCHLORIDE @ EMCURE PHARMS LTD 50MG A 202061 001 Jan 27, 2012 Mar DISC @ SPECGX LLC 50MG A 040773 001 Apr 25, 2007 Apr DISC @ TWI PHARMS 50MG A 040578 001 Apr 17, 2006 Apr DISC

BEPOTASTINE BESILATE SOLUTION/DROPS;OPHTHALMIC BEPOTASTINE BESILATE MY LAN@ MYLAN@ 1.5% A 206220 001 Mar 18, 2019 Feb DISC BEPREVE +! BAUSCH AND LOMB INC 1.5% N 022288 001 Sep 08, 2009 Feb CTEC

BETAMETHASONE DIPROPIONATE CREAM, AUGMENTED;TOPICAL BETAMETHASONE DIPROPIONATE AB ! GLENMARK GENERICS EQ 0.05% BASE A 078930 001 Sep 23, 2008 Feb CHRS DIPROLENE AF + @ MERCK SHARP DOHME EQ 0.05% BASE N 019555 001 Apr 27, 1987 Feb DISC LOTION;TOPICAL BETAMETHASONE DIPROPIONATE @ ACTAVIS MID ATLANTIC EQ 0.05% BASE A 070281 001 Jul 31, 1985 Apr DISC >A> @ INVATECH EQ 0.05% BASE A 070274 001 Aug 12, 1985 Sep CAHN >D> @ PHARMADERM EQ 0.05% BASE A 070274 001 Aug 12, 1985 Sep CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -16

OINTMENT;TOPICAL BETAMETHASONE DIPROPIONATE AB CADILA EQ 0.05% BASE A 214048 001 Jul 14, 2020 Jul CAHN AB ZYDUS PHARMS EQ 0.05% BASE A 214048 001 Jul 14, 2020 Jul NEWA SPRAY;TOPICAL BETAMETHASONE DIPROPIONATE @ TARO PHARMS EQ 0.05% BASE/SPRAY A 211722 001 Jun 17, 2020 Jun DISC AB EQ 0.05% BASE/SPRAY A 211722 001 Jun 17, 2020 Jun NFTG SERNIVO +! ENCORE DERMAT EQ 0.05% BASE/SPRAY N 208079 001 Feb 05, 2016 Jun CTEC AB +! EQ 0.05% BASE/SPRAY N 208079 001 Feb 05, 2016 Jun CFTG

BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE CREAM;TOPICAL WYNZORA +! MC2 0.064%;0.005% N 213422 001 Jul 20, 2020 Jul NEWA SUSPENSION;TOPICAL CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE AB TARO PHARMS 0.064%;0.005% A 213269 001 Sep 02, 2020 Aug NEWA AB TOLMAR 0.064%;0.005% A 210765 001 May 11, 2020 Apr NFTG CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE >A> AB PERRIGO UK FINCO 0.064%;0.005% A 212367 001 Sep 11, 2020 Sep NEWA TACLONEX AB +! LEO PHARMA AS 0.064%;0.005% N 022185 001 May 09, 2008 Apr CFTG

BETHANECHOL CHLORIDE TABLET;ORAL BETHANECHOL CHLORIDE AA ! AMNEAL PHARM 5MG A 040855 001 Nov 21, 2007 Jan CHRS AA ! 10MG A 040855 002 Nov 21, 2007 Jan CHRS AA ! 25MG A 040855 003 Nov 21, 2007 Jan CHRS AA ! 50MG A 040855 004 Nov 21, 2007 Jul CHRS >A> AA DISCOVERY THERAP 5MG A 040728 002 Oct 26, 2007 Sep CAHN >A> AA 10MG A 040728 003 Oct 26, 2007 Sep CAHN >A> AA 25MG A 040728 004 Oct 26, 2007 Sep CAHN >A> AA 50MG A 040728 001 Oct 26, 2007 Sep CAHN >D> AA ECI PHARMS LLC 5MG A 040728 002 Oct 26, 2007 Sep CAHN >D> AA 10MG A 040728 003 Oct 26, 2007 Sep CAHN >D> AA 25MG A 040728 004 Oct 26, 2007 Sep CAHN >D> AA 50MG A 040728 001 Oct 26, 2007 Sep CAHN @ HERITAGE PHARMA 5MG A 091256 001 May 04, 2010 Jul DISC @ 10MG A 091256 002 May 04, 2010 Jul DISC @ 25MG A 091256 003 May 04, 2010 Jul DISC @ 50MG A 091256 004 May 04, 2010 Jul DISC @ IMPAX LABS 25MG A 040721 003 Nov 01, 2006 Jan CMS1 URECHOLINE @ ODYSSEY PHARMS 5MG A 089095 001 Dec 19, 1985 Jan DISC @ 10MG A 088440 001 May 29, 1984 Jan DISC @ 25MG A 088441 001 May 29, 1984 Jan DISC @ 50MG A 089096 001 Dec 19, 1985 Jul DISC

BETRIXABAN CAPSULE;ORAL BEVYXXA + @ PORTOLA PHARMS INC 40MG N 208383 001 Jun 23, 2017 Aug DISC + @ 80MG N 208383 002 Jun 23, 2017 Aug DISC

BEXAROTENE CAPSULE;ORAL BEXAROTENE AB ANI PHARMS INC 75MG A 209861 001 May 08, 2018 Jan CAHN AB HIKMA 75MG A 203663 001 Jun 16, 2020 Jun NEWA

BICALUTAMIDE TABLET;ORAL BICALUTAMIDE @ MYLAN 50MG A 079185 001 Jul 06, 2009 Jan DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -17

BIMATOPROST IMPLANT;OPHTHALMIC DURYSTA +! ALLERGAN INC 10MCG N 211911 001 Mar 04, 2020 Mar NEWA SOLUTION/DROPS;OPHTHALMIC BIMATOPROST AT MICRO LABS 0.03% A 202505 001 Sep 08, 2020 Aug NEWA SOLUTION/DROPS;TOPICAL BIMATOPROST AT ALEMBIC PHARMS LTD 0.03% A 210515 001 Jan 21, 2020 Jan NEWA

BISOPROLOL FUMARATE TABLET;ORAL BISOPROLOL FUMARATE AB RUBICON 5MG A 075643 001 Nov 16, 2000 Aug CAHN AB 10MG A 075643 002 Nov 16, 2000 Aug CAHN @ TEVA PHARMS 5MG A 075644 001 Jun 26, 2001 Apr DISC @ 10MG A 075644 002 Jun 26, 2001 Apr DISC

BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE TABLET;ORAL BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE AB EDENBRIDGE PHARMS 2.5MG;6.25MG A 212678 001 Jul 09, 2020 Jul NEWA AB 5MG;6.25MG A 212678 002 Jul 09, 2020 Jul NEWA AB 10MG;6.25MG A 212678 003 Jul 09, 2020 Jul NEWA

BIVALIRUDIN INJECTABLE;INTRAVENOUS BIVALIRUDIN @ APOTEX 250MG/VIAL A 204876 001 Jul 06, 2017 Feb DISC >D> AP CIPLA 250MG/VIAL A 091602 001 Jul 16, 2018 Sep CAHN >A> AP HONG KONG 250MG/VIAL A 091602 001 Jul 16, 2018 Sep CAHN

BOSENTAN TABLET;ORAL BOSENTAN AB ALEMBIC PHARMS LTD 62.5MG A 211461 001 Jan 23, 2020 Jan NEWA AB 125MG A 211461 002 Jan 23, 2020 Jan NEWA @ CIPLA 62.5MG A 210342 001 Jan 03, 2020 Jun DISC @ 125MG A 210342 002 Jan 03, 2020 Jun DISC @ MYLAN 62.5MG A 205173 001 Jan 15, 2020 Jan DISC @ 125MG A 205173 002 Jan 15, 2020 Jan DISC

BREMELANOTIDE ACETATE SOLUTION;SUBCUTANEOUS VYLEESI (AUTOINJECTOR) +! PALATIN TECHNOLOGIES EQ 1.75MG BASE/0.3ML (EQ 1.75MG N 210557 001 Jun 21, 2019 Jul CAHN BASE/0.3 ML)

BRIMONIDINE TARTRATE SOLUTION/DROPS;OPHTHALMIC QOLIANA AT +! SANDOZ INC 0.15% N 021764 001 May 22, 2006 Jun CHRS AT + 0.15% N 021764 001 May 22, 2006 Jun CRLD

BROMFENAC SODIUM SOLUTION/DROPS;OPHTHALMIC BROMFENAC SODIUM AT2 GLAND PHARMA LTD EQ 0.09% ACID A 211029 001 Mar 17, 2020 Mar NEWA

BROMOCRIPTINE MESYLATE TABLET;ORAL BROMOCRIPTINE MESYLATE @ MYLAN EQ 2.5MG BASE A 076962 001 Sep 24, 2004 Jun DISC

BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE SYRUP;ORAL BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE AA ALKEM LABS LTD 2MG/5ML;10MG/5ML;30MG/5ML A 210647 001 Jul 14, 2020 Jul NEWA >A> AA BRECKENRIDGE 2MG/5ML;10MG/5ML;30MG/5ML A 203997 001 Sep 30, 2020 Sep NEWA >A> AA EYWA 2MG/5ML;10MG/5ML;30MG/5ML A 211170 001 Jun 16, 2020 Sep CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -18

SYRUP;ORAL BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE AA LANNETT CO INC 2MG/5ML;10MG/5ML;30MG/5ML A 213125 001 Apr 17, 2020 Apr NEWA @ PHARM ASSOC 2MG/5ML;10MG/5ML;30MG/5ML A 202940 001 Jul 21, 2014 Aug CAHN >D> AA WES PHARMA INC 2MG/5ML;10MG/5ML;30MG/5ML A 211170 001 Jun 16, 2020 Sep CAHN AA 2MG/5ML;10MG/5ML;30MG/5ML A 211170 001 Jun 16, 2020 Jun NEWA

BUDESONIDE AEROSOL, FOAM;RECTAL UCERIS +! SALIX 2MG/ACTUATION N 205613 001 Oct 07, 2014 Feb CAHN CAPSULE;ORAL BUDESONIDE AB RISING 3MG A 207367 001 Apr 07, 2017 Jul CAHN TABLET, EXTENDED RELEASE;ORAL BUDESONIDE >A> AB MYLAN 9MG A 208851 001 Sep 17, 2020 Sep NEWA

BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE AEROSOL, METERED;INHALATION BREZTRI AEROSPHERE +! ASTRAZENECA AB 0.16MG/INH;0.0048MG/INH;0.009MG/IN N 212122 001 Jul 23, 2020 Jul NEWA H

BUMETANIDE TABLET;ORAL BUMETANIDE AB RISING 0.5MG A 212019 001 Dec 12, 2019 Jan CAHN AB 1MG A 212019 002 Dec 12, 2019 Jan CAHN AB 2MG A 212019 003 Dec 12, 2019 Jan CAHN

BUPIVACAINE HYDROCHLORIDE IMPLANT;IMPLANTATION XARACOLL +! INNOCOLL PHARMS 100MG N 209511 001 Aug 28, 2020 Aug NEWA

BUPRENORPHINE FILM, EXTENDED RELEASE;TRANSDERMAL BUPRENORPHINE AB AMNEAL 5MCG/HR A 211586 001 Apr 14, 2020 Mar NEWA AB 7.5MCG/HR A 211586 002 Apr 14, 2020 Mar NFTG AB 10MCG/HR A 211586 003 Apr 14, 2020 Mar NEWA AB 15MCG/HR A 211586 004 Apr 14, 2020 Mar NEWA AB 20MCG/HR A 211586 005 Apr 14, 2020 Mar NEWA BUTRANS AB + PURDUE PHARMA LP 7.5MCG/HR N 021306 005 Jun 30, 2014 Mar CFTG

BUPRENORPHINE HYDROCHLORIDE TABLET;SUBLINGUAL BUPRENORPHINE HYDROCHLORIDE AB RUBICON EQ 2MG BASE A 090279 001 Jun 10, 2015 Aug CAHN AB EQ 8MG BASE A 090279 002 Jun 10, 2015 Aug CAHN

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE FILM;BUCCAL BUNAVAIL + @ BDSI EQ 2.1MG BASE;EQ 0.3MG BASE N 205637 001 Jun 06, 2014 Jun DISC + @ EQ 4.2MG BASE;EQ 0.7MG BASE N 205637 002 Jun 06, 2014 Jun DISC + @ EQ 6.3MG BASE;EQ 1MG BASE N 205637 003 Jun 06, 2014 Jun DISC FILM;BUCCAL, SUBLINGUAL BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE AB MYLAN TECHNOLOGIES EQ 2MG BASE;EQ 0.5MG BASE A 211785 001 Apr 17, 2020 Apr NEWA AB EQ 4MG BASE;EQ 1MG BASE A 211785 002 Apr 17, 2020 Apr NEWA TABLET;SUBLINGUAL BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE AB MAYNE PHARMA INC EQ 2MG BASE;EQ 0.5MG BASE A 206953 001 Jul 17, 2020 Jul NEWA AB EQ 8MG BASE;EQ 2MG BASE A 206953 002 Jul 17, 2020 Jul NEWA AB RHODES PHARMS EQ 2MG BASE;EQ 0.5MG BASE A 205601 001 Mar 30, 2020 Mar NEWA AB EQ 8MG BASE;EQ 2MG BASE A 205601 002 Mar 30, 2020 Mar NEWA AB WES PHARMA INC EQ 2MG BASE;EQ 0.5MG BASE A 209069 001 Jul 17, 2020 Jul NEWA AB EQ 8MG BASE;EQ 2MG BASE A 209069 002 Jul 17, 2020 Jul NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -19

BUPROPION HYDROCHLORIDE TABLET;ORAL BUPROPION HYDROCHLORIDE AB CADILA PHARMS LTD 75MG A 208606 001 Jan 16, 2020 Jan NEWA AB 100MG A 208606 002 Jan 16, 2020 Jan NEWA AB MICRO LABS 75MG A 207403 001 Apr 17, 2020 Apr NEWA AB 100MG A 207403 002 Apr 17, 2020 Apr NEWA TABLET, EXTENDED RELEASE;ORAL BUPROPION HYDROCHLORIDE >A> AB3 ADAPTIS 150MG A 211020 001 Jan 28, 2019 Sep CAHN >A> AB3 300MG A 211020 002 Jan 28, 2019 Sep CAHN >D> AB3 GRAVITI PHARMS 150MG A 211020 001 Jan 28, 2019 Sep CAHN >D> AB3 300MG A 211020 002 Jan 28, 2019 Sep CAHN @ JUBILANT GENERICS 100MG A 202774 001 Oct 11, 2013 Feb DISC @ 150MG A 202774 002 Oct 11, 2013 Feb DISC @ 150MG A 202775 001 Oct 11, 2013 Feb DISC @ 150MG A 207459 001 Jun 30, 2017 Feb DISC @ 200MG A 202774 003 Oct 11, 2013 Feb DISC @ 300MG A 207459 002 Jun 30, 2017 Feb DISC @ WATSON LABS INC 100MG A 077455 001 Jul 19, 2010 Apr DISC @ 150MG A 077455 002 Mar 12, 2008 Apr DISC @ 200MG A 077455 003 Jul 19, 2010 Apr DISC AB1 YICHANG HUMANWELL 100MG A 211347 001 Oct 16, 2018 Jun CMFD AB1 150MG A 211347 002 Oct 16, 2018 Jun CMFD AB1 200MG A 211347 003 Oct 16, 2018 Jun CMFD AB3 ZHEJIANG JUTAI PHARM 150MG A 211200 002 Apr 29, 2020 Jun NEWA

BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL CONTRAVE +! NALPROPION 90MG;8MG N 200063 001 Sep 10, 2014 Jan CAHN

BUSPIRONE HYDROCHLORIDE TABLET;ORAL BUSPIRONE HYDROCHLORIDE AB AUROBINDO PHARMA LTD 7.5MG A 078246 005 Feb 21, 2020 Jun NEWA AB ! MYLAN 7.5MG A 075467 002 Mar 28, 2001 Jun CHRS AB OXFORD PHARMS 5MG A 075388 001 May 09, 2002 Jul CMFD AB 10MG A 075388 002 May 09, 2002 Jul CMFD AB 15MG A 075388 003 May 09, 2002 Jul CMFD

BUSULFAN INJECTABLE;INJECTION BUSULFAN AP MYLAN INSTITUTIONAL 6MG/ML A 208536 001 Nov 20, 2017 Apr CTNA @ MYLAN LABS LTD 6MG/ML A 205184 001 Jul 13, 2018 Feb DISC

BUTABARBITAL SODIUM TABLET;ORAL BUTISOL SODIUM + @ MYLAN SPECIALITY LP 30MG N 000793 004 May DISC

CABERGOLINE TABLET;ORAL CABERGOLINE @ MYLAN 0.5MG A 202947 001 Dec 02, 2013 Jan DISC

CAFFEINE CITRATE SOLUTION;INTRAVENOUS CAFFEINE CITRATE >D> AP SUN PHARM EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A 090077 001 Sep 30, 2009 Sep DISC >A> @ EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A 090077 001 Sep 30, 2009 Sep DISC

CAFFEINE; ERGOTAMINE TARTRATE TABLET;ORAL ERGOTAMINE TARTRATE AND CAFFEINE >D> AA HIKMA INTL PHARMS 100MG;1MG A 040510 001 Sep 17, 2004 Sep DISC >A> @ 100MG;1MG A 040510 001 Sep 17, 2004 Sep DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -20

CALCITRIOL CAPSULE;ORAL CALCITRIOL AB SUN PHARM 0.25MCG A 204556 001 Feb 21, 2019 Mar CMFD AB 0.5MCG A 204556 002 Feb 21, 2019 Mar CMFD INJECTABLE;INJECTION CALCITRIOL AP ! AKORN 0.001MG/ML A 078066 001 Jan 29, 2008 Jan CTEC AP GLAND PHARMA LTD 0.001MG/ML A 211030 001 Feb 03, 2020 Jan NEWA

CALCIUM ACETATE CAPSULE;ORAL CALCIUM ACETATE @ LOTUS PHARM CO LTD 667MG A 203298 001 Jul 26, 2016 Jan DISC

CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE SOLUTION;INTRAPERITONEAL DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER AT +! FRESENIUS MEDCL 25.7MG/100ML;1.5GM/100ML;15.2MG/10 N 018883 001 Nov 30, 1984 Aug CHRS 0ML;567MG/100ML;392MG/100ML AT + 25.7MG/100ML;1.5GM/100ML;15.2MG/10 N 018883 001 Nov 30, 1984 Aug CRLD 0ML;567MG/100ML;392MG/100ML DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER AT +! FRESENIUS MEDCL 25.7MG/100ML;1.5GM/100ML;5.08MG/10 N 018883 004 Nov 30, 1984 Aug CHRS 0ML;538MG/100ML;448MG/100ML AT + 25.7MG/100ML;1.5GM/100ML;5.08MG/10 N 018883 004 Nov 30, 1984 Aug CRLD 0ML;538MG/100ML;448MG/100ML DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER AT +! FRESENIUS MEDCL 18.4MG/100ML;1.5GM/100ML;5.08MG/10 N 020171 001 Aug 19, 1992 Aug CHRS 0ML;538MG/100ML;448MG/100ML AT + 18.4MG/100ML;1.5GM/100ML;5.08MG/10 N 020171 001 Aug 19, 1992 Aug CRLD 0ML;538MG/100ML;448MG/100ML DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER AT +! FRESENIUS MEDCL 25.7MG/100ML;2.5GM/100ML;15.2MG/10 N 018883 002 Nov 30, 1984 Aug CHRS 0ML;567MG/100ML;392MG/100ML AT + 25.7MG/100ML;2.5GM/100ML;15.2MG/10 N 018883 002 Nov 30, 1984 Aug CRLD 0ML;567MG/100ML;392MG/100ML DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER AT +! FRESENIUS MEDCL 25.7MG/100ML;2.5GM/100ML;5.08MG/10 N 018883 005 Nov 30, 1984 Aug CHRS 0ML;538MG/100ML;448MG/100ML AT + 25.7MG/100ML;2.5GM/100ML;5.08MG/10 N 018883 005 Nov 30, 1984 Aug CRLD 0ML;538MG/100ML;448MG/100ML DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER AT +! FRESENIUS MEDCL 18.4MG/100ML;2.5GM/100ML;5.08MG/10 N 020171 002 Aug 19, 1992 Aug CHRS 0ML;538MG/100ML;448MG/100ML AT + 18.4MG/100ML;2.5GM/100ML;5.08MG/10 N 020171 002 Aug 19, 1992 Aug CRLD 0ML;538MG/100ML;448MG/100ML DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER AT +! FRESENIUS MEDCL 25.7MG/100ML;4.25GM/100ML;15.2MG/1 N 018883 003 Nov 30, 1984 Aug CHRS 00ML;567MG/100ML;392MG/100ML AT + 25.7MG/100ML;4.25GM/100ML;15.2MG/1 N 018883 003 Nov 30, 1984 Aug CRLD 00ML;567MG/100ML;392MG/100ML DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER AT +! FRESENIUS MEDCL 25.7MG/100ML;4.25GM/100ML;5.08MG/1 N 018883 006 Nov 30, 1984 Aug CHRS 00ML;538MG/100ML;448MG/100ML AT + 25.7MG/100ML;4.25GM/100ML;5.08MG/1 N 018883 006 Nov 30, 1984 Aug CRLD 00ML;538MG/100ML;448MG/100ML DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER AT +! FRESENIUS MEDCL 18.4MG/100ML;4.25GM/100ML;5.08MG/1 N 020171 003 Aug 19, 1992 Aug CHRS 00ML;538MG/100ML;448MG/100ML AT + 18.4MG/100ML;4.25GM/100ML;5.08MG/1 N 020171 003 Aug 19, 1992 Aug CRLD 00ML;538MG/100ML;448MG/100ML

CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE SOLUTION;ORAL XYWAV +! JAZZ 0.234GM/ML;0.096GM/ML;0.13GM/ML;0. N 212690 001 Jul 21, 2020 Aug CPOT 04GM/ML +! 0.234GM/ML;0.096GM/ML;0.13GM/ML;0. N 212690 001 Jul 21, 2020 Jul NEWA 4GM/ML RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -21

CAPECITABINE TABLET;ORAL CAPECITABINE AB RELIANCE LIFE 150MG A 211724 001 Apr 27, 2020 Apr NEWA AB 500MG A 211724 002 Apr 27, 2020 Apr NEWA

CAPMATINIB HYDROCHLORIDE TABLET;ORAL TABRECTA + NOVARTIS PHARM EQ 150MG BASE N 213591 001 May 06, 2020 May NEWA +! EQ 200MG BASE N 213591 002 May 06, 2020 May NEWA

CAPTOPRIL TABLET;ORAL CAPTOPRIL >A> @ ANNORA PHARMA 12.5MG A 074737 001 Oct 28, 1998 Sep CAHN >A> @ 25MG A 074737 002 Oct 28, 1998 Sep CAHN >A> @ 50MG A 074737 003 Oct 28, 1998 Sep CAHN >A> @ 100MG A 074737 004 Oct 28, 1998 Sep CAHN >D> @ COREPHARMA 12.5MG A 074737 001 Oct 28, 1998 Sep CAHN @ 12.5MG A 074737 001 Oct 28, 1998 Feb CAHN >D> @ 25MG A 074737 002 Oct 28, 1998 Sep CAHN @ 25MG A 074737 002 Oct 28, 1998 Feb CAHN >D> @ 50MG A 074737 003 Oct 28, 1998 Sep CAHN @ 50MG A 074737 003 Oct 28, 1998 Feb CAHN >D> @ 100MG A 074737 004 Oct 28, 1998 Sep CAHN @ 100MG A 074737 004 Oct 28, 1998 Feb CAHN @ SETON PHARMS 12.5MG A 212223 001 Oct 30, 2019 May DISC @ 25MG A 212223 002 Oct 30, 2019 May DISC @ 50MG A 212223 003 Oct 30, 2019 May DISC @ 100MG A 212223 004 Oct 30, 2019 May DISC @ TEVA 12.5MG A 074322 001 Feb 13, 1996 Apr DISC @ 25MG A 074322 002 Feb 13, 1996 Apr DISC @ 50MG A 074322 003 Feb 13, 1996 Apr DISC @ 100MG A 074322 004 Feb 13, 1996 Apr DISC @ WATSON LABS 12.5MG A 074386 001 May 23, 1996 Apr DISC @ 25MG A 074386 002 May 23, 1996 Apr DISC @ 50MG A 074386 003 May 23, 1996 Apr DISC @ 100MG A 074386 004 May 23, 1996 Apr DISC

CARBAMAZEPINE CAPSULE, EXTENDED RELEASE;ORAL CARBAMAZEPINE AB NOSTRUM LABS INC 100MG A 076697 001 May 20, 2011 May CMFD AB 200MG A 076697 002 May 20, 2011 May CMFD AB 300MG A 076697 003 May 20, 2011 May CMFD TABLET;ORAL CARBAMAZEPINE AB TORRENT PHARMS 100MG A 077272 001 Dec 07, 2005 Mar CTEC AB UMEDICA LABS PVT LTD 100MG A 207798 001 Apr 15, 2020 Mar NEWA AB 200MG A 207798 002 Apr 15, 2020 Mar NEWA TABLET, CHEWABLE;ORAL CARBAMAZEPINE AB ! TARO PHARM INDS 100MG A 075687 001 Oct 24, 2000 Aug CHRS TEGRETOL + @ NOVARTIS 100MG N 018281 001 Aug DISC TABLET, EXTENDED RELEASE;ORAL CARBAMAZEPINE AB UNIQUE PHARM 100MG A 211623 001 Apr 24, 2020 Apr NEWA AB 200MG A 211623 002 Apr 24, 2020 Apr NEWA AB 400MG A 211623 003 Apr 24, 2020 Apr NEWA

CARBIDOPA TABLET;ORAL CARBIDOPA AB ANI PHARMS INC 25MG A 203261 001 Mar 10, 2014 Jan CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -22

CARBIDOPA; ENTACAPONE; LEVODOPA TABLET;ORAL CARBIDOPA, LEVODOPA AND ENTACAPONE >D> AB MYLAN 12.5MG;200MG;50MG A 203424 001 Aug 13, 2020 Sep DISC >A> @ 12.5MG;200MG;50MG A 203424 001 Aug 13, 2020 Sep DISC AB 12.5MG;200MG;50MG A 203424 001 Aug 13, 2020 Jul NEWA >D> AB 18.75MG;200MG;75MG A 203424 002 Aug 13, 2020 Sep DISC >A> @ 18.75MG;200MG;75MG A 203424 002 Aug 13, 2020 Sep DISC AB 18.75MG;200MG;75MG A 203424 002 Aug 13, 2020 Jul NEWA >D> AB 25MG;200MG;100MG A 203424 003 Aug 13, 2020 Sep DISC >A> @ 25MG;200MG;100MG A 203424 003 Aug 13, 2020 Sep DISC AB 25MG;200MG;100MG A 203424 003 Aug 13, 2020 Jul NEWA >D> AB 31.25MG;200MG;125MG A 203424 004 Aug 13, 2020 Sep DISC >A> @ 31.25MG;200MG;125MG A 203424 004 Aug 13, 2020 Sep DISC AB 31.25MG;200MG;125MG A 203424 004 Aug 13, 2020 Jul NEWA >D> AB 37.5MG;200MG;150MG A 203424 005 Aug 13, 2020 Sep DISC >A> @ 37.5MG;200MG;150MG A 203424 005 Aug 13, 2020 Sep DISC AB 37.5MG;200MG;150MG A 203424 005 Aug 13, 2020 Jul NEWA >D> AB 50MG;200MG;200MG A 203424 006 Aug 13, 2020 Sep DISC >A> @ 50MG;200MG;200MG A 203424 006 Aug 13, 2020 Sep DISC AB 50MG;200MG;200MG A 203424 006 Aug 13, 2020 Jul NEWA STALEVO 125 >D> AB + ORION PHARMA 31.25MG;200MG;125MG N 021485 006 Aug 29, 2008 Sep CTEC >A> + 31.25MG;200MG;125MG N 021485 006 Aug 29, 2008 Sep CTEC AB + 31.25MG;200MG;125MG N 021485 006 Aug 29, 2008 Jul CTEC STALEVO 200 >D> AB +! ORION PHARMA 50MG;200MG;200MG N 021485 004 Aug 02, 2007 Sep CTEC >A> +! 50MG;200MG;200MG N 021485 004 Aug 02, 2007 Sep CTEC AB +! 50MG;200MG;200MG N 021485 004 Aug 02, 2007 Jul CTEC STALEVO 50 >D> AB +! ORION PHARMA 12.5MG;200MG;50MG N 021485 001 Jun 11, 2003 Sep CTEC >A> +! 12.5MG;200MG;50MG N 021485 001 Jun 11, 2003 Sep CTEC AB +! 12.5MG;200MG;50MG N 021485 001 Jun 11, 2003 Jul CTEC STALEVO 75 >D> AB + ORION PHARMA 18.75MG;200MG;75MG N 021485 005 Aug 29, 2008 Sep CTEC >A> + 18.75MG;200MG;75MG N 021485 005 Aug 29, 2008 Sep CTEC AB + 18.75MG;200MG;75MG N 021485 005 Aug 29, 2008 Jul CTEC

CARBIDOPA; LEVODOPA TABLET, EXTENDED RELEASE;ORAL SINEMET CR + @ MERCK SHARP DOHME 25MG;100MG N 019856 002 Dec 24, 1992 Jan DISC

CARBOPLATIN INJECTABLE;INJECTION CARBOPLATIN AP EUGIA PHARMA 600MG/60ML (10MG/ML) A 205487 004 Aug 03, 2020 Jul NEWA INJECTABLE;INTRAVENOUS CARBOPLATIN ! ACCORD HLTHCARE 1GM/100ML (10MG/ML) A 206775 005 Apr 06, 2020 Jul NEWA >D> @ EUGIA PHARMA 50MG/5ML (10MG/ML) A 205487 001 Mar 28, 2016 Sep CMFD >A> AP 50MG/5ML (10MG/ML) A 205487 001 Mar 28, 2016 Sep CMFD @ 50MG/5ML (10MG/ML) A 205487 001 Mar 28, 2016 Mar DISC >D> @ 150MG/15ML (10MG/ML) A 205487 002 Mar 28, 2016 Sep CMFD >A> AP 150MG/15ML (10MG/ML) A 205487 002 Mar 28, 2016 Sep CMFD @ 150MG/15ML (10MG/ML) A 205487 002 Mar 28, 2016 Mar DISC >D> @ 450MG/45ML (10MG/ML) A 205487 003 Mar 28, 2016 Sep CMFD >A> AP 450MG/45ML (10MG/ML) A 205487 003 Mar 28, 2016 Sep CMFD @ 450MG/45ML (10MG/ML) A 205487 003 Mar 28, 2016 Mar DISC >D> AP INGENUS PHARMS LLC 50MG/5ML (10MG/ML) A 208487 001 Apr 26, 2017 Sep CAHN >D> AP 150MG/15ML (10MG/ML) A 208487 002 Apr 26, 2017 Sep CAHN >D> AP 450MG/45ML (10MG/ML) A 208487 003 Apr 26, 2017 Sep CAHN >D> AP 600MG/60ML (10MG/ML) A 208487 004 Apr 26, 2017 Sep CAHN >A> AP NOVAST LABS 50MG/5ML (10MG/ML) A 208487 001 Apr 26, 2017 Sep CAHN >A> AP 150MG/15ML (10MG/ML) A 208487 002 Apr 26, 2017 Sep CAHN >A> AP 450MG/45ML (10MG/ML) A 208487 003 Apr 26, 2017 Sep CAHN >A> AP 600MG/60ML (10MG/ML) A 208487 004 Apr 26, 2017 Sep CAHN @ PLIVA LACHEMA 50MG/5ML (10MG/ML) A 078631 001 Dec 02, 2008 Apr DISC @ 150MG/15ML (10MG/ML) A 078631 002 Dec 02, 2008 Apr DISC @ 450MG/45ML (10MG/ML) A 078631 003 Dec 02, 2008 Apr DISC @ 600MG/60ML (10MG/ML) A 078631 004 Dec 02, 2008 Apr DISC @ TEVA PHARMS USA 50MG/5ML (10MG/ML) A 077139 001 Sep 21, 2005 May DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -23

INJECTABLE;INTRAVENOUS CARBOPLATIN @ 150MG/15ML (10MG/ML) A 077139 002 Sep 21, 2005 May DISC @ 450MG/45ML (10MG/ML) A 077139 003 Sep 21, 2005 May DISC @ 600MG/60ML (10MG/ML) A 077139 004 Sep 21, 2005 May DISC

CARFILZOMIB POWDER;INTRAVENOUS CARFILZOMIB >D> AP APOTEX 30MG/VIAL A 211185 001 Mar 20, 2020 Sep DISC >A> @ 30MG/VIAL A 211185 001 Mar 20, 2020 Sep DISC AP 30MG/VIAL A 211185 001 Mar 20, 2020 Mar NFTG >D> AP 60MG/VIAL A 209425 001 Mar 16, 2020 Sep DISC >A> @ 60MG/VIAL A 209425 001 Mar 16, 2020 Sep DISC AP 60MG/VIAL A 209425 001 Mar 16, 2020 Mar NEWA KYPROLIS >D> AP + ONYX THERAP 30MG/VIAL N 202714 002 Jun 03, 2016 Sep CTEC >A> + 30MG/VIAL N 202714 002 Jun 03, 2016 Sep CTEC AP + 30MG/VIAL N 202714 002 Jun 03, 2016 Mar CFTG

CARGLUMIC ACID TABLET, FOR SUSPENSION;ORAL CARBAGLU +! RECORDATI RARE 200MG N 022562 001 Mar 18, 2010 Aug CDFR

CARISOPRODOL TABLET;ORAL CARISOPRODOL @ HIKMA INTL PHARMS 350MG A 040124 001 Jan 24, 1996 Feb DISC >A> AA NOSTRUM LABS INC 350MG A 207237 002 Sep 21, 2020 Sep NEWA AA OXFORD PHARMS 350MG A 040188 001 Mar 07, 1997 Apr CMFD

CEDAZURIDINE; DECITABINE TABLET;ORAL INQOVI +! OTSUKA 100MG;35MG N 212576 001 Jul 07, 2020 Jul NEWA

CEFEPIME HYDROCHLORIDE INJECTABLE;INJECTION CEFEPIME HYDROCHLORIDE AP ASTRAL EQ 1GM BASE/VIAL A 212721 001 Jul 21, 2020 Jul NEWA AP EQ 2GM BASE/VIAL A 212721 002 Jul 21, 2020 Jul NEWA

CEFIXIME CAPSULE;ORAL CEFIXIME >D> AB ALKEM LABS LTD 400MG A 210574 001 Oct 09, 2018 Sep CTEC >A> ! 400MG A 210574 001 Oct 09, 2018 Sep CHRS >A> 400MG A 210574 001 Oct 09, 2018 Sep CTEC SUPRAX >D> AB +! LUPIN LTD 400MG N 203195 001 Jun 01, 2012 Sep DISC >A> + @ 400MG N 203195 001 Jun 01, 2012 Sep DISC FOR SUSPENSION;ORAL SUPRAX @ LUPIN PHARMS 100MG/5ML A 065129 001 Feb 23, 2004 Jan DISC TABLET;ORAL SUPRAX @ LUPIN PHARMS 400MG A 065130 001 Feb 12, 2004 Jan DISC

CEFOXITIN SODIUM INJECTABLE;INJECTION MEFOXIN IN PLASTIC CONTAINER @ MYLAN INSTITUTIONAL EQ 20MG BASE/ML A 063182 001 Jan 25, 1993 Mar DISC @ EQ 40MG BASE/ML A 063182 002 Jan 25, 1993 Mar DISC

CEFPROZIL FOR SUSPENSION;ORAL CEFPROZIL @ TEVA PHARMS 125MG/5ML A 065236 001 Dec 08, 2005 Apr DISC @ 250MG/5ML A 065236 002 Dec 08, 2005 Apr DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -24

CELECOXIB CAPSULE;ORAL CELECOXIB AB NANJING 200MG A 213598 001 May 13, 2020 Apr NEWA AB QINGDAO BAHEAL PHARM 50MG A 208856 001 Aug 07, 2019 Aug CMFD @ 50MG A 208856 001 Aug 07, 2019 May DISC AB 100MG A 208856 002 Aug 07, 2019 Aug CMFD @ 100MG A 208856 002 Aug 07, 2019 May DISC AB 200MG A 208856 003 Aug 07, 2019 Aug CMFD @ 200MG A 208856 003 Aug 07, 2019 May DISC AB 400MG A 208856 004 Aug 07, 2019 Aug CMFD @ 400MG A 208856 004 Aug 07, 2019 May DISC AB TIANJIN TIANYAO 50MG A 207872 001 Feb 25, 2020 Feb NEWA AB 100MG A 207872 002 Feb 25, 2020 Feb NEWA AB 200MG A 207872 003 Feb 25, 2020 Feb NEWA AB 400MG A 207872 004 Feb 25, 2020 Feb NEWA AB UMEDICA LABS PVT LTD 50MG A 210628 001 Nov 27, 2019 Jan CDFR AB 100MG A 210628 002 Nov 27, 2019 Jan CDFR AB 200MG A 210628 003 Nov 27, 2019 Jan CDFR AB 400MG A 210628 004 Nov 27, 2019 Jan CDFR >A> YILING@ 50MG A 211412 001 Mar 06, 2020 Sep DISC >A> @ 100MG A 211412 002 Mar 06, 2020 Sep DISC >A> @ 200MG A 211412 003 Mar 06, 2020 Sep DISC >A> @ 400MG A 211412 004 Mar 06, 2020 Sep DISC >D> AB YILING PHARM LTD 50MG A 211412 001 Mar 06, 2020 Sep DISC AB 50MG A 211412 001 Mar 06, 2020 Feb NEWA >D> AB 100MG A 211412 002 Mar 06, 2020 Sep DISC AB 100MG A 211412 002 Mar 06, 2020 Feb NEWA >D> AB 200MG A 211412 003 Mar 06, 2020 Sep DISC AB 200MG A 211412 003 Mar 06, 2020 Feb NEWA >D> AB 400MG A 211412 004 Mar 06, 2020 Sep DISC AB 400MG A 211412 004 Mar 06, 2020 Feb NEWA SOLUTION;ORAL >D> ELYXYB >D> +! DR REDDYS 25MG/ML N 212157 001 May 05, 2020 Sep DISC >A> + @ 25MG/ML N 212157 001 May 05, 2020 Sep DISC +! 25MG/ML N 212157 001 May 05, 2020 Jun CAHN +! 25MG/ML N 212157 001 May 05, 2020 May NEWA

CENOBAMATE TABLET;ORAL XCOPRI + SK LIFE 12.5MG N 212839 001 Mar 10, 2020 Mar NEWA + 25MG N 212839 002 Mar 10, 2020 Mar NEWA + 50MG N 212839 003 Mar 10, 2020 Mar NEWA + 100MG N 212839 004 Mar 10, 2020 Mar NEWA + 150MG N 212839 005 Mar 10, 2020 Mar NEWA +! 200MG N 212839 006 Mar 10, 2020 Mar NEWA

CHENODIOL TABLET;ORAL CHENODIOL ! LGM PHARMA 250MG A 091019 001 Oct 22, 2009 Aug CAHN

CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE CAPSULE;ORAL CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE AB MISEMER 5MG;2.5MG A 210579 001 Jul 29, 2020 Jul NEWA >A> AB NUVO PHARMS INC 5MG;2.5MG A 211421 001 Jul 07, 2020 Sep CAHN >D> AB SUNRISE PHARM INC 5MG;2.5MG A 211421 001 Jul 07, 2020 Sep CAHN AB 5MG;2.5MG A 211421 001 Jul 07, 2020 Jul NFTG LIBRAX AB +! BAUSCH 5MG;2.5MG N 012750 001 Jul CFTG +! 5MG;2.5MG N 012750 001 Jun CAHN

CHLOROQUINE PHOSPHATE TABLET;ORAL ARALEN + @ SANOFI AVENTIS US 500MG N 006002 001 Apr CPOT CHLOROQUINE PHOSPHATE @ HIKMA PHARMS EQ 150MG BASE A 083082 001 Feb DISC @ 250MG A 083082 001 Apr CPOT RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -25

TABLET;ORAL CHLOROQUINE PHOSPHATE >D> AA 500MG A 083082 002 Sep 17, 1999 Sep DISC >A> @ 500MG A 083082 002 Sep 17, 1999 Sep DISC AA 500MG A 083082 002 Sep 17, 1999 Apr CPOT @ IMPAX LABS 250MG A 080880 001 Apr CPOT @ 500MG A 040516 001 Aug 29, 2003 Apr CPOT AA IPCA LABS LTD 250MG A 090610 001 Dec 03, 2009 Apr CPOT AA 500MG A 090249 001 Dec 03, 2009 Apr CPOT @ MD PHARM 250MG A 087228 001 Apr CPOT AA ! NATCO PHARMA LTD EQ 150MG BASE A 091621 001 Jan 21, 2011 Feb CHRS AA ! 250MG A 091621 001 Jan 21, 2011 Apr CPOT AA ! 500MG A 090612 001 Jan 21, 2011 Apr CPOT @ PUREPAC PHARM 250MG A 080886 001 Apr CPOT @ TEVA 250MG A 087504 001 Jan 13, 1982 Apr CPOT @ WATSON LABS 250MG A 087979 001 Dec 21, 1982 Apr CPOT @ 500MG A 088030 001 Dec 21, 1982 Apr CPOT

CHLORPROMAZINE HYDROCHLORIDE INJECTABLE;INJECTION CHLORPROMAZINE HYDROCHLORIDE AP AUROBINDO PHARMA LTD 25MG/ML A 211816 001 Jul 07, 2020 Jul NEWA AP ! WEST-WARD PHARMS INT 25MG/ML A 083329 001 Jul CTEC TABLET;ORAL CHLORPROMAZINE HYDROCHLORIDE AB MAYNE PHARMA 10MG A 213590 001 Aug 31, 2020 Aug NEWA AB 25MG A 213590 002 Aug 31, 2020 Aug NEWA AB 50MG A 213590 003 Aug 31, 2020 Aug NEWA AB 100MG A 213590 004 Aug 31, 2020 Aug NEWA AB 200MG A 213590 005 Aug 31, 2020 Aug NEWA AB ZYDUS 10MG A 213368 001 Jan 17, 2020 Jan NEWA AB 25MG A 213368 002 Jan 17, 2020 Jan NEWA AB 50MG A 213368 003 Jan 17, 2020 Jan NEWA AB 100MG A 213368 004 Jan 17, 2020 Jan NEWA AB 200MG A 213368 005 Jan 17, 2020 Jan NEWA

CHLORTHALIDONE TABLET;ORAL CHLORTHALIDONE AB ALKEM LABS LTD 25MG A 213412 001 Feb 11, 2020 Jan NEWA AB 50MG A 213412 002 Feb 11, 2020 Jan NEWA AB DR REDDYS 25MG A 210742 001 Oct 12, 2018 Aug CAHN AB 50MG A 210742 002 Oct 12, 2018 Aug CAHN AB VISTAPHARM 25MG A 211063 001 Feb 26, 2019 Feb CAHN AB 50MG A 211063 002 Feb 26, 2019 Feb CAHN

CHLORZOXAZONE TABLET;ORAL CHLORZOXAZONE AA AUROBINDO PHARMA LTD 500MG A 089853 001 May 04, 1988 Aug CAHN AA AUROLIFE PHARMA LLC 500MG A 089853 001 May 04, 1988 Jun CMFD AB GLENMARK PHARMS LTD 375MG A 212185 001 May 26, 2020 May NEWA AB 750MG A 212185 002 May 26, 2020 May NEWA >A> AB I3 PHARMS 375MG A 212053 001 Sep 14, 2020 Sep NEWA >A> AB 750MG A 212053 002 Sep 14, 2020 Sep NEWA AB MAYNE PHARMA 375MG A 211849 001 Jul 21, 2020 Jul NEWA AA 500MG A 211849 002 Jul 21, 2020 Jul NEWA AB 750MG A 211849 003 Jul 21, 2020 Jul NEWA AB TEVA PHARMS USA INC 375MG A 212898 001 Jun 17, 2020 Jun NEWA AB 750MG A 212898 002 Jun 17, 2020 Jun NEWA

CHOLESTYRAMINE POWDER;ORAL CHOLESTYRAMINE AB AJANTA PHARMA LTD EQ 4GM RESIN/PACKET A 211119 001 Apr 06, 2020 Mar NEWA AB EQ 4GM RESIN/SCOOPFUL A 211119 002 Apr 06, 2020 Mar NEWA LOCHOLEST >D> @ ALLIED EQ 4GM RESIN/PACKET A 074561 001 Aug 15, 1996 Sep CAHN @ EQ 4GM RESIN/PACKET A 074561 001 Aug 15, 1996 Feb CAHN >D> @ EQ 4GM RESIN/SCOOPFUL A 074561 002 Aug 15, 1996 Sep CAHN @ EQ 4GM RESIN/SCOOPFUL A 074561 002 Aug 15, 1996 Feb CAHN >A> @ CHARTWELL RX EQ 4GM RESIN/PACKET A 074561 001 Aug 15, 1996 Sep CAHN >A> @ EQ 4GM RESIN/SCOOPFUL A 074561 002 Aug 15, 1996 Sep CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -26

POWDER;ORAL LOCHOLEST @ INVATECH EQ 4GM RESIN/PACKET A 074561 001 Aug 15, 1996 Jan CAHN @ EQ 4GM RESIN/SCOOPFUL A 074561 002 Aug 15, 1996 Jan CAHN LOCHOLEST LIGHT @ ALLIED EQ 4GM RESIN/PACKET A 074562 001 Aug 15, 1996 Feb CAHN @ EQ 4GM RESIN/SCOOPFUL A 074562 002 Aug 15, 1996 Feb CAHN

CHOLINE FENOFIBRATE CAPSULE, DELAYED RELEASE;ORAL FENOFIBRIC ACID AB MICRO LABS EQ 45MG FENOFIBRIC ACID A 213450 001 Jun 16, 2020 Jun NEWA AB EQ 135MG FENOFIBRIC ACID A 213450 002 Jun 16, 2020 Jun NEWA AB TWI PHARMS EQ 45MG FENOFIBRIC ACID A 210469 001 Jul 05, 2019 Mar CMFD AB EQ 135MG FENOFIBRIC ACID A 210469 002 Jul 05, 2019 Mar CMFD

CILOSTAZOL TABLET;ORAL CILOSTAZOL AB CHARTWELL RX 50MG A 077831 002 Sep 24, 2012 Aug CMS1

CIMETIDINE TABLET;ORAL CIMETIDINE >D> AB HIKMA 200MG A 074890 001 Dec 18, 1998 Sep DISC >A> @ 200MG A 074890 001 Dec 18, 1998 Sep DISC >D> AB 300MG A 074890 002 Dec 18, 1998 Sep DISC >A> @ 300MG A 074890 002 Dec 18, 1998 Sep DISC >D> AB 400MG A 074890 003 Dec 18, 1998 Sep DISC >A> @ 400MG A 074890 003 Dec 18, 1998 Sep DISC >D> AB 800MG A 074890 004 Dec 18, 1998 Sep DISC >A> @ 800MG A 074890 004 Dec 18, 1998 Sep DISC

CIMETIDINE HYDROCHLORIDE INJECTABLE;INJECTION CIMETIDINE HYDROCHLORIDE @ DAVA PHARMS INC EQ 300MG BASE/2ML A 074428 001 Apr 25, 1996 May DISC

CINACALCET HYDROCHLORIDE TABLET;ORAL CINACALCET HYDROCHLORIDE AB ACCORD HLTHCARE EQ 30MG BASE A 211892 001 May 15, 2020 May NEWA AB EQ 60MG BASE A 211892 002 May 15, 2020 May NEWA AB EQ 90MG BASE A 211892 003 May 15, 2020 May NEWA AB ACME LABS EQ 30MG BASE A 213325 001 May 18, 2020 May NEWA AB EQ 60MG BASE A 213325 002 May 18, 2020 May NEWA AB EQ 90MG BASE A 213325 003 May 18, 2020 May NEWA >A> AB DR REDDYS EQ 30MG BASE A 208368 001 Sep 18, 2020 Sep NEWA >A> AB EQ 60MG BASE A 208368 002 Sep 18, 2020 Sep NEWA >A> AB EQ 90MG BASE A 208368 003 Sep 18, 2020 Sep NEWA >A> AB HETERO LABS LTD V EQ 30MG BASE A 209403 001 Oct 07, 2020 Sep NEWA >A> AB EQ 60MG BASE A 209403 002 Oct 07, 2020 Sep NEWA >A> AB EQ 90MG BASE A 209403 003 Oct 07, 2020 Sep NEWA @ LUPIN LTD EQ 30MG BASE A 210548 001 Jun 28, 2019 Jan DISC @ EQ 60MG BASE A 210548 002 Jun 28, 2019 Jan DISC @ EQ 90MG BASE A 210548 003 Jun 28, 2019 Jan DISC

CIPROFLOXACIN; DEXAMETHASONE SUSPENSION/DROPS;OTIC CIPRODEX AB +! NOVARTIS 0.3%;0.1% N 021537 001 Jul 18, 2003 Jul CFTG CIPROFLOXACIN AND DEXAMETHASONE AB DR REDDYS LABS LTD 0.3%;0.1% A 205548 001 Aug 10, 2020 Jul NFTG

CISATRACURIUM BESYLATE INJECTABLE;INJECTION CISATRACURIUM BESYLATE AP AUROBINDO PHARMA LTD EQ 2MG BASE/ML A 209144 001 May 08, 2020 Apr NEWA AP HOSPIRA INC EQ 2MG BASE/ML A 203238 001 Mar 30, 2018 Jan CMFD AP PIRAMAL HLTHCARE UK EQ 2MG BASE/ML A 212190 001 May 04, 2020 Apr NEWA AP ZYDUS PHARMS EQ 2MG BASE/ML A 213527 001 Aug 31, 2020 Aug NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -27

CITALOPRAM HYDROBROMIDE TABLET;ORAL CITALOPRAM HYDROBROMIDE @ JUBILANT GENERICS EQ 10MG BASE A 205407 001 Dec 23, 2015 Mar DISC @ EQ 20MG BASE A 205407 002 Dec 23, 2015 Mar DISC @ EQ 40MG BASE A 205407 003 Dec 23, 2015 Mar DISC

CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE GEL;VAGINAL PHEXXI +! EVOFEM INC 1%;1.8%;0.4% N 208352 001 May 22, 2020 May NEWA

CLARITHROMYCIN TABLET;ORAL CLARITHROMYCIN >D> AB HIKMA 250MG A 065178 002 May 25, 2004 Sep DISC >A> @ 250MG A 065178 002 May 25, 2004 Sep DISC >D> AB 500MG A 065178 001 May 25, 2004 Sep DISC >A> @ 500MG A 065178 001 May 25, 2004 Sep DISC

CLASCOTERONE CREAM;TOPICAL WINLEVI +! CASSIOPEA SPA 1% N 213433 001 Aug 26, 2020 Aug NEWA

CLEMASTINE FUMARATE SYRUP;ORAL CLEMASTINE FUMARATE ! GENUS EQ 0.5MG BASE/5ML A 073399 001 Jun 30, 1994 Jul CAHN

CLINDAMYCIN PHOSPHATE AEROSOL, FOAM;TOPICAL CLINDAMYCIN PHOSPHATE @ TARO PHARM INDS LTD 1% A 210004 001 Mar 11, 2020 May DISC AT 1% A 210004 001 Mar 11, 2020 Feb NEWA GEL;TOPICAL CLINDAMYCIN PHOSPHATE AB SOLARIS PHARMA CORP EQ 1% BASE A 211872 001 Jul 29, 2020 Jul NEWA INJECTABLE;INJECTION CLINDAMYCIN PHOSPHATE @ ALVOGEN EQ 150MG BASE/ML A 062801 001 Jul 24, 1987 Jul DISC SOLUTION;TOPICAL CLINDAMYCIN PHOSPHATE >D> AT FOUGERA PHARMS EQ 1% BASE A 065254 001 Feb 14, 2006 Sep DISC >A> @ EQ 1% BASE A 065254 001 Feb 14, 2006 Sep DISC @ G AND W LABS INC EQ 1% BASE A 062811 001 Sep 01, 1988 Jul DISC @ VINTAGE PHARMS EQ 1% BASE A 203343 001 May 29, 2015 Jun DISC SWAB;TOPICAL CLEOCIN >D> AT + PHARMACIA AND UPJOHN EQ 1% BASE N 050537 002 Feb 22, 1994 Sep CHRS >A> AT +! EQ 1% BASE N 050537 002 Feb 22, 1994 Sep CHRS

CLOBAZAM SUSPENSION;ORAL CLOBAZAM AB HETERO LABS LTD III 2.5MG/ML A 209796 001 Feb 24, 2020 Feb NEWA AB LANNETT CO INC 2.5MG/ML A 213110 001 Apr 24, 2020 Apr NEWA @ TEVA PHARMS USA 2.5MG/ML A 211032 001 Jan 31, 2020 Apr DISC AB 2.5MG/ML A 211032 001 Jan 31, 2020 Jan NEWA TABLET;ORAL CLOBAZAM AB APOTEX 10MG A 209853 001 Jun 09, 2020 Jun NEWA AB 20MG A 209853 002 Jun 09, 2020 Jun NEWA

CLOBETASOL PROPIONATE CREAM;TOPICAL CLOBETASOL PROPIONATE AB1 ALEOR DERMACEUTICALS 0.05% A 213291 001 Jan 27, 2020 Jan NEWA AB1 ENCUBE 0.05% A 212982 001 Aug 28, 2020 Aug NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -28

CREAM;TOPICAL CLOBETASOL PROPIONATE (EMOLLIENT) AB2 ANI PHARMS INC 0.05% A 075733 001 Aug 22, 2001 Jun CAHN AB2 INGENUS PHARMS LLC 0.05% A 075733 001 Aug 22, 2001 May CAHN LOTION;TOPICAL IMPEKLO +! MYLAN 0.05% N 213691 001 May 19, 2020 Jun CAHN +! MYLAN LABS INC 0.05% N 213691 001 May 19, 2020 May NEWA SHAMPOO;TOPICAL CLOBETASOL PROPIONATE AB ALEOR DERMACEUTICALS 0.05% A 213290 001 May 18, 2020 May NEWA SPRAY;TOPICAL CLOBETASOL PROPIONATE >D> @ ALEOR DERMACEUTICALS 0.05% A 211191 001 Oct 02, 2019 Sep CMFD >A> AT 0.05% A 211191 001 Oct 02, 2019 Sep CMFD @ 0.05% A 211191 001 Oct 02, 2019 Jan DISC

CLOCORTOLONE PIVALATE CREAM;TOPICAL CLOCORTOLONE PIVALATE AB TARO 0.1% A 206370 001 Apr 21, 2020 Apr NFTG CLODERM AB +! EPI HLTH 0.1% N 017765 001 Apr CFTG

CLOFARABINE SOLUTION;INTRAVENOUS CLOFARABINE >D> AP INGENUS PHARMS LLC 20MG/20ML (1MG/ML) A 210270 001 Sep 14, 2018 Sep CAHN >A> AP NOVAST LABS 20MG/20ML (1MG/ML) A 210270 001 Sep 14, 2018 Sep CAHN

CLOMIPHENE CITRATE TABLET;ORAL MILOPHENE @ GRANATA BIO 50MG A 072196 001 Dec 20, 1988 Jul CAHN

CLOMIPRAMINE HYDROCHLORIDE CAPSULE;ORAL CLOMIPRAMINE HYDROCHLORIDE >A> AB AJANTA PHARMA LTD 25MG A 213897 001 Oct 02, 2020 Sep NEWA >A> AB 50MG A 213897 002 Oct 02, 2020 Sep NEWA >A> AB 75MG A 213897 003 Oct 02, 2020 Sep NEWA AB LEADING PHARMA LLC 25MG A 211364 001 Feb 07, 2020 Jan NEWA AB 50MG A 211364 002 Feb 07, 2020 Jan NEWA AB 75MG A 211364 003 Feb 07, 2020 Jan NEWA AB MANKIND PHARMA 25MG A 211767 001 Apr 08, 2019 Jan CMFD AB 50MG A 211767 002 Apr 08, 2019 Jan CMFD AB 75MG A 211767 003 Apr 08, 2019 Jan CMFD AB MICRO LABS 25MG A 213219 001 Jun 22, 2020 Jun NEWA AB 50MG A 213219 002 Jun 22, 2020 Jun NEWA AB 75MG A 213219 003 Jun 22, 2020 Jun NEWA @ TEVA 25MG A 074958 001 Aug 26, 1997 Feb DISC @ 50MG A 074958 002 Aug 26, 1997 Feb DISC @ 75MG A 074958 003 Aug 26, 1997 Feb DISC AB TULEX PHARMS INC 25MG A 210653 001 Apr 03, 2020 Mar NEWA AB 50MG A 210653 002 Apr 03, 2020 Mar NEWA AB 75MG A 210653 003 Apr 03, 2020 Mar NEWA AB UNIQUE PHARM LABS 25MG A 212285 001 Aug 07, 2020 Jul NEWA AB 50MG A 212285 002 Aug 07, 2020 Jul NEWA AB 75MG A 212285 003 Aug 07, 2020 Jul NEWA >D> AB VGYAAN 25MG A 213221 001 Jun 22, 2020 Sep DISC >A> @ 25MG A 213221 001 Jun 22, 2020 Sep DISC AB 25MG A 213221 001 Jun 22, 2020 Jun NEWA >D> AB 50MG A 213221 002 Jun 22, 2020 Sep DISC >A> @ 50MG A 213221 002 Jun 22, 2020 Sep DISC AB 50MG A 213221 002 Jun 22, 2020 Jun NEWA >D> AB 75MG A 213221 003 Jun 22, 2020 Sep DISC >A> @ 75MG A 213221 003 Jun 22, 2020 Sep DISC AB 75MG A 213221 003 Jun 22, 2020 Jun NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -29

CLONAZEPAM TABLET;ORAL CLONAZEPAM @ MYLAN 0.5MG A 075150 001 Oct 05, 1998 May DISC @ 1MG A 075150 002 Oct 05, 1998 Jun DISC @ 2MG A 075150 003 Oct 05, 1998 May DISC

CLONIDINE HYDROCHLORIDE INJECTABLE;INJECTION CLONIDINE HYDROCHLORIDE AP XGEN PHARMS 1MG/10ML (0.1MG/ML) A 203167 001 Oct 29, 2013 Feb CAHN AP 5MG/10ML (0.5MG/ML) A 203167 002 Oct 29, 2013 Feb CAHN TABLET;ORAL CLONIDINE HYDROCHLORIDE @ AUROBINDO PHARMA LTD 0.1MG A 070886 002 Aug 31, 1988 May CAHN @ 0.2MG A 070886 001 Aug 31, 1988 May CAHN @ 0.3MG A 070886 003 Aug 31, 1988 May CAHN >D> AB MYLAN 0.1MG A 070317 002 Jul 09, 1987 Sep DISC >A> @ 0.1MG A 070317 002 Jul 09, 1987 Sep DISC >D> AB 0.2MG A 070317 003 Jun 09, 1987 Sep DISC >A> @ 0.2MG A 070317 003 Jun 09, 1987 Sep DISC >D> AB 0.3MG A 070317 001 Jun 09, 1987 Sep DISC >A> @ 0.3MG A 070317 001 Jun 09, 1987 Sep DISC TABLET, EXTENDED RELEASE;ORAL CLONIDINE HYDROCHLORIDE AB1 UPSHER SMITH LABS 0.1MG A 211433 001 Oct 12, 2018 Feb CMFD

CLOPIDOGREL BISULFATE TABLET;ORAL CLOPIDOGREL BISULFATE >A> AB ADAPTIS EQ 75MG BASE A 204359 001 Feb 02, 2017 Sep CAHN AB ! APOTEX INC EQ 300MG BASE A 076274 002 Mar 04, 2014 May CHRS @ CELLTRION EQ 75MG BASE A 202266 001 Aug 14, 2012 Jun DISC @ EQ 300MG BASE A 202266 002 Nov 20, 2012 Jun DISC >D> AB GRAVITI PHARMS EQ 75MG BASE A 204359 001 Feb 02, 2017 Sep CAHN AB EQ 75MG BASE A 204359 001 Feb 02, 2017 Apr CAHN AB POLYGEN PHARMS EQ 75MG BASE A 213351 001 Jul 17, 2020 Jul NEWA AB EQ 300MG BASE A 213351 002 Jul 17, 2020 Jul NEWA PLAVIX AB + SANOFI AVENTIS US EQ 300MG BASE N 020839 002 Sep 20, 2007 May CHRS

CLORAZEPATE DIPOTASSIUM CAPSULE;ORAL CLORAZEPATE DIPOTASSIUM @ AUROLIFE PHARMA LLC 3.75MG A 072112 002 Aug 26, 1988 Feb CMS1 @ 7.5MG A 072112 003 Aug 26, 1988 Feb CMS1

COCAINE HYDROCHLORIDE SOLUTION;NASAL NUMBRINO CODY LABS INC 4% N 209575 001 Jan 10, 2020 Jan NEWA

CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE SYRUP;ORAL PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE AA PHARM ASSOC 10MG/5ML;5MG/5ML;6.25MG/5ML A 040660 001 Dec 07, 2006 Jun CAHN PROMETH VC W/ CODEINE AA ! NOSTRUM LABS INC 10MG/5ML;5MG/5ML;6.25MG/5ML A 088764 001 Oct 31, 1984 Jun CAHN

CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE SYRUP;ORAL PROMETHAZINE WITH CODEINE @ PHARM ASSOC 10MG/5ML;6.25MG/5ML A 040650 001 Jan 31, 2006 Jun CAHN @ VINTAGE 10MG/5ML;6.25MG/5ML A 040650 001 Jan 31, 2006 Apr DISC

COLCHICINE TABLET;ORAL COLCHICINE AB AMNEAL PHARMS 0.6MG A 204711 001 Sep 28, 2016 Jan CMFD AB GRANULES PHARMS 0.6MG A 210425 001 Feb 05, 2020 Jan NEWA ZYDUS PHARMS 0.3MG A 211519 002 Nov 14, 2019 Jul NEWA

RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -30

TABLET;ORAL COLCHICINE AB 0.6MG A 211519 001 Feb 19, 2019 Jul CMFD

COLESEVELAM HYDROCHLORIDE BAR, CHEWABLE;ORAL WELCHOL + @ DAIICHI SANKYO INC 3.75GM N 210895 001 Apr 03, 2019 Jun DISC FOR SUSPENSION;ORAL COLESEVELAM HYDROCHLORIDE AB GLENMARK PHARMS LTD 1.875GM/PACKET A 202190 001 Jul 16, 2018 Aug CTEC AB WATSON LABS INC 1.875GM/PACKET A 202178 001 Sep 01, 2020 Aug NEWA AB 3.75GM/PACKET A 202178 002 Sep 01, 2020 Aug NEWA TABLET;ORAL COLESEVELAM HYDROCHLORIDE AB INVAGEN PHARMS 625MG A 212602 001 Apr 20, 2020 Apr NEWA AB WATSON LABS INC 625MG A 200830 001 Sep 02, 2020 Aug NEWA AB ZHEJIANG JINGXIN 625MG A 209946 001 Jul 15, 2020 Jul NEWA

COLISTIMETHATE SODIUM INJECTABLE;INJECTION COLISTIMETHATE SODIUM @ EMCURE PHARMS LTD EQ 150MG BASE/VIAL A 202359 001 Sep 28, 2012 Aug DISC AP XGEN PHARMS EQ 150MG BASE/VIAL A 064216 001 Feb 26, 1999 Feb CAHN

>A> COPPER DOTATATE CU-64 >A> SOLUTION;INTRAVENOUS >A> DETECTNET >A> +! RADIOMEDIX 4mL (1mCi/ML) N 213227 001 Sep 03, 2020 Sep NEWA

CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE SOLUTION;INTRAVENOUS TRALEMENT +! AM REGENT EQ 0.3MG COPPER/ML;EQ 55MCG N 209376 001 Jul 02, 2020 Jul NEWA BASE/ML;EQ 60MCG BASE/ML;EQ 3MG BASE/ML

CYANOCOBALAMIN INJECTABLE;INJECTION CYANOCOBALAMIN >A> AP GLAND PHARMA LTD 1MG/ML A 214390 001 Sep 24, 2020 Sep NEWA SPRAY, METERED;NASAL CYANOCOBALAMIN AB PERRIGO UK FINCO 0.5MG/SPRAY A 212458 001 Sep 09, 2020 Aug NFTG NASCOBAL AB +! ENDO PHARMS INC 0.5MG/SPRAY N 021642 001 Jan 31, 2005 Aug CFTG

CYCLOBENZAPRINE HYDROCHLORIDE TABLET;ORAL CYCLOBENZAPRINE HYDROCHLORIDE AB MYLAN PHARMS INC 10MG A 073144 001 May 30, 1991 Jun CHRS AB ! RUBICON 10MG A 208170 003 May 31, 2017 Jun CHRS AB UNICHEM 5MG A 213324 001 Jul 06, 2020 Jul NEWA AB 7.5MG A 213324 002 Jul 06, 2020 Jul NEWA AB 10MG A 213324 003 Jul 05, 2020 Jul NEWA

CYCLOPHOSPHAMIDE CAPSULE;ORAL CYCLOPHOSPHAMIDE AB ANI PHARMS INC 25MG A 207014 001 Mar 19, 2018 Jan CAHN AB 50MG A 207014 002 Mar 19, 2018 Jan CAHN SOLUTION;INTRAVENOUS CYCLOPHOSPHAMIDE +! INGENUS PHARMS LLC 500MG/2.5ML (200MG/ML) N 212501 001 Jul 30, 2020 Jul NEWA +! 1GM/5ML (200MG/ML) N 212501 002 Jul 30, 2020 Jul NEWA TABLET;ORAL CYTOXAN + BAXTER HLTHCARE 25MG N 012141 002 Aug CMFD +! 50MG N 012141 001 Aug CMFD

RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -31

CYCLOSPORINE INJECTABLE;INJECTION CYCLOSPORINE AP PADDOCK LABS LLC 50MG/ML A 065151 001 Oct 07, 2003 Aug CAHN

CYPROHEPTADINE HYDROCHLORIDE TABLET;ORAL CYPROHEPTADINE HYDROCHLORIDE >D> AA APEX PHARMS INC 4MG A 207783 001 Dec 29, 2016 Sep CAHN AA APPCO 4MG A 206553 001 Nov 29, 2016 Mar CAHN @ PAR PHARM 4MG A 087129 001 May DISC >A> AA RISING 4MG A 207783 001 Dec 29, 2016 Sep CAHN

CYSTEAMINE BITARTRATE GRANULE;ORAL PROCYSBI + HORIZON PHARMA USA EQ 75MG BASE/PACKET N 213491 001 Feb 14, 2020 Feb NEWA +! EQ 300MG BASE/PACKET N 213491 002 Feb 14, 2020 Feb NEWA GRANULE, DELAYED RELEASE;ORAL PROCYSBI + HORIZON PHARMA USA EQ 75MG BASE/PACKET N 213491 001 Feb 14, 2020 Jul CDFR +! EQ 300MG BASE/PACKET N 213491 002 Feb 14, 2020 Jul CDFR

CYSTEAMINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC CYSTADROPS +! RECORDATI RARE EQ 0.37% BASE N 211302 001 Aug 19, 2020 Aug NEWA

CYSTEINE HYDROCHLORIDE SOLUTION;INTRAVENOUS NOURESS + @ AVADEL LEGACY 500MG/10ML (50MG/ML) N 212535 001 Dec 13, 2019 May CRLD @ 500MG/10ML (50MG/ML) N 212535 001 Dec 13, 2019 May DISC + @ EXELA PHARMA 500MG/10ML (50MG/ML) N 212535 001 Dec 13, 2019 Jul CAHN

CYTARABINE INJECTABLE;INJECTION CYTARABINE AP HONG KONG 20MG/ML A 206189 001 Jun 26, 2020 Jun NEWA

DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL DABIGATRAN ETEXILATE MESYLATE AB ALKEM LABS LTD EQ 75MG BASE A 208040 001 Mar 11, 2020 Feb NFTG AB EQ 150MG BASE A 208040 002 Mar 11, 2020 Feb NFTG AB HETERO LABS LTD III EQ 75MG BASE A 207961 001 May 06, 2020 Apr NEWA AB EQ 150MG BASE A 207961 002 May 06, 2020 Apr NEWA PRADAXA AB + BOEHRINGER INGELHEIM EQ 75MG BASE N 022512 001 Oct 19, 2010 Feb CFTG AB +! EQ 150MG BASE N 022512 002 Oct 19, 2010 Feb CFTG

DACTINOMYCIN INJECTABLE;INJECTION DACTINOMYCIN AP XGEN PHARMS 0.5MG/VIAL A 203999 001 May 20, 2019 Feb CAHN

DALFAMPRIDINE TABLET, EXTENDED RELEASE;ORAL DALFAMPRIDINE @ MYLAN 10MG A 206858 001 Jul 06, 2020 Jul DISC AB 10MG A 206858 001 Jul 06, 2020 Jul NEWA

DANTROLENE SODIUM INJECTABLE;INJECTION REVONTO AP USWM 20MG/VIAL A 078378 001 Jul 24, 2007 Jun CAHN

RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -32

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL QTERNMET XR + @ ASTRAZENECA AB 2.5MG;1GM;EQ 2.5MG BASE N 210874 001 May 02, 2019 Aug DISC + @ 5MG;1GM;EQ 2.5MG BASE N 210874 002 May 02, 2019 Aug DISC + @ 5MG;1GM;EQ 5MG BASE N 210874 003 May 02, 2019 Aug DISC + @ 10MG;1GM;EQ 5MG BASE N 210874 004 May 02, 2019 Aug DISC

DAPIPRAZOLE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC DAPIPRAZOLE HYDROCHLORIDE >D> @ BARADAINA LLC 0.5% A 204902 001 May 30, 2019 Sep CAHN >A> @ WOODWARD 0.5% A 204902 001 May 30, 2019 Sep CAHN

DAPSONE GEL;TOPICAL ACZONE AB +! ALMIRALL 7.5% N 207154 001 Feb 24, 2016 Jun CTEC DAPSONE AB TARO PHARMS 7.5% A 210191 001 Jun 26, 2019 Feb NEWA TABLET;ORAL DAPSONE >A> AB RISING 100MG A 207165 001 May 08, 2019 Sep CAHN >D> AB SAI LIFE SCIENCES 100MG A 207165 001 May 08, 2019 Sep CAHN

DAPTOMYCIN POWDER;IV (INFUSION) DAPTOMYCIN AP BE PHARMS 350MG/VIAL A 213425 001 Aug 20, 2020 Aug NEWA AP DR REDDYS 350MG/VIAL A 211403 001 Aug 31, 2020 Aug NEWA

DARIFENACIN HYDROBROMIDE TABLET, EXTENDED RELEASE;ORAL DARIFENACIN HYDROBROMIDE @ ALAN LABS INC EQ 7.5MG BASE A 209571 002 Oct 22, 2019 Apr DISC @ EQ 15MG BASE A 209571 001 Oct 22, 2019 Apr DISC @ ANCHEN PHARMS EQ 7.5MG BASE A 091190 001 Mar 13, 2015 Feb DISC @ EQ 15MG BASE A 091190 002 Mar 13, 2015 Feb DISC

DEFERASIROX GRANULE;ORAL DEFERASIROX AB ALKEM LABS LTD 90MG A 213374 001 Jul 14, 2020 Jul NFTG AB 180MG A 213374 002 Jul 14, 2020 Jul NFTG AB 360MG A 213374 003 Jul 14, 2020 Jul NFTG JADENU SPRINKLE AB + NOVARTIS 90MG N 207968 001 May 18, 2017 Jul CFTG AB + 180MG N 207968 002 May 18, 2017 Jul CFTG AB +! 360MG N 207968 003 May 18, 2017 Jul CFTG TABLET;ORAL DEFERASIROX AB ALEMBIC PHARMS LTD 180MG A 211824 003 Jun 15, 2020 Jun NEWA AB ALKEM LABS LTD 90MG A 210555 001 Mar 30, 2020 Mar NEWA AB 180MG A 210555 003 Jul 02, 2020 Jul NEWA AB 360MG A 210555 002 Mar 30, 2020 Mar NEWA AB AMNEAL 90MG A 210727 001 Dec 27, 2019 Feb CAHN AB 180MG A 210727 003 Jun 15, 2020 Jun NEWA AB 360MG A 210727 002 Dec 27, 2019 Feb CAHN AB CIPLA 90MG A 211852 001 Feb 11, 2020 Jan NEWA AB 180MG A 211852 003 Jun 15, 2020 Jun NEWA AB 360MG A 211852 002 Feb 11, 2020 Jan NEWA AB MSN 180MG A 210945 003 Jun 16, 2020 Jun NEWA AB PIRAMAL HLTHCARE UK 180MG A 212995 003 Jun 15, 2020 Jun NEWA AB SUN PHARM 180MG A 211641 003 Jun 15, 2020 Jun NEWA AB TEVA PHARMS USA 180MG A 209223 003 Apr 24, 2020 Apr NEWA AB ZYDUS PHARMS 180MG A 211383 003 Jun 15, 2020 Jun NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -33

DEFERIPRONE SOLUTION;ORAL FERRIPROX + CHIESI 80MG/ML N 208030 002 Apr 20, 2018 Mar CAHN +! 100MG/ML N 208030 001 Sep 09, 2015 Mar CAHN TABLET;ORAL DEFERIPRONE AB TARO PHARM INDS LTD 500MG A 208800 001 Feb 08, 2019 Aug CMFD FERRIPROX +! CHIESI 500MG N 021825 001 Oct 14, 2011 Mar CAHN + 1GM N 021825 002 Jul 25, 2019 Mar CAHN +! 1GM N 212269 001 May 19, 2020 May NEWA

DEFEROXAMINE MESYLATE INJECTABLE;INJECTION DEFEROXAMINE MESYLATE AP ! HOSPIRA 2GM/VIAL A 076019 002 Mar 17, 2004 Jul CHRS DESFERAL + @ NOVARTIS 2GM/VIAL N 016267 002 May 25, 2000 Jul DISC

DELAVIRDINE MESYLATE TABLET;ORAL RESCRIPTOR + @ VIIV HLTHCARE 200MG N 020705 002 Jul 14, 1999 Mar DISC

DESIPRAMINE HYDROCHLORIDE TABLET;ORAL DESIPRAMINE HYDROCHLORIDE @ ANI PHARMS INC 10MG A 205153 001 Oct 28, 2016 Aug DISC @ 25MG A 205153 002 Oct 28, 2016 Aug DISC @ 50MG A 205153 003 Oct 28, 2016 Aug DISC @ 75MG A 205153 004 Oct 28, 2016 Aug DISC @ 100MG A 205153 005 Oct 28, 2016 Aug DISC @ 150MG A 205153 006 Oct 28, 2016 Aug DISC

DESMOPRESSIN ACETATE INJECTABLE;INJECTION DESMOPRESSIN ACETATE AP UBI 0.004MG/ML A 210218 001 Feb 14, 2020 Feb NEWA >A> AP 0.004MG/ML A 210223 001 Sep 17, 2020 Sep NEWA TABLET;ORAL DESMOPRESSIN ACETATE @ IMPAX LABS INC 0.1MG A 077122 001 Jan 25, 2006 Aug DISC @ 0.2MG A 077122 002 Jan 25, 2006 Aug DISC MY LAN@ MYLAN@ 0.1MG A 200653 001 Jun 27, 2014 Jul DISC @ 0.2MG A 200653 002 Jun 27, 2014 Jul DISC

DESOGESTREL; ETHINYL ESTRADIOL TABLET;ORAL-28 DESOGESTREL AND ETHINYL ESTRADIOL AB NAARI PTE LTD 0.15MG,N/A;0.02MG,0.01MG A 209170 001 Jun 05, 2017 Jun CAHN @ 0.15MG;0.03MG A 207067 001 Sep 13, 2018 Jun CAHN EMOQUETTE @ VINTAGE PHARMS LLC 0.15MG;0.03MG A 076675 001 Feb 25, 2011 Apr DISC SIMLIYA AB AUROBINDO PHARMA LTD 0.15MG,N/A;0.02MG,0.01MG A 206853 001 Mar 22, 2017 Mar CTNA

DESONIDE GEL;TOPICAL DESONATE AB +! LEO PHARMA AS 0.05% N 021844 001 Oct 20, 2006 Apr CFTG DESONIDE AB CINTEX SVCS 0.05% A 202470 001 May 11, 2020 Aug CAHN AB TERESINA 0.05% A 202470 001 May 11, 2020 Apr NFTG LOTION;TOPICAL DESONIDE AB ALEOR DERMACEUTICALS 0.05% A 213632 001 Aug 24, 2020 Aug NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -34

DESOXIMETASONE CREAM;TOPICAL DESOXIMETASONE AB CADILA 0.25% A 205620 001 Sep 28, 2018 Mar CMFD AB COSETTE 0.25% A 209595 001 Mar 04, 2020 Feb NEWA OINTMENT;TOPICAL DESOXIMETASONE AB CADILA 0.25% A 205206 001 Sep 19, 2017 Aug CAHN

DESVENLAFAXINE TABLET, EXTENDED RELEASE;ORAL DESVENLAFAXINE >D> +! ALEMBIC PHARMS LTD 50MG N 204150 001 Mar 04, 2013 Sep CHRS >A> + 50MG N 204150 001 Mar 04, 2013 Sep CHRS

DESVENLAFAXINE SUCCINATE TABLET, EXTENDED RELEASE;ORAL DESVENLAFAXINE SUCCINATE @ MYLAN EQ 50MG BASE A 204095 001 Jun 29, 2015 Feb DISC AB RUBICON EQ 50MG BASE A 204028 001 Jun 29, 2015 Aug CAHN AB EQ 100MG BASE A 204028 002 Jun 29, 2015 Aug CAHN AB YICHANG HUMANWELL EQ 50MG BASE A 210014 001 Oct 01, 2018 Jun CMFD AB EQ 100MG BASE A 210014 002 Oct 01, 2018 Jun CMFD PRISTIQ >D> AB +! PF PRISM CV EQ 50MG BASE N 021992 001 Feb 29, 2008 Sep CHRS >A> AB + EQ 50MG BASE N 021992 001 Feb 29, 2008 Sep CHRS

DEXAMETHASONE SODIUM PHOSPHATE INJECTABLE;INJECTION DEXAMETHASONE SODIUM PHOSPHATE AP AUROBINDO PHARMA LTD EQ 10MG PHOSPHATE/ML A 210966 001 Jun 05, 2020 Jun NEWA >D> @ EQ 10MG PHOSPHATE/ML A 210967 001 Jun 07, 2019 Sep CMFD >A> AP EQ 10MG PHOSPHATE/ML A 210967 001 Jun 07, 2019 Sep CMFD

DEXAMETHASONE; TOBRAMYCIN SUSPENSION/DROPS;OPHTHALMIC TOBRADEX ST +! EYEVANCE 0.05%;0.3% N 050818 001 Feb 13, 2009 Feb CAHN

DEXMEDETOMIDINE HYDROCHLORIDE INJECTABLE;INJECTION DEXMEDETOMIDINE HYDROCHLORIDE AP AMNEAL PHARMS CO EQ 200MCG BASE/50ML (EQ 4MCG A 207551 001 May 20, 2020 May NEWA BASE/ML) AP EQ 400MCG BASE/100ML (EQ 4MCG A 207551 002 May 20, 2020 May NEWA BASE/ML) >D> @ CIPLA EQ 200MCG BASE/2ML (EQ 100MCG A 204843 001 Jan 18, 2019 Sep CAHN BASE/ML) AP GLAND PHARMA LTD EQ 200MCG BASE/50ML (EQ 4MCG A 209307 001 Jun 03, 2020 May NEWA BASE/ML) AP EQ 400MCG BASE/100ML (EQ 4MCG A 209307 002 Jun 03, 2020 May NEWA BASE/ML) AP HIKMA EQ 200MCG BASE/50ML (EQ 4MCG A 206407 001 Jan 30, 2020 Jan NEWA BASE/ML) AP EQ 400MCG BASE/100ML (EQ 4MCG A 206407 002 Jan 30, 2020 Jan NEWA BASE/ML) >A> @ HONG KONG EQ 200MCG BASE/2ML (EQ 100MCG A 204843 001 Jan 18, 2019 Sep CAHN BASE/ML) AP JIANGSU HENGRUI MED EQ 80MCG BASE/20ML (EQ 4MCG A 209065 002 Jun 12, 2020 Jun NEWA BASE/ML) AP EQ 200MCG BASE/2ML (EQ 100MCG A 209065 001 Sep 19, 2017 Jun CTNA BASE/ML) AP EQ 200MCG BASE/2ML (EQ 100MCG A 209065 001 Sep 19, 2017 Jan CTNA BASE/ML) AP EQ 200MCG BASE/50ML (EQ 4MCG A 209065 003 Jun 12, 2020 Jun NEWA BASE/ML) AP EQ 400MCG BASE/100ML (EQ 4MCG A 209065 004 Jun 12, 2020 Jun NEWA BASE/ML) AP MYLAN LABS LTD EQ 200MCG BASE/50ML (EQ 4MCG A 212571 001 Aug 27, 2020 Aug NEWA BASE/ML) AP EQ 400MCG BASE/100ML (EQ 4MCG A 212571 002 Aug 27, 2020 Aug NEWA BASE/ML) >A> AP PAR STERILE PRODUCTS EQ 200MCG BASE/50ML (EQ 4MCG A 208266 001 Sep 15, 2020 Sep NEWA BASE/ML) >A> AP EQ 400MCG BASE/100ML (EQ 4MCG A 208266 002 Sep 15, 2020 Sep NEWA

RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -35

INJECTABLE;INJECTION DEXMEDETOMIDINE HYDROCHLORIDE BASE/ML) PRECEDEX +! HOSPIRA EQ 1MG BASE/250ML (EQ 4MCG N 021038 005 Jan 31, 2020 Jun NEWA BASE/ML)

DEXMETHYLPHENIDATE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL DEXMETHYLPHENIDATE HYDROCHLORIDE AB GRANULES PHARMS 5MG A 213813 001 Sep 09, 2020 Aug NEWA AB 10MG A 213813 002 Sep 09, 2020 Aug NEWA AB 15MG A 213813 003 Sep 09, 2020 Aug NEWA AB 20MG A 213813 004 Sep 09, 2020 Aug NEWA AB 25MG A 213813 005 Sep 09, 2020 Aug NEWA AB 30MG A 213813 006 Sep 09, 2020 Aug NEWA AB 35MG A 213813 007 Sep 09, 2020 Aug NEWA AB 40MG A 213813 008 Sep 09, 2020 Aug NEWA TABLET;ORAL DEXMETHYLPHENIDATE HYDROCHLORIDE >D> AB BIONPHARMA INC 5MG A 209754 001 Mar 24, 2020 Sep DISC >A> @ 5MG A 209754 001 Mar 24, 2020 Sep DISC AB 5MG A 209754 001 Mar 24, 2020 Mar NEWA >D> AB 10MG A 209754 002 Mar 24, 2020 Sep DISC >A> @ 10MG A 209754 002 Mar 24, 2020 Sep DISC AB 10MG A 209754 002 Mar 24, 2020 Mar NEWA

DEXTROAMPHETAMINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL DEXTROAMPHETAMINE SULFATE @ PII 5MG A 205077 001 Jun 21, 2019 Jan DISC @ 10MG A 205077 002 Jun 21, 2019 Jan DISC @ 15MG A 205077 003 Jun 21, 2019 Jan DISC @ STRIDES PHARMA 5MG A 205077 001 Jun 21, 2019 Aug CAHN @ 10MG A 205077 002 Jun 21, 2019 Aug CAHN @ 15MG A 205077 003 Jun 21, 2019 Aug CAHN

DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE SYRUP;ORAL PROMETHAZINE DM AA ! SLATE 15MG/5ML;6.25MG/5ML A 040649 001 Feb 14, 2006 Mar CMFD @ 15MG/5ML;6.25MG/5ML A 040649 001 Feb 14, 2006 Feb CAHN PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE AA AMNEAL PHARMS 15MG/5ML;6.25MG/5ML A 090575 001 Feb 08, 2011 Mar CMFD @ HI TECH PHARMA 15MG/5ML;6.25MG/5ML A 040027 001 Jul 31, 1996 Mar DISC

DEXTROSE; POTASSIUM CHLORIDE INJECTABLE;INJECTION DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% >A> AP FRESENIUS KABI USA 5GM/100ML;75MG/100ML A 212346 001 Sep 10, 2020 Sep NEWA DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER >D> + BAXTER HLTHCARE 5GM/100ML;75MG/100ML N 017634 004 Sep CTEC >A> AP + 5GM/100ML;75MG/100ML N 017634 004 Sep CTEC DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% >A> AP FRESENIUS KABI USA 5GM/100ML;150MG/100ML A 212346 002 Sep 10, 2020 Sep NEWA

DEXTROSE; SODIUM CHLORIDE INJECTABLE;INJECTION DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER @ FRESENIUS KABI USA 2.5GM/100ML;450MG/100ML A 211190 001 Dec 20, 2019 Jun DISC DEXTROSE 5% AND SODIUM CHLORIDE 0.225% >A> AP FRESENIUS KABI USA 5GM/100ML;225MG/100ML A 211221 001 Sep 15, 2020 Sep NFTG DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER >D> +! ICU MEDICAL INC 5GM/100ML;225MG/100ML N 017606 001 Sep CFTG >A> AP +! 5GM/100ML;225MG/100ML N 017606 001 Sep CFTG DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER AP FRESENIUS KABI USA 5GM/100ML;300MG/100ML A 211194 001 Aug 26, 2020 Aug NFTG AP +! ICU MEDICAL INC 5GM/100ML;300MG/100ML N 017799 001 Aug CFTG DEXTROSE 5% AND SODIUM CHLORIDE 0.45% >A> AP FRESENIUS KABI USA 5GM/100ML;450MG/100ML A 211276 001 Sep 15, 2020 Sep NEWA DEXTROSE 5% AND SODIUM CHLORIDE 0.9% >A> AP FRESENIUS KABI USA 5GM/100ML;900MG/100ML A 211211 001 Sep 14, 2020 Sep NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -36

DIAZEPAM INJECTABLE;INJECTION DIAZEPAM >D> AP BELOTECA INC 10MG/2ML (5MG/ML) A 210363 001 Mar 18, 2019 Sep CHRS >A> ! 10MG/2ML (5MG/ML) A 210363 001 Mar 18, 2019 Sep CHRS >D> AP ! HOSPIRA 10MG/2ML (5MG/ML) A 072079 001 Dec 20, 1988 Sep DISC >A> @ 10MG/2ML (5MG/ML) A 072079 001 Dec 20, 1988 Sep DISC SPRAY;NASAL VALTOCO + NEURELIS INC 5MG/SPRAY N 211635 001 Jan 10, 2020 Jan NEWA + 7.5MG/SPRAY N 211635 002 Jan 10, 2020 Jan NEWA +! 10MG/SPRAY N 211635 003 Jan 10, 2020 Jan NEWA

DIAZOXIDE SUSPENSION;ORAL DIAZOXIDE AB NOVITIUM PHARMA 50MG/ML A 210799 001 Jul 08, 2020 Jul NEWA

DICLOFENAC EPOLAMINE SYSTEM;TOPICAL FLECTOR +! INST BIOCHEM 1.3% N 021234 001 Jan 31, 2007 Feb CDFR LICART +! IBSA INST BIO 1.3% N 206976 001 Dec 19, 2018 Apr CHRS + 1.3% N 206976 001 Dec 19, 2018 Apr CMFD

DICLOFENAC POTASSIUM CAPSULE;ORAL DICLOFENAC POTASSIUM @ STRIDES PHARMA 25MG A 210078 001 Dec 03, 2019 Jun DISC TABLET;ORAL CATAFLAM + @ NOVARTIS 50MG N 020142 002 Nov 24, 1993 Jan CRLD DICLOFENAC POTASSIUM >D> AB AMICI 50MG A 076561 001 Mar 18, 2004 Sep CAHN >A> AB ANDA REPOSITORY 50MG A 076561 001 Mar 18, 2004 Sep CAHN AB RUBICON 50MG A 075229 001 Nov 20, 1998 Aug CAHN

DICLOFENAC SODIUM GEL;TOPICAL DICLOFENAC SODIUM AB ENCUBE 1% A 210986 001 Jan 27, 2020 Jan NEWA SOLUTION;TOPICAL DICLOFENAC SODIUM >A> @ NOVAST LABS 1.5% A 206715 001 Aug 07, 2017 Sep CAHN >D> @ RICONPHARMA LLC 1.5% A 206715 001 Aug 07, 2017 Sep CAHN SOLUTION/DROPS;OPHTHALMIC DICLOFENAC SODIUM @ RUBICON 0.1% A 077600 001 Nov 13, 2008 Jul CAHN TABLET, DELAYED RELEASE;ORAL DICLOFENAC SODIUM @ MICRO LABS USA 50MG A 074986 001 Feb 26, 1999 Mar CAHN @ 75MG A 074986 002 Feb 26, 1999 Mar CAHN >D> AB MYLAN PHARMS INC 50MG A 075281 002 Feb 12, 2002 Sep DISC >A> @ 50MG A 075281 002 Feb 12, 2002 Sep DISC >D> AB 75MG A 075281 003 Feb 12, 2002 Sep DISC >A> @ 75MG A 075281 003 Feb 12, 2002 Sep DISC

DICLOFENAC SODIUM; MISOPROSTOL TABLET, DELAYED RELEASE;ORAL ARTHROTEC AB + PFIZER 50MG;0.2MG N 020607 001 Dec 24, 1997 Aug CAHN AB +! 75MG;0.2MG N 020607 002 Dec 24, 1997 Aug CAHN DICLOFENAC SODIUM AND MISOPROSTOL AB YUNG SHIN PHARM 50MG;0.2MG A 205143 001 Feb 19, 2020 Feb NEWA AB 75MG;0.2MG A 205143 002 Feb 19, 2020 Feb NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -37

DICYCLOMINE HYDROCHLORIDE SYRUP;ORAL DICYCLOMINE HYDROCHLORIDE AA ! GENERICS 10MG/5ML A 040169 001 Mar 24, 2005 May CTEC AA HIKMA 10MG/5ML A 212286 001 May 22, 2020 May NEWA

DIDANOSINE CAPSULE, DELAYED REL PELLETS;ORAL DIDANOSINE AUROBINDO PHARMA 125MG A 090094 001 Sep 24, 2008 Jun CTEC 200MG A 090094 002 Sep 24, 2008 Jun CTEC 250MG A 090094 003 Sep 24, 2008 Jun CTEC ! 400MG A 090094 004 Sep 24, 2008 Jun CHRS 400MG A 090094 004 Sep 24, 2008 Jun CTEC VIDEX EC + @ BRISTOL MYERS SQUIBB 125MG N 021183 001 Oct 31, 2000 Jun DISC + @ 200MG N 021183 002 Oct 31, 2000 Jun DISC + @ 250MG N 021183 003 Oct 31, 2000 Jun DISC + @ 400MG N 021183 004 Oct 31, 2000 Jun DISC FOR SOLUTION;ORAL VIDEX + @ BRISTOL-MYERS SQUIBB 10MG/ML N 020156 001 Oct 09, 1991 Jun DISC

DIETHYLPROPION HYDROCHLORIDE TABLET;ORAL TENUATE + @ NOSTRUM LABS INC 25MG N 011722 002 Mar CAHN TABLET, EXTENDED RELEASE;ORAL TENUATE DOSPAN + @ NOSTRUM LABS INC 75MG N 012546 001 Mar CAHN

DIHYDROERGOTAMINE MESYLATE SPRAY, METERED;NASAL DIHYDROERGOTAMINE MESYLATE AB CIPLA 0.5MG/SPRAY A 212907 001 May 20, 2020 May NEWA AB CUSTOPHARM INC 0.5MG/SPRAY A 211393 001 Feb 28, 2020 Feb NFTG MIGRANAL AB +! BAUSCH 0.5MG/SPRAY N 020148 001 Dec 08, 1997 Feb CFTG

DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL DILTIAZEM HYDROCHLORIDE AB2 ACCORD HLTHCARE 120MG A 206997 001 Apr 28, 2020 Apr NEWA AB2 180MG A 206997 002 Apr 28, 2020 Apr NEWA AB2 240MG A 206997 003 Apr 28, 2020 Apr NEWA AB2 APOTEX 120MG A 074943 003 Dec 19, 2000 Apr CTEC DILTZAC @ APOTEX 120MG A 076395 001 Feb 01, 2006 Apr DISC @ 180MG A 076395 002 Feb 01, 2006 Apr DISC @ 240MG A 076395 003 Feb 01, 2006 Apr DISC @ 300MG A 076395 004 Feb 01, 2006 Apr DISC @ 360MG A 076395 005 Feb 01, 2006 Apr DISC

DIMETHYL FUMARATE CAPSULE, DELAYED RELEASE;ORAL DIMETHYL FUMARATE >A> AB ACCORD HLTHCARE 120MG A 210499 001 Sep 24, 2020 Sep NEWA >A> AB 240MG A 210499 002 Sep 24, 2020 Sep NEWA >A> AB ALKEM LABS LTD 120MG A 210440 001 Sep 24, 2020 Sep NEWA >A> AB 240MG A 210440 002 Sep 24, 2020 Sep NEWA >A> AB AMNEAL 120MG A 210402 001 Sep 24, 2020 Sep NEWA >A> AB 240MG A 210402 002 Sep 24, 2020 Sep NEWA >A> AB CIPLA 120MG A 210305 001 Sep 24, 2020 Sep NEWA >A> AB 240MG A 210305 002 Sep 24, 2020 Sep NEWA >A> AB GLENMARK PHARMS LTD 120MG A 210309 001 Oct 06, 2020 Sep NEWA >A> AB 240MG A 210309 002 Oct 06, 2020 Sep NEWA >A> AB HETERO LABS LTD III 120MG A 210500 001 Sep 24, 2020 Sep NEWA >A> AB 240MG A 210500 002 Sep 24, 2020 Sep NEWA >A> AB LUPIN ATLANTIS 120MG A 210226 001 Oct 05, 2020 Sep NEWA >A> AB 240MG A 210226 002 Oct 05, 2020 Sep NEWA >A> AB MSN 120MG A 210460 001 Sep 24, 2020 Sep NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -38

CAPSULE, DELAYED RELEASE;ORAL DIMETHYL FUMARATE >A> AB 240MG A 210460 002 Sep 24, 2020 Sep NEWA AB MYLAN 120MG A 210531 001 Aug 17, 2020 Aug NFTG AB 240MG A 210531 002 Aug 17, 2020 Aug NFTG >A> AB ZYDUS PHARMS 120MG A 210538 001 Sep 24, 2020 Sep NEWA >A> AB 240MG A 210538 002 Sep 24, 2020 Sep NEWA TECFIDERA AB + BIOGEN IDEC INC 120MG N 204063 001 Mar 27, 2013 Aug CFTG AB +! 240MG N 204063 002 Mar 27, 2013 Aug CFTG

DIPHENHYDRAMINE HYDROCHLORIDE INJECTABLE;INJECTION DIPHENHYDRAMINE HYDROCHLORIDE >D> AP HOSPIRA 50MG/ML A 040140 001 Nov 20, 1998 Sep DISC >A> @ 50MG/ML A 040140 001 Nov 20, 1998 Sep DISC

DISOPYRAMIDE PHOSPHATE CAPSULE;ORAL NORPACE AB + PFIZER EQ 100MG BASE N 017447 001 Jul CAHN AB +! EQ 150MG BASE N 017447 002 Jul CAHN CAPSULE, EXTENDED RELEASE;ORAL NORPACE CR + PFIZER EQ 100MG BASE N 018655 001 Jul 20, 1982 Jul CAHN +! EQ 150MG BASE N 018655 002 Jul 20, 1982 Jul CAHN

DIVALPROEX SODIUM CAPSULE, DELAYED REL PELLETS;ORAL DIVALPROEX SODIUM AB AJANTA PHARMA LTD EQ 125MG VALPROIC ACID A 213181 001 Mar 02, 2020 Feb NEWA @ MYLAN EQ 125MG VALPROIC ACID A 090407 001 Mar 28, 2011 Jan DISC TABLET, DELAYED RELEASE;ORAL DIVALPROEX SODIUM @ MYLAN EQ 125MG VALPROIC ACID A 090062 001 Mar 17, 2009 Jan DISC @ EQ 250MG VALPROIC ACID A 090062 002 Mar 17, 2009 Jan DISC @ EQ 500MG VALPROIC ACID A 090062 003 Mar 17, 2009 Jan DISC TABLET, EXTENDED RELEASE;ORAL DIVALPROEX SODIUM @ IMPAX LABS EQ 250MG VALPROIC ACID A 078791 001 May 06, 2009 Aug DISC @ EQ 500MG VALPROIC ACID A 078791 002 Aug 04, 2009 Aug DISC >D> @ LUPIN LTD EQ 250MG VALPROIC ACID A 209286 001 Oct 18, 2019 Sep CMFD >A> AB EQ 250MG VALPROIC ACID A 209286 001 Oct 18, 2019 Sep CMFD @ EQ 250MG VALPROIC ACID A 209286 001 Oct 18, 2019 Apr DISC >D> @ EQ 500MG VALPROIC ACID A 209286 002 Oct 18, 2019 Sep CMFD >A> AB EQ 500MG VALPROIC ACID A 209286 002 Oct 18, 2019 Sep CMFD @ EQ 500MG VALPROIC ACID A 209286 002 Oct 18, 2019 Apr DISC

DOBUTAMINE HYDROCHLORIDE INJECTABLE;INJECTION DOBUTAMINE HYDROCHLORIDE >D> AP HOSPIRA EQ 12.5MG BASE/ML A 074086 001 Nov 29, 1993 Sep CHRS >A> AP ! EQ 12.5MG BASE/ML A 074086 001 Nov 29, 1993 Sep CHRS >D> AP ! EQ 12.5MG BASE/ML A 074292 001 Feb 16, 1995 Sep DISC >A> @ EQ 12.5MG BASE/ML A 074292 001 Feb 16, 1995 Sep DISC

DOCETAXEL INJECTABLE;INJECTION DOCETAXEL >D> @ CIPLA 20MG/2ML (10MG/ML) A 209634 001 Aug 24, 2018 Sep CAHN >D> @ 80MG/8ML (10MG/ML) A 209634 002 Aug 24, 2018 Sep CAHN >D> @ 160MG/16ML (10MG/ML) A 209634 003 Aug 24, 2018 Sep CAHN >A> @ HONG KONG 20MG/2ML (10MG/ML) A 209634 001 Aug 24, 2018 Sep CAHN >A> @ 80MG/8ML (10MG/ML) A 209634 002 Aug 24, 2018 Sep CAHN >A> @ 160MG/16ML (10MG/ML) A 209634 003 Aug 24, 2018 Sep CAHN AP SHILPA MEDICARE LTD 20MG/ML (20MG/ML) A 210327 001 May 16, 2019 Jan CMFD AP 80MG/4ML (20MG/ML) A 210327 002 May 16, 2019 Jan CMFD AP 160MG/8ML (20MG/ML) A 210327 003 May 16, 2019 Jan CMFD

RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -39

DOFETILIDE CAPSULE;ORAL DOFETILIDE AB ACCORD HLTHCARE 0.125MG A 213338 001 Jun 19, 2020 Jun NEWA AB 0.25MG A 213338 002 Jun 19, 2020 Jun NEWA AB 0.5MG A 213338 003 Jun 19, 2020 Jun NEWA AB MSN 0.125MG A 213220 001 Jan 29, 2020 Jan NEWA AB 0.25MG A 213220 002 Jan 29, 2020 Jan NEWA AB 0.5MG A 213220 003 Jan 29, 2020 Jan NEWA

DOLUTEGRAVIR SODIUM TABLET, FOR SUSPENSION;ORAL TIVICAY PD +! VIIV HLTHCARE EQ 5MG BASE N 213983 001 Jun 12, 2020 Jun NEWA

DONEPEZIL HYDROCHLORIDE TABLET;ORAL DONEPEZIL HYDROCHLORIDE AB GRAVITI PHARMS 5MG A 202114 001 Jul 05, 2013 Apr CAHN AB 10MG A 202114 002 Jul 05, 2013 Apr CAHN @ HERITAGE PHARMA 5MG A 077344 001 May 31, 2011 Jul DISC @ 10MG A 077344 002 May 31, 2011 Jul DISC @ MYLAN PHARMS INC 5MG A 090521 001 May 31, 2011 Mar DISC @ 10MG A 090521 002 May 31, 2011 Mar DISC AB RISING 5MG A 202114 001 Jul 05, 2013 Aug CAHN AB 10MG A 202114 002 Jul 05, 2013 Aug CAHN

DORZOLAMIDE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC DORZOLAMIDE HYDROCHLORIDE @ INDOCO EQ 2% BASE A 202053 001 Sep 11, 2014 Aug CAHN

DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE SOLUTION/DROPS;OPHTHALMIC DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE @ INDOCO EQ 2% BASE;EQ 0.5% BASE A 202054 001 Sep 03, 2014 Aug CAHN AT MICRO LABS EQ 2.0% BASE;EQ 0.5% BASE A 204777 001 May 28, 2020 May NEWA

DOXAZOSIN MESYLATE TABLET;ORAL CARDURA AB +! UPJOHN EQ 1MG BASE N 019668 001 Nov 02, 1990 Jun CAHN AB + EQ 2MG BASE N 019668 002 Nov 02, 1990 Jun CAHN AB + EQ 4MG BASE N 019668 003 Nov 02, 1990 Jun CAHN AB + EQ 8MG BASE N 019668 004 Nov 02, 1990 Jun CAHN DOXAZOSIN MESYLATE @ ANI PHARMS INC EQ 1MG BASE A 075432 001 Oct 18, 2000 Jan DISC @ EQ 2MG BASE A 075432 002 Oct 18, 2000 Jan DISC @ EQ 4MG BASE A 075432 003 Oct 18, 2000 Jan DISC @ EQ 8MG BASE A 075432 004 Oct 18, 2000 Jan DISC @ DAVA PHARMS INC EQ 1MG BASE A 076161 001 Jun 10, 2004 Jul DISC @ EQ 2MG BASE A 076161 002 Jun 10, 2004 Jul DISC @ EQ 4MG BASE A 076161 003 Jun 10, 2004 Jul DISC @ EQ 8MG BASE A 076161 004 Jun 10, 2004 Jul DISC TABLET, EXTENDED RELEASE;ORAL CARDURA XL + UPJOHN EQ 4MG BASE N 021269 001 Feb 22, 2005 Jun CAHN +! EQ 8MG BASE N 021269 002 Feb 22, 2005 Jun CAHN

DOXEPIN HYDROCHLORIDE CAPSULE;ORAL DOXEPIN HYDROCHLORIDE AB CONTRACT PHARMACAL EQ 10MG BASE A 213474 001 Jul 28, 2020 Jul NEWA AB EQ 25MG BASE A 213474 002 Jul 28, 2020 Jul NEWA AB EQ 50MG BASE A 213474 003 Jul 28, 2020 Jul NEWA AB EQ 75MG BASE A 213474 004 Jul 28, 2020 Jul NEWA AB EQ 100MG BASE A 213474 005 Jul 28, 2020 Jul NEWA AB LANNETT CO INC EQ 10MG BASE A 212997 001 Jul 24, 2020 Jul NEWA AB EQ 25MG BASE A 212997 002 Jul 24, 2020 Jul NEWA AB EQ 50MG BASE A 212997 003 Jul 24, 2020 Jul NEWA AB EQ 75MG BASE A 212997 004 Jul 24, 2020 Jul NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -40

CAPSULE;ORAL DOXEPIN HYDROCHLORIDE AB EQ 100MG BASE A 212997 005 Jul 24, 2020 Jul NEWA AB TARO PHARM INDS LTD EQ 10MG BASE A 213063 001 Jul 01, 2020 Jun NEWA AB EQ 25MG BASE A 213063 002 Jul 01, 2020 Jun NEWA AB EQ 50MG BASE A 213063 003 Jul 01, 2020 Jun NEWA AB EQ 75MG BASE A 213063 004 Jul 01, 2020 Jun NEWA AB EQ 100MG BASE A 213063 005 Jul 01, 2020 Jun NEWA AB UPSHER SMITH LABS EQ 10MG BASE A 210268 001 Sep 04, 2020 Aug NEWA AB EQ 25MG BASE A 210268 002 Sep 04, 2020 Aug NEWA AB EQ 50MG BASE A 210268 003 Sep 04, 2020 Aug NEWA AB EQ 75MG BASE A 210268 004 Sep 04, 2020 Aug NEWA AB EQ 100MG BASE A 210268 005 Sep 04, 2020 Aug NEWA CONCENTRATE;ORAL DOXEPIN HYDROCHLORIDE AA ! LANNETT CO INC EQ 10MG BASE/ML A 074721 001 Dec 29, 1998 May CHRS @ TEVA PHARMS EQ 10MG BASE/ML A 071609 001 Nov 09, 1987 May DISC TABLET;ORAL DOXEPIN HYDROCHLORIDE AB PAR PHARM INC EQ 3MG BASE A 202510 001 Jul 24, 2020 Jul NEWA AB EQ 6MG BASE A 202510 002 Jul 24, 2020 Jul NEWA

DOXERCALCIFEROL CAPSULE;ORAL DOXERCALCIFEROL >A> AB AVET 0.5MCG A 205360 001 Sep 15, 2020 Sep NEWA >A> AB 1MCG A 205360 002 Sep 15, 2020 Sep NEWA >A> AB 2.5MCG A 205360 003 Sep 15, 2020 Sep NEWA INJECTABLE;INJECTION DOXERCALCIFEROL AP MEITHEAL 4MCG/2ML (2MCG/ML) A 211670 001 Feb 07, 2020 Feb CAHN AP NANJING KING-FRIEND 4MCG/2ML (2MCG/ML) A 211670 001 Feb 07, 2020 Jan NEWA

DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL;INJECTION DOXORUBICIN HYDROCHLORIDE >A> AB ZYDUS 20MG/10ML (2MG/ML) A 212299 001 Sep 10, 2020 Sep NEWA >A> AB 50MG/25ML (2MG/ML) A 212299 002 Sep 10, 2020 Sep NEWA

DOXYCYCLINE CAPSULE;ORAL DOXYCYCLINE @ MYLAN PHARMS INC EQ 150MG BASE A 202778 001 Jun 08, 2012 Jan DISC

DOXYCYCLINE HYCLATE CAPSULE;ORAL DOXYCYCLINE HYCLATE >D> AB ZHEJIANG YONGTAI EQ 50MG BASE A 212610 001 Mar 31, 2020 Sep DISC >A> @ EQ 50MG BASE A 212610 001 Mar 31, 2020 Sep DISC AB EQ 50MG BASE A 212610 001 Mar 31, 2020 Mar NEWA >D> AB EQ 100MG BASE A 212610 002 Mar 31, 2020 Sep DISC >A> @ EQ 100MG BASE A 212610 002 Mar 31, 2020 Sep DISC AB EQ 100MG BASE A 212610 002 Mar 31, 2020 Mar NEWA SYSTEM, EXTENDED RELEASE;PERIODONTAL ATRIDOX +! DEN-MAT 50MG N 050751 001 Sep 03, 1998 Jul CAHN TABLET;ORAL DOXYCYCLINE HYCLATE AB AJANTA PHARMA LTD EQ 75MG BASE A 211584 001 Jun 01, 2020 May NEWA AB EQ 150MG BASE A 211584 002 Jun 01, 2020 May NEWA AB ALEMBIC PHARMS LTD EQ 20MG BASE A 210537 001 Mar 03, 2020 Feb NEWA AB EQ 75MG BASE A 211744 001 Jun 30, 2020 Jun NEWA AB EQ 100MG BASE A 210536 001 May 14, 2020 May NEWA AB EQ 150MG BASE A 211744 002 Jun 30, 2020 Jun NEWA AB ! CARIBE HOLDINGS EQ 100MG BASE A 062269 002 Nov 08, 1982 Jul CHRS @ HERITAGE PHARMA EQ 20MG BASE A 065163 001 May 13, 2005 Jul DISC AB HIKMA INTL PHARMS EQ 100MG BASE A 065095 001 Jul 02, 2003 Jul CHRS >A> AB MYLAN EQ 75MG BASE A 209987 001 Oct 05, 2020 Sep NEWA >A> AB EQ 150MG BASE A 209987 002 Oct 05, 2020 Sep NEWA >D> AB OAKLOCK LLC EQ 100MG BASE A 210664 001 Mar 16, 2020 Sep DISC >A> @ EQ 100MG BASE A 210664 001 Mar 16, 2020 Sep DISC AB EQ 100MG BASE A 210664 001 Mar 16, 2020 Mar NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -41

TABLET, DELAYED RELEASE;ORAL DORYX + @ MAYNE PHARMA EQ 80MG BASE N 050795 004 Apr 11, 2013 Jul DISC + EQ 80MG BASE N 050795 004 Apr 11, 2013 Mar CMFD DOXYCYCLINE HYCLATE AB PRINSTON INC EQ 50MG BASE A 207494 003 Feb 19, 2019 Feb NEWA

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE TABLET, DELAYED RELEASE;ORAL DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE AB MYLAN PHARMS INC 10MG;10MG A 207825 001 Jul 06, 2020 Jul NEWA

DRONABINOL CAPSULE;ORAL DRONABINOL AB ASCENT PHARMS INC 2.5MG A 207421 001 Feb 07, 2020 Jan NEWA AB 5MG A 207421 002 Feb 07, 2020 Jan NEWA AB 10MG A 207421 003 Feb 07, 2020 Jan NEWA MARINOL AB + ALKEM LABS LTD 2.5MG N 018651 001 May 31, 1985 Jan CAHN AB +! 5MG N 018651 002 May 31, 1985 Jan CAHN AB + 10MG N 018651 003 May 31, 1985 Jan CAHN SOLUTION;ORAL SYNDROS >D> +! BENUVIA 5MG/ML N 205525 001 Mar 23, 2017 Sep CAHN +! 5MG/ML N 205525 001 Mar 23, 2017 Feb CAHN >A> +! GUA ZHUANG 5MG/ML N 205525 001 Mar 23, 2017 Sep CAHN

DROSPIRENONE; ETHINYL ESTRADIOL TABLET;ORAL DROSPIRENONE AND ETHINYL ESTRADIOL AB ALLIED 3MG;0.02MG A 203291 001 Jul 18, 2017 Jan CAHN TABLET;ORAL-28 DROSPIRENONE AND ETHINYL ESTRADIOL @ APOTEX 3MG;0.03MG A 205876 001 Sep 21, 2016 Jul DISC AB HETERO LABS LTD 3MG;0.03MG A 213034 001 Jan 24, 2020 Jan NEWA AB NAARI PTE LTD 3MG;0.03MG A 207245 001 Nov 22, 2016 Jun CAHN

DULOXETINE HYDROCHLORIDE CAPSULE, DELAYED REL PELLETS;ORAL DULOXETINE HYDROCHLORIDE >D> @ QINGDAO BAHEAL PHARM EQ 20MG BASE A 210599 001 Apr 17, 2019 Sep CMFD >A> AB EQ 20MG BASE A 210599 001 Apr 17, 2019 Sep CMFD @ EQ 20MG BASE A 210599 001 Apr 17, 2019 May DISC >D> @ EQ 30MG BASE A 210599 002 Apr 17, 2019 Sep CMFD >A> AB EQ 30MG BASE A 210599 002 Apr 17, 2019 Sep CMFD @ EQ 30MG BASE A 210599 002 Apr 17, 2019 May DISC >D> @ EQ 60MG BASE A 210599 003 Apr 17, 2019 Sep CMFD >A> AB EQ 60MG BASE A 210599 003 Apr 17, 2019 Sep CMFD @ EQ 60MG BASE A 210599 003 Apr 17, 2019 May DISC @ YAOPHARMA CO LTD EQ 20MG BASE A 207219 001 Aug 16, 2019 Mar DISC @ EQ 30MG BASE A 207219 002 Aug 16, 2019 Mar DISC @ EQ 60MG BASE A 207219 003 Aug 16, 2019 Mar DISC

DUTASTERIDE CAPSULE;ORAL DUTASTERIDE AB ACELLA 0.5MG A 206373 001 Mar 17, 2016 Jul CAHN @ ACTAVIS LABS FL INC 0.5MG A 202808 001 Nov 20, 2015 Jan DISC @ APOTEX INC 0.5MG A 204292 001 Nov 24, 2015 Feb DISC AB AUROBINDO PHARMA LTD 0.5MG A 202660 001 Nov 20, 2015 May CAHN @ HIKMA 0.5MG A 202204 001 Nov 23, 2015 Feb DISC @ STRIDES PHARMA 0.5MG A 208227 001 Jun 22, 2018 Mar CAHN

EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE AB TEVA PHARMS USA 600MG;200MG;300MG A 091215 001 Nov 09, 2018 Aug CMFD

RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -42

EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE AB LAURUS LABS LTD 400MG;300MG;300MG A 213038 001 May 14, 2020 May NFTG AB 600MG;300MG;300MG A 212786 001 May 14, 2020 May NFTG SYMFI AB +! MYLAN LABS LTD 600MG;300MG;300MG N 022142 001 Mar 22, 2018 May CFTG SYMFI LO AB +! MYLAN 400MG;300MG;300MG N 208255 001 Feb 05, 2018 May CFTG

ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM CAPSULE;ORAL ORIAHNN (COPACKAGED) +! ABBVIE INC EQ 300MG BASE,1MG,0.5MG; EQ 300MG N 213388 001 May 29, 2020 May NEWA BASE

ELETRIPTAN HYDROBROMIDE TABLET;ORAL ELETRIPTAN HYDROBROMIDE @ YUNG SHIN PHARM EQ 20MG BASE A 209680 001 Jul 13, 2020 Aug DISC AB EQ 20MG BASE A 209680 001 Jul 13, 2020 Jul NEWA @ EQ 40MG BASE A 209680 002 Jul 13, 2020 Aug DISC AB EQ 40MG BASE A 209680 002 Jul 13, 2020 Jul NEWA RELPAX AB + UPJOHN EQ 20MG BASE N 021016 001 Dec 26, 2002 Jul CAHN AB +! EQ 40MG BASE N 021016 002 Dec 26, 2002 Jul CAHN

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL TRIJARDY XR + BOEHRINGER INGELHEIM 5MG;2.5MG;1GM N 212614 001 Jan 27, 2020 Jan NEWA + 10MG;5MG;1GM N 212614 002 Jan 27, 2020 Jan NEWA + 12.5MG;2.5MG;1GM N 212614 003 Jan 27, 2020 Jan NEWA +! 25MG;5MG;1GM N 212614 004 Jan 27, 2020 Jan NEWA

EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE AB AMNEAL PHARMS CO 200MG;300MG A 209721 004 Aug 22, 2018 Aug CMFD >D> AB MACLEODS PHARMS LTD 200MG;300MG A 203442 001 May 15, 2020 Sep DISC >A> @ 200MG;300MG A 203442 001 May 15, 2020 Sep DISC AB 200MG;300MG A 203442 001 May 15, 2020 May NEWA @ MYLAN 200MG;300MG A 206436 001 Apr 09, 2018 Feb DISC AB ZYDUS PHARMS 200MG;300MG A 212689 001 Feb 28, 2020 Feb NEWA

ENALAPRIL MALEATE SOLUTION;ORAL EPANED +! AZURITY 1MG/ML N 208686 001 Sep 20, 2016 May CAHN

ENTECAVIR TABLET;ORAL ENTECAVIR @ MYLAN 0.5MG A 206226 001 Mar 26, 2019 Jan DISC @ 1MG A 206226 002 Mar 26, 2019 Jan DISC AB PHARMADAX INC 0.5MG A 212106 001 Aug 10, 2020 Jul NEWA AB 1MG A 212106 002 Aug 10, 2020 Jul NEWA AB SUNSHINE 0.5MG A 211978 001 May 20, 2020 May NEWA AB 1MG A 211978 002 May 20, 2020 May NEWA @ YAOPHARMA CO LTD 0.5MG A 212201 001 Nov 04, 2019 Apr DISC @ 1MG A 212201 002 Nov 04, 2019 Apr DISC

ENZALUTAMIDE TABLET;ORAL XTANDI + ASTELLAS 40MG N 213674 001 Aug 04, 2020 Aug NEWA +! 80MG N 213674 002 Aug 04, 2020 Aug NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -43

EPHEDRINE SULFATE SOLUTION;INTRAVENOUS AKOVAZ AP +! EXELA PHARMA 50MG/ML (50MG/ML) N 208289 001 Apr 29, 2016 Jul CAHN EMERPHED +! NEXUS PHARMS 50MG/10ML (5MG/ML) N 213407 001 Apr 17, 2020 Apr NEWA EPHEDRINE SULFATE AP ANDERSEN 50MG/ML (50MG/ML) A 209646 001 Aug 04, 2020 Jul NEWA >A> AP DR REDDYS LABS LTD 50MG/ML (50MG/ML) A 212649 001 Oct 03, 2020 Sep NEWA AP FRESENIUS KABI USA 50MG/ML (50MG/ML) A 209646 001 Aug 04, 2020 Aug CAHN

EPINEPHRINE SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS ADRENALIN AP +! PAR STERILE PRODUCTS EQ 30MG BASE/30ML (EQ 1MG BASE/ML) N 204640 001 Dec 18, 2013 Apr CFTG EPINEPHRINE AP INTL MEDICATION SYS EQ 30MG BASE/30ML (EQ 1MG BASE/ML) A 211880 001 Apr 24, 2020 Apr NFTG

EPIRUBICIN HYDROCHLORIDE INJECTABLE;INJECTION EPIRUBICIN HYDROCHLORIDE >D> @ ZENNOVA 50MG/25ML (2MG/ML) A 090266 001 Apr 15, 2011 Sep CAHN >A> @ 50MG/25ML (2MG/ML) A 090266 001 Apr 15, 2011 Sep CAHN >D> @ 200MG/100ML (2MG/ML) A 090266 002 Apr 15, 2011 Sep CAHN >A> @ 200MG/100ML (2MG/ML) A 090266 002 Apr 15, 2011 Sep CAHN

EPLERENONE TABLET;ORAL EPLERENONE AB COREPHARMA 25MG A 078482 001 Jul 30, 2008 Feb CAHN AB 50MG A 078482 002 Jul 30, 2008 Feb CAHN AB PIRAMAL HLTHCARE UK 25MG A 212765 001 Aug 10, 2020 Jul NEWA AB 50MG A 212765 002 Aug 10, 2020 Jul NEWA

EPROSARTAN MESYLATE TABLET;ORAL EPROSARTAN MESYLATE @ MYLAN PHARMS INC EQ 400MG BASE A 202012 001 Nov 16, 2011 Apr DISC @ EQ 600MG BASE A 202012 002 Nov 16, 2011 Apr DISC

EPTIFIBATIDE INJECTABLE;INJECTION EPTIFIBATIDE >D> AP AMNEAL PHARMS 2MG/ML A 205581 001 Dec 08, 2016 Sep DISC >A> @ 2MG/ML A 205581 001 Dec 08, 2016 Sep DISC >D> AP 75MG/100ML A 205581 002 Dec 08, 2016 Sep DISC >A> @ 75MG/100ML A 205581 002 Dec 08, 2016 Sep DISC >D> AP HYBIO 2MG/ML A 207864 001 Mar 20, 2020 Sep DISC >A> @ 2MG/ML A 207864 001 Mar 20, 2020 Sep DISC AP 2MG/ML A 207864 001 Mar 20, 2020 Mar NEWA >D> AP 75MG/100ML A 207864 002 Mar 20, 2020 Sep DISC >A> @ 75MG/100ML A 207864 002 Mar 20, 2020 Sep DISC AP 75MG/100ML A 207864 002 Mar 20, 2020 Mar NEWA

ERAVACYCLINE DIHYDROCHLORIDE POWDER;INTRAVENOUS XERAVA +! TETRAPHASE PHARMS EQ 100MG BASE/VIAL N 211109 002 Jun 03, 2020 Jun NEWA

ERLOTINIB HYDROCHLORIDE TABLET;ORAL ERLOTINIB HYDROCHLORIDE AB ACCORD HLTHCARE EQ 25MG BASE A 211083 001 Jul 02, 2020 Jul NEWA AB EQ 100MG BASE A 211083 002 Jul 02, 2020 Jul NEWA AB EQ 150MG BASE A 211083 003 Jul 02, 2020 Jul NEWA AB ZYDUS PHARMS EQ 25MG BASE A 213065 001 Apr 16, 2020 Apr NEWA AB EQ 100MG BASE A 213065 002 Apr 16, 2020 Apr NEWA AB EQ 150MG BASE A 213065 003 Apr 16, 2020 Apr NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -44

ERYTHROMYCIN TABLET;ORAL ERYTHROMYCIN AB TORRENT 250MG A 212015 001 Jul 06, 2020 Jul NEWA AB 500MG A 212015 002 Jul 06, 2020 Jul NEWA

ERYTHROMYCIN LACTOBIONATE INJECTABLE;INJECTION ERYTHROMYCIN LACTOBIONATE >A> AP EXELA PHARMA EQ 500MG BASE/VIAL A 211086 001 Sep 17, 2020 Sep NEWA

ESCITALOPRAM OXALATE SOLUTION;ORAL ESCITALOPRAM OXALATE AA ANTRIM PHARMS LLC EQ 5MG BASE/5ML A 203967 001 May 26, 2015 Jan CAHN AA ! HETERO LABS LTD III EQ 5MG BASE/5ML A 202221 001 Jun 12, 2012 Apr CHRS LEXAPRO + @ ALLERGAN EQ 5MG BASE/5ML N 021365 001 Nov 27, 2002 Apr DISC TABLET;ORAL ESCITALOPRAM OXALATE >D> AB HIKMA PHARMS EQ 5MG BASE A 078766 001 Sep 11, 2012 Sep DISC >A> @ EQ 5MG BASE A 078766 001 Sep 11, 2012 Sep DISC >D> AB EQ 10MG BASE A 078766 002 Sep 11, 2012 Sep DISC >A> @ EQ 10MG BASE A 078766 002 Sep 11, 2012 Sep DISC >D> AB EQ 20MG BASE A 078766 003 Sep 11, 2012 Sep DISC >A> @ EQ 20MG BASE A 078766 003 Sep 11, 2012 Sep DISC @ MACLEODS PHARMS LTD EQ 5MG BASE A 202210 001 Sep 11, 2012 May DISC @ EQ 10MG BASE A 202210 002 Sep 11, 2012 May DISC @ EQ 20MG BASE A 202210 003 Sep 11, 2012 May DISC AB RISING EQ 5MG BASE A 078777 001 Sep 11, 2012 Aug CAHN AB EQ 10MG BASE A 078777 002 Sep 11, 2012 Aug CAHN AB EQ 20MG BASE A 078777 003 Sep 11, 2012 Aug CAHN

ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED REL PELLETS;ORAL ESOMEPRAZOLE MAGNESIUM >A> AB CISEN EQ 20MG BASE A 213158 001 Sep 22, 2020 Sep NEWA >A> AB EQ 40MG BASE A 213158 002 Sep 22, 2020 Sep NEWA >A> AB CSPC OUYI EQ 20MG BASE A 212949 001 Oct 02, 2020 Sep NEWA >A> AB EQ 40MG BASE A 212949 002 Oct 02, 2020 Sep NEWA AB HETERO LABS LTD III EQ 20MG BASE A 211977 001 Jun 02, 2020 May NEWA AB EQ 40MG BASE A 211977 002 Jun 02, 2020 May NEWA FOR SUSPENSION, DELAYED RELEASE;ORAL ESOMEPRAZOLE MAGNESIUM AB CIPLA EQ 10MG BASE/PACKET A 211752 001 Mar 23, 2020 Mar NFTG AB EQ 20MG BASE/PACKET A 211751 001 Mar 23, 2020 Mar NFTG AB EQ 40MG BASE/PACKET A 211751 002 Mar 23, 2020 Mar NFTG NEXIUM AB + ASTRAZENECA PHARMS EQ 10MG BASE/PACKET N 022101 001 Feb 27, 2008 Mar CFTG AB + EQ 20MG BASE/PACKET N 021957 001 Oct 20, 2006 Mar CFTG AB +! EQ 40MG BASE/PACKET N 021957 002 Oct 20, 2006 Mar CFTG

ESOMEPRAZOLE MAGNESIUM; NAPROXEN TABLET, DELAYED RELEASE;ORAL NAPROXEN AND ESOMEPRAZOLE MAGNESIUM AB DR REDDYS LABS LTD EQ 20MG BASE;375MG A 204206 001 Feb 18, 2020 Feb NEWA AB EQ 20MG BASE;500MG A 204206 002 Feb 18, 2020 Feb NEWA VIMOVO AB + HORIZON EQ 20MG BASE;375MG N 022511 002 Apr 30, 2010 Feb CTEC AB +! EQ 20MG BASE;500MG N 022511 001 Apr 30, 2010 Feb CTEC

ESOMEPRAZOLE SODIUM INJECTABLE;INTRAVENOUS ESOMEPRAZOLE SODIUM AP GLAND PHARMA LTD EQ 20MG BASE/VIAL A 203349 001 Apr 01, 2020 Mar NEWA AP EQ 40MG BASE/VIAL A 203349 002 Apr 01, 2020 Mar NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -45

ESOMEPRAZOLE STRONTIUM CAPSULE, DELAYED RELEASE;ORAL ESOMEPRAZOLE STRONTIUM >D> + @ BELCHER 24.65MG N 202342 001 Aug 06, 2013 Sep CAHN >A> + @ 24.65MG N 202342 001 Aug 06, 2013 Sep CAHN + @ 24.65MG N 202342 001 Aug 06, 2013 Mar CAHN >D> + @ 49.3MG N 202342 002 Aug 06, 2013 Sep CAHN >A> + @ 49.3MG N 202342 002 Aug 06, 2013 Sep CAHN + @ 49.3MG N 202342 002 Aug 06, 2013 Mar CAHN

ESTAZOLAM TABLET;ORAL ESTAZOLAM AB NOVITIUM PHARMA 1MG A 074826 001 Jul 03, 1997 Jul CAHN AB 2MG A 074826 002 Jul 03, 1997 Jul CAHN AB PAR PHARM 1MG A 074826 001 Jul 03, 1997 Aug CAHN AB 2MG A 074826 002 Jul 03, 1997 Aug CAHN

ESTRADIOL FILM, EXTENDED RELEASE;TRANSDERMAL ESTRADIOL >A> AB3 AMNEAL 0.025MG/24HR A 211396 001 Sep 28, 2020 Sep NEWA >A> AB3 0.0375MG/24HR A 211396 002 Sep 28, 2020 Sep NEWA >A> AB3 0.05MG/24HR A 211396 003 Sep 28, 2020 Sep NEWA >A> AB3 0.075MG/24HR A 211396 004 Sep 28, 2020 Sep NEWA >A> AB3 0.1MG/24HR A 211396 005 Sep 28, 2020 Sep NEWA

ESTRADIOL VALERATE INJECTABLE;INJECTION DELESTROGEN AO +! PAR STERILE PRODUCTS 10MG/ML N 009402 002 Apr CTEC ESTRADIOL VALERATE AO HIKMA 10MG/ML A 203723 001 Apr 21, 2020 Apr NEWA AO 20MG/ML A 203723 002 Apr 21, 2020 Apr NEWA AO 40MG/ML A 203723 003 Apr 21, 2020 Apr NEWA

ESTRADIOL; NORETHINDRONE ACETATE TABLET;ORAL ESTRADIOL AND NORETHINDRONE ACETATE @ NAARI PTE LTD 1MG;0.5MG A 210233 001 Feb 28, 2018 Jun CAHN @ TEVA PHARMS USA 0.5MG;0.1MG A 200747 001 Mar 08, 2012 Jan DISC

ESTROPIPATE TABLET;ORAL ESTROPIPATE @ MYLAN 0.75MG A 040359 001 Aug 26, 1999 Jan DISC @ 1.5MG A 040359 002 Aug 26, 1999 Jan DISC

ESZOPICLONE TABLET;ORAL ESZOPICLONE @ HIKMA 1MG A 091153 001 Apr 15, 2014 Feb DISC @ 2MG A 091153 002 Apr 15, 2014 Feb DISC @ 3MG A 091153 003 Apr 15, 2014 Feb DISC

ETHACRYNATE SODIUM INJECTABLE;INJECTION ETHACRYNATE SODIUM AP VPI PHARMS INC EQ 50MG BASE/VIAL A 208663 001 Jun 09, 2020 Jun NEWA

ETHACRYNIC ACID TABLET;ORAL ETHACRYNIC ACID AB UPSHER SMITH LABS 25MG A 212417 001 Feb 19, 2020 Feb NEWA

ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE TABLET;ORAL-28 NORQUEST FE @ PFIZER 0.035MG;75MG;1MG N 018926 001 Jul 18, 1986 Jul CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -46

ETHINYL ESTRADIOL; LEVONORGESTREL SYSTEM;TRANSDERMAL TWIRLA +! AGILE 0.03MG/24HR;0.12MG/24HR N 204017 001 Feb 14, 2020 Feb NEWA TABLET;ORAL BALCOLTRA +! AVION PHARMS 0.02MG;0.1MG N 208612 001 Jan 09, 2018 Jan CHRS + 0.02MG;0.1MG N 208612 001 Jan 09, 2018 Jan CRLD >A> TYBLUME >A> +! EXELTIS USA INC 0.02MG;0.1MG N 209405 001 Mar 30, 2020 Sep CDFR TABLET;ORAL-28 ELIFEMME @ XIROMED 0.03MG,0.04MG,0.03MG;0.05MG,0.075M A 202507 001 Dec 04, 2015 Mar DISC G,0.125MG LEVONORGESTREL AND ETHINYL ESTRADIOL >D> AB ACCORD HLTHCARE 0.02MG;0.1MG A 207065 001 Aug 17, 2020 Sep CAHN AB 0.02MG;0.1MG A 207065 001 Aug 17, 2020 Aug NEWA @ MYLAN LABS LTD 0.03MG,0.04MG,0.03MG;0.05MG,0.075M A 202970 001 Mar 23, 2018 Feb DISC G,0.125MG >A> AB NAARI PTE LTD 0.02MG;0.1MG A 207065 001 Aug 17, 2020 Sep CAHN ORSYTHIA @ VINTAGE PHARMS LLC 0.02MG;0.1MG A 077099 001 May 11, 2011 Jun DISC >D> TABLET, CHEWABLE;ORAL >D> TYBLUME >D> +! EXELTIS USA INC 0.02MG;0.1MG N 209405 001 Mar 30, 2020 Sep CDFR +! 0.02MG;0.1MG N 209405 001 Mar 30, 2020 Jun CTNA +! 0.02MG;0.1MG N 209405 001 Mar 30, 2020 Mar NEWA

ETHINYL ESTRADIOL; NORETHINDRONE TABLET;ORAL-28 BREVICON 28-DAY @ ALLERGAN 0.035MG;0.5MG N 017743 001 Aug DISC DASETTA 7/7/7 AB ! NOVAST LABS LTD 0.035MG,0.035MG,0.035MG;0.5MG,0.75 A 090946 001 Dec 22, 2011 Aug CHRS MG,1MG NORETHINDRONE AND ETHINYL ESTRADIOL AB NAARI PTE LTD 0.035MG;1MG A 206864 001 Apr 28, 2017 Jun CAHN ORTHO-NOVUM 7/7/7-28 + @ JANSSEN PHARMS 0.035MG,0.035MG,0.035MG;0.5MG,0.75 N 018985 002 Apr 04, 1984 Aug DISC MG,1MG TABLET, CHEWABLE;ORAL NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE AB NAARI PTE LTD 0.035MG;0.4MG A 207066 001 Mar 29, 2017 Jun CAHN

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE TABLET;ORAL LOESTRIN 24 FE AB + TEVA BRANDED PHARM 0.02MG;1MG N 021871 001 Feb 17, 2006 Jan CAHN NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE @ MYLAN LABS LTD 0.02MG;1MG A 202742 001 Oct 30, 2014 Jun DISC TABLET;ORAL-21 GILDESS 1.5/30 @ VINTAGE PHARMS LLC 0.03MG;1.5MG A 077075 002 Jul 24, 2012 Jun DISC LOESTRIN 21 1.5/30 AB + TEVA BRANDED PHARM 0.03MG;1.5MG N 017875 001 Jan CAHN LOESTRIN 21 1/20 AB + TEVA BRANDED PHARM 0.02MG;1MG N 017876 001 Jan CAHN LOESTRIN FE 1.5/30 AB +! TEVA BRANDED PHARM 0.03MG;1.5MG N 017355 001 Jan CAHN TABLET;ORAL-28 CHABELINA FE AB NOVAST LABS 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG A 202962 001 Apr 15, 2020 Mar NEWA GILDESS FE 1.5/30 @ VINTAGE PHARMS LLC 0.03MG;1.5MG A 077075 001 Apr 28, 2005 Jun DISC LOESTRIN FE 1/20 AB + TEVA BRANDED PHARM 0.02MG;1MG N 017354 001 Jan CAHN NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL @ MYLAN LABS LTD 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG A 205069 001 Jun 22, 2018 Feb DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -47

TABLET, CHEWABLE;ORAL FINZALA @ TEVA PHARMS USA INC 0.02MG;1MG A 210087 001 Apr 07, 2020 Jul DISC AB 0.02MG;1MG A 210087 001 Apr 07, 2020 Mar NEWA

ETHINYL ESTRADIOL; NORGESTIMATE TABLET;ORAL-28 NORGESTIMATE AND ETHINYL ESTRADIOL AB ! GLENMARK GENERICS 0.035MG,0.035MG,0.035MG;0.18MG,0.2 A 200494 001 Jun 17, 2011 Aug CHRS 15MG,0.25MG AB ! GLENMARK PHARMS 0.025MG,0.025MG,0.025MG;0.18MG,0.2 A 204057 001 Feb 23, 2016 Jul CHRS 15MG,0.25MG ORTHO TRI-CYCLEN + @ JANSSEN PHARMS 0.035MG,0.035MG,0.035MG;0.18MG,0.2 N 019697 001 Jul 03, 1992 Aug DISC 15MG,0.25MG ORTHO TRI-CYCLEN LO + @ JANSSEN PHARMS 0.025MG,0.025MG,0.025MG;0.18MG,0.2 N 021241 001 Aug 22, 2002 Jul DISC 15MG,0.25MG TRI-PREVIFEM @ VINTAGE PHARMS LLC 0.035MG,0.035MG,0.035MG;0.18MG,0.2 A 076335 001 Mar 26, 2004 Jun DISC 15MG,0.25MG

ETHOSUXIMIDE CAPSULE;ORAL ETHOSUXIMIDE AB PURACAP PHARM LLC 250MG A 210654 001 Mar 16, 2020 Mar NEWA

ETODOLAC CAPSULE;ORAL ETODOLAC >D> @ ECI PHARMS LLC 300MG A 074929 001 Jan 30, 1998 Sep CAHN >A> @ PHARMA LIFE 300MG A 074929 001 Jan 30, 1998 Sep CAHN TABLET;ORAL ETODOLAC >D> @ ECI PHARMS LLC 400MG A 074927 001 Oct 30, 1997 Sep CAHN >D> @ INVATECH 400MG A 074839 001 Jul 11, 1997 Sep CAHN >D> @ 400MG A 074846 001 Feb 28, 1997 Sep CAHN >A> @ PHARMA LIFE 400MG A 074927 001 Oct 30, 1997 Sep CAHN >A> @ PHARMGEN 400MG A 074839 001 Jul 11, 1997 Sep CAHN >A> @ 400MG A 074846 001 Feb 28, 1997 Sep CAHN @ TEVA 400MG A 075009 001 Nov 26, 1997 Feb DISC @ 500MG A 075009 002 Dec 28, 1999 Feb DISC

ETOMIDATE INJECTABLE;INJECTION ETOMIDATE @ MYLAN LABS LTD 2MG/ML A 078289 001 Jan 02, 2009 Feb DISC

EVEROLIMUS TABLET;ORAL EVEROLIMUS AB HIKMA 2.5MG A 207486 001 Jun 08, 2020 Jun NEWA AB 5MG A 207486 002 Jun 08, 2020 Jun NEWA AB 7.5MG A 207486 003 Jun 08, 2020 Jun NEWA AB MYLAN 2.5MG A 212936 001 Jun 08, 2020 Jun NEWA AB 5MG A 212936 002 Jun 08, 2020 Jun NEWA AB 7.5MG A 212936 003 Jun 08, 2020 Jun NEWA AB 10MG A 212936 004 Jun 08, 2020 Jun NEWA AB TEVA PHARMS USA 2.5MG A 210050 001 Dec 09, 2019 Jun CMFD @ 2.5MG A 210050 001 Dec 09, 2019 Jun DISC AB 5MG A 210050 002 Dec 09, 2019 Jun CMFD @ 5MG A 210050 002 Dec 09, 2019 Jun DISC AB 7.5MG A 210050 003 Dec 09, 2019 Jun CMFD @ 7.5MG A 210050 003 Dec 09, 2019 Jun DISC @ 10MG A 210050 004 Dec 09, 2019 Jun DISC ZORTRESS AB + NOVARTIS 0.75MG N 021560 003 Apr 20, 2010 Jul CHRS +! 1MG N 021560 004 Aug 10, 2018 Jul CHRS RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -48

EXEMESTANE TABLET;ORAL EXEMESTANE @ MAYNE PHARMA INC 25MG A 208764 001 Aug 08, 2019 Jan DISC AB QILU 25MG A 213547 001 Apr 13, 2020 Mar NEWA

EZETIMIBE TABLET;ORAL EZETIMIBE @ MYLAN 10MG A 201790 001 Apr 26, 2019 Feb DISC @ TEVA PHARMS USA 10MG A 078724 001 Jun 12, 2017 Mar DISC

FAMCICLOVIR TABLET;ORAL FAMCICLOVIR >D> AB HIKMA 125MG A 090128 001 Mar 21, 2011 Sep DISC >A> @ 125MG A 090128 001 Mar 21, 2011 Sep DISC >D> AB 250MG A 090128 002 Mar 21, 2011 Sep DISC >A> @ 250MG A 090128 002 Mar 21, 2011 Sep DISC >D> AB 500MG A 090128 003 Mar 21, 2011 Sep DISC >A> @ 500MG A 090128 003 Mar 21, 2011 Sep DISC

FAMOTIDINE TABLET;ORAL FAMOTIDINE AB ! AUROBINDO PHARMA LTD 40MG A 206530 002 Dec 22, 2015 Jan CHRS MY LAN@ MYLAN@ 20MG A 075704 001 Apr 16, 2001 Feb DISC TE VA@ TEVA@ 20MG A 075311 001 Apr 16, 2001 Mar DISC @ 40MG A 075311 002 Apr 16, 2001 Mar DISC PEPCID + @ VALEANT PHARMS NORTH 20MG N 019462 001 Oct 15, 1986 Jan DISC + @ 40MG N 019462 002 Oct 15, 1986 Jan DISC

FEBUXOSTAT TABLET;ORAL FEBUXOSTAT AB SUNSHINE 40MG A 213069 001 Jun 02, 2020 May NEWA AB 80MG A 213069 002 Jun 02, 2020 May NEWA

FENFLURAMINE HYDROCHLORIDE SOLUTION;ORAL FINTEPLA +! ZOGENIX INC EQ 2.2MG BASE/ML N 212102 001 Jun 25, 2020 Jun NEWA

FENOFIBRATE CAPSULE;ORAL FENOFIBRATE (MICRONIZED) AB ANI PHARMS INC 67MG A 209504 001 Apr 30, 2018 Jan CAHN AB 134MG A 209504 002 Apr 30, 2018 Jan CAHN AB 200MG A 209504 003 Apr 30, 2018 Jan CAHN @ MYLAN PHARMS INC 43MG A 202579 001 Jan 10, 2013 Mar DISC @ 130MG A 202579 002 Jan 10, 2013 Mar DISC TABLET;ORAL FENOFIBRATE AB ALEMBIC PHARMS LTD 54MG A 213252 001 Jan 17, 2020 Jan NEWA AB 160MG A 213252 002 Jan 17, 2020 Jan NEWA AB APPCO 54MG A 210670 001 Sep 06, 2019 Jan CAHN AB 160MG A 210670 002 Sep 06, 2019 Jan CAHN AB DR REDDYS 54MG A 210670 001 Sep 06, 2019 Aug CAHN AB 160MG A 210670 002 Sep 06, 2019 Aug CAHN AB GRAVITI PHARMS 48MG A 211122 001 Mar 18, 2020 Mar NEWA AB 54MG A 210606 001 Aug 17, 2018 Jan CMFD AB 145MG A 211122 002 Mar 18, 2020 Mar NEWA AB 160MG A 210606 002 Aug 17, 2018 Jan CMFD AB MANKIND PHARMA 54MG A 213864 001 Jun 12, 2020 Jun NEWA AB 160MG A 213864 002 Jun 12, 2020 Jun NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -49

FENOFIBRIC ACID TABLET;ORAL FIBRICOR + @ ATHENA 35MG N 022418 001 Aug 14, 2009 Jul DISC

FENTANYL FILM, EXTENDED RELEASE;TRANSDERMAL FENTANYL-100 >D> AB LAVIPHARM LABS 100MCG/HR A 077051 004 Aug 04, 2006 Sep DISC >A> @ 100MCG/HR A 077051 004 Aug 04, 2006 Sep DISC FENTANYL-25 >D> AB LAVIPHARM LABS 25MCG/HR A 077051 001 Aug 04, 2006 Sep DISC >A> @ 25MCG/HR A 077051 001 Aug 04, 2006 Sep DISC FENTANYL-37 AB SPECGX LLC 37.5MCG/HR A 077154 006 Jan 14, 2020 Jul NEWA FENTANYL-50 >D> AB LAVIPHARM LABS 50MCG/HR A 077051 002 Aug 04, 2006 Sep DISC >A> @ 50MCG/HR A 077051 002 Aug 04, 2006 Sep DISC FENTANYL-62 AB MYLAN TECHNOLOGIES 62.5MCG/HR A 076258 007 Dec 29, 2014 Jul CTEC AB SPECGX LLC 62.5MCG/HR A 077154 007 Jan 14, 2020 Jul NEWA FENTANYL-75 >D> AB LAVIPHARM LABS 75MCG/HR A 077051 003 Aug 04, 2006 Sep DISC >A> @ 75MCG/HR A 077051 003 Aug 04, 2006 Sep DISC FENTANYL-87 AB MYLAN TECHNOLOGIES 87.5MCG/HR A 076258 008 Dec 29, 2014 Jul CTEC

FENTANYL CITRATE INJECTABLE;INJECTION FENTANYL CITRATE AP FRESENIUS KABI USA EQ 0.05MG BASE/ML A 212086 001 Sep 01, 2020 Aug NEWA FENTANYL CITRATE PRESERVATIVE FREE AP +! HIKMA EQ 0.05MG BASE/ML N 019101 001 Jul 11, 1984 Feb CAHN

FERRIC DERISOMALTOSE SOLUTION;INTRAVENOUS MONOFERRIC + @ PHARMACOSMOS AS 100MG/ML (100MG/ML) N 208171 001 Jan 16, 2020 Jun DISC +! 100MG/ML (100MG/ML) N 208171 001 Jan 16, 2020 Jan NEWA + @ 500MG/5ML (100MG/ML) N 208171 002 Jan 16, 2020 Jun DISC +! 500MG/5ML (100MG/ML) N 208171 002 Jan 16, 2020 Jan NEWA +! 1GM/10ML (100MG/ML) N 208171 003 Jan 16, 2020 Jan NEWA

>D> FERRIC MALTOL >D> CAPSULE;ORAL >D> ACCRUFER >D> +! SHIELD TX 30MG IRON N 212320 001 Jul 25, 2019 Sep DISC >A> + @ 30MG IRON N 212320 001 Jul 25, 2019 Sep DISC

FERRIC PYROPHOSPHATE CITRATE SOLUTION;INTRAVENOUS TRIFERIC AVNU +! ROCKWELL MEDICAL INC 6.75MG IRON/4.5ML (1.5MG IRON/ML) N 212860 001 Mar 27, 2020 Mar NEWA

FESOTERODINE FUMARATE TABLET, EXTENDED RELEASE;ORAL FESOTERODINE FUMARATE @ DR REDDYS LABS LTD 4MG A 204975 001 Aug 13, 2019 Feb DISC @ 8MG A 204975 002 Aug 13, 2019 Feb DISC

FEXOFENADINE HYDROCHLORIDE TABLET;ORAL FEXOFENADINE HYDROCHLORIDE @ BARR 30MG A 076191 001 Aug 31, 2005 Mar DISC @ 60MG A 076191 002 Aug 31, 2005 Mar DISC @ 180MG A 076191 003 Aug 31, 2005 Mar DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -50

FIDAXOMICIN FOR SUSPENSION;ORAL DIFICID +! CUBIST PHARMS LLC 40MG/ML N 213138 001 Jan 24, 2020 Jan NEWA

FINASTERIDE TABLET;ORAL FINASTERIDE @ TEVA 1MG A 076905 001 Nov 05, 2013 Mar DISC

FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL FINGOLIMOD HYDROCHLORIDE @ BIOCON LTD EQ 0.5MG BASE A 207979 001 Dec 04, 2019 Jun DISC AB GLENMARK PHARMS LTD EQ 0.5MG BASE A 207985 001 Jun 18, 2020 Jun NEWA AB HETERO LABS LTD V EQ 0.5MG BASE A 207933 001 May 18, 2020 May NEWA AB STRIDES PHARMA EQ 0.5MG BASE A 207971 001 Jun 29, 2020 Jun NEWA AB TEVA PHARMS USA EQ 0.5MG BASE A 208008 001 Jul 02, 2020 Jul NEWA

FLECAINIDE ACETATE TABLET;ORAL FLECAINIDE ACETATE >A> AB BEXIMCO PHARMS USA 50MG A 210683 001 Sep 16, 2020 Sep NEWA >A> AB 100MG A 210683 002 Sep 16, 2020 Sep NEWA >A> AB 150MG A 210683 003 Sep 16, 2020 Sep NEWA

FLORTAUCIPIR F-18 SOLUTION;INTRAVENOUS TAUVID +! AVID RADIOPHARMS INC 30ML (8.1-51mCi/ML) N 212123 001 May 28, 2020 May NEWA +! 50ML (8.1-51mCi/ML) N 212123 002 May 28, 2020 May NEWA

FLUCONAZOLE FOR SUSPENSION;ORAL FLUCONAZOLE @ HIKMA 50MG/5ML A 076246 001 Jul 29, 2004 Feb DISC @ 200MG/5ML A 076246 002 Jul 29, 2004 Feb DISC INJECTABLE;INJECTION FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER @ HIKMA FARMACEUTICA 200MG/100ML (2MG/ML) A 078764 001 Jan 30, 2012 Mar DISC @ 400MG/200ML (2MG/ML) A 078764 002 Jan 30, 2012 Mar DISC @ HOSPIRA 200MG/100ML (2MG/ML) A 076304 001 Jul 29, 2004 Mar DISC @ 400MG/200ML (2MG/ML) A 076304 002 Jul 29, 2004 Mar DISC @ WOODWARD 200MG/100ML (2MG/ML) A 077988 001 May 26, 2010 Mar DISC @ 400MG/200ML (2MG/ML) A 077988 002 May 26, 2010 Mar DISC TABLET;ORAL FLUCONAZOLE AB ANI PHARMS INC 50MG A 078423 001 Mar 07, 2011 Jul CAHN AB 100MG A 078423 002 Mar 07, 2011 Jul CAHN AB 150MG A 078423 003 Mar 07, 2011 Jul CAHN AB 200MG A 078423 004 Mar 07, 2011 Jul CAHN @ MYLAN 50MG A 076351 001 Jul 29, 2004 Jan DISC @ 100MG A 076351 002 Jul 29, 2004 Jan DISC @ 150MG A 076351 003 Jul 29, 2004 Jan DISC @ 200MG A 076351 004 Jul 29, 2004 Jan DISC @ TEVA 50MG A 074681 001 Jul 29, 2004 Mar DISC @ 100MG A 074681 002 Jul 29, 2004 Mar DISC @ 150MG A 074681 003 Jul 29, 2004 Mar DISC @ 200MG A 074681 004 Jul 29, 2004 Mar DISC

FLUCYTOSINE CAPSULE;ORAL FLUCYTOSINE AB AUROBINDO PHARMA LTD 250MG A 213665 001 May 01, 2020 Apr NEWA AB 500MG A 213665 002 May 01, 2020 Apr NEWA AB STRIDES PHARMA 250MG A 212632 001 Apr 17, 2020 Apr NEWA AB 500MG A 212632 002 Apr 17, 2020 Apr NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -51

FLUDEOXYGLUCOSE F-18 INJECTABLE;INTRAVENOUS FLUDEOXYGLUCOSE F18 @ UNIV TX SW MEDCTR 20-200mCi/ML A 210265 001 Feb 06, 2020 May DISC AP 20-200mCi/ML A 210265 001 Feb 06, 2020 Jan NEWA

FLUDROCORTISONE ACETATE TABLET;ORAL FLUDROCORTISONE ACETATE >D> AB HIKMA PHARMS 0.1MG A 091302 001 Jul 22, 2011 Sep DISC >A> @ 0.1MG A 091302 001 Jul 22, 2011 Sep DISC

FLUNISOLIDE SPRAY, METERED;NASAL FLUNISOLIDE ! APOTEX 0.029MG/SPRAY A 077436 001 Aug 09, 2007 Mar CHRS 0.029MG/SPRAY A 077436 001 Aug 09, 2007 Mar CMFD NASALIDE + @ IVAX RES 0.025MG/SPRAY N 018148 001 Aug CRLD

FLUOCINOLONE ACETONIDE OIL;TOPICAL FLUOCINOLONE ACETONIDE AT AMNEAL 0.01% A 201759 001 Oct 17, 2011 Aug CAHN AT 0.01% A 201764 001 Oct 17, 2011 Aug CAHN OIL/DROPS;OTIC FLUOCINOLONE ACETONIDE AT AMNEAL 0.01% A 091306 001 Oct 17, 2011 Aug CAHN

FLUOCINONIDE CREAM;TOPICAL FLUOCINONIDE AB1 AMNEAL 0.05% A 210554 001 Aug 21, 2018 Apr CMFD AB CADILA 0.1% A 208989 001 Feb 10, 2020 Feb CAHN AB ZYDUS PHARMS 0.1% A 208989 001 Feb 10, 2020 Jan NEWA SOLUTION;TOPICAL FLUOCINONIDE TE VA@ TEVA@ 0.05% A 072511 001 Feb 07, 1989 Mar DISC

FLUORODOPA F-18 SOLUTION;INTRAVENOUS FLUORODOPA F18 + @ FEINSTEIN 0.42-8.33mCi/ML N 200655 001 Oct 10, 2019 Aug DISC

FLUOROESTRADIOL F-18 SOLUTION;INTRAVENOUS CERIANNA +! ZIONEXA 50ML (4-100mCi/ML) N 212155 001 May 20, 2020 May NEWA

FLUOROURACIL INJECTABLE;INJECTION FLUOROURACIL >D> @ INGENUS PHARMS LLC 500MG/10ML (50MG/ML) A 209219 001 Dec 12, 2019 Sep CAHN @ 500MG/10ML (50MG/ML) A 209219 001 Dec 12, 2019 Apr DISC >D> @ 500MG/10ML (50MG/ML) A 209271 001 Dec 11, 2019 Sep CAHN @ 500MG/10ML (50MG/ML) A 209271 001 Dec 11, 2019 Apr DISC >D> @ 1GM/20ML (50MG/ML) A 209219 002 Dec 12, 2019 Sep CAHN @ 1GM/20ML (50MG/ML) A 209219 002 Dec 12, 2019 Apr DISC >D> @ 2.5GM/50ML (50MG/ML) A 209271 002 Dec 11, 2019 Sep CAHN @ 2.5GM/50ML (50MG/ML) A 209271 002 Dec 11, 2019 Apr DISC >A> @ NOVAST LABS 500MG/10ML (50MG/ML) A 209219 001 Dec 12, 2019 Sep CAHN >A> @ 500MG/10ML (50MG/ML) A 209271 001 Dec 11, 2019 Sep CAHN >A> @ 1GM/20ML (50MG/ML) A 209219 002 Dec 12, 2019 Sep CAHN >A> @ 2.5GM/50ML (50MG/ML) A 209271 002 Dec 11, 2019 Sep CAHN SOLUTION;TOPICAL EFUDEX + BAUSCH@ 5% N 016831 002 Aug DISC FLUOROURACIL ! TARO 5% A 076526 002 Nov 05, 2003 Aug CTEC AT ! 5% A 076526 002 Nov 05, 2003 Mar CHRS RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -52

FLUOXETINE HYDROCHLORIDE CAPSULE;ORAL FLUOXETINE HYDROCHLORIDE AB1 ACCORD HLTHCARE EQ 10MG BASE A 202729 001 Aug 27, 2020 Aug NEWA AB1 EQ 20MG BASE A 202729 002 Aug 27, 2020 Aug NEWA AB EQ 40MG BASE A 202729 003 Aug 27, 2020 Aug NEWA @ BARR EQ 10MG BASE A 074803 002 Jan 30, 2002 Mar DISC @ EQ 20MG BASE A 074803 001 Aug 02, 2001 Mar DISC @ SPECGX LLC EQ 10MG BASE A 075658 001 Jan 29, 2002 May DISC @ EQ 20MG BASE A 075658 002 Jan 29, 2002 May DISC SOLUTION;ORAL FLUOXETINE HYDROCHLORIDE AA AUROBINDO PHARMA LTD EQ 20MG BASE/5ML A 079209 001 Mar 20, 2009 Mar CMFD @ SPECGX LLC EQ 20MG BASE/5ML A 075920 001 Jan 29, 2002 May DISC TABLET;ORAL FLUOXETINE HYDROCHLORIDE AB AUROBINDO PHARMA LTD EQ 10MG BASE A 213286 001 Apr 08, 2020 Mar NEWA AB EQ 20MG BASE A 213286 002 Apr 08, 2020 Mar NEWA AB EQ 60MG BASE A 213265 001 Jun 10, 2020 Jun NEWA SARAFEM + @ APIL EQ 15MG BASE N 021860 002 May 19, 2006 Jul DISC + EQ 15MG BASE N 021860 002 May 19, 2006 Apr CTEC SELFEMRA @ TEVA PHARMS USA EQ 10MG BASE A 200151 001 Feb 03, 2014 Apr DISC @ EQ 15MG BASE A 200151 002 Feb 03, 2014 Apr DISC @ EQ 20MG BASE A 200151 003 Feb 03, 2014 Apr DISC

FLUPHENAZINE HYDROCHLORIDE TABLET;ORAL FLUPHENAZINE HYDROCHLORIDE AB AMNEAL 1MG A 213647 001 Jul 09, 2020 Jul NEWA AB 2.5MG A 213647 002 Jul 09, 2020 Jul NEWA AB 5MG A 213647 003 Jul 09, 2020 Jul NEWA AB 10MG A 213647 004 Jul 09, 2020 Jul NEWA @ SANDOZ 1MG A 089586 002 Oct 16, 1987 Mar DISC @ 2.5MG A 089586 003 Oct 16, 1987 Mar DISC @ 5MG A 089586 004 Oct 16, 1987 Mar DISC @ 10MG A 089586 001 Oct 16, 1987 Mar DISC

FLURANDRENOLIDE CREAM;TOPICAL CORDRAN SP + @ ALMIRALL 0.025% N 012806 003 Aug DISC

FLURBIPROFEN TABLET;ORAL FLURBIPROFEN >D> MYLAN 50MG A 074358 001 Jun 20, 1994 Sep DISC >A> @ 50MG A 074358 001 Jun 20, 1994 Sep DISC >D> AB ! 100MG A 074358 002 Jun 20, 1994 Sep DISC >A> @ 100MG A 074358 002 Jun 20, 1994 Sep DISC >D> AB TEVA 100MG A 074431 001 May 31, 1995 Sep CHRS >A> ! 100MG A 074431 001 May 31, 1995 Sep CTEC >A> AB ! 100MG A 074431 001 May 31, 1995 Sep CHRS

FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE POWDER;INHALATION TRELEGY ELLIPTA >A> +! GLAXOSMITHKLINE 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ N 209482 002 Sep 09, 2020 Sep NEWA 0.025MG BASE/INH

FLUTICASONE PROPIONATE POWDER;INHALATION ARMONAIR DIGIHALER + TEVA PHARM 0.055MG/INH N 208798 004 Feb 20, 2020 Mar NEWA + 0.113MG/INH N 208798 005 Feb 20, 2020 Mar NEWA +! 0.232MG/INH N 208798 006 Feb 20, 2020 Mar NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -53

FLUVOXAMINE MALEATE CAPSULE, EXTENDED RELEASE;ORAL FLUVOXAMINE MALEATE >A> AB BIONPHARMA INC 100MG A 212182 002 Sep 16, 2020 Sep NEWA AB 150MG A 212182 001 May 11, 2020 Apr NEWA TABLET;ORAL FLUVOXAMINE MALEATE >D> @ ECI PHARMS LLC 25MG A 075900 001 Feb 23, 2006 Sep CAHN >D> @ 50MG A 075900 002 Feb 23, 2006 Sep CAHN >D> @ 100MG A 075900 003 Feb 23, 2006 Sep CAHN >A> @ PHARMA LIFE 25MG A 075900 001 Feb 23, 2006 Sep CAHN >A> @ 50MG A 075900 002 Feb 23, 2006 Sep CAHN >A> @ 100MG A 075900 003 Feb 23, 2006 Sep CAHN @ TEVA 25MG A 075893 001 Sep 10, 2002 Mar DISC @ 50MG A 075893 002 Sep 10, 2002 Mar DISC @ 100MG A 075893 003 Sep 10, 2002 Mar DISC

FOLIC ACID INJECTABLE;INJECTION FOLIC ACID AP X-GEN PHARMS INC 5MG/ML A 202522 001 Nov 06, 2019 Jan CAHN AP XGEN PHARMS 5MG/ML A 202522 001 Nov 06, 2019 Feb CAHN TABLET;ORAL FOLIC ACID >D> AA HIKMA 1MG A 080600 001 Sep DISC >A> @ HIKMA PHARMS 1MG A 080600 001 Sep DISC @ VINTAGE 1MG A 040756 001 Jun 04, 2010 Jun DISC

FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS FOSAPREPITANT DIMEGLUMINE AP ACCORD HLTHCARE EQ 150MG BASE/VIAL A 204025 001 Aug 26, 2020 Aug NEWA AP NAVINTA LLC EQ 150MG BASE/VIAL A 212957 002 Aug 20, 2020 Aug NEWA AP QILU EQ 150MG BASE/VIAL A 213106 001 Sep 08, 2020 Aug NEWA

FOSFOMYCIN TROMETHAMINE FOR SOLUTION;ORAL >A> FOSFOMYCIN TROMETHAMINE >A> AA XIROMED EQ 3GM BASE/PACKET A 212548 001 Oct 06, 2020 Sep NFTG MONUROL >D> +! ZAMBON SPA EQ 3GM BASE/PACKET N 050717 001 Dec 19, 1996 Sep CFTG >A> AA +! EQ 3GM BASE/PACKET N 050717 001 Dec 19, 1996 Sep CFTG

FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE TABLET;ORAL FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE AB ! AUROBINDO PHARMA 20MG;12.5MG A 079245 002 Jul 09, 2009 Apr CHRS @ EMCURE PHARMS LTD 10MG;12.5MG A 079025 001 Sep 17, 2010 Apr DISC @ 20MG;12.5MG A 079025 002 Sep 17, 2010 Apr DISC

FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE POWDER;INTRAVENOUS AKYNZEO +! HELSINN HLTHCARE EQ 235MG BASE/VIAL;EQ 0.25MG N 210493 001 Apr 19, 2018 May CMS1 BASE/VIAL SOLUTION;INTRAVENOUS AKYNZEO +! HELSINN HLTHCARE EQ 235MG BASE/20ML (EQ 11.75MG N 210493 002 May 27, 2020 May NEWA BASE/ML);EQ 0.25MG BASE/20ML (EQ 0.0125MG BASE/ML)

FOSPHENYTOIN SODIUM INJECTABLE;INJECTION FOSPHENYTOIN SODIUM >D> AP AMNEAL EQ 50MG PHENYTOIN NA/ML A 078476 001 Mar 18, 2008 Sep DISC >A> @ EQ 50MG PHENYTOIN NA/ML A 078476 001 Mar 18, 2008 Sep DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -54

FOSTEMSAVIR TROMETHAMINE TABLET, EXTENDED RELEASE;ORAL RUKOBIA +! VIIV HLTHCARE EQ 600MG BASE N 212950 001 Jul 02, 2020 Jul NEWA

FULVESTRANT INJECTABLE;INTRAMUSCULAR FULVESTRANT AO CHIA TAI TIANQING 50MG/ML A 211422 001 Feb 07, 2020 Jan NEWA AO DR REDDYS 50MG/ML A 209246 001 Aug 07, 2020 Jul NEWA

FUROSEMIDE INJECTABLE;INJECTION FUROSEMIDE >D> AP AMNEAL PHARMS CO 10MG/ML A 207552 001 Jul 20, 2016 Sep DISC >A> @ 10MG/ML A 207552 001 Jul 20, 2016 Sep DISC AP GLAND PHARMA LTD 10MG/ML A 213902 001 Jul 01, 2020 Jun NEWA TABLET;ORAL FUROSEMIDE @ AVET 20MG N 018413 001 Nov 30, 1983 Jan DISC @ 40MG N 018413 002 Nov 30, 1983 Jan DISC

GABAPENTIN CAPSULE;ORAL GABAPENTIN AB CSPC OUYI 100MG A 075477 001 Mar 23, 2005 Jan CMFD AB 300MG A 075477 002 Mar 23, 2005 Jan CMFD AB 400MG A 075477 003 Mar 23, 2005 Jan CMFD @ JIANGSU HENGRUI MED 100MG A 091008 001 Oct 26, 2017 May DISC @ 300MG A 091008 002 Oct 26, 2017 May DISC @ 400MG A 091008 003 Oct 26, 2017 May DISC @ TEVA PHARMS 100MG A 075435 001 Oct 08, 2004 Mar DISC @ 300MG A 075435 002 Oct 08, 2004 Mar DISC @ 400MG A 075435 003 Oct 08, 2004 Mar DISC AB ZHEJIANG YONGTAI 100MG A 213603 001 Aug 17, 2020 Aug NEWA AB 300MG A 213603 002 Aug 17, 2020 Aug NEWA AB 400MG A 213603 003 Aug 17, 2020 Aug NEWA NEURONTIN AB + UPJOHN 100MG N 020235 001 Dec 30, 1993 Jun CAHN AB + 300MG N 020235 002 Dec 30, 1993 Jun CAHN AB +! 400MG N 020235 003 Dec 30, 1993 Jun CAHN SOLUTION;ORAL GABAPENTIN @ VISTAPHARM 250MG/5ML A 211330 001 Dec 03, 2019 May DISC NEURONTIN AA +! UPJOHN 250MG/5ML N 021129 001 Mar 02, 2000 Jun CAHN TABLET;ORAL GABAPENTIN @ MYLAN PHARMS INC 600MG A 090335 001 Jun 01, 2010 Mar DISC @ 800MG A 090335 002 Jun 01, 2010 Mar DISC @ TEVA PHARMS USA 600MG A 205807 001 Mar 10, 2017 Mar DISC @ 800MG A 205807 002 Mar 10, 2017 Mar DISC GRALISE BX +! ALMATICA 300MG N 022544 001 Jan 28, 2011 Jan CAHN BX +! 600MG N 022544 002 Jan 28, 2011 Jan CAHN NEURONTIN AB + UPJOHN 600MG N 020882 001 Oct 09, 1998 Jun CAHN AB +! 800MG N 020882 002 Oct 09, 1998 Jun CAHN

GADOTERATE MEGLUMINE SOLUTION;INTRAVENOUS CLARISCAN >A> AP GE HEALTHCARE 37.69GM/100ML (376.9MG/ML) A 210016 004 Aug 04, 2020 Sep NFTG DOTAREM >D> +! GUERBET 37.69GM/100ML (376.9MG/ML) N 204781 001 Mar 20, 2013 Sep CFTG >A> AP +! 37.69GM/100ML (376.9MG/ML) N 204781 001 Mar 20, 2013 Sep CFTG RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -55

GALANTAMINE HYDROBROMIDE TABLET;ORAL GALANTAMINE HYDROBROMIDE @ HIKMA EQ 4MG BASE A 077608 001 Feb 11, 2009 Feb DISC @ EQ 8MG BASE A 077608 002 Feb 11, 2009 Feb DISC @ EQ 12MG BASE A 077608 003 Feb 11, 2009 Feb DISC

GEMCITABINE HYDROCHLORIDE INJECTABLE;INJECTION GEMCITABINE HYDROCHLORIDE @ APOTEX 200MG/5.26ML (38MG/ML) A 206776 001 May 23, 2017 Feb DISC @ 1GM/26.3ML (38MG/ML) A 206776 002 May 23, 2017 Feb DISC @ 2GM/52.6ML (38MG/ML) A 206776 003 May 23, 2017 Feb DISC @ EMCURE PHARMS LTD EQ 200MG BASE/VIAL A 202063 001 Sep 11, 2012 Aug DISC @ EQ 1GM BASE/VIAL A 202063 002 Sep 11, 2012 Aug DISC >D> @ INGENUS PHARMS LLC 200MG/5.26ML (38MG/ML) A 210383 001 Feb 14, 2019 Sep CAHN >D> @ 1GM/26.3ML (38MG/ML) A 210383 002 Feb 14, 2019 Sep CAHN >D> @ 2GM/52.6ML (38MG/ML) A 210383 003 Feb 14, 2019 Sep CAHN @ MYLAN LABS LTD EQ 200MG BASE/VIAL A 200145 001 Jul 25, 2011 Jul DISC @ EQ 1GM BASE/VIAL A 200145 002 Jul 25, 2011 May DISC @ EQ 2GM BASE/VIAL A 200145 003 Jul 25, 2011 Mar DISC >A> @ NOVAST LABS 200MG/5.26ML (38MG/ML) A 210383 001 Feb 14, 2019 Sep CAHN >A> @ 1GM/26.3ML (38MG/ML) A 210383 002 Feb 14, 2019 Sep CAHN >A> @ 2GM/52.6ML (38MG/ML) A 210383 003 Feb 14, 2019 Sep CAHN AP SHILPA MEDICARE LTD EQ 200MG BASE/VIAL A 207575 001 Feb 22, 2019 Jan CMFD AP EQ 1GM BASE/VIAL A 207575 002 Feb 22, 2019 Jan CMFD @ TEVA PHARMS EQ 200MG BASE/VIAL A 077983 002 Jan 25, 2011 Mar DISC @ EQ 1GM BASE/VIAL A 077983 001 Jan 25, 2011 Mar DISC

GEMFIBROZIL TABLET;ORAL GEMFIBROZIL AB CADILA 600MG A 204189 001 Aug 28, 2018 Feb CAHN >D> AB HIKMA PHARMS 600MG A 078599 001 Aug 16, 2010 Sep DISC >A> @ 600MG A 078599 001 Aug 16, 2010 Sep DISC @ TEVA 600MG A 074256 001 Oct 31, 1993 Feb DISC

GLIMEPIRIDE TABLET;ORAL GLIMEPIRIDE @ MYLAN 1MG A 077624 001 Nov 28, 2005 Apr DISC @ 2MG A 077624 002 Nov 28, 2005 Apr DISC @ 4MG A 077624 003 Nov 28, 2005 Apr DISC

GLYBURIDE TABLET;ORAL GLYBURIDE AB1 ORIENT PHARMA CO LTD 1.25MG A 206483 001 Feb 22, 2019 May CMFD AB1 2.5MG A 206483 002 Feb 22, 2019 May CMFD AB1 5MG A 206483 003 Feb 22, 2019 May CMFD >D> AB1 PHARMADAX INC 1.25MG A 203581 001 Apr 14, 2016 Sep CAHN >D> AB1 2.5MG A 203581 002 Apr 14, 2016 Sep CAHN >D> AB1 5MG A 203581 003 Apr 14, 2016 Sep CAHN >A> AB1 SWISS PHARM 1.25MG A 203581 001 Apr 14, 2016 Sep CAHN >A> AB1 2.5MG A 203581 002 Apr 14, 2016 Sep CAHN >A> AB1 5MG A 203581 003 Apr 14, 2016 Sep CAHN GLYBURIDE (MICRONIZED) @ MYLAN 1.5MG A 074792 001 Jun 26, 1998 Jan DISC @ 3MG A 074792 002 Jun 26, 1998 Jan DISC @ 6MG A 074792 003 Aug 17, 1999 Jan DISC

GLYCOPYRROLATE INJECTABLE;INJECTION GLYCOPYRROLATE AP ACCORD HLTHCARE 0.2MG/ML A 213238 001 Jul 08, 2020 Jul NEWA AP RICONPHARMA LLC 0.2MG/ML A 210083 001 Feb 21, 2020 Feb NEWA POWDER;INHALATION SEEBRI + @ NOVARTIS 15.6MCG/INH N 207923 001 Oct 29, 2015 Mar CAHN + @ SUNOVION PHARMS INC 15.6MCG/INH N 207923 001 Oct 29, 2015 Mar DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -56

SOLUTION;INTRAMUSCULAR, INTRAVENOUS GLYRX-PF EXELA PHARMA 1MG/5ML (0.2MG/ML) N 210997 003 Apr 09, 2020 Apr NEWA TABLET;ORAL GLYCOPYRROLATE LGM PHARMA 1.5MG A 091522 001 Mar 12, 2012 Aug CAHN

GLYCOPYRROLATE; INDACATEROL MALEATE POWDER;INHALATION UTIBRON + @ NOVARTIS 15.6MCG/INH;27.5MCG/INH N 207930 001 Oct 29, 2015 Mar CAHN + @ SUNOVION PHARMS INC 15.6MCG/INH;27.5MCG/INH N 207930 001 Oct 29, 2015 Mar DISC

GRANISETRON HYDROCHLORIDE INJECTABLE;INJECTION GRANISETRON HYDROCHLORIDE @ MYLAN LABS LTD EQ 0.1MG BASE/ML (EQ 0.1MG A 203454 001 Apr 04, 2017 Apr DISC BASE/ML) @ EQ 1MG BASE/ML (EQ 1MG BASE/ML) A 203454 002 Apr 04, 2017 Apr DISC @ EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A 203453 001 Jan 31, 2017 Mar DISC AP PUNISKA EQ 0.1MG BASE/ML (EQ 0.1MG A 078262 001 Dec 31, 2007 May CAHN BASE/ML) AP EQ 1MG BASE/ML (EQ 1MG BASE/ML) A 078258 001 Jun 30, 2008 May CAHN AP EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A 078258 002 Jun 30, 2008 May CAHN @ YUNG SHIN PHARM EQ 0.1MG BASE/ML (EQ 0.1MG A 202647 001 Mar 06, 2020 Apr DISC BASE/ML) AP EQ 0.1MG BASE/ML (EQ 0.1MG A 202647 001 Mar 06, 2020 Feb NEWA BASE/ML) @ EQ 1MG BASE/ML (EQ 1MG BASE/ML) A 202648 001 Jun 29, 2020 Aug DISC AP EQ 1MG BASE/ML (EQ 1MG BASE/ML) A 202648 001 Jun 29, 2020 Jun NEWA @ EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A 202648 002 Jun 29, 2020 Aug DISC AP EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A 202648 002 Jun 29, 2020 Jun NEWA TABLET;ORAL GRANISETRON HYDROCHLORIDE @ MYLAN EQ 1MG BASE A 078725 001 Jan 30, 2008 Jan DISC

GRISEOFULVIN, MICROSIZE SUSPENSION;ORAL GRISEOFULVIN AB COSETTE 125MG/5ML A 065438 001 Oct 08, 2010 May CAHN

GRISEOFULVIN, ULTRAMICROSIZE TABLET;ORAL GRIS-PEG AB + BAUSCH 125MG N 050475 001 Aug CAHN AB + 250MG N 050475 002 Aug CAHN AB + VALEANT PHARMS INC 250MG N 050475 002 Jul CHRS GRISEOFULVIN, ULTRAMICROSIZE AB ! MOUNTAIN 250MG A 204371 002 Jan 09, 2014 Jul CHRS

GUANIDINE HYDROCHLORIDE TABLET;ORAL >D> GUANIDINE HYDROCHLORIDE >D> MERCK SHARP DOHME 125MG N 001546 001 Sep DISC >A> @ 125MG N 001546 001 Sep DISC

HALCINONIDE SOLUTION;TOPICAL HALOG ! SUN PHARM INDS INC 0.1% N 017823 001 Mar CMFD

HALOBETASOL PROPIONATE LOTION;TOPICAL HALOBETASOL PROPIONATE @ PERRIGO ISRAEL 0.05% A 211464 001 Jun 03, 2020 Jun DISC AB 0.05% A 211464 001 Jun 03, 2020 May NFTG ULTRAVATE +! SUN PHARM INDUSTRIES 0.05% N 208183 001 Nov 06, 2015 Jun CTEC AB +! 0.05% N 208183 001 Nov 06, 2015 May CFTG OINTMENT;TOPICAL HALOBETASOL PROPIONATE >A> AB QUAGEN 0.05% A 213560 001 Oct 06, 2020 Sep NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -57

HALOPERIDOL TABLET;ORAL HALOPERIDOL AB UPSHER SMITH LABS 0.5MG A 211061 001 Jan 08, 2020 Jun CAHN AB 1MG A 211061 002 Jan 08, 2020 Jun CAHN AB 2MG A 211061 003 Jan 08, 2020 Jun CAHN AB 5MG A 211061 004 Jan 08, 2020 Jun CAHN AB 10MG A 211061 005 Jan 08, 2020 Jun CAHN AB 20MG A 211061 006 Jan 08, 2020 Jun CAHN

HALOPERIDOL LACTATE INJECTABLE;INJECTION HALOPERIDOL AP FRESENIUS KABI USA EQ 5MG BASE/ML A 210356 001 Jul 01, 2019 Aug CMFD @ TEVA PHARMS USA EQ 5MG BASE/ML A 076035 001 Aug 29, 2001 Mar DISC

HEPARIN SODIUM INJECTABLE;INJECTION HEPARIN SODIUM AP GLAND PHARMA LTD 1,000 UNITS/ML A 205323 002 Nov 18, 2019 Apr NEWA AP NANJING KING-FRIEND 5,000 UNITS/ML A 212061 001 Jul 15, 2020 Jul NEWA AP 20,000 UNITS/ML A 211004 001 Feb 24, 2020 Feb NEWA + @ PFIZER 10,000 UNITS/ML N 201370 003 Jul 21, 2011 Jun DISC HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER AP FRESENIUS KABI USA 200 UNITS/100ML A 212441 001 Jul 24, 2020 Jul NEWA HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE 2,000 UNITS/1000ML N 018609 004 Apr 23, 2020 Apr NEWA HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER AP FRESENIUS KABI USA 200 UNITS/100ML A 212441 002 Jul 24, 2020 Jul NEWA HEPARIN SODIUM PRESERVATIVE FREE AP +! FRESENIUS KABI USA 10,000 UNITS/ML N 017029 019 Nov 22, 2010 Mar CTEC >D> ! HOSPIRA 10,000 UNITS/ML A 089522 001 May 04, 1987 Sep DISC >A> @ 10,000 UNITS/ML A 089522 001 May 04, 1987 Sep DISC AP NANJING KING-FRIEND 10,000 UNITS/ML A 212060 001 Apr 02, 2020 Mar NEWA

HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE SYRUP;ORAL HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE @ NOSTRUM LABS INC 1.5MG/5ML;5MG/5ML A 210663 001 Jun 11, 2019 Apr CAHN TABLET;ORAL HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE AA ! NOVEL LABS INC 1.5MG;5MG A 091528 001 Apr 20, 2011 Jan CHRS TUSSIGON @ KING PHARMS 1.5MG;5MG A 088508 001 Jul 30, 1985 Jan DISC

HYDRALAZINE HYDROCHLORIDE INJECTABLE;INJECTION HYDRALAZINE HYDROCHLORIDE >A> AP I3 PHARMS 20MG/ML A 203110 001 Jun 29, 2015 Sep CAHN >D> AP XGEN PHARMS 20MG/ML A 203110 001 Jun 29, 2015 Sep CAHN AP 20MG/ML A 203110 001 Jun 29, 2015 Feb CAHN TABLET;ORAL HYDRALAZINE HYDROCHLORIDE @ STRIDES PHARMA 10MG A 200770 004 Jun 25, 2019 Jan DISC

HYDROCHLOROTHIAZIDE CAPSULE;ORAL HYDROCHLOROTHIAZIDE @ IVAX SUB TEVA PHARMS 12.5MG A 077005 001 Jul 13, 2005 Mar DISC TABLET;ORAL HYDROCHLOROTHIAZIDE >D> AB HIKMA INTL PHARMS 50MG A 084878 001 Sep DISC >A> @ 50MG A 084878 001 Sep DISC @ MYLAN PHARMS INC 25MG A 040735 002 Jan 23, 2007 Jan DISC @ 50MG A 040735 003 Jan 23, 2007 Jan DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -58

HYDROCHLOROTHIAZIDE; LISINOPRIL TABLET;ORAL LISINOPRIL AND HYDROCHLOROTHIAZIDE @ COREPHARMA 12.5MG;10MG A 076674 001 Oct 05, 2004 Feb CAHN @ 12.5MG;20MG A 076674 002 Oct 05, 2004 Feb CAHN @ 25MG;20MG A 076674 003 Oct 05, 2004 Feb CAHN >D> AB HIKMA INTL PHARMS 12.5MG;10MG A 076265 001 Jul 08, 2002 Sep DISC >A> @ 12.5MG;10MG A 076265 001 Jul 08, 2002 Sep DISC >D> AB 12.5MG;20MG A 076265 002 Jul 08, 2002 Sep DISC >A> @ 12.5MG;20MG A 076265 002 Jul 08, 2002 Sep DISC >D> AB 25MG;20MG A 076265 003 Jul 08, 2002 Sep DISC >A> @ 25MG;20MG A 076265 003 Jul 08, 2002 Sep DISC

HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM TABLET;ORAL LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE >D> AB HIKMA 12.5MG;50MG A 077732 002 Oct 06, 2010 Sep DISC >A> @ 12.5MG;50MG A 077732 002 Oct 06, 2010 Sep DISC >D> AB 12.5MG;100MG A 077732 001 Apr 06, 2010 Sep DISC >A> @ 12.5MG;100MG A 077732 001 Apr 06, 2010 Sep DISC >D> AB 25MG;100MG A 077732 003 Oct 06, 2010 Sep DISC >A> @ 25MG;100MG A 077732 003 Oct 06, 2010 Sep DISC

HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE TABLET;ORAL LOPRESSOR HCT >D> AB +! US PHARMS HOLDINGS I 25MG;100MG N 018303 002 Dec 31, 1984 Sep DISC >A> + @ 25MG;100MG N 018303 002 Dec 31, 1984 Sep DISC METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE >D> AB ALEMBIC PHARMS LTD 25MG;100MG A 202870 002 Nov 06, 2013 Sep CHRS >A> AB ! 25MG;100MG A 202870 002 Nov 06, 2013 Sep CHRS

HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE TABLET;ORAL MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE @ HERITAGE PHARMS INC 12.5MG;7.5MG A 202150 001 Mar 07, 2014 Apr DISC @ 12.5MG;15MG A 202150 002 Mar 07, 2014 Apr DISC @ 25MG;15MG A 202150 003 Mar 07, 2014 Apr DISC

HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL TABLET;ORAL OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE AB ACCORD HLTHCARE 12.5MG;20MG A 209281 001 Feb 07, 2019 Jul CMFD AB 12.5MG;40MG A 209281 002 Feb 07, 2019 Jul CMFD AB 25MG;40MG A 209281 003 Feb 07, 2019 Jul CMFD AB UMEDICA LABS PVT LTD 12.5MG;20MG A 208847 001 Sep 17, 2019 May CMFD @ 12.5MG;20MG A 208847 001 Sep 17, 2019 Mar DISC AB 12.5MG;40MG A 208847 003 Sep 17, 2019 May CMFD @ 12.5MG;40MG A 208847 003 Sep 17, 2019 Mar DISC AB 25MG;40MG A 208847 002 Sep 17, 2019 May CMFD @ 25MG;40MG A 208847 002 Sep 17, 2019 Mar DISC

HYDROCHLOROTHIAZIDE; SPIRONOLACTONE TABLET;ORAL ALDACTAZIDE AB + PFIZER 25MG;25MG N 012616 004 Dec 30, 1982 Jul CAHN +! 50MG;50MG N 012616 005 Dec 30, 1982 Jul CAHN

HYDROCHLOROTHIAZIDE; TELMISARTAN TABLET;ORAL TELMISARTAN AND HYDROCHLOROTHIAZIDE @ MACLEODS PHARMS LTD 12.5MG;40MG A 204169 001 Nov 02, 2015 May DISC @ 12.5MG;80MG A 204169 002 Nov 02, 2015 May DISC @ 25MG;80MG A 204169 003 Nov 02, 2015 May DISC @ MYLAN 12.5MG;40MG A 091648 001 Feb 25, 2014 Apr DISC @ 12.5MG;80MG A 091648 002 Feb 25, 2014 Apr DISC @ 25MG;80MG A 091648 003 Feb 25, 2014 Apr DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -59

HYDROCHLOROTHIAZIDE; TRIAMTERENE CAPSULE;ORAL TRIAMTERENE AND HYDROCHLOROTHIAZIDE AB CADILA 25MG;37.5MG A 208358 001 Feb 11, 2019 Feb CAHN @ DURAMED PHARMS BARR 25MG;37.5MG A 075052 001 Jun 18, 1999 Mar DISC TABLET;ORAL TRIAMTERENE AND HYDROCHLOROTHIAZIDE @ PLIVA 25MG;37.5MG A 074026 001 Apr 26, 1996 Mar DISC

HYDROCODONE BITARTRATE CAPSULE, EXTENDED RELEASE;ORAL HYDROCODONE BITARTRATE AB ALVOGEN 10MG A 206986 001 Jan 21, 2020 Jan NFTG AB 15MG A 206986 002 Jan 21, 2020 Jan NFTG AB 20MG A 206986 003 Jan 21, 2020 Jan NFTG AB 30MG A 206986 004 Jan 21, 2020 Jan NFTG AB 40MG A 206986 005 Jan 21, 2020 Jan NFTG AB 50MG A 206986 006 Jan 21, 2020 Jan NFTG ZOHYDRO ER AB +! PERSION 10MG N 202880 001 Oct 25, 2013 Jan CFTG AB + 15MG N 202880 002 Oct 25, 2013 Jan CFTG AB + 20MG N 202880 003 Oct 25, 2013 Jan CFTG AB + 30MG N 202880 004 Oct 25, 2013 Jan CFTG AB + 40MG N 202880 005 Oct 25, 2013 Jan CFTG AB + 50MG N 202880 006 Oct 25, 2013 Jan CFTG

HYDROCORTISONE ENEMA;RECTAL HYDROCORTISONE @ TEVA PHARMS 100MG/60ML A 074171 001 May 27, 1994 Mar DISC GRANULE;ORAL >A> ALKINDI SPRINKLE >A> + ETON 0.5MG N 213876 001 Sep 29, 2020 Sep NEWA >A> + 1MG N 213876 002 Sep 29, 2020 Sep NEWA >A> + 2MG N 213876 003 Sep 29, 2020 Sep NEWA >A> +! 5MG N 213876 004 Sep 29, 2020 Sep NEWA LOTION;TOPICAL HYDROCORTISONE @ FOUGERA PHARMS 2.5% A 040351 001 Jul 25, 2000 Apr DISC STIE-CORT AT ! PERRIGO CO 2.5% A 089074 001 Nov 26, 1985 Apr CHRS OINTMENT;TOPICAL HYDROCORTISONE @ ACTAVIS MID ATLANTIC 1% A 087796 001 Oct 13, 1982 Mar DISC TABLET;ORAL HYDROCORTISONE >D> AB HIKMA INTL PHARMS 5MG A 083365 002 Feb 23, 2015 Sep DISC >A> @ 5MG A 083365 002 Feb 23, 2015 Sep DISC >D> AB 10MG A 083365 003 Feb 23, 2015 Sep DISC >A> @ 10MG A 083365 003 Feb 23, 2015 Sep DISC >D> AB 20MG A 083365 001 Sep DISC >A> @ 20MG A 083365 001 Sep DISC AB STRIDES PHARMA 5MG A 207029 001 Apr 27, 2017 Feb CAHN AB 10MG A 207029 002 Apr 27, 2017 Feb CAHN AB 20MG A 207029 003 Apr 27, 2017 Feb CAHN @ VINTAGE 5MG A 040761 001 Jul 16, 2007 Aug DISC @ 10MG A 040761 002 Jul 16, 2007 Aug DISC @ 20MG A 040761 003 Jul 16, 2007 Aug DISC

HYDROCORTISONE ACETATE CREAM;TOPICAL CARMOL HC @ FOUGERA PHARMS 1% A 080505 001 Aug CAIN HYDROCORTISONE ACETATE @ IMPERIUM 2.5% A 040259 001 Jul 29, 1999 Jun CAHN U-CORT TARO 1% A 089472 001 Jun 13, 1988 Aug CAIN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -60

HYDROCORTISONE VALERATE OINTMENT;TOPICAL HYDROCORTISONE VALERATE AB COSETTE 0.2% A 211764 001 Mar 04, 2020 Feb NEWA

HYDROMORPHONE HYDROCHLORIDE INJECTABLE;INJECTION DILAUDID +! FRESENIUS KABI USA 0.2MG/ML N 019034 006 Jan 16, 2020 Jan NEWA >D> AP +! 1MG/ML N 019034 003 Apr 30, 2009 Sep CTEC >A> +! 1MG/ML N 019034 003 Apr 30, 2009 Sep CTEC HYDROMORPHONE HYDROCHLORIDE @ BARR 10MG/ML A 076444 001 Apr 25, 2003 Mar DISC >D> AP HOSPIRA INC 1MG/ML N 200403 001 Dec 01, 2011 Sep DISC >A> @ 1MG/ML N 200403 001 Dec 01, 2011 Sep DISC >D> AP 2MG/ML N 200403 002 Dec 01, 2011 Sep DISC >A> @ 2MG/ML N 200403 002 Dec 01, 2011 Sep DISC TABLET;ORAL HYDROMORPHONE HYDROCHLORIDE AB NOSTRUM LABS INC 8MG A 076723 001 Oct 18, 2005 Feb CAHN TABLET, EXTENDED RELEASE;ORAL HYDROMORPHONE HYDROCHLORIDE >A> AB ASCENT PHARMS INC 8MG A 212133 001 Sep 23, 2020 Sep NEWA >A> AB 12MG A 212133 002 Sep 23, 2020 Sep NEWA >A> AB 16MG A 212133 003 Sep 23, 2020 Sep NEWA >A> AB 32MG A 212133 004 Sep 23, 2020 Sep NEWA

HYDROXYCHLOROQUINE SULFATE TABLET;ORAL HYDROXYCHLOROQUINE SULFATE AB ACCORD HLTHCARE 200MG A 213342 001 Apr 07, 2020 Mar NEWA >D> AB APPCO 200MG A 210441 001 May 01, 2018 Sep CAHN AB 200MG A 210441 001 May 01, 2018 Mar CAHN >A> AB DR REDDYS 200MG A 210441 001 May 01, 2018 Sep CAHN AB HAVIX 200MG A 212902 001 May 14, 2020 May NEWA >D> AB HIKMA 200MG A 040760 001 Aug 15, 2007 Sep DISC >A> @ HIKMA PHARMS 200MG A 040760 001 Aug 15, 2007 Sep DISC AB LAURUS LABS LTD 200MG A 210959 001 Jan 15, 2019 Mar CMFD AB LUPIN LTD 200MG A 210543 001 Jul 06, 2018 Mar CMFD

HYDROXYPROGESTERONE CAPROATE SOLUTION;INTRAMUSCULAR HYDROXYPROGESTERONE CAPROATE @ AM REGENT 1250MG/5ML (250MG/ML) A 210724 001 Aug 09, 2019 Feb DISC AP1 1250MG/5ML (250MG/ML) A 210724 001 Aug 09, 2019 Jan CMS1

HYDROXYUREA CAPSULE;ORAL HYDROXYUREA AB LEADING PHARMA LLC 500MG A 213438 001 Apr 08, 2020 Mar NEWA

HYDROXYZINE HYDROCHLORIDE SYRUP;ORAL HYDROXYZINE HYDROCHLORIDE @ VINTAGE PHARMS 10MG/5ML A 040391 001 Apr 10, 2002 May DISC TABLET;ORAL HYDROXYZINE HYDROCHLORIDE @ AUROBINDO PHARMA LTD 10MG A 087871 002 Dec 20, 1982 May CAHN @ 25MG A 087871 003 Dec 20, 1982 May CAHN @ 50MG A 087871 001 Dec 20, 1982 May CAHN >A> AB DISCOVERY THERAP 10MG A 040804 001 Jun 30, 2008 Sep CAHN >A> AB 25MG A 040804 002 Jun 30, 2008 Sep CAHN >A> AB 50MG A 040804 003 Jun 30, 2008 Sep CAHN >D> AB ECI PHARMS LLC 10MG A 040804 001 Jun 30, 2008 Sep CAHN >D> AB 25MG A 040804 002 Jun 30, 2008 Sep CAHN >D> AB 50MG A 040804 003 Jun 30, 2008 Sep CAHN >A> AB NUVO PHARMS INC 10MG A 207121 002 Mar 29, 2017 Sep CMS1 >A> AB 50MG A 207121 003 Mar 29, 2017 Sep CMS1

RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -61

HYDROXYZINE PAMOATE CAPSULE;ORAL VISTARIL AB + PFIZER EQ 25MG HYDROCHLORIDE N 011459 002 Jul CMFD AB + EQ 50MG HYDROCHLORIDE N 011459 004 Jul CMFD

IBANDRONATE SODIUM INJECTABLE;INTRAVENOUS BONIVA >D> AP +! ROCHE EQ 3MG BASE/3ML N 021858 001 Jan 06, 2006 Sep DISC >A> + @ EQ 3MG BASE/3ML N 021858 001 Jan 06, 2006 Sep DISC IBANDRONATE SODIUM >D> AP APOTEX EQ 3MG BASE/3ML A 204222 001 Oct 16, 2015 Sep CHRS >A> AP ! EQ 3MG BASE/3ML A 204222 001 Oct 16, 2015 Sep CHRS

IBUPROFEN TABLET;ORAL IBUPROFEN AB AUROBINDO PHARMA LTD 400MG A 213794 001 May 08, 2020 Apr NEWA AB 600MG A 213794 002 May 08, 2020 Apr NEWA AB 800MG A 213794 003 May 08, 2020 Apr NEWA

IBUPROFEN LYSINE INJECTABLE;INTRAVENOUS IBUPROFEN LYSINE AP XGEN PHARMS EQ 20MG BASE/2ML (EQ 10MG BASE/ML) A 202402 001 Mar 30, 2016 Feb CAHN

IBUPROFEN; OXYCODONE HYDROCHLORIDE TABLET;ORAL COMBUNOX + @ FOREST LABS 400MG;5MG N 021378 001 Nov 26, 2004 Apr CRLD OXYCODONE HYDROCHLORIDE AND IBUPROFEN ACTAVIS ELIZABETH 400MG;5MG A 078769 001 Jan 04, 2008 Apr CTEC @ BARR LABS INC 400MG;5MG A 078316 001 Nov 29, 2007 Apr DISC

ICATIBANT ACETATE INJECTABLE;SUBCUTANEOUS ICATIBANT ACETATE AP CIPLA EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A 212446 001 Jul 13, 2020 Jul NEWA >A> AP DR REDDYS EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A 213054 001 Oct 05, 2020 Sep NEWA AP FRESENIUS KABI USA EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A 208317 001 Jun 18, 2020 Jun NEWA AP JIANGSU HANSOH PHARM EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A 211021 001 Mar 09, 2020 Feb NEWA AP SLAYBACK PHARMA LLC EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A 211501 001 Sep 01, 2020 Aug NEWA

ICOSAPENT ETHYL CAPSULE;ORAL ICOSAPENT ETHYL AB DR REDDYS 1GM A 209499 001 Aug 07, 2020 Jul NEWA AB HIKMA 1GM A 209457 001 May 21, 2020 May NFTG >A> AB TEVA PHARMS USA 500MG A 209525 001 Sep 11, 2020 Sep NFTG >A> AB 1GM A 209525 002 Sep 11, 2020 Sep NEWA VASCEPA >D> + AMARIN PHARMS 500MG N 202057 002 Feb 16, 2017 Sep CFTG >A> AB + 500MG N 202057 002 Feb 16, 2017 Sep CFTG AB +! 1GM N 202057 001 Jul 26, 2012 May CFTG

IMATINIB MESYLATE TABLET;ORAL IMATINIB MESYLATE AB EUGIA PHARMA EQ 100MG BASE A 212773 001 Jul 23, 2020 Jul NEWA AB EQ 400MG BASE A 212773 002 Jul 23, 2020 Jul NEWA AB ZYDUS PHARMS EQ 100MG BASE A 210658 001 Apr 08, 2020 Mar NEWA AB EQ 400MG BASE A 210658 002 Apr 08, 2020 Mar NEWA

IMIPRAMINE HYDROCHLORIDE TABLET;ORAL IMIPRAMINE HYDROCHLORIDE AB OXFORD PHARMS 10MG A 040751 003 Feb 28, 2008 Apr CMFD AB 25MG A 040751 002 Feb 28, 2008 Apr CMFD AB 50MG A 040751 001 Feb 28, 2008 Apr CMFD RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -62

INDACATEROL MALEATE POWDER;INHALATION ARCAPTA NEOHALER + @ NOVARTIS EQ 75MCG BASE N 022383 001 Jul 01, 2011 Mar CAHN + @ SUNOVION PHARMS INC EQ 75MCG BASE N 022383 001 Jul 01, 2011 Mar DISC

INDINAVIR SULFATE CAPSULE;ORAL CRIXIVAN + @ MERCK SHARP DOHME EQ 200MG BASE N 020685 003 Mar 13, 1996 Mar DISC + @ EQ 400MG BASE N 020685 001 Mar 13, 1996 Aug DISC

INDOMETHACIN CAPSULE;ORAL INDOMETHACIN @ HERITAGE 25MG N 018851 001 May 18, 1984 Jul DISC AB 25MG N 018851 001 May 18, 1984 Jan CAHN @ 50MG N 018851 002 May 18, 1984 Jul DISC AB 50MG N 018851 002 May 18, 1984 Jan CAHN @ HERITAGE PHARMA 25MG A 070719 001 Feb 12, 1986 Apr DISC @ 50MG A 070756 001 Feb 12, 1986 Mar DISC CAPSULE, EXTENDED RELEASE;ORAL INDOMETHACIN MY LAN@ MYLAN@ 75MG A 202139 001 Mar 20, 2014 May DISC SUPPOSITORY;RECTAL INDOMETHACIN ! COSETTE 50MG A 073314 001 Aug 31, 1992 Jul CAHN

INGENOL MEBUTATE GEL;TOPICAL INGENOL MEBUTATE @ PERRIGO UK FINCO 0.015% A 209018 001 Jan 07, 2019 Jun DISC @ 0.05% A 209019 001 Jan 09, 2019 Jun DISC PICATO +! LEO LABS 0.015% N 202833 001 Jan 23, 2012 Jun CTEC +! 0.05% N 202833 002 Jan 23, 2012 Jun CTEC

IPRATROPIUM BROMIDE SOLUTION;INHALATION IPRATROPIUM BROMIDE @ WATSON LABS 0.02% A 076291 001 May 09, 2005 Apr DISC SPRAY, METERED;NASAL IPRATROPIUM BROMIDE AB APOTEX INC 0.021MG/SPRAY A 076156 001 Apr 18, 2003 Jan CMFD

IRBESARTAN TABLET;ORAL IRBESARTAN @ HIKMA 75MG A 090201 001 Oct 15, 2012 Feb DISC @ 150MG A 090201 002 Oct 15, 2012 Feb DISC @ 300MG A 090201 003 Oct 15, 2012 Feb DISC

IRINOTECAN HYDROCHLORIDE INJECTABLE;INJECTION IRINOTECAN HYDROCHLORIDE @ CIPLA LTD 40MG/2ML (20MG/ML) A 077219 001 Feb 20, 2008 Apr DISC @ 100MG/5ML (20MG/ML) A 077219 002 Feb 20, 2008 Apr DISC >D> AP INGENUS PHARMS LLC 40MG/2ML (20MG/ML) A 206935 001 May 26, 2017 Sep CAHN >D> AP 100MG/5ML (20MG/ML) A 206935 002 May 26, 2017 Sep CAHN >A> AP NOVAST LABS 40MG/2ML (20MG/ML) A 206935 001 May 26, 2017 Sep CAHN >A> AP 100MG/5ML (20MG/ML) A 206935 002 May 26, 2017 Sep CAHN @ PLIVA LACHEMA 40MG/2ML (20MG/ML) A 078122 001 Oct 31, 2008 Apr DISC @ 100MG/5ML (20MG/ML) A 078122 002 Oct 31, 2008 Apr DISC >A> AP SHILPA MEDICARE LTD 300MG/15ML (20MG/ML) A 208718 003 Aug 16, 2019 Sep NEWA >D> AP ZENNOVA 40MG/2ML (20MG/ML) A 090393 002 May 13, 2011 Sep CAHN >A> AP 40MG/2ML (20MG/ML) A 090393 002 May 13, 2011 Sep CAHN >D> AP 100MG/5ML (20MG/ML) A 090393 003 May 13, 2011 Sep CAHN >A> AP 100MG/5ML (20MG/ML) A 090393 003 May 13, 2011 Sep CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -63

ISOSORBIDE DINITRATE TABLET;ORAL ISOSORBIDE DINITRATE >D> AB HIKMA INTL PHARMS 30MG A 040591 001 Jan 10, 2007 Sep DISC >A> @ 30MG A 040591 001 Jan 10, 2007 Sep DISC

ISOSORBIDE MONONITRATE TABLET;ORAL ISOSORBIDE MONONITRATE >D> AB HIKMA 20MG A 075361 001 Oct 05, 2000 Sep DISC >A> @ HIKMA PHARMS 20MG A 075361 001 Oct 05, 2000 Sep DISC TABLET, EXTENDED RELEASE;ORAL ISOSORBIDE MONONITRATE @ HIKMA INTL PHARMS 30MG A 076813 002 Mar 30, 2006 Feb DISC @ 60MG A 076813 001 Jan 07, 2005 Feb DISC >D> AB VINTAGE PHARMS 30MG A 090598 001 Aug 11, 2010 Sep DISC >A> @ 30MG A 090598 001 Aug 11, 2010 Sep DISC >D> AB 60MG A 090598 002 Aug 11, 2010 Sep DISC >A> @ 60MG A 090598 002 Aug 11, 2010 Sep DISC >D> AB 120MG A 090598 003 Aug 11, 2010 Sep DISC >A> @ 120MG A 090598 003 Aug 11, 2010 Sep DISC

ISOTRETINOIN CAPSULE;ORAL ABSORICA LD + @ SUN PHARM 20MG N 211913 003 Nov 05, 2019 Jun DISC + @ 28MG N 211913 005 Nov 05, 2019 Jun DISC

ITRACONAZOLE CAPSULE;ORAL ITRACONAZOLE AB STRIDES PHARMA 100MG A 206410 001 Jul 02, 2019 Aug CAHN SOLUTION;ORAL ITRACONAZOLE AA ANNORA PHARMA 10MG/ML A 212239 001 Sep 01, 2020 Aug NEWA AP OTE X@ APOTEX@ 10MG/ML A 208481 001 Aug 02, 2019 Feb DISC

IVERMECTIN CREAM;TOPICAL IVERMECTIN @ PERRIGO UK FINCO 1% A 210225 001 Apr 13, 2020 Jul DISC AB 1% A 210225 001 Apr 13, 2020 Mar NEWA LOTION;TOPICAL IVERMECTIN AB TARO 0.5% A 210720 001 May 06, 2020 Apr NFTG SKLICE AB +! ARBOR PHARMS LLC 0.5% N 202736 001 Feb 07, 2012 Apr CFTG

KETOCONAZOLE TABLET;ORAL KETOCONAZOLE AB HAVIX 200MG A 075912 001 Jan 10, 2002 Apr CMFD

KETOROLAC TROMETHAMINE INJECTABLE;INJECTION KETOROLAC TROMETHAMINE >D> AP AMPHASTAR PHARM 15MG/ML A 076209 001 Jul 21, 2004 Sep DISC >A> @ 15MG/ML A 076209 001 Jul 21, 2004 Sep DISC >D> AP 30MG/ML A 076209 002 Jul 21, 2004 Sep DISC >A> @ 30MG/ML A 076209 002 Jul 21, 2004 Sep DISC >D> AP HOSPIRA 15MG/ML A 074993 001 Jan 27, 1999 Sep DISC >A> @ 15MG/ML A 074993 001 Jan 27, 1999 Sep DISC >D> AP 30MG/ML A 074993 002 Jan 27, 1999 Sep DISC >A> @ 30MG/ML A 074993 002 Jan 27, 1999 Sep DISC AP NEPHRON 30MG/ML A 211445 001 Aug 20, 2020 Aug NEWA TABLET;ORAL KETOROLAC TROMETHAMINE AB MYLAN 10MG A 074761 001 May 16, 1997 Feb CHRS PL IVA@ PLIVA@ 10MG A 075284 001 Jun 23, 1999 Apr DISC AB ! TEVA 10MG A 074754 001 May 16, 1997 Feb CHRS RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -64

LABETALOL HYDROCHLORIDE INJECTABLE;INJECTION NORMODYNE + @ SCHERING 5MG/ML N 018686 001 Aug 01, 1984 Jan CRLD TABLET;ORAL LABETALOL HYDROCHLORIDE >D> AB ATHEM 100MG A 207863 001 Feb 04, 2019 Sep CAHN >D> AB 200MG A 207863 002 Feb 04, 2019 Sep CAHN >D> AB 300MG A 207863 003 Feb 04, 2019 Sep CAHN >A> AB EPIC PHARMA LLC 100MG A 212990 001 Sep 30, 2020 Sep NEWA >A> AB 200MG A 212990 002 Sep 30, 2020 Sep NEWA >A> AB 300MG A 212990 003 Sep 30, 2020 Sep NEWA >A> AB EYWA 100MG A 207863 001 Feb 04, 2019 Sep CAHN >A> AB 200MG A 207863 002 Feb 04, 2019 Sep CAHN >A> AB 300MG A 207863 003 Feb 04, 2019 Sep CAHN AB HERITAGE PHARMA 100MG A 074787 001 Aug 03, 1998 Feb CMFD AB 200MG A 074787 002 Aug 03, 1998 Feb CMFD

LACTITOL FOR SOLUTION;ORAL PIZENSY + @ BRAINTREE LABS 10GM N 211281 001 Feb 12, 2020 Aug DISC +! 10GM N 211281 001 Feb 12, 2020 Feb NEWA + 10GM/PACKET N 211281 001 Feb 12, 2020 Feb NEWA

LACTULOSE SOLUTION;ORAL LACTULOSE >A> AA CHARTWELL RX 10GM/15ML A 209517 001 Nov 23, 2018 Sep CAHN >D> AA HIKMA 10GM/15ML A 073591 001 May 29, 1992 Sep DISC >A> @ 10GM/15ML A 073591 001 May 29, 1992 Sep DISC >D> AA LIFEPHARMA 10GM/15ML A 209517 001 Nov 23, 2018 Sep CAHN SOLUTION;ORAL, RECTAL ENULOSE @ ACTAVIS MID ATLANTIC 10GM/15ML A 071548 001 Aug 15, 1988 Jul DISC LACTULOSE AA ! FRESENIUS KABI 10GM/15ML A 090502 001 Jan 25, 2012 Jul CHRS

LAMIVUDINE TABLET;ORAL LAMIVUDINE >A> AB BIOPHARM 150MG A 203586 001 Nov 21, 2016 Sep CAHN >D> AB ECI PHARMS LLC 150MG A 203586 001 Nov 21, 2016 Sep CAHN >A> AB PHARMA LIFE 150MG A 203586 001 Nov 21, 2016 Sep CAHN

LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL TEMIXYS +! CELLTRION 300MG;300MG N 211284 001 Nov 16, 2018 May CHRS + 300MG;300MG N 211284 001 Nov 16, 2018 May CRLD

LAMIVUDINE; ZIDOVUDINE TABLET;ORAL LAMIVUDINE AND ZIDOVUDINE @ MYLAN LABS LTD 150MG;300MG A 079079 001 Aug 12, 2019 Apr CAHN

LAMOTRIGINE TABLET;ORAL LAMOTRIGINE @ CIPLA 25MG A 077783 001 Nov 01, 2010 Aug DISC @ 100MG A 077783 002 Nov 01, 2010 Aug DISC @ 150MG A 077783 003 Nov 01, 2010 Aug DISC @ 200MG A 077783 004 Nov 01, 2010 Aug DISC @ MYLAN 25MG A 077420 001 Jan 27, 2009 Mar DISC @ 100MG A 077420 002 Jan 27, 2009 Mar DISC @ 150MG A 077420 003 Jan 27, 2009 Mar DISC @ 200MG A 077420 004 Jan 27, 2009 Mar DISC TABLET, EXTENDED RELEASE;ORAL LAMOTRIGINE AB DR REDDYS LABS LTD 250MG A 202383 006 Sep 06, 2018 Mar NEWA AB ZYDUS PHARMS 25MG A 207763 001 Apr 01, 2020 Mar NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -65

TABLET, EXTENDED RELEASE;ORAL LAMOTRIGINE AB 50MG A 207763 002 Apr 01, 2020 Mar NEWA AB 100MG A 207763 003 Apr 01, 2020 Mar NEWA AB 200MG A 207763 004 Apr 01, 2020 Mar NEWA AB 250MG A 207763 005 Apr 01, 2020 Mar NEWA AB 300MG A 207763 006 Apr 01, 2020 Mar NEWA

LANSOPRAZOLE CAPSULE, DELAYED REL PELLETS;ORAL LANSOPRAZOLE AB HETERO LABS LTD III 15MG A 203083 001 May 18, 2020 May NEWA AB 30MG A 203083 002 May 18, 2020 May NEWA

LANTHANUM CARBONATE POWDER;ORAL FOSRENOL + TAKEDA PHARMS USA EQ 750MG BASE N 204734 001 Sep 24, 2014 Jul CAHN +! EQ 1GM BASE N 204734 002 Sep 24, 2014 Jul CAHN TABLET, CHEWABLE;ORAL FOSRENOL @ TAKEDA PHARMS USA EQ 250MG BASE N 021468 001 Oct 26, 2004 Jul CAHN AB + EQ 500MG BASE N 021468 002 Oct 26, 2004 Jul CAHN AB + EQ 750MG BASE N 021468 003 Nov 23, 2005 Jul CAHN AB +! EQ 1GM BASE N 021468 004 Nov 23, 2005 Jul CAHN

LAPATINIB DITOSYLATE TABLET;ORAL >A> LAPATINIB DITOSYLATE >A> AB NATCO PHARMA LTD EQ 250MG BASE A 203007 001 Sep 29, 2020 Sep NFTG TYKERB >D> +! NOVARTIS EQ 250MG BASE N 022059 001 Mar 13, 2007 Sep CFTG >A> AB +! EQ 250MG BASE N 022059 001 Mar 13, 2007 Sep CFTG

LASMIDITAN SUCCINATE TABLET;ORAL REYVOW + ELI LILLY AND CO 50MG N 211280 001 Jan 31, 2020 Jan NEWA +! 100MG N 211280 002 Jan 31, 2020 Jan NEWA

LATANOPROST SOLUTION/DROPS;OPHTHALMIC LATANOPROST @ AUROBINDO PHARMA LTD 0.005% A 206519 001 Sep 03, 2019 Mar DISC XALATAN AT +! UPJOHN 0.005% N 020597 001 Jun 05, 1996 Jun CAHN

LEFLUNOMIDE TABLET;ORAL LEFLUNOMIDE @ BARR 10MG A 077083 001 Sep 13, 2005 Apr DISC @ 20MG A 077083 002 Sep 13, 2005 Apr DISC AB FOSUN PHARMA 10MG A 077087 001 Sep 13, 2005 Aug CMFD AB 20MG A 077087 002 Sep 13, 2005 Aug CMFD AB LUPIN LTD 10MG A 211863 001 Feb 04, 2020 Jan NEWA AB 20MG A 211863 002 Feb 04, 2020 Jan NEWA @ TEVA PHARMS 10MG A 077084 001 Sep 13, 2005 Apr DISC @ 20MG A 077084 002 Sep 13, 2005 Apr DISC

LEMBOREXANT TABLET;ORAL DAYVIGO + EISAI INC 5MG N 212028 001 Apr 07, 2020 Apr NEWA +! 10MG N 212028 002 Apr 07, 2020 Apr NEWA

LETROZOLE TABLET;ORAL LETROZOLE >D> AB HIKMA 2.5MG A 090838 001 Jun 03, 2011 Sep DISC >A> @ 2.5MG A 090838 001 Jun 03, 2011 Sep DISC >D> AB HIKMA PHARMS 2.5MG A 203796 001 Jun 03, 2016 Sep DISC >A> @ 2.5MG A 203796 001 Jun 03, 2016 Sep DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -66

TABLET;ORAL LETROZOLE @ JIANGSU HENGRUI MED 2.5MG A 202716 001 May 16, 2013 May DISC @ VINTAGE PHARMS LLC 2.5MG A 090789 001 Jun 03, 2011 Jul DISC

LEUCOVORIN CALCIUM TABLET;ORAL LEUCOVORIN CALCIUM AB EPIC PHARMA LLC EQ 5MG BASE A 074544 001 Aug 28, 1997 Mar CMFD AB EQ 25MG BASE A 074544 002 Aug 28, 1997 Mar CMFD AB HIKMA EQ 10MG BASE A 072734 001 Feb 22, 1993 Jul CTEC AB EQ 15MG BASE A 072735 001 Feb 22, 1993 Jul CTEC >A> AB NOVAST LABS EQ 5MG BASE A 211132 001 Jul 30, 2020 Sep CAHN >A> AB EQ 10MG BASE A 211132 002 Jul 30, 2020 Sep CAHN >A> AB EQ 15MG BASE A 211132 003 Jul 30, 2020 Sep CAHN >A> AB EQ 25MG BASE A 211132 004 Jul 30, 2020 Sep CAHN >D> AB RICONPHARMA LLC EQ 5MG BASE A 211132 001 Jul 30, 2020 Sep CAHN AB EQ 5MG BASE A 211132 001 Jul 30, 2020 Jul NEWA >D> AB EQ 10MG BASE A 211132 002 Jul 30, 2020 Sep CAHN AB EQ 10MG BASE A 211132 002 Jul 30, 2020 Jul NEWA >D> AB EQ 15MG BASE A 211132 003 Jul 30, 2020 Sep CAHN AB EQ 15MG BASE A 211132 003 Jul 30, 2020 Jul NEWA >D> AB EQ 25MG BASE A 211132 004 Jul 30, 2020 Sep CAHN AB EQ 25MG BASE A 211132 004 Jul 30, 2020 Jul NEWA

LEUPROLIDE ACETATE INJECTABLE;INJECTION LUPRON DEPOT-PED KIT + @ ABBVIE ENDOCRINE INC 3.75MG/VIAL,7.5MG/VIAL N 020263 003 Apr 16, 1993 May CTNA + @ 7.5MG/VIAL,7.5MG/VIAL N 020263 004 Apr 16, 1993 May CTNA +! 7.5MG/VIAL N 020263 002 Apr 16, 1993 May CTNA +! 11.25MG/VIAL N 020263 005 Jan 21, 1994 May CTNA +! 11.25MG/VIAL N 020263 007 Aug 15, 2011 May CTNA +! 15MG/VIAL N 020263 006 Jan 21, 1994 May CTNA +! 30MG/VIAL N 020263 008 Aug 15, 2011 May CTNA INJECTABLE;SUBCUTANEOUS ELIGARD KIT +! TOLMAR THERAP 7.5MG/VIAL N 021343 001 Jan 23, 2002 May CTNA +! 22.5MG/VIAL N 021379 001 Jul 24, 2002 May CTNA +! 30MG/VIAL N 021488 001 Feb 13, 2003 May CTNA +! 45MG/VIAL N 021731 001 Dec 14, 2004 May CTNA POWDER;INTRAMUSCULAR LUPRON DEPOT-PED KIT + @ ABBVIE ENDOCRINE INC 3.75MG,7.5MG N 020263 003 Apr 16, 1993 May CPOT + @ 3.75MG/VIAL,7.5MG/VIAL N 020263 003 Apr 16, 1993 May CDFR +! 7.5MG N 020263 002 Apr 16, 1993 May CPOT +! 7.5MG/VIAL N 020263 002 Apr 16, 1993 May CDFR + @ 7.5MG,7.5MG N 020263 004 Apr 16, 1993 May CPOT + @ 7.5MG/VIAL,7.5MG/VIAL N 020263 004 Apr 16, 1993 May CDFR +! 11.25MG N 020263 005 Jan 21, 1994 May CPOT +! 11.25MG/VIAL N 020263 005 Jan 21, 1994 May CDFR +! 11.25MG N 020263 007 Aug 15, 2011 May CPOT +! 11.25MG/VIAL N 020263 007 Aug 15, 2011 May CDFR +! 15MG N 020263 006 Jan 21, 1994 May CPOT +! 15MG/VIAL N 020263 006 Jan 21, 1994 May CDFR +! 30MG N 020263 008 Aug 15, 2011 May CPOT +! 30MG/VIAL N 020263 008 Aug 15, 2011 May CDFR POWDER;SUBCUTANEOUS ELIGARD KIT +! TOLMAR THERAP 7.5MG N 021343 001 Jan 23, 2002 May CPOT +! 7.5MG/VIAL N 021343 001 Jan 23, 2002 May CDFR +! 22.5MG N 021379 001 Jul 24, 2002 May CPOT +! 22.5MG/VIAL N 021379 001 Jul 24, 2002 May CDFR +! 30MG N 021488 001 Feb 13, 2003 May CPOT +! 30MG/VIAL N 021488 001 Feb 13, 2003 May CDFR +! 45MG N 021731 001 Dec 14, 2004 May CPOT +! 45MG/VIAL N 021731 001 Dec 14, 2004 May CDFR FENSOLVI KIT +! TOLMAR 45MG N 213150 001 May 01, 2020 May NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -67

LEVAMLODIPINE MALEATE TABLET;ORAL CONJUPRI + @ CSPC OUYI EQ 1.25MG BASE N 212895 001 Dec 19, 2019 May DISC

LEVETIRACETAM INJECTABLE;INTRAVENOUS LEVETIRACETAM @ FRESENIUS KABI USA 500MG/5ML (100MG/ML) A 090813 001 May 26, 2010 Jul DISC AP XGEN PHARMS 500MG/5ML (100MG/ML) A 091485 001 Aug 05, 2011 Feb CAHN LEVETIRACETAM IN SODIUM CHLORIDE AP NEXUS PHARMS 500MG/100ML (5MG/ML) A 213532 001 Jul 06, 2020 Jul NEWA AP 1000MG/100ML (10MG/ML) A 213532 002 Jul 06, 2020 Jul NEWA AP 1500MG/100ML (15MG/ML) A 213532 003 Jul 06, 2020 Jul NEWA SOLUTION;ORAL LEVETIRACETAM AA ACI HEALTHCARE LTD 100MG/ML A 078582 001 Jan 15, 2009 Jun CMFD TABLET;ORAL LEVETIRACETAM @ TEVA PHARMS 250MG A 078101 001 Jan 15, 2009 Apr DISC @ 500MG A 078101 002 Jan 15, 2009 Apr DISC @ 750MG A 078101 003 Jan 15, 2009 Apr DISC @ 1GM A 078101 004 Jan 15, 2009 Apr DISC AB VIWIT PHARM 250MG A 078869 001 Mar 13, 2009 Mar CAHN AB 250MG A 078869 001 Mar 13, 2009 Mar CAHN AB 500MG A 078869 002 Mar 13, 2009 Mar CAHN AB 500MG A 078869 002 Mar 13, 2009 Mar CAHN AB 750MG A 078869 003 Mar 13, 2009 Mar CAHN AB 750MG A 078869 003 Mar 13, 2009 Mar CAHN AB 1GM A 078869 004 Mar 13, 2009 Mar CAHN AB 1GM A 078869 004 Mar 13, 2009 Mar CAHN AB VKT PHARMA 250MG A 090767 001 Jul 28, 2010 Jul CAHN AB 500MG A 090767 002 Jul 28, 2010 Jul CAHN AB 750MG A 090767 003 Jul 28, 2010 Jul CAHN AB 1GM A 090767 004 Jul 28, 2010 Jul CAHN AB ZHEJIANG JINGXIN 250MG A 091491 001 Dec 14, 2010 Jun CAHN AB 500MG A 091491 002 Dec 14, 2010 Jun CAHN AB 750MG A 091491 003 Dec 14, 2010 Jun CAHN AB 1GM A 091491 004 Dec 14, 2010 Jun CAHN TABLET, EXTENDED RELEASE;ORAL LEVETIRACETAM @ ACTAVIS ELIZABETH 500MG A 091557 001 Sep 12, 2011 Apr DISC @ 750MG A 091557 002 Sep 12, 2011 Apr DISC >D> AB DEXCEL PHARMA 500MG A 202167 001 Sep 04, 2015 Sep CAHN >D> AB 750MG A 202167 002 Sep 04, 2015 Sep CAHN >D> AB ECI PHARMS LLC 500MG A 204754 001 Aug 26, 2016 Sep CAHN >D> AB 750MG A 204754 002 Aug 26, 2016 Sep CAHN >A> AB FLORIDA 500MG A 202167 001 Sep 04, 2015 Sep CAHN >A> AB 750MG A 202167 002 Sep 04, 2015 Sep CAHN AB OVERSEAS 750MG A 212688 001 Jun 11, 2020 Jun NEWA >A> AB PHARMA LIFE 500MG A 204754 001 Aug 26, 2016 Sep CAHN >A> AB 750MG A 204754 002 Aug 26, 2016 Sep CAHN @ TEVA PHARMS 500MG A 091430 001 Sep 12, 2011 Apr DISC @ 750MG A 091430 002 Sep 12, 2011 Apr DISC

LEVOCETIRIZINE DIHYDROCHLORIDE SOLUTION;ORAL LEVOCETIRIZINE DIHYDROCHLORIDE @ APOTEX 2.5MG/5ML A 202915 001 Aug 21, 2014 Feb DISC TABLET;ORAL LEVOCETIRIZINE DIHYDROCHLORIDE @ APOTEX 5MG A 203027 001 Feb 13, 2015 Feb DISC

LEVOFLOXACIN INJECTABLE;INJECTION LEVOFLOXACIN AP GLAND PHARMA LTD EQ 500MG/20ML (EQ 25MG/ML) A 205540 001 Apr 22, 2020 Apr NEWA AP EQ 750MG/30ML (EQ 25MG/ML) A 205540 002 Apr 22, 2020 Apr NEWA SOLUTION/DROPS;OPHTHALMIC LEVOFLOXACIN @ RUBICON 0.5% A 078282 001 Dec 20, 2010 Jul CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -68

LEVOLEUCOVORIN CALCIUM POWDER;INTRAVENOUS LEVOLEUCOVORIN CALCIUM @ AMNEAL EQ 50MG BASE/VIAL A 207547 001 Feb 13, 2017 Aug DISC SOLUTION;INTRAVENOUS LEVOLEUCOVORIN CALCIUM >D> AP ! INGENUS PHARMS LLC EQ 175MG BASE/17.5ML (EQ 10MG A 210623 001 May 03, 2018 Sep CAHN BASE/ML) AP ! EQ 175MG BASE/17.5ML (EQ 10MG A 210623 001 May 03, 2018 Apr CHRS BASE/ML) >D> AP ! EQ 250MG BASE/25ML (EQ 10MG A 210623 002 May 03, 2018 Sep CAHN BASE/ML) AP ! EQ 250MG BASE/25ML (EQ 10MG A 210623 002 May 03, 2018 Apr CHRS BASE/ML) >A> AP ! NOVAST LABS EQ 175MG BASE/17.5ML (EQ 10MG A 210623 001 May 03, 2018 Sep CAHN BASE/ML) >A> AP ! EQ 250MG BASE/25ML (EQ 10MG A 210623 002 May 03, 2018 Sep CAHN BASE/ML) @ SANDOZ INC EQ 250MG BASE/25ML (EQ 10MG A 203563 002 Mar 09, 2015 Apr DISC BASE/ML)

LEVORPHANOL TARTRATE TABLET;ORAL LEVORPHANOL TARTRATE AB NOVITIUM PHARMA 2MG A 213479 001 Jul 01, 2020 Jun NEWA

LEVOTHYROXINE SODIUM POWDER;INTRAVENOUS LEVOTHYROXINE SODIUM AP DR REDDYS 100MCG/VIAL A 208837 001 Mar 27, 2020 Mar NEWA

LEVOTHYROXINE SODIUM ** **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL THYRO-TABS AB2, + ALVOGEN 0.3MG N 021116 009 Oct 24, 2002 Jan CHRS AB4

LIDOCAINE OINTMENT;TOPICAL LIDOCAINE @ GENEYORK PHARMS 5% A 212486 001 Oct 17, 2019 Aug CAHN AT MACLEODS PHARMS LTD 5% A 211697 001 Mar 16, 2020 Mar NEWA @ SUNGEN PHARMA 5% A 212486 001 Oct 17, 2019 Mar DISC AT 5% A 212486 001 Oct 17, 2019 Mar CPOT @ TEVA PHARMS USA 5% A 210256 001 Jan 16, 2018 Apr DISC PATCH;TOPICAL LIDOCAINE AB AMNEAL 5% A 206463 001 Aug 24, 2020 Aug NEWA AB RHODES PHARMS 5% A 209190 001 Apr 30, 2020 Apr NEWA

LIDOCAINE HYDROCHLORIDE INJECTABLE;INJECTION LIDOCAINE HYDROCHLORIDE AP HUONS 1% A 212821 001 May 07, 2020 Apr NEWA AP WEST-WARD PHARMS INT 1% A 080407 001 Mar CMFD AP 2% A 080407 002 Mar CMFD LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE AP WEST-WARD PHARMS INT 1% A 084625 001 Mar CMFD AP 2% A 084625 002 Mar CMFD SOLUTION;ORAL LIDOCAINE HYDROCHLORIDE AT ! HI TECH PHARMA 2% A 040014 001 Jul 10, 1995 Aug CHRS LIDOCAINE HYDROCHLORIDE VISCOUS @ LANNETT CO INC 2% A 040708 001 Feb 27, 2007 Aug DISC SOLUTION;TOPICAL LIDOCAINE HYDROCHLORIDE AT WOCKHARDT BIO AG 4% A 087881 001 Nov 18, 1982 Jun CMFD RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -69

LIDOCAINE; PRILOCAINE CREAM;TOPICAL LIDOCAINE AND PRILOCAINE >A> AB RHODES PHARMS 2.5%;2.5% A 213253 001 Sep 21, 2020 Sep NEWA

LINCOMYCIN HYDROCHLORIDE INJECTABLE;INJECTION LINCOMYCIN AP XGEN PHARMS EQ 300MG BASE/ML A 201746 001 Jun 04, 2015 Feb CAHN

LINEZOLID TABLET;ORAL LINEZOLID @ GATE PHARMS 600MG A 091210 001 Feb 05, 2016 Apr DISC @ TEVA PHARMS USA 600MG A 078061 001 May 18, 2015 May DISC

LIOTHYRONINE SODIUM INJECTABLE;INJECTION LIOTHYRONINE SODIUM AP XGEN PHARMS EQ 0.01MG BASE/ML A 076923 001 Aug 17, 2005 Feb CAHN TABLET;ORAL LIOTHYRONINE SODIUM AB SUN PHARM EQ 0.005MG BASE A 091382 001 Apr 20, 2016 Jan CMFD AB EQ 0.025MG BASE A 091382 002 Apr 20, 2016 Jan CMFD AB EQ 0.05MG BASE A 091382 003 Apr 20, 2016 Jan CMFD AB TEVA PHARMS USA EQ 0.005MG BASE A 211510 001 Oct 26, 2018 Jul CMFD AB EQ 0.025MG BASE A 211510 002 Oct 26, 2018 Jul CMFD AB EQ 0.05MG BASE A 211510 003 Oct 26, 2018 Jul CMFD

LISDEXAMFETAMINE DIMESYLATE CAPSULE;ORAL VYVANSE + TAKEDA PHARMS USA 10MG N 021977 007 Oct 30, 2014 Jul CAHN + 20MG N 021977 004 Dec 10, 2007 Jul CAHN + 30MG N 021977 001 Feb 23, 2007 Jul CAHN + 40MG N 021977 005 Dec 10, 2007 Jul CAHN + 50MG N 021977 002 Feb 23, 2007 Jul CAHN + 60MG N 021977 006 Dec 10, 2007 Jul CAHN +! 70MG N 021977 003 Feb 23, 2007 Jul CAHN TABLET, CHEWABLE;ORAL VYVANSE + TAKEDA PHARMS USA 10MG N 208510 001 Jan 28, 2017 Jul CAHN + 20MG N 208510 002 Jan 28, 2017 Jul CAHN + 30MG N 208510 003 Jan 28, 2017 Jul CAHN + 40MG N 208510 004 Jan 28, 2017 Jul CAHN + 50MG N 208510 005 Jan 28, 2017 Jul CAHN +! 60MG N 208510 006 Jan 28, 2017 Jul CAHN

LISINOPRIL SOLUTION;ORAL QBRELIS +! AZURITY 1MG/ML N 208401 001 Jul 29, 2016 May CAHN TABLET;ORAL LISINOPRIL @ ASCENT PHARMS INC 2.5MG A 075903 001 Jul 01, 2002 Jul CAHN @ 5MG A 075903 002 Jul 01, 2002 Jul CAHN @ 10MG A 075903 003 Jul 01, 2002 Jul CAHN @ 20MG A 075903 004 Jul 01, 2002 Jul CAHN @ 30MG A 075903 005 Jul 01, 2002 Jul CAHN @ 40MG A 075903 006 Jul 01, 2002 Jul CAHN AB COREPHARMA 2.5MG A 076102 001 Sep 30, 2002 Feb CAHN AB 5MG A 076102 002 Sep 30, 2002 Feb CAHN AB 10MG A 076102 003 Sep 30, 2002 Feb CAHN AB 20MG A 076102 004 Sep 30, 2002 Feb CAHN AB 30MG A 076102 005 Sep 30, 2002 Feb CAHN AB 40MG A 076102 006 Sep 30, 2002 Feb CAHN >D> @ INVATECH 2.5MG A 075999 001 Jul 01, 2002 Sep CAHN >D> @ 5MG A 075999 002 Jul 01, 2002 Sep CAHN >D> @ 10MG A 075999 003 Jul 01, 2002 Sep CAHN >D> @ 20MG A 075999 004 Jul 01, 2002 Sep CAHN >D> @ 30MG A 075999 005 Jul 01, 2002 Sep CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -70

TABLET;ORAL LISINOPRIL >D> @ 40MG A 075999 006 Jul 01, 2002 Sep CAHN >A> @ PHARMGEN 2.5MG A 075999 001 Jul 01, 2002 Sep CAHN >A> @ 5MG A 075999 002 Jul 01, 2002 Sep CAHN >A> @ 10MG A 075999 003 Jul 01, 2002 Sep CAHN >A> @ 20MG A 075999 004 Jul 01, 2002 Sep CAHN >A> @ 30MG A 075999 005 Jul 01, 2002 Sep CAHN >A> @ 40MG A 075999 006 Jul 01, 2002 Sep CAHN >A> AB YILING 2.5MG A 212041 001 Sep 15, 2020 Sep NEWA >A> AB 5MG A 212041 002 Sep 15, 2020 Sep NEWA >A> AB 10MG A 212041 003 Sep 15, 2020 Sep NEWA

LITHIUM CARBONATE CAPSULE;ORAL LITHIUM CARBONATE AB + HIKMA 150MG N 017812 002 Jan 28, 1987 Jan CAHN AB + 300MG N 017812 001 Jan CAHN AB +! 600MG N 017812 003 Jan 28, 1987 Jan CAHN @ MYLAN 150MG A 076243 002 Feb 24, 2003 Jan DISC @ 300MG A 076243 001 Jun 27, 2002 Jan DISC

LITHIUM CITRATE SYRUP;ORAL LITHIUM CITRATE AA +! HIKMA EQ 300MG CARBONATE/5ML N 018421 001 Jan CAHN

LOFEXIDINE HYDROCHLORIDE TABLET;ORAL LUCEMYRA +! USWM EQ 0.18MG BASE N 209229 001 May 16, 2018 Jun CAHN

LOMITAPIDE MESYLATE CAPSULE;ORAL JUXTAPID + AMRYT EQ 5MG BASE N 203858 001 Dec 21, 2012 May CAHN + EQ 10MG BASE N 203858 002 Dec 21, 2012 May CAHN + EQ 20MG BASE N 203858 003 Dec 21, 2012 May CAHN + EQ 30MG BASE N 203858 004 Apr 23, 2015 May CAHN >D> + EQ 40MG BASE N 203858 005 Apr 23, 2015 Sep DISC >A> + @ EQ 40MG BASE N 203858 005 Apr 23, 2015 Sep DISC + EQ 40MG BASE N 203858 005 Apr 23, 2015 May CAHN >D> +! EQ 60MG BASE N 203858 006 Apr 23, 2015 Sep DISC >A> + @ EQ 60MG BASE N 203858 006 Apr 23, 2015 Sep DISC +! EQ 60MG BASE N 203858 006 Apr 23, 2015 May CAHN

LORAZEPAM INJECTABLE;INJECTION LORAZEPAM >D> AP HOSPIRA 2MG/ML A 074243 001 Apr 12, 1994 Sep DISC >A> @ 2MG/ML A 074243 001 Apr 12, 1994 Sep DISC TABLET;ORAL LORAZEPAM @ MYLAN 0.5MG A 077657 001 Mar 16, 2006 Mar DISC @ 1MG A 077657 002 Mar 16, 2006 Mar DISC @ 2MG A 077657 003 Mar 16, 2006 Mar DISC

LOSARTAN POTASSIUM TABLET;ORAL LOSARTAN POTASSIUM @ HIKMA 25MG A 077459 001 Oct 06, 2010 Feb DISC @ 50MG A 077459 002 Oct 06, 2010 Feb DISC @ 100MG A 077459 003 Oct 06, 2010 Feb DISC

LOVASTATIN TABLET;ORAL LOVASTATIN AB COREPHARMA 10MG A 077748 001 Feb 28, 2007 Feb CAHN AB 20MG A 077748 002 Feb 28, 2007 Feb CAHN AB 40MG A 077748 003 Feb 28, 2007 Feb CAHN

RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -71

LURBINECTEDIN POWDER;INTRAVENOUS ZEPZELCA +! JAZZ 4MG/VIAL N 213702 001 Jun 15, 2020 Jun NEWA

MAFENIDE ACETATE CREAM;TOPICAL SULFAMYLON +! RISING EQ 85MG BASE/GM N 016763 001 May CAHN

MAGNESIUM SULFATE INJECTABLE;INJECTION MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER AP BAXTER HLTHCARE CORP 1GM/100ML A 211965 001 Aug 11, 2020 Jul NEWA MAGNESIUM SULFATE IN PLASTIC CONTAINER AP BAXTER HLTHCARE CORP 2GM/50ML (40MG/ML) A 211966 001 Jun 01, 2020 May NEWA AP 4GM/50ML (80MG/ML) A 211966 002 Jun 01, 2020 May NEWA AP 4GM/100ML (40MG/ML) A 211966 003 Jun 01, 2020 May NEWA AP GLAND PHARMA LTD 2GM/50ML (40MG/ML) A 213917 001 Jul 10, 2020 Jul NEWA AP 4GM/100ML (40MG/ML) A 213917 002 Jul 10, 2020 Jul NEWA

MAZINDOL TABLET;ORAL SANOREX + @ NOVARTIS 1MG N 017247 001 Jan CAHN + @ 2MG N 017247 002 Jan CAHN

MECAMYLAMINE HYDROCHLORIDE TABLET;ORAL MECAMYLAMINE HYDROCHLORIDE ! LGM PHARMA 2.5MG A 204054 001 Mar 19, 2013 Aug CAHN

MECLIZINE HYDROCHLORIDE TABLET;ORAL MECLIZINE HYDROCHLORIDE AA ANNORA PHARMA 25MG A 087128 001 Aug CAHN AA INDICUS PHARMA 50MG A 205136 003 Feb 22, 2019 Jun CTEC @ MYLAN PHARMS INC 12.5MG A 202640 001 Sep 17, 2012 Jan DISC @ 25MG A 202640 002 Sep 17, 2012 Jan DISC AA ZYDUS 12.5MG A 213957 001 Jun 23, 2020 Jun NEWA AA 25MG A 213957 002 Jun 23, 2020 Jun NEWA

MEFENAMIC ACID CAPSULE;ORAL MEFENAMIC ACID >A> AB STRIDES PHARMA 250MG A 209209 001 Sep 18, 2020 Sep NEWA PONSTEL AB +! AVION PHARMS 250MG N 015034 003 Jul CAHN

MEFLOQUINE HYDROCHLORIDE TABLET;ORAL MEFLOQUINE HYDROCHLORIDE ! BARR 250MG A 076392 001 Dec 29, 2003 Feb CTEC @ HIKMA 250MG A 076523 001 Oct 01, 2004 Feb DISC

MEGESTROL ACETATE SUSPENSION;ORAL MEGESTROL ACETATE @ HIKMA 40MG/ML A 075997 001 Feb 15, 2002 Feb DISC AB ! PAR PHARM 40MG/ML A 075671 001 Jul 25, 2001 Feb CHRS @ TEVA PHARMS 40MG/ML A 075681 001 May 05, 2003 Apr DISC TABLET;ORAL MEGESTROL ACETATE >D> AB HIKMA 20MG A 074458 001 Sep 29, 1995 Sep DISC >A> @ 20MG A 074458 001 Sep 29, 1995 Sep DISC >D> AB 40MG A 074458 002 Sep 29, 1995 Sep DISC >A> @ 40MG A 074458 002 Sep 29, 1995 Sep DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -72

MELOXICAM SOLUTION;INTRAVENOUS ANJESO +! BAUDAX 30MG/ML (30MG/ML) N 210583 001 Feb 20, 2020 Feb NEWA TABLET, ORALLY DISINTEGRATING;ORAL QMIIZ ODT + @ TERSERA 7.5MG N 211210 001 Oct 19, 2018 Apr DISC + @ 15MG N 211210 002 Oct 19, 2018 Apr DISC

MELPHALAN HYDROCHLORIDE INJECTABLE;INJECTION MELPHALAN HYDROCHLORIDE @ ALVOGEN EQ 50MG BASE/VIAL A 204817 001 May 17, 2019 May DISC AP BPI LABS LLC EQ 50MG BASE/VIAL A 209197 001 May 08, 2020 Apr NEWA AP INGENUS PHARMS LLC EQ 50MG BASE/VIAL A 210947 001 Feb 18, 2020 Feb NEWA @ PAR STERILE PRODUCTS EQ 50MG BASE/VIAL A 204773 001 Aug 22, 2016 Feb DISC @ TWI PHARMS EQ 50MG BASE/VIAL A 211463 001 Sep 13, 2019 Jan DISC US WM@ USWM@ EQ 50MG BASE/VIAL A 207032 001 May 03, 2019 Jun CAHN POWDER;INTRAVENOUS EVOMELA +! ACROTECH EQ 50MG BASE/VIAL N 207155 001 Mar 10, 2016 Mar CTEC AP +! EQ 50MG BASE/VIAL N 207155 001 Mar 10, 2016 Feb CFTG MELPHALAN HYDROCHLORIDE @ ACTAVIS LLC EQ 50MG BASE/VIAL A 209323 001 Mar 06, 2020 Mar DISC AP EQ 50MG BASE/VIAL A 209323 001 Mar 06, 2020 Feb NFTG

MEMANTINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL MEMANTINE HYDROCHLORIDE AB ANI PHARMS INC 7MG A 205365 001 Feb 28, 2020 Feb NEWA AB 14MG A 205365 002 Feb 28, 2020 Feb NEWA AB 21MG A 205365 003 Feb 28, 2020 Feb NEWA AB 28MG A 205365 004 Feb 28, 2020 Feb NEWA SOLUTION;ORAL MEMANTINE HYDROCHLORIDE >D> AA MEDLEY PHARMS 2MG/ML A 210319 001 Aug 31, 2020 Sep CAHN AA 2MG/ML A 210319 001 Aug 31, 2020 Aug NEWA >A> AA SAPTALIS PHARMS 2MG/ML A 210319 001 Aug 31, 2020 Sep CAHN TABLET;ORAL MEMANTINE HYDROCHLORIDE @ CHARTWELL 5MG A 090244 001 Jul 11, 2018 Mar CAHN @ 10MG A 090244 002 Jul 11, 2018 Mar CAHN AB HIKMA 5MG A 208173 001 Feb 28, 2020 Feb NEWA AB 10MG A 208173 002 Feb 28, 2020 Feb NEWA AB NINGBO 5MG A 212947 001 Apr 03, 2020 Apr CAHN AB 5MG A 212947 001 Apr 03, 2020 Mar NEWA AB 10MG A 212947 002 Apr 03, 2020 Apr CAHN AB 10MG A 212947 002 Apr 03, 2020 Mar NEWA @ TEVA PHARMS 5MG A 090052 001 Oct 25, 2011 Apr DISC @ 10MG A 090052 002 Oct 25, 2011 Apr DISC

MEPERIDINE HYDROCHLORIDE TABLET;ORAL MEPERIDINE HYDROCHLORIDE AA ! EPIC PHARMA 50MG A 040331 001 May 28, 1999 Feb CHRS AA ! 100MG A 040331 002 May 28, 1999 Feb CHRS @ HIKMA 50MG A 040110 001 Mar 12, 1997 Feb DISC @ 100MG A 040110 002 Mar 12, 1997 Feb DISC

MEPROBAMATE TABLET;ORAL MEPROBAMATE @ ACELLA 400MG A 084153 001 Aug CAHN

MESALAMINE SUPPOSITORY;RECTAL MESALAMINE AB ACTAVIS MID ATLANTIC 1GM A 205654 001 Aug 14, 2020 Aug NEWA AB ANNORA PHARMA 1GM A 213377 001 Mar 19, 2020 Mar NEWA >A> AB APTAPHARMA INC 1GM A 207448 001 Apr 19, 2019 Sep CAHN >D> AB PHARM SOURCING 1GM A 207448 001 Apr 19, 2019 Sep CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -73

SUPPOSITORY;RECTAL MESALAMINE AB ZYDUS PHARMS 1GM A 208953 001 Feb 12, 2020 Jan NEWA

METAXALONE TABLET;ORAL METAXALONE AB MOUNTAIN 400MG A 040486 001 Feb 27, 2015 Mar CTEC AB RISING 800MG A 208774 001 Sep 24, 2018 Jul CAHN AB SCIEGEN PHARMS INC 400MG A 207466 002 Mar 13, 2020 Mar NEWA

METFORMIN HYDROCHLORIDE SOLUTION;ORAL METFORMIN HYDROCHLORIDE AB SAPTALIS PHARMS 500MG/5ML A 211309 001 Mar 03, 2020 Feb NFTG RIOMET AB +! RANBAXY 500MG/5ML N 021591 001 Sep 11, 2003 Feb CFTG +! 500MG/5ML N 021591 001 Sep 11, 2003 Jan CAHN TABLET;ORAL METFORMIN HYDROCHLORIDE @ HERITAGE PHARMA 500MG A 075978 001 Jan 25, 2002 Mar DISC @ 850MG A 075978 002 Jan 25, 2002 Mar DISC @ 1GM A 075978 003 Nov 05, 2002 Mar DISC @ MACLEODS PHARMS LTD 500MG A 205330 001 Oct 31, 2017 May DISC @ 850MG A 205330 002 Oct 31, 2017 May DISC @ 1GM A 205330 003 Oct 31, 2017 May DISC @ MYLAN 500MG A 075976 001 Jan 24, 2002 Jan DISC @ 850MG A 075976 002 Jan 24, 2002 Jan DISC @ 1GM A 075976 003 Jan 24, 2002 Jan DISC TABLET, EXTENDED RELEASE;ORAL FORTAMET >D> + @ ANDRX LABS LLC 1GM N 021574 002 Apr 27, 2004 Sep CMFD >A> AB2 + 1GM N 021574 002 Apr 27, 2004 Sep CMFD METFORMIN HYDROCHLORIDE AB2 AJANTA PHARMA LTD 500MG A 213651 001 Apr 09, 2020 Mar NEWA AB2 1GM A 213651 002 Apr 09, 2020 Mar NEWA @ APOTEX 750MG A 076706 002 Dec 29, 2005 May DISC @ BARR 750MG A 076863 001 Oct 14, 2004 Apr DISC >D> @ MACLEODS PHARMS LTD 500MG A 206955 001 Dec 07, 2016 Sep CMFD >A> AB1 500MG A 206955 001 Dec 07, 2016 Sep CMFD @ 500MG A 206955 001 Dec 07, 2016 May DISC >D> @ 750MG A 206955 002 Dec 07, 2016 Sep CMFD >A> AB 750MG A 206955 002 Dec 07, 2016 Sep CMFD @ 750MG A 206955 002 Dec 07, 2016 May DISC AB1 YICHANG HUMANWELL 500MG A 211052 001 Sep 24, 2018 Jun CMFD AB 750MG A 211052 002 Sep 24, 2018 Jun CMFD

METHADONE HYDROCHLORIDE CONCENTRATE;ORAL METHADONE HYDROCHLORIDE AA SPECGX LLC 10MG/ML A 207368 001 Aug 22, 2019 May CAHN SOLUTION;ORAL METHADONE HYDROCHLORIDE AA SPECGX LLC 5MG/5ML A 207537 001 Oct 02, 2019 May CAHN AA 10MG/5ML A 207537 002 Oct 01, 2019 May CAHN TABLET;ORAL DOLOPHINE HYDROCHLORIDE + @ HIKMA 5MG N 006134 002 Jun DISC + @ 10MG N 006134 010 Jun DISC METHADONE HYDROCHLORIDE AA NOSTRUM LABS INC 5MG A 210484 001 Aug 02, 2018 Mar CAHN AA 5MG A 210484 001 Aug 02, 2018 Mar CAHN AA 10MG A 210484 002 Aug 02, 2018 Mar CAHN AA 10MG A 210484 002 Aug 02, 2018 Mar CAHN AA ROXANE 5MG A 088108 001 Mar 08, 1983 May CMFD AA 10MG A 088109 001 Mar 08, 1983 May CMFD AA ! SPECGX LLC 5MG A 040517 001 Apr 27, 2004 Jun CHRS AA ! 10MG A 040517 002 Apr 27, 2004 Jun CHRS >A> AA THEPHARMANETWORK LLC 5MG A 090635 002 Sep 22, 2020 Sep NEWA AA VISTAPHARM 10MG A 204166 001 Mar 16, 2020 Mar NEWA METHADOSE @ SPECGX LLC 5MG A 040050 001 Apr 15, 1993 May DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -74

TABLET;ORAL METHADOSE @ 10MG A 040050 002 Apr 15, 1993 May DISC

METHAZOLAMIDE TABLET;ORAL METHAZOLAMIDE >A> @ ATHEM 25MG A 040102 001 Aug 28, 1996 Sep CAHN >A> @ 50MG A 040102 002 Aug 28, 1996 Sep CAHN @ BAUSCH 25MG A 207438 001 Oct 05, 2018 Jul CAHN @ 50MG A 207438 002 Oct 05, 2018 Jul CAHN >D> @ INVATECH 25MG A 040102 001 Aug 28, 1996 Sep CAHN >D> @ 50MG A 040102 002 Aug 28, 1996 Sep CAHN

METHENAMINE HIPPURATE TABLET;ORAL METHENAMINE HIPPURATE @ IMPAX LABS INC 1GM A 076411 001 Jun 20, 2003 Jul DISC

METHIMAZOLE TABLET;ORAL METHIMAZOLE >A> AB DISCOVERY THERAP 5MG A 040547 001 Feb 18, 2005 Sep CAHN >A> AB 10MG A 040547 002 Feb 18, 2005 Sep CAHN >A> @ 15MG A 040619 003 Jul 12, 2005 Sep CAHN >A> @ 20MG A 040547 004 Feb 18, 2005 Sep CAHN >D> AB ECI PHARMS LLC 5MG A 040547 001 Feb 18, 2005 Sep CAHN >D> AB 10MG A 040547 002 Feb 18, 2005 Sep CAHN >D> @ 15MG A 040619 003 Jul 12, 2005 Sep CAHN >D> @ 20MG A 040547 004 Feb 18, 2005 Sep CAHN

METHOCARBAMOL TABLET;ORAL METHOCARBAMOL AA AUROBINDO PHARMA LTD 750MG A 213967 001 Aug 12, 2020 Jul NEWA @ HIKMA INTL PHARMS 500MG A 085159 001 Feb DISC @ 750MG A 085123 001 Feb DISC

METHOHEXITAL SODIUM INJECTABLE;INJECTION BREVITAL SODIUM + @ PAR STERILE PRODUCTS 2.5GM/VIAL N 011559 002 Jul DISC

METHOTREXATE >D> SOLUTION;INTRAVENOUS >D> METHOTREXATE >D> +! ACCORD HLTHCARE 5GM/50ML (100MG/ML) N 214121 001 Aug 24, 2020 Sep DISC >A> + @ 5GM/50ML (100MG/ML) N 214121 001 Aug 24, 2020 Sep DISC +! 5GM/50ML (100MG/ML) N 214121 001 Aug 24, 2020 Aug NEWA

METHOTREXATE SODIUM INJECTABLE;INJECTION METHOTREXATE SODIUM PRESERVATIVE FREE @ MYLAN LABS LTD EQ 50MG BASE/2ML (EQ 25MG BASE/ML) A 201529 001 Mar 29, 2012 Jan DISC @ EQ 100MG BASE/4ML (EQ 25MG A 201529 002 Mar 29, 2012 Jan DISC BASE/ML) @ EQ 200MG BASE/8ML (EQ 25MG A 201529 003 Mar 29, 2012 Jan DISC BASE/ML) PHARMACHEMIE BV EQ 100MG BASE/4ML (EQ 25MG A 040843 003 Feb 27, 2012 Jan CTEC BASE/ML) SOLUTION;ORAL XATMEP +! AZURITY EQ 2MG BASE/ML N 208400 001 Apr 25, 2017 May CAHN +! EQ 2.5MG BASE/ML N 208400 001 Apr 25, 2017 Jul CPOT TABLET;ORAL METHOTREXATE SODIUM AB ACCORD HLTHCARE EQ 2.5MG BASE A 213343 001 Jan 24, 2020 Jan NEWA + @ DAVA PHARMS INC EQ 2.5MG BASE N 008085 002 Mar DISC AB EUGIA PHARMA EQ 2.5MG BASE A 210454 001 Jan 30, 2020 Jan NEWA AB ! HIKMA EQ 2.5MG BASE A 040054 001 Aug 01, 1994 Mar CHRS RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -75

METHSCOPOLAMINE BROMIDE TABLET;ORAL METHSCOPOLAMINE BROMIDE AA BAYSHORE PHARMS LLC 2.5MG A 200602 001 Sep 24, 2012 Apr CTEC AA ! 5MG A 200602 002 Sep 24, 2012 Apr CTEC AA BRECKENRIDGE PHARM 2.5MG A 040642 001 Dec 06, 2011 Apr CMFD AA 5MG A 040642 002 Dec 06, 2011 Apr CMFD

METHYLDOPA TABLET;ORAL METHYLDOPA @ HERITAGE PHARMA 250MG A 070098 001 Feb 20, 1986 Apr DISC @ 500MG A 070343 001 Feb 20, 1986 Apr DISC @ WATSON LABS 500MG A 070625 001 Jun 06, 1986 Apr DISC

METHYLENE BLUE SOLUTION;INTRAVENOUS PROVAYBLUE +! PROVEPHARM SAS 10MG/2ML (5MG/ML) N 204630 002 Jul 18, 2019 Jun NEWA

METHYLERGONOVINE MALEATE TABLET;ORAL METHYLERGONOVINE MALEATE AB TULEX PHARMS INC 0.2MG A 212233 001 May 01, 2020 Apr NEWA

METHYLPHENIDATE TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL COTEMPLA XR-ODT + NEOS THERAPS INC 8.6MG N 205489 001 Jun 19, 2017 Jul CTEC AB + 8.6MG N 205489 001 Jun 19, 2017 Jun CFTG + 17.3MG N 205489 002 Jun 19, 2017 Jul CTEC AB + 17.3MG N 205489 002 Jun 19, 2017 Jun CFTG +! 25.9MG N 205489 003 Jun 19, 2017 Jul CTEC AB +! 25.9MG N 205489 003 Jun 19, 2017 Jun CFTG +! 25.9MG N 205489 003 Jun 19, 2017 Jun CHRS METHYLPHENIDATE @ ACTAVIS ELIZABETH 8.6MG A 210924 001 Jun 19, 2020 Jul DISC AB 8.6MG A 210924 001 Jun 19, 2020 Jun NFTG @ 17.3MG A 210924 002 Jun 19, 2020 Jul DISC AB 17.3MG A 210924 002 Jun 19, 2020 Jun NFTG @ 25.9MG A 210924 003 Jun 19, 2020 Jul DISC AB 25.9MG A 210924 003 Jun 19, 2020 Jun NFTG

METHYLPHENIDATE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL ADHANSIA XR >D> + PURDUE PHARMA LP 85MG N 212038 006 Feb 27, 2019 Sep CHRS >A> +! 85MG N 212038 006 Feb 27, 2019 Sep CHRS JORNAY PM >D> + IRONSHORE PHARMS 100MG N 209311 005 Aug 08, 2018 Sep CHRS >A> +! 100MG N 209311 005 Aug 08, 2018 Sep CHRS METHYLPHENIDATE HYDROCHLORIDE @ BARR LABS INC 10MG A 079031 004 Oct 15, 2014 Apr DISC @ 20MG A 079031 001 Jul 13, 2012 Apr DISC @ 30MG A 079031 002 Jul 13, 2012 Apr DISC @ 40MG A 079031 003 Jul 13, 2012 Apr DISC SOLUTION;ORAL METHYLPHENIDATE HYDROCHLORIDE AA ALKEM LABS LTD 5MG/5ML A 211647 001 Mar 30, 2020 Mar NEWA AA 10MG/5ML A 211647 002 Mar 30, 2020 Mar NEWA AA ANDA REPOSITORY 5MG/5ML A 210764 001 Apr 10, 2020 Jul CAHN AA 10MG/5ML A 210764 002 Apr 10, 2020 Jul CAHN >A> AA EYWA 5MG/5ML A 210139 001 Oct 03, 2018 Sep CAHN >A> AA 10MG/5ML A 210139 002 Oct 03, 2018 Sep CAHN >D> AA NOVELGENIX THERAPS 5MG/5ML A 210139 001 Oct 03, 2018 Sep CAHN >D> AA 10MG/5ML A 210139 002 Oct 03, 2018 Sep CAHN AA PATRIN PHARMA INC 5MG/5ML A 210764 001 Apr 10, 2020 Mar NEWA AA 10MG/5ML A 210764 002 Apr 10, 2020 Mar NEWA AA QUAGEN 5MG/5ML A 213567 001 Jun 04, 2020 Jun NEWA AA 10MG/5ML A 213567 002 Jun 04, 2020 Jun NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -76

TABLET;ORAL METHYLPHENIDATE HYDROCHLORIDE AB NOSTRUM LABS INC 5MG A 207587 001 Mar 03, 2017 Aug CAHN AB 10MG A 207587 002 Mar 03, 2017 Aug CAHN AB 20MG A 207587 003 Mar 03, 2017 Aug CAHN AB PRINSTON INC 5MG A 212697 001 Jul 23, 2020 Jul NEWA AB 10MG A 212697 002 Jul 23, 2020 Jul NEWA AB 20MG A 212697 003 Jul 23, 2020 Jul NEWA @ WATSON LABS 5MG A 040220 001 Aug 29, 1997 Apr DISC @ 10MG A 040220 002 Aug 29, 1997 Apr DISC @ 20MG A 040220 003 Aug 29, 1997 Apr DISC TABLET, EXTENDED RELEASE;ORAL METHYLPHENIDATE HYDROCHLORIDE AB ACTAVIS LABS FL 18MG A 076772 001 Mar 22, 2018 Jul CMFD @ 18MG A 076772 001 Mar 22, 2018 Mar DISC AB 27MG A 076772 002 Mar 22, 2018 Jul CMFD @ 27MG A 076772 002 Mar 22, 2018 Mar DISC AB 36MG A 076772 003 Mar 22, 2018 Jul CMFD @ 36MG A 076772 003 Mar 22, 2018 Mar DISC AB 54MG A 076655 001 Mar 21, 2018 Jul CMFD @ 54MG A 076655 001 Mar 21, 2018 Mar DISC >A> AB ALKEM LABS LTD 20MG A 212288 001 Oct 06, 2020 Sep NEWA @ ANI PHARMS INC 18MG A 208607 001 Jul 14, 2017 Aug DISC @ 27MG A 208607 002 Jul 14, 2017 Aug DISC @ 36MG A 208607 003 Jul 14, 2017 Aug DISC @ 54MG A 208607 004 Jul 14, 2017 Aug DISC AB DR REDDYS 18MG A 213473 001 Jul 29, 2020 Jul NEWA AB 27MG A 213473 002 Jul 29, 2020 Jul NEWA AB 36MG A 213473 003 Jul 29, 2020 Jul NEWA AB 54MG A 213473 004 Jul 29, 2020 Jul NEWA AB SUN PHARM INDS INC 18MG A 205135 001 Aug 19, 2020 Aug NEWA AB 27MG A 205135 002 Aug 19, 2020 Aug NEWA AB 36MG A 205135 003 Aug 19, 2020 Aug NEWA AB 54MG A 205135 004 Aug 19, 2020 Aug NEWA

METHYLPREDNISOLONE TABLET;ORAL METHYLPREDNISOLONE @ DURAMED PHARMS BARR 4MG A 088497 001 Feb 21, 1984 Mar DISC >D> @ NOVAST LABS 4MG A 210985 001 Jan 09, 2019 Sep CMFD >A> AB 4MG A 210985 001 Jan 09, 2019 Sep CMFD

METHYLPREDNISOLONE ACETATE INJECTABLE;INJECTION METHYLPREDNISOLONE ACETATE AB AMNEAL 40MG/ML A 210043 001 May 20, 2019 Jul CMFD AB 80MG/ML A 210043 002 May 20, 2019 Jul CMFD

METHYLTESTOSTERONE CAPSULE;ORAL TESTRED >A> AB ! BAUSCH 10MG A 083976 001 Sep CAHN >D> AB ! VALEANT PHARM INTL 10MG A 083976 001 Sep CAHN

METOCLOPRAMIDE HYDROCHLORIDE SPRAY, METERED;NASAL GIMOTI +! EVOKE PHARMA INC EQ 15MG BASE/SPRAY N 209388 001 Jun 19, 2020 Jun NEWA

METOLAZONE TABLET;ORAL METOLAZONE @ ANI PHARMS INC 2.5MG A 075543 001 Jan 06, 2004 May CMS1 @ 5MG A 075543 002 Mar 01, 2004 May CMS1

METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE;ORAL METOPROLOL SUCCINATE @ ACTAVIS ELIZABETH EQ 25MG TARTRATE A 204161 001 Nov 25, 2016 Mar DISC @ EQ 50MG TARTRATE A 204161 002 Nov 25, 2016 Mar DISC @ EQ 100MG TARTRATE A 204161 003 Nov 25, 2016 Mar DISC @ EQ 200MG TARTRATE A 204161 004 Nov 25, 2016 Mar DISC

RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -77

TABLET, EXTENDED RELEASE;ORAL METOPROLOL SUCCINATE @ ACTAVIS LABS FL INC EQ 25MG TARTRATE A 076862 002 Aug 03, 2009 Jan DISC @ EQ 100MG TARTRATE A 077298 001 Apr 15, 2010 Jan DISC @ EQ 200MG TARTRATE A 077298 002 Apr 15, 2010 Jan DISC AB PHARMADAX INC EQ 25MG TARTRATE A 203028 001 Mar 31, 2020 Mar NEWA AB EQ 50MG TARTRATE A 203028 002 Mar 31, 2020 Mar NEWA AB EQ 100MG TARTRATE A 203699 001 Mar 30, 2020 Mar NEWA AB EQ 200MG TARTRATE A 203699 002 Mar 30, 2020 Mar NEWA

METOPROLOL TARTRATE TABLET;ORAL METOPROLOL TARTRATE @ HERITAGE PHARMA 50MG A 074141 001 Jan 31, 1995 Feb DISC @ 100MG A 074141 002 Jan 31, 1995 Feb DISC AB YOUNGTECH PHARMS INC 25MG A 208955 001 Feb 05, 2020 Jan NEWA AB 50MG A 208955 002 Feb 05, 2020 Jan NEWA AB 100MG A 208955 003 Feb 05, 2020 Jan NEWA

METRONIDAZOLE CAPSULE;ORAL FLAGYL AB +! PFIZER 375MG N 020334 001 May 03, 1995 Aug CAHN GEL;VAGINAL VANDAZOLE >D> BX TEVA PHARMS 0.75% N 021806 001 May 20, 2005 Sep CHRS >A> BX ! 0.75% N 021806 001 May 20, 2005 Sep CHRS INJECTABLE;INJECTION METRONIDAZOLE IN PLASTIC CONTAINER AP GLAND PHARMA LTD 500MG/100ML A 212435 001 Aug 03, 2020 Jul NEWA @ MYLAN LABS LTD 500MG/100ML A 205531 001 May 09, 2017 Jun DISC TABLET;ORAL FLAGYL AB + PFIZER 250MG N 012623 001 Aug CAHN AB +! 500MG N 012623 003 Aug CAHN TABLET, EXTENDED RELEASE;ORAL FLAGYL ER + @ PFIZER 750MG N 020868 001 Nov 26, 1997 Aug CAHN

METYROSINE CAPSULE;ORAL DEMSER AB +! BAUSCH 250MG N 017871 001 Jul CFTG METYROSINE AB AMNEAL 250MG A 213734 001 Jul 24, 2020 Jul NFTG

MEXILETINE HYDROCHLORIDE CAPSULE;ORAL MEXILETINE HYDROCHLORIDE AB ANI PHARMS INC 150MG A 074450 001 May 16, 1996 Jun CMFD AB 200MG A 074450 002 May 16, 1996 Jun CMFD AB 250MG A 074450 003 May 16, 1996 Jun CMFD AB CROSSMEDIKA SA 150MG A 213500 001 Jul 22, 2020 Jul NEWA AB 200MG A 213500 002 Jul 22, 2020 Jul NEWA AB 250MG A 213500 003 Jul 22, 2020 Jul NEWA AB TEVA 150MG A 074377 001 May 16, 1995 Jun CTEC AB 200MG A 074377 002 May 16, 1995 Jun CTEC AB ! 250MG A 074377 003 May 16, 1995 Jun CTEC

MICONAZOLE >D> TABLET;BUCCAL >D> ORAVIG >D> +! FORTOVIA 50MG N 022404 001 Apr 16, 2010 Sep DISC >A> + @ 50MG N 022404 001 Apr 16, 2010 Sep DISC

MIDAZOLAM HYDROCHLORIDE INJECTABLE;INJECTION MIDAZOLAM HYDROCHLORIDE >D> AP HOSPIRA EQ 1MG BASE/ML A 075856 001 Jun 13, 2002 Sep DISC >A> @ EQ 1MG BASE/ML A 075856 001 Jun 13, 2002 Sep DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -78

INJECTABLE;INJECTION MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE @ MYLAN ASI EQ 1MG BASE/ML A 090315 001 Nov 29, 2010 Jan DISC @ EQ 5MG BASE/ML A 090315 002 Nov 29, 2010 Jan DISC

MIDODRINE HYDROCHLORIDE TABLET;ORAL MIDODRINE HYDROCHLORIDE AB AUROBINDO PHARMA LTD 2.5MG A 212774 001 Aug 10, 2020 Jul NEWA AB 5MG A 212774 002 Aug 10, 2020 Jul NEWA AB 10MG A 212774 003 Aug 10, 2020 Jul NEWA >A> AB CEROVENE INC 2.5MG A 207849 001 Oct 01, 2020 Sep NEWA >A> AB 5MG A 207849 002 Oct 01, 2020 Sep NEWA >A> AB 10MG A 207849 003 Oct 01, 2020 Sep NEWA AB ZYDUS 2.5MG A 213055 001 Sep 01, 2020 Aug NEWA AB 5MG A 213055 002 Sep 01, 2020 Aug NEWA AB 10MG A 213055 003 Sep 01, 2020 Aug NEWA

MIFEPRISTONE TABLET;ORAL KORLYM AB +! CORCEPT THERAP 300MG N 202107 001 Feb 17, 2012 Jul CFTG MIFEPRISTONE AB TEVA PHARMS USA INC 300MG A 211436 001 Aug 03, 2020 Jul NFTG

MIGLUSTAT CAPSULE;ORAL MIGLUSTAT >D> AB AMERIGEN PHARMS LTD 100MG A 208342 001 Apr 17, 2018 Sep CAHN >A> AB ANI PHARMS INC 100MG A 208342 001 Apr 17, 2018 Sep CAHN AB EDENBRIDGE PHARMS 100MG A 209821 001 Aug 06, 2020 Jul NEWA

MILNACIPRAN HYDROCHLORIDE TABLET;ORAL MILNACIPRAN HYDROCHLORIDE >A> @ ANDA REPOSITORY 12.5MG A 205071 001 Jan 27, 2016 Sep CAHN >A> @ 25MG A 205071 002 Jan 27, 2016 Sep CAHN >A> @ 50MG A 205071 003 Jan 27, 2016 Sep CAHN >A> @ 100MG A 205071 004 Jan 27, 2016 Sep CAHN >D> @ USPHARMA WINDLAS 12.5MG A 205071 001 Jan 27, 2016 Sep CAHN >D> @ 25MG A 205071 002 Jan 27, 2016 Sep CAHN >D> @ 50MG A 205071 003 Jan 27, 2016 Sep CAHN >D> @ 100MG A 205071 004 Jan 27, 2016 Sep CAHN

MILRINONE LACTATE INJECTABLE;INJECTION MILRINONE LACTATE AP MEITHEAL EQ 1MG BASE/ML A 211671 001 Mar 24, 2020 Apr CAHN AP NANJING KING-FRIEND EQ 1MG BASE/ML A 211671 001 Mar 24, 2020 Mar NEWA MILRINONE LACTATE IN DEXTROSE 5% AP AUROBINDO PHARMA LTD EQ 20MG BASE/100ML (EQ 0.2MG A 209666 001 Sep 03, 2020 Aug NEWA BASE/ML) AP EQ 40MG BASE/200ML (EQ 0.2MG A 209666 002 Sep 03, 2020 Aug NEWA BASE/ML) MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER AP GLAND PHARMA LTD EQ 20MG BASE/100ML (EQ 0.2MG A 213585 001 Jul 16, 2020 Jul NEWA BASE/ML) AP EQ 40MG BASE/200ML (EQ 0.2MG A 213585 002 Jul 16, 2020 Jul NEWA BASE/ML)

MINOCYCLINE HYDROCHLORIDE AEROSOL, FOAM;TOPICAL ZILXI +! FOAMIX EQ 1.5% BASE N 213690 001 May 28, 2020 May NEWA CAPSULE, EXTENDED RELEASE;ORAL XIMINO JOURNEY EQ 45MG BASE N 201922 001 Jul 11, 2012 Feb CAHN @ EQ 67.5MG BASE N 201922 002 Jul 11, 2012 Feb CAHN EQ 90MG BASE N 201922 003 Jul 11, 2012 Feb CAHN @ EQ 112.5MG BASE N 201922 004 Jul 11, 2012 Feb CAHN EQ 135MG BASE N 201922 005 Jul 11, 2012 Feb CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -79

TABLET;ORAL MINOCYCLINE HYDROCHLORIDE AB AUROBINDO PHARMA LTD EQ 50MG BASE A 213662 001 May 01, 2020 Apr NEWA AB EQ 75MG BASE A 213662 002 May 01, 2020 Apr NEWA AB EQ 100MG BASE A 213662 003 May 01, 2020 Apr NEWA

MIRABEGRON TABLET, EXTENDED RELEASE;ORAL MIRABEGRON @ SAWAI USA 25MG A 209446 001 Dec 27, 2019 Jan DISC MYRBETRIQ +! APGDI 25MG N 202611 001 Jun 28, 2012 Jan CTEC

MIRTAZAPINE TABLET, ORALLY DISINTEGRATING;ORAL MIRTAZAPINE @ IMPAX LABS INC 15MG A 076901 001 Jun 28, 2005 Jul DISC @ 30MG A 076901 002 Jun 28, 2005 Jul DISC @ 45MG A 076901 003 Jun 28, 2005 Jul DISC

MISOPROSTOL TABLET;ORAL CYTOTEC AB + PFIZER 0.1MG N 019268 003 Sep 21, 1990 Aug CAHN AB +! 0.2MG N 019268 001 Dec 27, 1988 Aug CAHN MISOPROSTOL >A> @ ACQ PHARMA 0.1MG A 210201 001 Jul 02, 2019 Sep CAHN >A> @ 0.2MG A 210201 002 Jul 02, 2019 Sep CAHN >D> @ ZYDUS PHARMS 0.1MG A 210201 001 Jul 02, 2019 Sep CAHN >D> @ 0.2MG A 210201 002 Jul 02, 2019 Sep CAHN

MITOMYCIN POWDER;PYELOCALYCEAL JELMYTO +! UROGEN PHARMA 40MG/VIAL N 211728 001 Apr 15, 2020 Apr NEWA

MOMETASONE FUROATE CREAM;TOPICAL MOMETASONE FUROATE >D> AB FOUGERA PHARMS 0.1% A 076171 001 Apr 08, 2005 Sep DISC >A> @ 0.1% A 076171 001 Apr 08, 2005 Sep DISC SPRAY, METERED;NASAL MOMETASONE FUROATE AB AMNEAL PHARMS 0.05MG/SPRAY A 207989 001 Apr 03, 2017 Mar CPOT AB APOTEX INC 0.05MG/SPRAY A 091161 001 Mar 22, 2016 Mar CPOT NASONEX AB +! MERCK SHARP DOHME 0.05MG/SPRAY N 020762 001 Oct 01, 1997 Mar CPOT

MONOMETHYL FUMARATE CAPSULE, DELAYED RELEASE;ORAL BAFIERTAM +! BANNER LIFE SCIENCES 95MG N 210296 001 Apr 28, 2020 Apr NEWA

MONTELUKAST SODIUM GRANULE;ORAL MONTELUKAST SODIUM AB AUROBINDO PHARMA LTD EQ 4MG BASE/PACKET A 213471 001 Feb 18, 2020 Feb NEWA TABLET;ORAL MONTELUKAST SODIUM >A> AB ADAPTIS EQ 10MG BASE A 209012 001 Apr 24, 2017 Sep CAHN >D> AB GRAVITI PHARMS EQ 10MG BASE A 209012 001 Apr 24, 2017 Sep CAHN AB EQ 10MG BASE A 209012 001 Apr 24, 2017 May CAHN @ HIKMA EQ 10MG BASE A 090655 001 Aug 03, 2012 Feb DISC TABLET, CHEWABLE;ORAL MONTELUKAST SODIUM >A> AB ADAPTIS EQ 4MG BASE A 209011 001 Apr 18, 2017 Sep CAHN >A> AB EQ 5MG BASE A 209011 002 Apr 18, 2017 Sep CAHN AB AMNEAL PHARMS EQ 4MG BASE A 205107 001 Sep 04, 2020 Aug NEWA AB EQ 5MG BASE A 205107 002 Sep 04, 2020 Aug NEWA >D> AB GRAVITI PHARMS EQ 4MG BASE A 209011 001 Apr 18, 2017 Sep CAHN AB EQ 4MG BASE A 209011 001 Apr 18, 2017 Apr CAHN >D> AB EQ 5MG BASE A 209011 002 Apr 18, 2017 Sep CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -80

TABLET, CHEWABLE;ORAL MONTELUKAST SODIUM AB EQ 5MG BASE A 209011 002 Apr 18, 2017 Apr CAHN @ JUBILANT GENERICS EQ 4MG BASE A 203795 001 Feb 27, 2015 Jan DISC @ EQ 5MG BASE A 203795 002 Feb 27, 2015 Jan DISC

MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL KADIAN + ALLERGAN 70MG N 020616 010 Jul 09, 2012 Apr CTEC MORPHINE SULFATE @ TEVA PHARMS USA 20MG A 202718 001 Dec 29, 2014 Apr DISC @ 30MG A 202718 002 Dec 29, 2014 Apr DISC @ 40MG A 202718 007 Jun 03, 2015 Apr DISC @ 50MG A 202718 003 Dec 29, 2014 Apr DISC @ 60MG A 202718 004 Dec 29, 2014 Apr DISC @ 70MG A 202718 008 Jun 03, 2015 Apr DISC @ 80MG A 202718 005 Dec 29, 2014 Apr DISC @ 100MG A 202718 006 Dec 29, 2014 Apr DISC INJECTABLE;INJECTION DURAMORPH PF AP +! HIKMA 0.5MG/ML N 018565 001 Sep 18, 1984 Feb CAHN AP +! 1MG/ML N 018565 002 Sep 18, 1984 Feb CAHN INFUMORPH AP +! HIKMA 10MG/ML N 018565 003 Jul 19, 1991 Feb CAHN AP +! 25MG/ML N 018565 004 Jul 19, 1991 Feb CAHN MORPHINE SULFATE >D> AP HIKMA 4MG/ML A 205758 001 May 21, 2015 Sep CHRS >A> ! 4MG/ML A 205758 001 May 21, 2015 Sep CTEC >A> AP ! 4MG/ML A 205758 001 May 21, 2015 Sep CHRS AP 4MG/ML A 205758 001 May 21, 2015 Feb CAHN >D> AP 8MG/ML A 205758 002 May 21, 2015 Sep CHRS >A> ! 8MG/ML A 205758 002 May 21, 2015 Sep CTEC >A> AP ! 8MG/ML A 205758 002 May 21, 2015 Sep CHRS AP 8MG/ML A 205758 002 May 21, 2015 Feb CAHN AP 10MG/ML A 205758 003 May 21, 2015 Feb CAHN @ HOSPIRA 1MG/ML A 071850 001 May 11, 1988 May DISC >D> +! HOSPIRA INC 2MG/ML N 202515 001 Nov 14, 2011 Sep DISC >A> + @ 2MG/ML N 202515 001 Nov 14, 2011 Sep DISC >D> AP +! 4MG/ML N 202515 002 Nov 14, 2011 Sep DISC >A> + @ 4MG/ML N 202515 002 Nov 14, 2011 Sep DISC >D> AP +! 8MG/ML N 202515 003 Nov 14, 2011 Sep DISC >A> + @ 8MG/ML N 202515 003 Nov 14, 2011 Sep DISC >D> AP +! 10MG/ML N 202515 004 Nov 14, 2011 Sep DISC >A> + @ 10MG/ML N 202515 004 Nov 14, 2011 Sep DISC + @ ICU MEDICAL INC 1MG/ML N 019916 001 Oct 30, 1992 May DISC SOLUTION;INTRAMUSCULAR >D> MORPHINE SULFATE (AUTOINJECTOR) >D> +! MERIDIAN MEDCL TECHN 10MG/0.7ML (10MG/0.7ML) N 019999 001 Jul 12, 1990 Sep DISC >A> + @ 10MG/0.7ML (10MG/0.7ML) N 019999 001 Jul 12, 1990 Sep DISC +! 10MG/0.7ML (10MG/0.7ML) N 019999 001 Jul 12, 1990 Jun CPOT +! 15MG/ML N 019999 001 Jul 12, 1990 Jun CTNA +! 15MG/ML N 019999 001 Jul 12, 1990 Jun CDFR TABLET, EXTENDED RELEASE;ORAL MORPHABOND ER + @ DAIICHI SANKYO INC 15MG N 206544 001 Oct 02, 2015 Aug DISC + @ 30MG N 206544 002 Oct 02, 2015 Aug DISC + @ 60MG N 206544 003 Oct 02, 2015 Aug DISC + @ 100MG N 206544 004 Oct 02, 2015 Aug DISC MORPHINE SULFATE @ NESHER PHARMS 15MG A 076733 001 May 19, 2004 Mar DISC @ 100MG A 077855 001 Sep 27, 2007 Mar DISC @ 200MG A 077855 002 Sep 27, 2007 Mar DISC

MOXIFLOXACIN HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC MOXIFLOXACIN HYDROCHLORIDE AT1 GLAND PHARMA LTD EQ 0.5% BASE A 208778 001 Mar 30, 2020 Mar NEWA AT1 MYLAN EQ 0.5% BASE A 206447 001 Mar 30, 2020 Mar NEWA TABLET;ORAL AVELOX + @ BAYER HLTHCARE EQ 400MG BASE N 021085 001 Dec 10, 1999 Apr DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -81

TABLET;ORAL MOXIFLOXACIN HYDROCHLORIDE AB ! DR REDDYS LABS LTD EQ 400MG BASE A 076938 001 Mar 04, 2014 Apr CHRS

MUPIROCIN CALCIUM CREAM;TOPICAL MUPIROCIN AB ! GLENMARK PHARMS INC EQ 2% BASE A 201587 001 Jan 24, 2013 Apr CTEC AB TARO EQ 2% BASE A 207116 001 Apr 27, 2020 Apr NEWA

MYCOPHENOLATE MOFETIL CAPSULE;ORAL MYCOPHENOLATE MOFETIL @ VINTAGE PHARMS LLC 250MG A 090111 001 Dec 22, 2009 Jun DISC TABLET;ORAL MYCOPHENOLATE MOFETIL AB CONCORD BIOTECH LTD 500MG A 212087 001 Jul 31, 2020 Jul NEWA

MYCOPHENOLIC ACID TABLET, DELAYED RELEASE;ORAL MYCOPHENOLIC ACID @ TEVA PHARMS USA 180MG A 202720 001 Oct 30, 2014 Mar DISC @ 360MG A 202720 002 Oct 30, 2014 Mar DISC

NABILONE CAPSULE;ORAL CESAMET +! BAUSCH 1MG N 018677 001 Dec 26, 1985 Mar CAHN

NABUMETONE TABLET;ORAL NABUMETONE >D> AB IMPAX LABS INC 500MG A 075189 001 May 26, 2000 Sep DISC >A> @ 500MG A 075189 001 May 26, 2000 Sep DISC >D> AB 750MG A 075189 002 Sep 24, 2001 Sep DISC >A> @ 750MG A 075189 002 Sep 24, 2001 Sep DISC AB 750MG A 075189 002 Sep 24, 2001 Jul CHRS AB ! INVAGEN PHARMS 750MG A 078671 002 Mar 07, 2008 Jul CHRS AB LGM PHARMA 500MG A 203166 001 Aug 30, 2019 Aug CAHN AB 750MG A 203166 002 Aug 30, 2019 Aug CAHN 1GM A 203166 003 Aug 30, 2019 Aug CAHN

NADOLOL TABLET;ORAL CORGARD AB + USWM 20MG N 018063 005 Oct 28, 1986 Jun CAHN AB + 40MG N 018063 001 Jun CAHN AB +! 80MG N 018063 002 Jun CAHN @ 120MG N 018063 003 Jun CAHN @ 160MG N 018063 004 Jun CAHN NADOLOL VG YAA N@ VGYAAN@ 20MG A 212856 001 Sep 13, 2019 Mar DISC @ 40MG A 212856 002 Sep 13, 2019 Mar DISC @ 80MG A 212856 003 Sep 13, 2019 Mar DISC

NAFARELIN ACETATE SPRAY, METERED;NASAL SYNAREL +! PFIZER EQ 0.2MG BASE/SPRAY N 019886 001 Feb 13, 1990 Jul CAHN

NAFCILLIN SODIUM INJECTABLE;INJECTION NAFCILLIN SODIUM @ FRESENIUS EQ 1GM BASE/VIAL A 206682 001 Dec 10, 2019 Jul DISC @ EQ 2GM BASE/VIAL A 206682 002 Dec 10, 2019 Jul DISC AP EQ 10GM BASE/VIAL A 206761 001 Jun 02, 2020 May NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -82

NAFTIFINE HYDROCHLORIDE CREAM;TOPICAL NAFTIFINE HYDROCHLORIDE >A> AB GENZUM 2.0% A 210038 001 Sep 22, 2020 Sep NEWA

NALBUPHINE HYDROCHLORIDE INJECTABLE;INJECTION NALBUPHINE HYDROCHLORIDE @ MYLAN LABS LTD 10MG/ML A 206506 001 Feb 06, 2019 Feb DISC @ 10MG/ML A 207595 001 Jan 11, 2019 Feb DISC @ 20MG/ML A 206506 002 Feb 06, 2019 Feb DISC @ 20MG/ML A 207595 002 Jan 11, 2019 Feb DISC

NALOXEGOL OXALATE TABLET;ORAL MOVANTIK + REDHILL EQ 12.5MG BASE N 204760 001 Sep 16, 2014 Jul CAHN +! EQ 25MG BASE N 204760 002 Sep 16, 2014 Jul CAHN

NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION NALOXONE HYDROCHLORIDE AP DR REDDYS 1MG/ML A 213209 001 Mar 16, 2020 Mar NEWA AP ! INTL MEDICATION 1MG/ML A 072076 001 Mar 24, 1988 Mar CTEC @ PAR STERILE PRODUCTS 0.4MG/ML A 211286 001 Jan 17, 2020 Jul DISC AP 0.4MG/ML A 211286 001 Jan 17, 2020 Jan NEWA SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS EVZIO (AUTOINJECTOR) >D> +! KALEO INC 2MG/0.4ML (2MG/0.4ML) N 209862 001 Oct 19, 2016 Sep DISC >A> + @ 2MG/0.4ML (2MG/0.4ML) N 209862 001 Oct 19, 2016 Sep DISC

NALTREXONE HYDROCHLORIDE TABLET;ORAL NALTREXONE HYDROCHLORIDE AB CHARTWELL 50MG A 207905 001 Jul 21, 2017 Aug CAHN

NAPROXEN SUSPENSION;ORAL NAPROXEN AB AMNEAL 25MG/ML A 212705 001 Jul 31, 2020 Jul NEWA TABLET;ORAL NAPROXEN >D> @ FOSUN PHARMA 250MG A 074140 001 Dec 21, 1993 Sep CAHN >D> @ 375MG A 074140 002 Dec 21, 1993 Sep CAHN >D> @ 500MG A 074140 003 Dec 21, 1993 Sep CAHN >A> @ GRANULES 250MG A 074140 001 Dec 21, 1993 Sep CAHN >A> @ 375MG A 074140 002 Dec 21, 1993 Sep CAHN >A> @ 500MG A 074140 003 Dec 21, 1993 Sep CAHN @ MYLAN 250MG A 074121 001 Dec 21, 1993 Jan DISC @ 375MG A 074121 002 Dec 21, 1993 Jan DISC @ 500MG A 074121 003 Dec 21, 1993 Jan DISC AB SCIEGEN PHARMS INC 250MG A 212517 001 Feb 21, 2020 Feb NEWA AB 375MG A 212517 002 Feb 21, 2020 Feb NEWA AB 500MG A 212517 003 Feb 21, 2020 Feb NEWA TABLET, DELAYED RELEASE;ORAL NAPROXEN >A> AB NUVO PHARMS INC 375MG A 091432 001 Sep 19, 2011 Sep CAHN >A> AB 500MG A 091432 002 Sep 19, 2011 Sep CAHN @ PLIVA 375MG A 075337 001 May 26, 1999 Mar DISC @ 500MG A 075337 002 May 26, 1999 Mar DISC >D> AB SUNRISE PHARM INC 375MG A 091432 001 Sep 19, 2011 Sep CAHN >D> AB 500MG A 091432 002 Sep 19, 2011 Sep CAHN

NAPROXEN SODIUM TABLET;ORAL NAPROXEN SODIUM @ TEVA EQ 250MG BASE A 074198 001 Dec 21, 1993 Mar DISC @ EQ 500MG BASE A 074198 002 Dec 21, 1993 Mar DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -83

NATEGLINIDE TABLET;ORAL NATEGLINIDE @ ALVOGEN 60MG A 205055 001 Dec 11, 2015 Mar DISC @ 120MG A 205055 002 Dec 11, 2015 Mar DISC >A> AB INDICUS PHARMA 60MG A 205544 001 Jun 18, 2018 Sep CAHN >A> AB 120MG A 205544 002 Jun 18, 2018 Sep CAHN >D> AB WILSHIRE PHARMS INC 60MG A 205544 001 Jun 18, 2018 Sep CAHN >D> AB 120MG A 205544 002 Jun 18, 2018 Sep CAHN

NEBIVOLOL HYDROCHLORIDE TABLET;ORAL NEBIVOLOL HYDROCHLORIDE >D> @ AMERIGEN PHARMS LTD EQ 2.5MG BASE A 203659 001 Apr 16, 2015 Sep CAHN >D> @ EQ 5MG BASE A 203659 002 Apr 16, 2015 Sep CAHN >D> @ EQ 10MG BASE A 203659 003 Apr 16, 2015 Sep CAHN >D> @ EQ 20MG BASE A 203659 004 Apr 16, 2015 Sep CAHN >A> @ ANI PHARMS INC EQ 2.5MG BASE A 203659 001 Apr 16, 2015 Sep CAHN >A> @ EQ 5MG BASE A 203659 002 Apr 16, 2015 Sep CAHN >A> @ EQ 10MG BASE A 203659 003 Apr 16, 2015 Sep CAHN >A> @ EQ 20MG BASE A 203659 004 Apr 16, 2015 Sep CAHN

NEOMYCIN SULFATE TABLET;ORAL NEOMYCIN SULFATE @ BRECKENRIDGE 500MG A 065468 001 Mar 29, 2010 Apr DISC @ NOSTRUM LABS INC 500MG A 065468 001 Mar 29, 2010 Jul CAHN AA XGEN PHARMS 500MG A 065220 001 Jul 28, 2006 Feb CAHN

NEOMYCIN SULFATE; POLYMYXIN B SULFATE SOLUTION;IRRIGATION NEOMYCIN AND POLYMYXIN B SULFATE AT WATSON LABS EQ 40MG BASE/ML;200,000 UNITS/ML A 062664 001 Apr 08, 1986 Mar CMFD AT XGEN PHARMS EQ 40MG BASE/ML;200,000 UNITS/ML A 065106 001 Jan 31, 2006 Feb CAHN AT EQ 40MG BASE/ML;200,000 UNITS/ML A 065108 001 Jan 31, 2006 Feb CAHN

NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS BLOXIVERZ AP +! EXELA PHARMA 5MG/10ML (0.5MG/ML) N 204078 001 May 31, 2013 Jul CAHN AP +! 10MG/10ML (1MG/ML) N 204078 002 May 31, 2013 Jul CAHN NEOSTIGMINE METHYLSULFATE +! FRESENIUS KABI USA 3MG/3ML (1MG/ML) N 203629 003 Sep 18, 2018 Aug CHRS + 3MG/3ML (1MG/ML) N 203629 003 Sep 18, 2018 Aug CRLD +! 5MG/10ML (0.5MG/ML) N 203629 001 Jan 08, 2015 Aug CHRS + 5MG/10ML (0.5MG/ML) N 203629 001 Jan 08, 2015 Aug CRLD +! 10MG/10ML (1MG/ML) N 203629 002 Jan 08, 2015 Aug CHRS + 10MG/10ML (1MG/ML) N 203629 002 Jan 08, 2015 Aug CRLD

NETARSUDIL MESYLATE SOLUTION/DROPS;OPHTHALMIC RHOPRESSA +! AERIE PHARMS INC EQ 0.02% BASE N 208254 001 Dec 18, 2017 Feb CAIN

NIACIN TABLET, EXTENDED RELEASE;ORAL NIACIN @ MYLAN 500MG A 203742 001 Feb 22, 2019 Jan DISC @ 750MG A 203742 002 Feb 22, 2019 Jan DISC @ 1GM A 203742 003 Feb 22, 2019 Jan DISC

NICARDIPINE HYDROCHLORIDE CAPSULE;ORAL NICARDIPINE HYDROCHLORIDE EPIC PHARMA 20MG A 074928 001 Mar 19, 1998 Aug CTEC ! 30MG A 074928 002 Mar 19, 1998 Aug CHRS 30MG A 074928 002 Mar 19, 1998 Aug CTEC @ MYLAN 20MG A 074642 001 Jul 18, 1996 Aug DISC @ 30MG A 074642 002 Jul 18, 1996 Aug DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -84

INJECTABLE;INJECTION NICARDIPINE HYDROCHLORIDE AM REGENT 25MG/10ML (2.5MG/ML) A 090534 001 Nov 17, 2009 May CMFD +! EXELA PHARMA SCIENCE 25MG/10ML (2.5MG/ML) N 022276 001 Jul 24, 2008 Aug CHRS + 25MG/10ML (2.5MG/ML) N 022276 001 Jul 24, 2008 Aug CRLD INJECTABLE;INTRAVENOUS NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE +! EXELA PHARMA SCIENCE 20MG/200ML (0.1MG/ML) N 022276 002 Apr 07, 2016 Aug CHRS + 20MG/200ML (0.1MG/ML) N 022276 002 Apr 07, 2016 Aug CRLD 20MG/200ML (0.1MG/ML) N 022276 002 Apr 07, 2016 May CMFD +! 40MG/200ML (0.2MG/ML) N 022276 003 Apr 07, 2016 Aug CHRS + 40MG/200ML (0.2MG/ML) N 022276 003 Apr 07, 2016 Aug CRLD 40MG/200ML (0.2MG/ML) N 022276 003 Apr 07, 2016 May CMFD

NIFEDIPINE CAPSULE;ORAL NIFEDIPINE AB ACELLA 10MG A 072781 001 Jul 30, 1993 Jul CAHN

NIFURTIMOX TABLET;ORAL LAMPIT + BAYER HEALTHCARE 30MG N 213464 001 Aug 06, 2020 Aug NEWA +! 120MG N 213464 002 Aug 06, 2020 Aug NEWA

NIMODIPINE SOLUTION;ORAL NYMALIZE + @ ARBOR PHARMS LLC 3MG/ML N 203340 001 May 10, 2013 Apr DISC +! 3MG/ML N 203340 001 May 10, 2013 Apr CPOT +! 6MG/ML N 203340 002 Apr 08, 2020 Apr NEWA

NIRAPARIB TOSYLATE CAPSULE;ORAL ZEJULA +! GLAXOSMITHKLINE EQ 100MG BASE N 208447 001 Mar 27, 2017 Jan CAHN

NITROFURANTOIN, MACROCRYSTALLINE CAPSULE;ORAL NITROFURANTOIN >D> @ INVATECH 25MG A 074336 001 Jan 25, 1995 Sep CAHN >D> @ 50MG A 074336 002 Jan 25, 1995 Sep CAHN >D> @ 100MG A 074336 003 Jan 25, 1995 Sep CAHN >A> @ PHARMGEN 25MG A 074336 001 Jan 25, 1995 Sep CAHN >A> @ 50MG A 074336 002 Jan 25, 1995 Sep CAHN >A> @ 100MG A 074336 003 Jan 25, 1995 Sep CAHN

NITROGLYCERIN FILM, EXTENDED RELEASE;TRANSDERMAL NITRO-DUR BX +! USPHARMA 0.1MG/HR N 020145 001 Apr 04, 1995 Mar CTEC BX +! 0.2MG/HR N 020145 002 Apr 04, 1995 Mar CTEC BX +! 0.4MG/HR N 020145 004 Apr 04, 1995 Mar CTEC BX +! 0.6MG/HR N 020145 005 Apr 04, 1995 Mar CTEC TABLET;SUBLINGUAL NITROGLYCERIN @ ACTAVIS LABS FL INC 0.3MG A 203693 001 Oct 16, 2017 Mar DISC @ 0.4MG A 203693 002 Oct 16, 2017 Mar DISC @ 0.6MG A 203693 003 Oct 16, 2017 Mar DISC NITROSTAT AB + UPJOHN 0.3MG N 021134 001 May 01, 2000 Jul CAHN AB + 0.4MG N 021134 002 May 01, 2000 Jul CAHN AB +! 0.6MG N 021134 003 May 01, 2000 Jul CAHN

NIZATIDINE CAPSULE;ORAL NIZATIDINE @ MYLAN PHARMS INC 150MG A 075806 001 Jul 05, 2002 May DISC @ 300MG A 075806 002 Jul 05, 2002 May DISC AB ! WATSON LABS 300MG A 075616 002 Jul 09, 2002 May CHRS RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -85

NORETHINDRONE TABLET;ORAL-28 NOR-QD AB1 +! TEVA BRANDED PHARM 0.35MG N 017060 001 Jan CAHN NORETHINDRONE AB1 NAARI PTE LTD 0.35MG A 206807 001 Dec 13, 2016 Jun CAHN

NUSINERSEN SODIUM SOLUTION;INTRATHECAL SPINRAZA +! BIOGEN IDEC EQ 12MG BASE/5ML (EQ 2.4MG N 209531 001 Dec 23, 2016 Jun CPOT BASE/ML)

NYSTATIN CREAM;TOPICAL NYSTATIN @ VINTAGE 100,000 UNITS/GM A 065315 001 May 31, 2006 Jul DISC POWDER;TOPICAL NYSTATIN AT XGEN PHARMS 100,000 UNITS/GM A 065175 001 Dec 17, 2004 Feb CAHN SUSPENSION;ORAL NYSTATIN AA SOCORRO 100,000 UNITS/ML A 062832 001 Dec 27, 1991 May CMFD

NYSTATIN; TRIAMCINOLONE ACETONIDE CREAM;TOPICAL NYSTATIN AND TRIAMCINOLONE ACETONIDE AT TORRENT 100,000 UNITS/GM;0.1% A 213142 001 Jul 14, 2020 Jul NEWA OINTMENT;TOPICAL NYSTATIN AND TRIAMCINOLONE ACETONIDE AT CADILA 100,000 UNITS/GM;0.1% A 207764 001 Nov 08, 2018 Jun CAHN @ VITRUVIAS THERAP 100,000 UNITS/GM;0.1% A 207316 001 Nov 18, 2019 May CPOT @ 100000 UNITS/GM;0.1% A 207316 001 Nov 18, 2019 May DISC AT ZYDUS PHARMS 100,000 UNITS/GM;0.1% A 207764 001 Nov 08, 2018 Mar CMFD

OCTREOTIDE ACETATE CAPSULE, DELAYED RELEASE;ORAL MYCAPSSA +! CHIASMA EQ 20MG BASE N 208232 001 Jun 26, 2020 Jun NEWA INJECTABLE;INJECTION OCTREOTIDE ACETATE @ HERITAGE PHARMS INC EQ 0.05MG BASE/ML A 204669 001 Dec 27, 2018 Feb DISC @ EQ 0.1MG BASE/ML A 204669 002 Dec 27, 2018 Feb DISC @ EQ 0.5MG BASE/ML A 204669 003 Dec 27, 2018 Feb DISC SANDOSTATIN + @ NOVARTIS EQ 0.2MG BASE/ML N 019667 004 Jun 12, 1991 May DISC + @ EQ 1MG BASE/ML N 019667 005 Jun 12, 1991 May DISC SOLUTION;SUBCUTANEOUS BYNFEZIA PEN +! SUN PHARM EQ 2.5MG BASE/ML (EQ 2.5MG N 213224 001 Jan 28, 2020 Jan NEWA BASE/ML)

OLANZAPINE TABLET;ORAL OLANZAPINE >D> AB HIKMA 2.5MG A 204866 001 Jun 16, 2017 Sep DISC >A> @ 2.5MG A 204866 001 Jun 16, 2017 Sep DISC >D> AB 5MG A 204866 002 Jun 16, 2017 Sep DISC >A> @ 5MG A 204866 002 Jun 16, 2017 Sep DISC >D> AB 7.5MG A 204866 003 Jun 16, 2017 Sep DISC >A> @ 7.5MG A 204866 003 Jun 16, 2017 Sep DISC >D> AB 10MG A 204866 004 Jun 16, 2017 Sep DISC >A> @ 10MG A 204866 004 Jun 16, 2017 Sep DISC >D> AB 15MG A 204866 005 Jun 16, 2017 Sep DISC >A> @ 15MG A 204866 005 Jun 16, 2017 Sep DISC >D> AB 20MG A 204866 006 Jun 16, 2017 Sep DISC >A> @ 20MG A 204866 006 Jun 16, 2017 Sep DISC AB INDOCO 2.5MG A 206155 001 Jul 31, 2020 Jul NEWA AB 5MG A 206155 002 Jul 31, 2020 Jul NEWA AB 7.5MG A 206155 003 Jul 31, 2020 Jul NEWA AB 10MG A 206155 004 Jul 31, 2020 Jul NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -86

TABLET;ORAL OLANZAPINE AB 15MG A 206155 005 Jul 31, 2020 Jul NEWA AB 20MG A 206155 006 Jul 31, 2020 Jul NEWA @ IVAX PHARMS INC 20MG A 077301 001 Apr 29, 2015 Mar DISC @ JIANGSU HANSOH PHARM 2.5MG A 209399 001 Sep 24, 2018 May DISC @ 5MG A 209399 002 Sep 24, 2018 May DISC @ 10MG A 209399 003 Sep 24, 2018 May DISC @ TEVA PHARMS 2.5MG A 076000 001 Oct 24, 2011 Jan DISC @ 5MG A 076000 002 Oct 24, 2011 Jan DISC @ 7.5MG A 076000 003 Oct 24, 2011 Jan DISC @ 10MG A 076000 004 Oct 24, 2011 Jan DISC @ 15MG A 076000 005 Oct 24, 2011 Jan DISC

OLMESARTAN MEDOXOMIL TABLET;ORAL OLMESARTAN MEDOXOMIL AB INVENTIA 5MG A 208659 001 May 18, 2020 May NEWA AB 20MG A 208659 002 May 18, 2020 May NEWA AB 40MG A 208659 003 May 18, 2020 May NEWA @ JUBILANT GENERICS 5MG A 205482 001 Apr 24, 2017 Feb DISC @ 20MG A 205482 002 Apr 24, 2017 Feb DISC @ 40MG A 205482 003 Apr 24, 2017 Feb DISC AB SANDOZ INC 5MG A 090237 001 Apr 13, 2020 Mar NEWA AB 20MG A 090237 002 Apr 13, 2020 Mar NEWA AB 40MG A 090237 003 Apr 13, 2020 Mar NEWA

OLOPATADINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC OLOPATADINE HYDROCHLORIDE @ CIPLA EQ 0.1% BASE A 206046 001 Jul 26, 2017 Mar DISC @ EQ 0.2% BASE A 206087 001 Dec 05, 2017 Mar DISC >D> AT SOMERSET THERAPS LLC EQ 0.1% BASE A 206306 001 Dec 07, 2015 Sep DISC >A> @ EQ 0.1% BASE A 206306 001 Dec 07, 2015 Sep DISC @ WATSON LABS INC EQ 0.7% BASE A 208637 001 Feb 19, 2020 Mar DISC AT EQ 0.7% BASE A 208637 001 Feb 19, 2020 Feb NFTG PATADAY ONCE DAILY RELIEF +! NOVARTIS EQ 0.7% BASE N 206276 001 Jan 30, 2015 Mar CTEC AT +! EQ 0.7% BASE N 206276 001 Jan 30, 2015 Feb CFTG SPRAY, METERED;NASAL OLOPATADINE HYDROCHLORIDE AB AKORN INC 0.665MG/SPRAY A 213757 001 Aug 19, 2020 Aug NEWA AB AMNEAL 0.665MG/SPRAY A 210901 001 Jan 28, 2020 Jan NEWA

OMEGA-3-ACID ETHYL ESTERS CAPSULE;ORAL OMEGA-3-ACID ETHYL ESTERS AB CSPC NBP PHARM CO 1GM CONTAINS AT LEAST 900MG OF THE A 211979 001 May 12, 2020 Apr NEWA ETHYL ESTERS OF OMEGA-3 FATTY ACIDS AB GLW 1GM CONTAINS AT LEAST 900MG OF THE A 212504 001 Aug 19, 2020 Aug NEWA ETHYL ESTERS OF OMEGA-3 FATTY ACIDS AB PURACAP PHARM LLC 1GM CONTAINS AT LEAST 900MG OF THE A 210093 001 Jun 15, 2020 Jun NEWA ETHYL ESTERS OF OMEGA-3 FATTY ACIDS AB SOFGEN PHARMS 1GM CONTAINS AT LEAST 900MG OF THE A 211355 001 Jul 10, 2019 Feb CMFD ETHYL ESTERS OF OMEGA-3 FATTY ACIDS

OMEPRAZOLE CAPSULE, DELAYED REL PELLETS;ORAL OMEPRAZOLE @ MYLAN 10MG A 205070 001 Jun 29, 2018 Feb DISC @ 20MG A 075876 002 May 29, 2003 Jan DISC @ 20MG A 205070 002 Jun 29, 2018 Feb DISC @ 40MG A 205070 003 Jun 29, 2018 Feb DISC @ TEVA PHARMS USA 40MG A 204661 002 Jun 13, 2017 May DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -87

OMEPRAZOLE; SODIUM BICARBONATE CAPSULE;ORAL OMEPRAZOLE AND SODIUM BICARBONATE AB GUARDIAN DRUG 20MG;1.1GM A 212587 001 Apr 30, 2020 Apr NEWA AB 40MG;1.1GM A 212587 002 Apr 30, 2020 Apr NEWA

ONDANSETRON >D> FILM;ORAL >D> ZUPLENZ >D> + FORTOVIA 4MG N 022524 001 Jul 02, 2010 Sep DISC >A> + @ 4MG N 022524 001 Jul 02, 2010 Sep DISC + 4MG N 022524 001 Jul 02, 2010 May CAHN >D> +! 8MG N 022524 002 Jul 02, 2010 Sep DISC >A> + @ 8MG N 022524 002 Jul 02, 2010 Sep DISC +! 8MG N 022524 002 Jul 02, 2010 May CAHN TABLET, ORALLY DISINTEGRATING;ORAL ONDANSETRON @ BARR 4MG A 076693 001 Jun 25, 2007 Mar DISC @ 8MG A 076693 002 Jun 25, 2007 Mar DISC @ TEVA 4MG A 076810 001 Jun 25, 2007 Mar DISC @ 8MG A 076810 002 Jun 25, 2007 Mar DISC

ONDANSETRON HYDROCHLORIDE INJECTABLE;INJECTION ONDANSETRON HYDROCHLORIDE @ EMCURE PHARMS EQ 2MG BASE/ML A 090424 001 Apr 16, 2010 May DISC AP ! GLAND PHARMA LTD EQ 2MG BASE/ML A 090648 001 Jun 15, 2012 Jun CHRS >D> AP HOSPIRA EQ 2MG BASE/ML A 077840 001 Jan 19, 2007 Sep DISC >A> @ EQ 2MG BASE/ML A 077840 001 Jan 19, 2007 Sep DISC AP ! QILU EQ 2MG BASE/ML A 203711 001 Sep 08, 2014 Mar CHRS TABLET;ORAL ONDANSETRON HYDROCHLORIDE @ MYLAN EQ 4MG BASE A 076930 001 Jun 25, 2007 Jan DISC @ EQ 8MG BASE A 076930 002 Jun 25, 2007 Jan DISC @ PLIVA HRVATSKA DOO EQ 4MG BASE A 077112 001 Jun 25, 2007 Mar DISC @ EQ 8MG BASE A 077112 002 Jun 25, 2007 Mar DISC @ EQ 24MG BASE A 077112 003 Jun 25, 2007 Mar DISC

OPICAPONE CAPSULE;ORAL ONGENTYS + NEUROCRINE 25MG N 212489 001 Apr 24, 2020 Apr NEWA +! 50MG N 212489 002 Apr 24, 2020 Apr NEWA

OSELTAMIVIR PHOSPHATE CAPSULE;ORAL OSELTAMIVIR PHOSPHATE AB MSN EQ 30MG BASE A 212544 001 May 20, 2020 May NEWA AB EQ 45MG BASE A 212544 002 May 20, 2020 May NEWA AB EQ 75MG BASE A 212544 003 May 20, 2020 May NEWA FOR SUSPENSION;ORAL OSELTAMIVIR PHOSPHATE AB AJANTA PHARMA LTD EQ 6MG BASE/ML A 212784 001 May 27, 2020 May NEWA

OSILODROSTAT PHOSPHATE TABLET;ORAL ISTURISA + RECORDATI RARE EQ 1MG BASE N 212801 001 Mar 06, 2020 Mar NEWA + EQ 5MG BASE N 212801 002 Mar 06, 2020 Mar NEWA +! EQ 10MG BASE N 212801 003 Mar 06, 2020 Mar NEWA

OXACILLIN SODIUM INJECTABLE;INJECTION OXACILLIN SODIUM AP FRESENIUS KABI USA EQ 1GM BASE/VIAL A 206198 001 Jul 20, 2020 Jul NEWA AP EQ 2GM BASE/VIAL A 206198 002 Jul 20, 2020 Jul NEWA AP EQ 10GM BASE/VIAL A 206199 001 Jul 27, 2020 Jul NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -88

OXALIPLATIN INJECTABLE;INTRAVENOUS OXALIPLATIN @ ACCORD HLTHCARE 200MG/40ML (5MG/ML) A 207474 003 Mar 21, 2017 Aug DISC @ FRESENIUS KABI USA 200MG/40ML (5MG/ML) A 090030 003 Jan 31, 2017 Aug DISC @ GLAND PHARMA LTD 200MG/40ML (5MG/ML) A 207325 003 Oct 18, 2017 Aug DISC ! QILU 200MG/40ML (5MG/ML) A 204368 003 Jun 07, 2016 Aug CMFD @ 200MG/40ML (5MG/ML) A 204368 003 Jun 07, 2016 Aug DISC

OXAPROZIN TABLET;ORAL DAYPRO AB +! PFIZER 600MG N 018841 004 Oct 29, 1992 Jul CAHN OXAPROZIN AB CHARTWELL 600MG A 075987 001 Sep 02, 2004 Mar CAHN @ IVAX SUB TEVA PHARMS 600MG A 075846 001 May 13, 2002 Mar DISC

OXAPROZIN POTASSIUM TABLET;ORAL DAYPRO ALTA @ PFIZER 600MG N 020776 001 Oct 17, 2002 Jul CAHN

OXAZEPAM CAPSULE;ORAL OXAZEPAM AB FRONTIDA BIOPHARM 10MG A 071026 002 Aug 10, 1987 Mar CMFD AB 15MG A 071026 003 Aug 10, 1987 Mar CMFD AB 30MG A 071026 001 Aug 10, 1987 Mar CMFD

OXCARBAZEPINE TABLET;ORAL OXCARBAZEPINE @ HIKMA 150MG A 077795 001 Oct 09, 2007 Feb DISC @ 300MG A 077795 002 Oct 09, 2007 Feb DISC @ 600MG A 077795 003 Oct 09, 2007 Feb DISC

OXYBUTYNIN CHLORIDE TABLET;ORAL OXYBUTYNIN CHLORIDE >D> AB ATHEM 5MG A 211062 001 Feb 06, 2019 Sep CAHN >A> AB EYWA 5MG A 211062 001 Feb 06, 2019 Sep CAHN AB LEADING PHARMA LLC 5MG A 212798 001 Apr 06, 2020 Mar NEWA AB RISING 5MG A 209025 001 Dec 21, 2017 Aug CAHN TABLET, EXTENDED RELEASE;ORAL OXYBUTYNIN CHLORIDE @ IMPAX PHARMS 5MG A 076745 002 May 09, 2007 Jul DISC @ 10MG A 076745 003 May 09, 2007 Jul DISC @ 15MG A 076745 001 Nov 09, 2006 Jul DISC @ MYLAN PHARMS INC 10MG A 076644 001 Nov 09, 2006 Jan DISC @ 15MG A 076644 002 May 10, 2007 Jan DISC

OXYCODONE HYDROCHLORIDE SOLUTION;ORAL OXYCODONE HYDROCHLORIDE @ ANI PHARMS INC 100MG/5ML A 203447 001 Aug 30, 2017 Jan DISC AA AUROLIFE PHARMA LLC 5MG/5ML A 212429 001 Jan 27, 2020 Jan NEWA AA 100MG/5ML A 212429 002 Jan 27, 2020 Jan NEWA @ HIKMA 100MG/5ML A 203208 001 Jul 12, 2013 Feb DISC AA RHODES PHARMS 100MG/5ML A 205853 001 Apr 29, 2020 Apr NEWA TABLET;ORAL OXYCODONE HYDROCHLORIDE @ NESHER PHARMS 5MG A 077290 001 Dec 08, 2005 Mar DISC @ 10MG A 077290 002 Dec 08, 2005 Mar DISC @ 15MG A 077290 003 Dec 08, 2005 Mar DISC @ 20MG A 077290 004 Dec 08, 2005 Mar DISC @ 30MG A 077290 005 Dec 08, 2005 Mar DISC ROXYBOND @ OHEMO LIFE 5MG N 209777 001 Apr 20, 2017 May CAHN @ 15MG N 209777 002 Apr 20, 2017 May CAHN @ 30MG N 209777 003 Apr 20, 2017 May CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -89

OXYMETAZOLINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC UPNEEQ +! RVL PHARMS 0.1% N 212520 001 Jul 08, 2020 Jul NEWA

OXYMORPHONE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL OXYMORPHONE HYDROCHLORIDE @ ACTAVIS ELIZABETH 5MG A 079046 003 Jul 11, 2013 Mar DISC @ 7.5MG A 079046 001 Dec 13, 2010 Mar DISC @ 10MG A 079046 004 Jul 11, 2013 Mar DISC @ 15MG A 079046 002 Dec 13, 2010 Mar DISC @ 20MG A 079046 005 Jul 11, 2013 Mar DISC @ 30MG A 079046 006 Jul 11, 2013 Mar DISC @ 40MG A 079046 007 Jul 11, 2013 Mar DISC >D> AB HIKMA 5MG A 200822 002 Jul 15, 2013 Sep DISC >A> @ 5MG A 200822 002 Jul 15, 2013 Sep DISC >D> AB 7.5MG A 200822 003 Jul 15, 2013 Sep DISC >A> @ 7.5MG A 200822 003 Jul 15, 2013 Sep DISC >D> AB 10MG A 200822 004 Jul 15, 2013 Sep DISC >A> @ 10MG A 200822 004 Jul 15, 2013 Sep DISC >D> AB 15MG A 200822 005 Jul 15, 2013 Sep DISC >A> @ 15MG A 200822 005 Jul 15, 2013 Sep DISC >D> AB 20MG A 200822 006 Jul 15, 2013 Sep DISC >A> @ 20MG A 200822 006 Jul 15, 2013 Sep DISC >D> AB 30MG A 200822 007 Jul 15, 2013 Sep DISC >A> @ 30MG A 200822 007 Jul 15, 2013 Sep DISC >D> AB 40MG A 200822 001 Jul 15, 2013 Sep DISC >A> @ 40MG A 200822 001 Jul 15, 2013 Sep DISC >D> AB IMPAX LABS 5MG A 079087 001 Jun 14, 2010 Sep CTEC >A> 5MG A 079087 001 Jun 14, 2010 Sep CTEC >D> AB 7.5MG A 079087 002 Dec 21, 2010 Sep CTEC >A> 7.5MG A 079087 002 Dec 21, 2010 Sep CTEC >D> AB 10MG A 079087 003 Jun 14, 2010 Sep CTEC >A> 10MG A 079087 003 Jun 14, 2010 Sep CTEC >D> AB 15MG A 079087 004 Dec 21, 2010 Sep CTEC >A> 15MG A 079087 004 Dec 21, 2010 Sep CTEC >D> AB 20MG A 079087 005 Jun 14, 2010 Sep CTEC >A> 20MG A 079087 005 Jun 14, 2010 Sep CTEC >D> AB 30MG A 079087 006 Jul 22, 2010 Sep CTEC >A> 30MG A 079087 006 Jul 22, 2010 Sep CTEC @ SPECGX LLC 5MG A 202946 001 Jun 27, 2014 May DISC @ 7.5MG A 202946 002 Jun 27, 2014 May DISC @ 10MG A 202946 003 Jun 27, 2014 May DISC @ 15MG A 202946 004 Jun 27, 2014 May DISC @ 20MG A 202946 005 Jun 27, 2014 May DISC @ 30MG A 202946 006 Jun 27, 2014 May DISC @ 40MG A 202946 007 Jun 27, 2014 May DISC

OZANIMOD HYDROCHLORIDE CAPSULE;ORAL ZEPOSIA + CELGENE INTL 0.23MG N 209899 001 Mar 25, 2020 Mar NEWA + 0.46MG N 209899 002 Mar 25, 2020 Mar NEWA +! 0.92MG N 209899 003 Mar 25, 2020 Mar NEWA

PACLITAXEL INJECTABLE;INJECTION PACLITAXEL AP MSN 6MG/ML A 213434 001 Aug 24, 2020 Aug NEWA

PALONOSETRON HYDROCHLORIDE INJECTABLE;INTRAVENOUS PALONOSETRON HYDROCHLORIDE AP INGENUS PHARMS LLC EQ 0.25MG BASE/5ML (EQ 0.05MG A 208789 001 May 22, 2020 May NEWA BASE/ML) RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -90

PAMIDRONATE DISODIUM INJECTABLE;INJECTION PAMIDRONATE DISODIUM @ TEVA PHARMS USA 30MG/10ML (3MG/ML) A 076153 001 Mar 27, 2002 Mar DISC @ 90MG/10ML (9MG/ML) A 076153 002 Mar 27, 2002 Mar DISC

PANTOPRAZOLE SODIUM FOR SUSPENSION, DELAYED RELEASE;ORAL PANTOPRAZOLE SODIUM AB SUN PHARM EQ 40MG BASE A 213725 001 Jun 30, 2020 Jun NFTG PROTONIX AB +! WYETH PHARMS EQ 40MG BASE N 022020 001 Nov 14, 2007 Jun CFTG TABLET, DELAYED RELEASE;ORAL PANTOPRAZOLE SODIUM @ MACLEODS PHARMS LTD EQ 20MG BASE A 200821 001 Feb 16, 2012 May DISC @ EQ 40MG BASE A 200821 002 Feb 16, 2012 May DISC @ TEVA EQ 20MG BASE A 077056 001 Aug 02, 2007 May DISC @ EQ 40MG BASE A 077056 002 Aug 02, 2007 May DISC

PAROXETINE HYDROCHLORIDE TABLET;ORAL PAROXETINE HYDROCHLORIDE @ JUBILANT GENERICS EQ 10MG BASE A 205528 001 Nov 27, 2015 Jan DISC @ EQ 20MG BASE A 205528 002 Nov 27, 2015 Jan DISC @ EQ 30MG BASE A 205528 003 Nov 27, 2015 Jan DISC @ EQ 40MG BASE A 205528 004 Nov 27, 2015 Jan DISC

PASIREOTIDE DIASPARTATE SOLUTION;SUBCUTANEOUS SIGNIFOR + RECORDATI RARE EQ 0.3MG BASE/ML (EQ 0.3MG N 200677 001 Dec 14, 2012 Feb CAHN BASE/ML) + EQ 0.6MG BASE/ML (EQ 0.6MG N 200677 002 Dec 14, 2012 Feb CAHN BASE/ML) +! EQ 0.9MG BASE/ML (EQ 0.9MG N 200677 003 Dec 14, 2012 Feb CAHN BASE/ML)

PASIREOTIDE PAMOATE FOR SUSPENSION;INTRAMUSCULAR SIGNIFOR LAR KIT + RECORDATI RARE EQ 10MG BASE/VIAL N 203255 004 Jun 29, 2018 Feb CAHN + EQ 20MG BASE/VIAL N 203255 001 Dec 15, 2014 Feb CAHN + EQ 30MG BASE/VIAL N 203255 005 Jun 29, 2018 Feb CAHN + EQ 40MG BASE/VIAL N 203255 002 Dec 15, 2014 Feb CAHN +! EQ 60MG BASE/VIAL N 203255 003 Dec 15, 2014 Feb CAHN

PAZOPANIB HYDROCHLORIDE TABLET;ORAL VOTRIENT + @ NOVARTIS EQ 400MG BASE N 022465 002 Oct 19, 2009 Jan CRLD

PEGAPTANIB SODIUM INJECTABLE;INTRAVITREAL MACUGEN + @ VALEANT PHARMS LLC EQ 0.3MG ACID/0.09ML N 021756 001 Dec 17, 2004 Aug DISC

PEMETREXED SOLUTION;INTRAVENOUS PEMETREXED +! ACTAVIS LLC 100MG/4ML (25MG/ML) N 208419 001 Aug 21, 2020 Aug NEWA +! 500MG/20ML (25MG/ML) N 208419 002 Aug 21, 2020 Aug NEWA +! 1GM/40ML (25MG/ML) N 208419 003 Aug 21, 2020 Aug NEWA PEMFEXY +! EAGLE PHARMS 500MG/20ML (25MG/ML) N 209472 001 Feb 08, 2020 Feb NEWA

PEMIGATINIB TABLET;ORAL PEMAZYRE + INCYTE CORP 4.5MG N 213736 001 Apr 17, 2020 Apr NEWA + 9MG N 213736 002 Apr 17, 2020 Apr NEWA +! 13.5MG N 213736 003 Apr 17, 2020 Apr NEWA

RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -91

PENICILLAMINE CAPSULE;ORAL PENICILLAMINE AB ANI PHARMS INC 250MG A 209921 001 May 07, 2019 Jan CAHN AB APOTEX 250MG A 213310 001 Apr 28, 2020 Apr NEWA AB DR REDDYS 250MG A 211867 001 Aug 04, 2020 Jul NEWA TABLET;ORAL PENICILLAMINE @ TEVA PHARMS USA 250MG A 211497 001 Feb 13, 2020 Aug DISC AB 250MG A 211497 001 Feb 13, 2020 Feb NEWA

PENTETATE CALCIUM TRISODIUM SOLUTION;INHALATION, INTRAVENOUS PENTETATE CALCIUM TRISODIUM >A> + @ HAMELN EQ 1GM BASE/5ML (EQ 200MG BASE/ML) N 021749 001 Aug 11, 2004 Sep DISC >A> + @ EQ 1GM BASE/5ML (EQ 200MG BASE/ML) N 021749 001 Aug 11, 2004 Sep DISC >D> +! HAMELN PHARMA PLUS EQ 1GM BASE/5ML (EQ 200MG BASE/ML) N 021749 001 Aug 11, 2004 Sep DISC

>D> PENTETATE ZINC TRISODIUM >D> SOLUTION;INHALATION, INTRAVENOUS >D> PENTETATE ZINC TRISODIUM >D> +! HAMELN PHARMA PLUS EQ 1GM BASE/5ML (EQ 200MG BASE/ML) N 021751 001 Aug 11, 2004 Sep DISC >A> + @ EQ 1GM BASE/5ML (EQ 200MG BASE/ML) N 021751 001 Aug 11, 2004 Sep DISC

PERMETHRIN CREAM;TOPICAL ELIMITE + @ MYLAN 5% N 019855 001 Aug 25, 1989 Feb DISC PERMETHRIN AB ! PERRIGO ISRAEL 5% A 076369 001 Apr 21, 2003 Feb CHRS

PERPHENAZINE TABLET;ORAL PERPHENAZINE AB ZYDUS PHARMS 2MG A 205232 001 Apr 06, 2020 Mar NEWA AB 4MG A 205232 002 Apr 06, 2020 Mar NEWA AB 8MG A 205232 003 Apr 06, 2020 Mar NEWA AB 16MG A 205232 004 Apr 06, 2020 Mar NEWA

PHENDIMETRAZINE TARTRATE TABLET;ORAL PHENDIMETRAZINE TARTRATE AA NOSTRUM LABS INC 35MG A 203600 001 Dec 27, 2017 Mar CAHN AA 35MG A 203600 001 Dec 27, 2017 Mar CAHN

PHENOXYBENZAMINE HYDROCHLORIDE CAPSULE;ORAL DIBENZYLINE AB + CONCORDIA 10MG N 008708 001 Jun CMFD

PHENTERMINE HYDROCHLORIDE CAPSULE;ORAL PHENTERMINE HYDROCHLORIDE @ BARR 15MG A 090591 001 Mar 18, 2010 Mar DISC @ 30MG A 090591 002 Mar 18, 2010 Mar DISC TABLET;ORAL PHENTERMINE HYDROCHLORIDE @ BARR 37.5MG A 090470 001 Aug 31, 2009 Mar DISC

PHENYLEPHRINE HYDROCHLORIDE SOLUTION;INTRAVENOUS PHENYLEPHRINE HYDROCHLORIDE AP1 ACCORD HLTHCARE 10MG/ML (10MG/ML) A 213237 001 Jul 01, 2020 Jun NEWA AP1 50MG/5ML (10MG/ML) A 213237 002 Jul 01, 2020 Jun NEWA AP1 100MG/10ML (10MG/ML) A 213237 003 Jul 01, 2020 Jun NEWA AP1 APOLLO 10MG/ML (10MG/ML) A 211081 001 Jul 17, 2020 Jul NEWA AP1 50MG/5ML (10MG/ML) A 211081 002 Jul 17, 2020 Jul NEWA AP1 100MG/10ML (10MG/ML) A 211081 003 Jul 17, 2020 Jul NEWA AP1 CAPLIN 10MG/ML (10MG/ML) A 213318 001 Jun 11, 2020 Jun NEWA AP1 50MG/5ML (10MG/ML) A 213318 002 Jun 11, 2020 Jun NEWA AP1 100MG/10ML (10MG/ML) A 213318 003 Jun 11, 2020 Jun NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -92

SOLUTION;INTRAVENOUS PHENYLEPHRINE HYDROCHLORIDE AP1 GLAND PHARMA LTD 50MG/5ML (10MG/ML) A 211920 001 Jun 05, 2020 Jun NEWA AP1 100MG/10ML (10MG/ML) A 211920 002 Jun 05, 2020 Jun NEWA AP1 RICONPHARMA LLC 10MG/ML (10MG/ML) A 209967 001 Jan 16, 2020 Jan NEWA AP1 50MG/5ML (10MG/ML) A 209967 002 Jan 16, 2020 Jan NEWA AP1 100MG/10ML (10MG/ML) A 209967 003 Jan 16, 2020 Jan NEWA AP1 SAGENT PHARMS INC 10MG/ML (10MG/ML) A 209967 001 Jan 16, 2020 Jun CAHN AP1 50MG/5ML (10MG/ML) A 209967 002 Jan 16, 2020 Jun CAHN AP1 100MG/10ML (10MG/ML) A 209967 003 Jan 16, 2020 Jun CAHN VAZCULEP AP1 +! EXELA PHARMA 10MG/ML (10MG/ML) N 204300 001 Jun 27, 2014 Jul CAHN AP1 +! 50MG/5ML (10MG/ML) N 204300 002 Jun 27, 2014 Jul CAHN AP1 +! 100MG/10ML (10MG/ML) N 204300 003 Jun 27, 2014 Jul CAHN

PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE SYRUP;ORAL PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE AA ! PHARM ASSOC 5MG/5ML;6.25MG/5ML A 040654 001 Dec 07, 2006 Jun CAHN

PHENYTOIN SUSPENSION;ORAL DILANTIN-125 AB +! UPJOHN 125MG/5ML N 008762 001 Jul CAHN DILANTIN-30 @ UPJOHN 30MG/5ML N 008762 002 Jul CAHN TABLET, CHEWABLE;ORAL DILANTIN AB ! PHARMACIA 50MG A 084427 001 Aug CAHN AB ! UPJOHN 50MG A 084427 001 Jul CAHN

PHENYTOIN SODIUM CAPSULE;ORAL DILANTIN ! UPJOHN 30MG EXTENDED A 084349 001 Jul CAHN AB ! 100MG EXTENDED A 084349 002 Jul CAHN EXTENDED PHENYTOIN SODIUM @ LUPIN LTD 100MG EXTENDED A 211633 001 Sep 30, 2019 Apr DISC

PILOCARPINE HYDROCHLORIDE SOLUTION;OPHTHALMIC PILOCARPINE HYDROCHLORIDE >A> AT AMNEAL 1% A 214193 001 Sep 21, 2020 Sep NEWA >A> AT 2% A 214193 002 Sep 21, 2020 Sep NEWA >A> AT 4% A 214193 003 Sep 21, 2020 Sep NEWA TABLET;ORAL PILOCARPINE HYDROCHLORIDE AB AUROBINDO PHARMA LTD 5MG A 212377 001 Aug 13, 2019 Mar CMFD @ 5MG A 212377 001 Aug 13, 2019 Feb DISC AB 7.5MG A 212377 002 Aug 13, 2019 Mar CMFD @ 7.5MG A 212377 002 Aug 13, 2019 Feb DISC >D> AB INNOGENIX 5MG A 076963 001 Dec 22, 2004 Sep CAHN >D> AB 7.5MG A 076963 002 Feb 27, 2007 Sep CAHN >A> AB MLV 5MG A 076963 001 Dec 22, 2004 Sep CAHN >A> AB 7.5MG A 076963 002 Feb 27, 2007 Sep CAHN

PIOGLITAZONE HYDROCHLORIDE TABLET;ORAL PIOGLITAZONE HYDROCHLORIDE @ MYLAN PHARMS INC EQ 15MG BASE A 076801 001 Aug 17, 2012 Jan DISC @ EQ 30MG BASE A 076801 002 Aug 17, 2012 Jan DISC @ EQ 45MG BASE A 076801 003 Aug 17, 2012 Jan DISC AB NOSTRUM LABS INC EQ 15MG BASE A 078472 001 Feb 13, 2013 Jul CAHN AB EQ 30MG BASE A 078472 002 Feb 13, 2013 Jul CAHN AB EQ 45MG BASE A 078472 003 Feb 13, 2013 Jul CAHN

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM INJECTABLE;INJECTION PIPERACILLIN AND TAZOBACTAM AP ASTRAL EQ 2GM BASE/VIAL;EQ 250MG A 212287 001 Jul 29, 2019 Apr CMFD BASE/VIAL AP EQ 3GM BASE/VIAL;EQ 375MG A 212287 002 Jul 29, 2019 Apr CMFD

RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -93

INJECTABLE;INJECTION PIPERACILLIN AND TAZOBACTAM BASE/VIAL AP EQ 4GM BASE/VIAL;EQ 500MG A 212287 003 Jul 29, 2019 Apr CMFD BASE/VIAL

PIROXICAM CAPSULE;ORAL PIROXICAM AB STRIDES PHARMA 10MG A 206136 001 Jun 20, 2017 Mar CAHN AB 20MG A 206136 002 Jun 20, 2017 Mar CAHN

PODOFILOX SOLUTION;TOPICAL CONDYLOX AT +! TEVA BRANDED PHARM 0.5% N 019795 001 Dec 13, 1990 Jan CAHN

POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE FOR SOLUTION;ORAL PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE AA NOSTRUM LABS INC 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11 A 202060 001 Mar 08, 2017 Jul CAHN .2GM/BOT

POLYMYXIN B SULFATE INJECTABLE;INJECTION AEROSPORIN @ GLAXOSMITHKLINE EQ 500,000 UNITS BASE/VIAL A 062036 001 Jan CMS1 POLYMYXIN B SULFATE @ MYLAN ASI EQ 500,000 UNITS BASE/VIAL A 090110 001 Jun 29, 2011 Aug DISC AP XGEN PHARMS EQ 500,000 UNITS BASE/VIAL A 063000 001 Sep 30, 1994 Feb CAHN

POSACONAZOLE SUSPENSION;ORAL NOXAFIL AB +! SCHERING 40MG/ML N 022003 001 Sep 15, 2006 May CFTG POSACONAZOLE AB HIKMA 40MG/ML A 208773 001 May 15, 2020 May NFTG

POTASSIUM CHLORIDE CAPSULE, EXTENDED RELEASE;ORAL MICRO-K + @ NESHER PHARMS 8MEQ N 018238 001 May DISC MICRO-K 10 + @ NESHER PHARMS 10MEQ N 018238 002 May 14, 1984 May DISC POTASSIUM CHLORIDE AB STRIDES PHARMA 8MEQ A 205549 001 Dec 08, 2015 Mar CAHN AB 10MEQ A 205549 002 Dec 08, 2015 Mar CAHN INJECTABLE;INJECTION POTASSIUM CHLORIDE 10MEQ AP FRESENIUS KABI USA 14.9MG/ML A 211087 001 Sep 09, 2020 Aug NEWA AP 746MG/100ML A 211087 002 Sep 09, 2020 Aug NEWA POTASSIUM CHLORIDE 20MEQ AP FRESENIUS KABI USA 29.8MG/ML A 211087 003 Sep 09, 2020 Aug NEWA POTASSIUM CHLORIDE 40MEQ AP FRESENIUS KABI USA 2.98GM/100ML A 211087 004 Sep 09, 2020 Aug NEWA TABLET, EXTENDED RELEASE;ORAL POTASSIUM CHLORIDE AB1 AMNEAL 10MEQ A 212861 001 May 08, 2020 Apr NEWA @ 15MEQ A 212861 002 May 08, 2020 Aug DISC AB1 15MEQ A 212861 002 May 08, 2020 Apr NEWA AB1 20MEQ A 212861 003 May 08, 2020 Apr NEWA >D> AB1 CENTAUR PHARMS PVT 10MEQ A 213588 001 Aug 21, 2020 Sep CAHN AB1 10MEQ A 213588 001 Aug 21, 2020 Aug NEWA >D> AB1 20MEQ A 213588 002 Aug 21, 2020 Sep CAHN AB1 20MEQ A 213588 002 Aug 21, 2020 Aug NEWA AB2 GRANULES PHARMS 8MEQ A 211797 001 Mar 04, 2020 Feb NEWA AB2 10MEQ A 211797 002 Mar 04, 2020 Feb NEWA @ STRIDES PHARMA 8MEQ A 206881 001 Jan 22, 2019 Feb CAHN @ 10MEQ A 206630 001 Mar 29, 2019 Aug CAHN @ 10MEQ A 206881 002 Jan 22, 2019 Feb CAHN @ 10MEQ A 210097 001 Jun 17, 2019 Feb CAHN @ 15MEQ A 206630 002 Mar 29, 2019 Aug CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -94

TABLET, EXTENDED RELEASE;ORAL POTASSIUM CHLORIDE @ 20MEQ A 206630 003 Mar 29, 2019 Aug CAHN @ 20MEQ A 210098 001 Apr 26, 2019 Feb CAHN >A> AB1 UNICHEM 10MEQ A 213588 001 Aug 21, 2020 Sep CAHN >A> AB1 20MEQ A 213588 002 Aug 21, 2020 Sep CAHN >A> AB1 ZYDUS PHARMS 10MEQ A 210395 001 Sep 17, 2020 Sep NEWA >A> AB1 20MEQ A 210395 002 Sep 17, 2020 Sep NEWA

POTASSIUM CHLORIDE; SODIUM CHLORIDE INJECTABLE;INJECTION POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45% >A> AP FRESENIUS KABI USA 150MG/100ML;450MG/100ML A 212347 001 Sep 17, 2020 Sep NEWA POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% >A> AP FRESENIUS KABI USA 300MG/100ML;900MG/100ML A 212347 002 Sep 17, 2020 Sep NEWA

POTASSIUM CITRATE TABLET, EXTENDED RELEASE;ORAL POTASSIUM CITRATE AB BIONPHARMA INC 10MEQ A 212799 001 Jun 29, 2020 Jun NEWA AB 15MEQ A 212799 002 Jun 29, 2020 Jun NEWA AB RISING 5MEQ A 077440 001 Jun 09, 2006 Apr CAHN AB 10MEQ A 077440 002 Jun 09, 2006 Apr CAHN

PRALIDOXIME CHLORIDE INJECTABLE;INJECTION PRALIDOXIME CHLORIDE (AUTOINJECTOR) +! MERIDIAN MEDCL TECHN 300MG/ML N 018986 001 Apr 26, 1983 Jun CTNA SOLUTION;INTRAMUSCULAR PRALIDOXIME CHLORIDE (AUTOINJECTOR) +! MERIDIAN MEDCL TECHN 300MG/ML N 018986 001 Apr 26, 1983 Jun CDFR >D> +! 600MG/2ML (300MG/ML) N 018986 001 Apr 26, 1983 Sep DISC >A> + @ 600MG/2ML (300MG/ML) N 018986 001 Apr 26, 1983 Sep DISC +! 600MG/2ML (300MG/ML) N 018986 001 Apr 26, 1983 Jun CPOT

>A> PRALSETINIB >A> CAPSULE;ORAL >A> GAVRETO >A> +! BLUEPRINT MEDICINES 100MG N 213721 001 Sep 04, 2020 Sep NEWA

PRAMIPEXOLE DIHYDROCHLORIDE TABLET;ORAL PRAMIPEXOLE DIHYDROCHLORIDE AB GRAVITI PHARMS 0.25MG A 211088 001 Oct 03, 2018 May CAHN AB 0.5MG A 211088 002 Oct 03, 2018 May CAHN AB 0.75MG A 211088 003 Oct 03, 2018 May CAHN AB 1MG A 211088 004 Oct 03, 2018 May CAHN AB 1.5MG A 211088 005 Oct 03, 2018 May CAHN @ HERITAGE PHARMA 0.125MG A 077724 001 Feb 19, 2008 Apr DISC @ 0.25MG A 077724 002 Feb 19, 2008 Apr DISC @ 0.5MG A 077724 003 Feb 19, 2008 Apr DISC @ 1MG A 077724 004 Feb 19, 2008 Apr DISC @ 1.5MG A 077724 005 Feb 19, 2008 Apr DISC @ MACLEODS PHARMS LTD 0.125MG A 202164 001 Sep 20, 2012 Jun DISC @ 0.25MG A 202164 002 Sep 20, 2012 Jun DISC @ 0.5MG A 202164 003 Sep 20, 2012 Jun DISC @ 1MG A 202164 004 Sep 20, 2012 Jun DISC @ 1.5MG A 202164 005 Sep 20, 2012 Jun DISC @ MYLAN 0.125MG A 077854 001 Oct 08, 2010 Jan DISC @ 0.25MG A 077854 002 Oct 08, 2010 Jan DISC @ 0.5MG A 077854 003 Oct 08, 2010 Jan DISC @ 0.75MG A 090764 001 Apr 09, 2010 Jan DISC @ 1MG A 077854 004 Oct 08, 2010 Jan DISC @ 1.5MG A 077854 005 Oct 08, 2010 Jan DISC AB RISING 0.25MG A 211088 001 Oct 03, 2018 Aug CAHN AB 0.5MG A 211088 002 Oct 03, 2018 Aug CAHN AB 0.75MG A 211088 003 Oct 03, 2018 Aug CAHN AB 1MG A 211088 004 Oct 03, 2018 Aug CAHN AB 1.5MG A 211088 005 Oct 03, 2018 Aug CAHN AB ZENNOVA 0.125MG A 090151 001 Apr 30, 2012 Feb CAHN AB 0.25MG A 090151 002 Apr 30, 2012 Feb CAHN AB 0.5MG A 090151 003 Apr 30, 2012 Feb CAHN AB 0.75MG A 090151 006 Apr 30, 2012 Feb CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -95

TABLET;ORAL PRAMIPEXOLE DIHYDROCHLORIDE AB 1MG A 090151 004 Apr 30, 2012 Feb CAHN AB 1.5MG A 090151 005 Apr 30, 2012 Feb CAHN

PRASTERONE INSERT;VAGINAL INTRAROSA +! MILLICENT 6.5MG N 208470 001 Nov 16, 2016 Jun CAHN

PRASUGREL HYDROCHLORIDE TABLET;ORAL PRASUGREL >A> AB ANDA REPOSITORY EQ 5MG BASE A 205790 001 Oct 16, 2017 Sep CAHN >A> AB EQ 10MG BASE A 205790 002 Oct 16, 2017 Sep CAHN AB DR REDDYS LABS LTD EQ 5MG BASE A 205926 001 Jul 07, 2020 Jul NEWA AB EQ 10MG BASE A 205926 002 Jul 07, 2020 Jul NEWA >D> AB USPHARMA WINDLAS EQ 5MG BASE A 205790 001 Oct 16, 2017 Sep CAHN >D> AB EQ 10MG BASE A 205790 002 Oct 16, 2017 Sep CAHN

PRAVASTATIN SODIUM TABLET;ORAL PRAVASTATIN SODIUM >D> AB APPCO 10MG A 209869 001 Apr 13, 2018 Sep CAHN AB 10MG A 209869 001 Apr 13, 2018 Jul CAHN >D> AB 20MG A 209869 002 Apr 13, 2018 Sep CAHN AB 20MG A 209869 002 Apr 13, 2018 Jul CAHN >D> AB 40MG A 209869 003 Apr 13, 2018 Sep CAHN AB 40MG A 209869 003 Apr 13, 2018 Jul CAHN >D> AB 80MG A 209869 004 Apr 13, 2018 Sep CAHN AB 80MG A 209869 004 Apr 13, 2018 Jul CAHN >A> AB BIOCON PHARMA 10MG A 209869 001 Apr 13, 2018 Sep CAHN >A> AB 20MG A 209869 002 Apr 13, 2018 Sep CAHN >A> AB 40MG A 209869 003 Apr 13, 2018 Sep CAHN >A> AB 80MG A 209869 004 Apr 13, 2018 Sep CAHN >D> AB ZYDUS PHARMS USA 10MG A 077751 001 Apr 30, 2008 Sep DISC >A> @ 10MG A 077751 001 Apr 30, 2008 Sep DISC

PREDNICARBATE CREAM;TOPICAL DERMATOP E EMOLLIENT + @ VALEANT BERMUDA 0.1% N 020279 001 Oct 29, 1993 Apr DISC PREDNICARBATE @ FOUGERA PHARMS 0.1% A 077287 001 Sep 19, 2006 Apr DISC OINTMENT;TOPICAL DERMATOP + @ VALEANT PHARMS NORTH 0.1% N 019568 001 Sep 23, 1991 Feb DISC PREDNICARBATE ! FOUGERA PHARMS 0.1% A 077236 001 Mar 09, 2007 Feb CTEC AB ! 0.1% A 077236 001 Mar 09, 2007 Feb CHRS

PREDNISOLONE ACETATE SUSPENSION/DROPS;OPHTHALMIC OMNIPRED AB +! NOVARTIS 1% N 017469 001 Jan CHRS AB + 1% N 017469 001 Jan CRLD

PREDNISOLONE SODIUM PHOSPHATE SOLUTION;ORAL PREDNISOLONE SODIUM PHOSPHATE PHARM ASSOC EQ 30MG BASE/5ML A 204962 001 Mar 11, 2020 Feb NEWA @ VINTAGE EQ 15MG BASE/5ML A 079010 001 May 26, 2009 Jun DISC

PREDNISONE TABLET;ORAL PREDNISONE @ AMNEAL 1MG A 213385 001 Jun 16, 2020 Aug DISC AB 1MG A 213385 001 Jun 16, 2020 Jun NEWA @ 5MG A 213385 002 Jun 16, 2020 Aug DISC AB 5MG A 213385 002 Jun 16, 2020 Jun NEWA @ 10MG A 213386 001 Jun 24, 2020 Aug DISC AB 10MG A 213386 001 Jun 24, 2020 Jun NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -96

TABLET;ORAL PREDNISONE @ 20MG A 213386 002 Jun 24, 2020 Aug DISC AB 20MG A 213386 002 Jun 24, 2020 Jun NEWA >D> AB HIKMA PHARMS 50MG A 088465 001 Jun 01, 1984 Sep DISC >A> @ 50MG A 088465 001 Jun 01, 1984 Sep DISC AB STRIDES PHARMA 1MG A 210785 001 Sep 02, 2020 Aug NEWA TABLET, DELAYED RELEASE;ORAL PREDNISONE @ ACTAVIS LABS FL INC 1MG A 204867 001 Apr 25, 2017 Apr DISC @ 2MG A 204867 002 Apr 25, 2017 Apr DISC @ 5MG A 204867 003 Apr 25, 2017 Apr DISC RAYOS + HORIZON PHARMA USA 1MG N 202020 001 Jul 26, 2012 Apr CTEC + 2MG N 202020 002 Jul 26, 2012 Apr CTEC +! 5MG N 202020 003 Jul 26, 2012 Apr CTEC

PREGABALIN CAPSULE;ORAL LYRICA AB + PFIZER 25MG N 021446 001 Dec 30, 2004 Jun CAHN AB + 50MG N 021446 002 Dec 30, 2004 Jun CAHN AB + 75MG N 021446 003 Dec 30, 2004 Jun CAHN AB + 100MG N 021446 004 Dec 30, 2004 Jun CAHN AB + 150MG N 021446 005 Dec 30, 2004 Jun CAHN AB + 200MG N 021446 006 Dec 30, 2004 Jun CAHN AB + 225MG N 021446 007 Dec 30, 2004 Jun CAHN AB +! 300MG N 021446 008 Dec 30, 2004 Jun CAHN PREGABALIN AB ACTAVIS ELIZABETH 25MG A 091025 001 Jul 09, 2020 Jul NEWA AB 50MG A 091025 002 Jul 09, 2020 Jul NEWA AB 75MG A 091025 003 Jul 09, 2020 Jul NEWA AB 100MG A 091025 004 Jul 09, 2020 Jul NEWA AB 150MG A 091025 005 Jul 09, 2020 Jul NEWA AB 200MG A 091025 006 Jul 09, 2020 Jul NEWA AB 225MG A 091025 007 Jul 09, 2020 Jul NEWA AB 300MG A 091025 008 Jul 09, 2020 Jul NEWA AB CELLTRION 50MG A 212865 001 Mar 20, 2020 Mar NEWA AB 75MG A 212865 002 Mar 20, 2020 Mar NEWA AB 100MG A 212865 003 Mar 20, 2020 Mar NEWA AB 150MG A 212865 004 Mar 20, 2020 Mar NEWA AB HIKAL 25MG A 213423 001 Mar 23, 2020 Mar NEWA AB 50MG A 213423 002 Mar 23, 2020 Mar NEWA AB 75MG A 213423 003 Mar 23, 2020 Mar NEWA AB 100MG A 213423 004 Mar 23, 2020 Mar NEWA AB 150MG A 213423 005 Mar 23, 2020 Mar NEWA AB 200MG A 213423 006 Mar 23, 2020 Mar NEWA AB 225MG A 213423 007 Mar 23, 2020 Mar NEWA AB 300MG A 213423 008 Mar 23, 2020 Mar NEWA MY LAN@ MYLAN@ 25MG A 091228 001 Sep 20, 2019 Feb DISC @ 50MG A 091228 002 Sep 20, 2019 Feb DISC @ 75MG A 091228 003 Sep 20, 2019 Feb DISC @ 100MG A 091228 004 Sep 20, 2019 Feb DISC @ 150MG A 091228 005 Sep 20, 2019 Feb DISC @ 200MG A 091228 006 Sep 20, 2019 Feb DISC @ 225MG A 091228 007 Sep 20, 2019 Feb DISC @ 300MG A 091228 008 Sep 20, 2019 Feb DISC SOLUTION;ORAL LYRICA AA +! PFIZER 20MG/ML N 022488 001 Jan 04, 2010 Jun CAHN TABLET, EXTENDED RELEASE;ORAL LYRICA CR + PFIZER 82.5MG N 209501 001 Oct 11, 2017 Jun CAHN + 165MG N 209501 002 Oct 11, 2017 Jun CAHN +! 330MG N 209501 003 Oct 11, 2017 Jun CAHN

PRIMIDONE SUSPENSION;ORAL MYSOLINE + @ NURO PHARMA 250MG/5ML N 010401 001 Aug CRLD RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -97

TABLET;ORAL PRIMIDONE >D> AB HIKMA INTL PHARMS 250MG A 040667 002 Jul 27, 2006 Sep DISC >A> @ 250MG A 040667 002 Jul 27, 2006 Sep DISC

PROCHLORPERAZINE MALEATE TABLET;ORAL COMPAZINE + @ GLAXOSMITHKLINE EQ 5MG BASE N 010571 001 Mar CRLD + @ EQ 10MG BASE N 010571 002 Mar CRLD + @ EQ 25MG BASE N 010571 003 Mar CRLD PROCHLORPERAZINE MALEATE @ SANDOZ EQ 5MG BASE A 040101 001 Jul 19, 1996 Mar DISC @ EQ 10MG BASE A 040101 002 Jul 19, 1996 Mar DISC PROCOMP AB ! JUBILANT CADISTA EQ 10MG BASE A 040268 002 Feb 27, 1998 Mar CHRS

PROGESTERONE >D> SYSTEM;VAGINAL >D> MILPROSA >D> +! FERRING PHARMS INC 1.78GM N 201110 001 Apr 29, 2020 Sep DISC >A> + @ 1.78GM N 201110 001 Apr 29, 2020 Sep DISC +! 1.78GM N 201110 001 Apr 29, 2020 Apr NEWA

PROMETHAZINE HYDROCHLORIDE INJECTABLE;INJECTION PROMETHAZINE HYDROCHLORIDE AP XGEN PHARMS 25MG/ML A 040737 001 Apr 24, 2008 Feb CAHN AP 50MG/ML A 040737 002 Apr 24, 2008 Feb CAHN SUPPOSITORY;RECTAL PROMETHAZINE HYDROCHLORIDE @ WATSON LABS INC 12.5MG A 040479 001 Jun 24, 2003 Mar DISC @ 25MG A 040479 002 Jun 24, 2003 Mar DISC SYRUP;ORAL PROMETHAZINE HYDROCHLORIDE @ PHARM ASSOC 6.25MG/5ML A 040643 001 Apr 26, 2006 Jun CAHN @ VINTAGE 6.25MG/5ML A 040643 001 Apr 26, 2006 Jun DISC

PROPAFENONE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL PROPAFENONE HYDROCHLORIDE AB TWI PHARMS 225MG A 212928 001 Jun 18, 2020 Jun NEWA AB 325MG A 212928 002 Jun 18, 2020 Jun NEWA AB 425MG A 212928 003 Jun 18, 2020 Jun NEWA AB UPSHER SMITH LABS 225MG A 212744 001 Jun 25, 2020 Jun NEWA AB 325MG A 212744 002 Jun 25, 2020 Jun NEWA AB 425MG A 212744 003 Jun 25, 2020 Jun NEWA

PROPOFOL INJECTABLE;INJECTION PROPOFOL >A> AB INNOPHARMA 10MG/ML A 205576 001 Sep 16, 2020 Sep NEWA AB WEST-WARD PHARMS INT 10MG/ML A 074848 001 Apr 19, 2005 Jul CMFD

PROPRANOLOL HYDROCHLORIDE TABLET;ORAL PROPRANOLOL HYDROCHLORIDE @ IMPAX LABS INC 10MG A 071972 001 Apr 06, 1988 Jul DISC @ 20MG A 071972 002 Apr 06, 1988 Jul DISC @ 40MG A 071972 003 Apr 06, 1988 Jul DISC >D> AB ! 80MG A 071976 001 Apr 06, 1988 Sep DISC >A> @ 80MG A 071976 001 Apr 06, 1988 Sep DISC >D> AB WATSON LABS 80MG A 070178 001 May 13, 1986 Sep CHRS >A> AB ! 80MG A 070178 001 May 13, 1986 Sep CHRS

PYRAZINAMIDE TABLET;ORAL PYRAZINAMIDE AB ! AKORN 500MG A 081319 001 Jun 30, 1992 Jul CTEC ! 500MG A 081319 001 Jun 30, 1992 Feb CHRS 500MG A 081319 001 Jun 30, 1992 Feb CTEC @ DAVA PHARMS INC 500MG A 080157 001 Feb DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -98

TABLET;ORAL PYRAZINAMIDE AB MACLEODS PHARMS LTD 500MG A 212541 001 Jul 27, 2020 Jul NEWA @ NOVITIUM PHARMA 500MG A 080157 001 Jul CAHN

PYRIDOSTIGMINE BROMIDE SYRUP;ORAL PYRIDOSTIGMINE BROMIDE >A> AA ELYSIUM 60MG/5ML A 208797 001 Jan 09, 2020 Sep CAHN >D> AA INVATECH 60MG/5ML A 208797 001 Jan 09, 2020 Sep CAHN TABLET;ORAL PYRIDOSTIGMINE BROMIDE >D> ELYSIUM 30MG A 211181 002 May 14, 2019 Sep CAHN >D> AB 60MG A 211181 001 Jul 20, 2018 Sep CAHN >A> EYWA 30MG A 211181 002 May 14, 2019 Sep CAHN >A> AB 60MG A 211181 001 Jul 20, 2018 Sep CAHN

PYRIMETHAMINE TABLET;ORAL DARAPRIM AB +! VYERA PHARMS LLC 25MG N 008578 001 Feb CFTG PYRIMETHAMINE AB CEROVENE INC 25MG A 207127 001 Feb 28, 2020 Feb NFTG

QUETIAPINE FUMARATE TABLET;ORAL QUETIAPINE FUMARATE AB ZENNOVA EQ 25MG BASE A 090960 001 Mar 27, 2012 Feb CAHN AB EQ 50MG BASE A 090960 002 Mar 27, 2012 Feb CAHN AB EQ 100MG BASE A 090960 003 Mar 27, 2012 Feb CAHN AB EQ 200MG BASE A 090960 004 Mar 27, 2012 Feb CAHN AB EQ 300MG BASE A 090960 005 Mar 27, 2012 Feb CAHN AB EQ 400MG BASE A 090960 006 Mar 27, 2012 Feb CAHN

QUINAPRIL HYDROCHLORIDE TABLET;ORAL QUINAPRIL HYDROCHLORIDE MY LAN@ MYLAN@ EQ 5MG BASE A 076694 001 Dec 23, 2004 Mar DISC @ EQ 10MG BASE A 076694 002 Dec 23, 2004 Mar DISC @ EQ 20MG BASE A 076694 003 Dec 23, 2004 Mar DISC @ EQ 40MG BASE A 076694 004 Dec 23, 2004 Mar DISC

QUINIDINE SULFATE TABLET;ORAL QUINIDINE SULFATE ! SANDOZ 200MG A 088072 002 May CHRS 200MG A 088072 002 May CTEC ! 300MG A 088072 001 Sep 26, 1983 Apr CHRS 300MG A 088072 001 Sep 26, 1983 Apr CTEC @ WATSON LABS 200MG A 083288 001 Apr DISC @ 300MG A 085583 001 Apr DISC

RALOXIFENE HYDROCHLORIDE TABLET;ORAL RALOXIFENE HYDROCHLORIDE AB CADILA PHARMS LTD 60MG A 211324 001 Aug 18, 2020 Aug NEWA

RAMELTEON TABLET;ORAL RAMELTEON AB GRANULES PHARMS 8MG A 213186 001 Aug 21, 2020 Aug NEWA AB I3 PHARMS 8MG A 212650 001 Apr 10, 2020 Mar NEWA

RAMIPRIL CAPSULE;ORAL RAMIPRIL @ TEVA PHARMS 1.25MG A 077470 001 Jun 18, 2008 Mar DISC @ 2.5MG A 077470 002 Jun 18, 2008 Mar DISC @ 5MG A 077470 003 Jun 18, 2008 Mar DISC @ 10MG A 077470 004 Jun 18, 2008 Mar DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -99

RANITIDINE HYDROCHLORIDE CAPSULE;ORAL RANITIDINE HYDROCHLORIDE @ AJANTA PHARMA LTD EQ 150MG BASE A 209859 001 Sep 27, 2018 Jun DISC @ EQ 300MG BASE A 209859 002 Sep 27, 2018 Jun DISC @ APPCO EQ 150MG BASE A 211893 001 Apr 05, 2019 May DISC @ EQ 300MG BASE A 211893 002 Apr 05, 2019 May DISC SYRUP;ORAL RANITIDINE HYDROCHLORIDE @ AMNEAL PHARMS EQ 15MG BASE/ML A 078312 001 Sep 02, 2008 Apr DISC @ HI TECH PHARMA EQ 15MG BASE/ML A 091078 001 Mar 22, 2011 May DISC AA NOSTRUM LABS INC EQ 15MG BASE/ML A 078684 001 Aug 27, 2009 Jul CAHN @ TARO EQ 15MG BASE/ML A 077476 001 Jun 13, 2011 May DISC TABLET;ORAL RANITIDINE HYDROCHLORIDE @ AMNEAL PHARMS NY EQ 150MG BASE A 077824 001 Oct 13, 2006 Jan DISC @ EQ 300MG BASE A 077824 002 Oct 13, 2006 Jan DISC @ HERITAGE PHARMA EQ 150MG BASE A 075165 001 Sep 30, 1998 Apr DISC @ EQ 300MG BASE A 075165 002 Sep 30, 1998 Apr DISC >D> AB NOSTRUM LABS INC EQ 150MG BASE A 203694 001 Nov 30, 2017 Sep DISC >A> @ EQ 150MG BASE A 203694 001 Nov 30, 2017 Sep DISC AB EQ 150MG BASE A 203694 001 Nov 30, 2017 Jul CAHN >D> AB EQ 300MG BASE A 203694 002 Nov 30, 2017 Sep DISC >A> @ EQ 300MG BASE A 203694 002 Nov 30, 2017 Sep DISC AB EQ 300MG BASE A 203694 002 Nov 30, 2017 Jul CAHN @ STRIDES PHARMA EQ 150MG BASE A 205512 001 Aug 22, 2016 Apr DISC @ EQ 150MG BASE A 210010 001 Aug 01, 2018 Jan DISC @ EQ 300MG BASE A 205512 002 Aug 22, 2016 Apr DISC AB ! EQ 300MG BASE A 205512 002 Aug 22, 2016 Jan CHRS @ EQ 300MG BASE A 210010 002 Aug 01, 2018 Jan DISC

RANOLAZINE TABLET, EXTENDED RELEASE;ORAL RANOLAZINE AB ANI PHARMS INC 500MG A 210482 001 Oct 29, 2019 Jan CAHN AB 1GM A 210482 002 Oct 29, 2019 Jan CAHN @ CIPLA 500MG A 211291 001 May 28, 2019 Jul DISC @ 1GM A 211291 002 May 28, 2019 Jul DISC AB MANKIND PHARMA 500MG A 212284 001 Feb 12, 2020 Jan NEWA AB 1GM A 212284 002 Feb 12, 2020 Jan NEWA AB MICRO LABS 500MG A 211745 001 Feb 27, 2020 Feb NEWA AB 1GM A 211745 002 Feb 27, 2020 Feb NEWA >D> AB SUNGEN PHARMA 500MG A 212781 001 Mar 23, 2020 Sep DISC >A> @ 500MG A 212781 001 Mar 23, 2020 Sep DISC AB 500MG A 212781 001 Mar 23, 2020 Mar NEWA >D> AB 1GM A 212781 002 Mar 23, 2020 Sep DISC >A> @ 1GM A 212781 002 Mar 23, 2020 Sep DISC AB 1GM A 212781 002 Mar 23, 2020 Mar NEWA AB SUNSHINE 500MG A 211865 001 Mar 23, 2020 Mar NEWA AB 1GM A 211865 002 Mar 23, 2020 Mar NEWA

RASAGILINE MESYLATE TABLET;ORAL RASAGILINE MESYLATE @ WATSON LABS INC EQ 0.5MG BASE A 201823 001 Jul 01, 2013 Mar DISC @ EQ 1MG BASE A 201823 002 Jul 01, 2013 Mar DISC

REMIMAZOLAM BESYLATE POWDER;INTRAVENOUS BYFAVO +! ACACIA EQ 20MG BASE/VIAL N 212295 001 Jul 02, 2020 Jul CAHN +! COSMO EQ 20MG BASE/VIAL N 212295 001 Jul 02, 2020 Jul NEWA

REPAGLINIDE TABLET;ORAL REPAGLINIDE @ ACTAVIS TOTOWA 0.5MG A 090008 001 Jan 22, 2014 Mar DISC @ 1MG A 090008 002 Jan 22, 2014 Mar DISC @ 2MG A 090008 003 Jan 22, 2014 Mar DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -100

RIBAVIRIN CAPSULE;ORAL RIBAVIRIN @ TEVA 200MG A 076277 001 Oct 04, 2004 Mar DISC TABLET;ORAL RIBAVIRIN @ BEXIMCO PHARMS USA 200MG A 202546 001 Aug 12, 2014 Feb DISC @ 400MG A 202546 002 Aug 12, 2014 Feb DISC @ 500MG A 202546 003 Aug 12, 2014 Feb DISC @ 600MG A 202546 004 Aug 12, 2014 Feb DISC @ ZYDUS PHARMS USA 400MG A 077094 002 Mar 16, 2007 Feb DISC @ 500MG A 077094 004 Apr 18, 2008 Feb DISC @ 600MG A 077094 003 Mar 16, 2007 Feb DISC

RIFAMPIN INJECTABLE;INJECTION RIFAMPIN @ EMCURE PHARMS LTD 600MG/VIAL A 204101 001 Aug 18, 2014 May DISC

RILUZOLE TABLET;ORAL RILUZOLE AB KENTON 50MG A 206045 001 Dec 09, 2019 Mar CAHN

RIMEGEPANT SULFATE TABLET, ORALLY DISINTEGRATING;ORAL NURTEC ODT +! BIOHAVEN PHARM EQ 75MG BASE N 212728 001 Feb 27, 2020 Feb NEWA

RIPRETINIB TABLET;ORAL QINLOCK +! DECIPHERA PHARMS 50MG N 213973 001 May 15, 2020 May NEWA

RISDIPLAM FOR SOLUTION;ORAL EVRYSDI +! GENENTECH INC 0.75MG/ML N 213535 001 Aug 07, 2020 Aug NEWA

RISPERIDONE TABLET;ORAL RISPERIDONE @ MYLAN 0.25MG A 076288 001 Sep 15, 2008 Jun DISC >D> AB 0.5MG A 076288 002 Sep 15, 2008 Sep DISC >A> @ 0.5MG A 076288 002 Sep 15, 2008 Sep DISC >D> AB 1MG A 076288 003 Sep 15, 2008 Sep DISC >A> @ 1MG A 076288 003 Sep 15, 2008 Sep DISC >D> AB 2MG A 076288 004 Sep 15, 2008 Sep DISC >A> @ 2MG A 076288 004 Sep 15, 2008 Sep DISC >D> AB 3MG A 076288 005 Sep 15, 2008 Sep DISC >A> @ 3MG A 076288 005 Sep 15, 2008 Sep DISC >D> AB 4MG A 076288 006 Sep 15, 2008 Sep DISC >A> @ 4MG A 076288 006 Sep 15, 2008 Sep DISC TABLET, ORALLY DISINTEGRATING;ORAL RISPERIDONE @ ACTAVIS LABS FL INC 0.5MG A 076996 001 Apr 19, 2011 Mar DISC @ 1MG A 076996 002 Apr 19, 2011 Mar DISC @ 2MG A 076996 003 Apr 19, 2011 Mar DISC @ 3MG A 076996 004 Apr 19, 2011 Mar DISC @ 4MG A 076996 005 Apr 19, 2011 Mar DISC @ HERITAGE PHARMA 0.5MG A 076908 001 Mar 12, 2012 Apr DISC @ 1MG A 076908 002 Mar 12, 2012 Apr DISC @ 2MG A 076908 003 Mar 12, 2012 Apr DISC

RITODRINE HYDROCHLORIDE INJECTABLE;INJECTION YUTOPAR @ ASTRAZENECA 15MG/ML N 018580 002 Sep 27, 1984 Jan CMS1 RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -101

RIVASTIGMINE TARTRATE CAPSULE;ORAL RIVASTIGMINE TARTRATE @ APOTEX INC EQ 1.5MG BASE A 091072 001 May 16, 2013 May DISC @ EQ 3MG BASE A 091072 002 May 16, 2013 May DISC @ EQ 4.5MG BASE A 091072 003 May 16, 2013 May DISC @ EQ 6MG BASE A 091072 004 May 16, 2013 May DISC

RIZATRIPTAN BENZOATE TABLET;ORAL RIZATRIPTAN BENZOATE >D> AB ECI PHARMS LLC EQ 5MG BASE A 202047 001 Dec 31, 2012 Sep CAHN >D> AB EQ 10MG BASE A 202047 002 Dec 31, 2012 Sep CAHN >A> AB PHARMA LIFE EQ 5MG BASE A 202047 001 Dec 31, 2012 Sep CAHN >A> AB EQ 10MG BASE A 202047 002 Dec 31, 2012 Sep CAHN TABLET, ORALLY DISINTEGRATING;ORAL RIZATRIPTAN BENZOATE @ MYLAN PHARMS INC EQ 5MG BASE A 078173 001 Dec 31, 2012 Feb DISC @ EQ 10MG BASE A 078173 002 Dec 31, 2012 Feb DISC

ROCURONIUM BROMIDE INJECTABLE;INJECTION ROCURONIUM BROMIDE >A> AP PIRAMAL CRITICAL 50MG/5ML (10MG/ML) A 210437 001 Aug 13, 2019 Sep CAHN >A> AP 100MG/10ML (10MG/ML) A 210437 002 Aug 13, 2019 Sep CAHN >D> AP SANOVEL ILAC 50MG/5ML (10MG/ML) A 210437 001 Aug 13, 2019 Sep CAHN >D> AP 100MG/10ML (10MG/ML) A 210437 002 Aug 13, 2019 Sep CAHN @ TEVA PHARMS 50MG/5ML (10MG/ML) A 078717 001 Nov 26, 2008 Mar DISC @ 100MG/10ML (10MG/ML) A 078717 002 Nov 26, 2008 Mar DISC

ROFLUMILAST TABLET;ORAL ROFLUMILAST @ MICRO LABS 500MCG A 208180 001 Mar 22, 2019 Jun DISC AB STRIDES PHARMA 500MCG A 208247 001 Mar 30, 2020 Mar NEWA

ROMIDEPSIN SOLUTION;INTRAVENOUS ROMIDEPSIN >D> + TEVA PHARMS USA INC 10MG/2ML (5MG/ML) N 208574 001 Mar 13, 2020 Sep DISC >A> + @ 10MG/2ML (5MG/ML) N 208574 001 Mar 13, 2020 Sep DISC + 10MG/2ML (5MG/ML) N 208574 001 Mar 13, 2020 Mar NEWA +! 27.5MG/5.5ML (5MG/ML) N 208574 002 Mar 13, 2020 Mar NEWA

ROPINIROLE HYDROCHLORIDE TABLET;ORAL ROPINIROLE HYDROCHLORIDE @ HIKMA EQ 0.25MG BASE A 077852 001 May 05, 2008 Feb DISC @ EQ 0.5MG BASE A 077852 002 May 05, 2008 Feb DISC @ EQ 1MG BASE A 077852 003 May 05, 2008 Feb DISC @ EQ 2MG BASE A 077852 004 May 05, 2008 Feb DISC @ EQ 3MG BASE A 077852 005 May 05, 2008 Feb DISC @ EQ 4MG BASE A 077852 006 May 05, 2008 Feb DISC @ EQ 5MG BASE A 077852 007 May 19, 2008 Feb DISC TABLET, EXTENDED RELEASE;ORAL REQUIP XL + @ GLAXOSMITHKLINE LLC EQ 8MG BASE N 022008 004 Jun 13, 2008 Mar DISC ROPINIROLE HYDROCHLORIDE @ WATSON LABS INC EQ 2MG BASE A 200431 001 Jun 06, 2012 Mar DISC @ EQ 4MG BASE A 200431 002 Jun 06, 2012 Mar DISC @ EQ 6MG BASE A 200431 003 Jun 06, 2012 Mar DISC @ EQ 8MG BASE A 200431 004 Jun 06, 2012 Mar DISC @ EQ 12MG BASE A 200431 005 Jun 06, 2012 Mar DISC

ROPIVACAINE HYDROCHLORIDE SOLUTION;INJECTION ROPIVACAINE HYDROCHLORIDE AP CAPLIN 40MG/20ML (2MG/ML) A 212808 001 Apr 09, 2020 Mar NEWA AP 100MG/20ML (5MG/ML) A 212808 002 Apr 09, 2020 Mar NEWA AP 150MG/30ML (5MG/ML) A 212808 003 Apr 09, 2020 Mar NEWA AP 200MG/20ML (10MG/ML) A 212808 004 Apr 09, 2020 Mar NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -102

SOLUTION;INJECTION ROPIVACAINE HYDROCHLORIDE AP HIKMA 40MG/20ML (2MG/ML) A 214074 001 Jul 20, 2020 Jul NEWA AP 150MG/30ML (5MG/ML) A 214074 002 Jul 20, 2020 Jul NEWA AP 150MG/20ML (7.5MG/ML) A 214074 003 Jul 20, 2020 Jul NEWA AP 200MG/20ML (10MG/ML) A 214074 004 Jul 20, 2020 Jul NEWA >D> AP MYLAN ASI 40MG/20ML (2MG/ML) A 090318 001 Sep 23, 2014 Sep DISC >A> @ 40MG/20ML (2MG/ML) A 090318 001 Sep 23, 2014 Sep DISC >D> AP 150MG/20ML (7.5MG/ML) A 090318 003 Sep 23, 2014 Sep DISC >A> @ 150MG/20ML (7.5MG/ML) A 090318 003 Sep 23, 2014 Sep DISC

ROSUVASTATIN CALCIUM CAPSULE;ORAL EZALLOR SPRINKLE + SUN PHARMA GLOBAL EQ 5MG BASE N 208647 001 Dec 18, 2018 Aug CTNA + EQ 10MG BASE N 208647 002 Dec 18, 2018 Aug CTNA + EQ 20MG BASE N 208647 003 Dec 18, 2018 Aug CTNA +! EQ 40MG BASE N 208647 004 Dec 18, 2018 Aug CTNA TABLET;ORAL ROSUVASTATIN CALCIUM @ APOTEX INC 5MG A 079145 001 Jul 19, 2016 Jun DISC @ 10MG A 079145 002 Jul 19, 2016 Jun DISC @ 20MG A 079145 003 Jul 19, 2016 Jun DISC @ 40MG A 079145 004 Jul 19, 2016 Jun DISC >A> AB LUPIN 5MG A 205587 001 Jul 31, 2017 Sep CAHN >A> AB 10MG A 205587 002 Jul 31, 2017 Sep CAHN >A> AB 20MG A 205587 003 Jul 31, 2017 Sep CAHN >A> AB 40MG A 205587 004 Jul 31, 2017 Sep CAHN >D> AB LUPIN LTD 5MG A 205587 001 Jul 31, 2017 Sep CAHN >D> AB 10MG A 205587 002 Jul 31, 2017 Sep CAHN >D> AB 20MG A 205587 003 Jul 31, 2017 Sep CAHN >D> AB 40MG A 205587 004 Jul 31, 2017 Sep CAHN AB RENATA 5MG A 207062 001 Oct 31, 2016 Jul CAHN AB 10MG A 207062 002 Oct 31, 2016 Jul CAHN AB 20MG A 207062 003 Oct 31, 2016 Jul CAHN AB 40MG A 207062 004 Oct 31, 2016 Jul CAHN AB SUNSHINE 5MG A 210667 001 Apr 01, 2020 Mar NEWA AB 10MG A 210667 002 Apr 01, 2020 Mar NEWA AB 20MG A 210667 003 Apr 01, 2020 Mar NEWA AB 40MG A 210667 004 Apr 01, 2020 Mar NEWA @ ZHEJIANG YONGTAI 5MG A 212059 001 Nov 04, 2019 Apr DISC @ 10MG A 212059 002 Nov 04, 2019 Apr DISC @ 20MG A 212059 003 Nov 04, 2019 Apr DISC @ 40MG A 212059 004 Nov 04, 2019 Apr DISC

SAFINAMIDE MESYLATE TABLET;ORAL XADAGO + MDD US 50MG N 207145 001 Mar 21, 2017 Jul CAHN +! 100MG N 207145 002 Mar 21, 2017 Jul CAHN

SAPROPTERIN DIHYDROCHLORIDE POWDER;ORAL KUVAN AB + BIOMARIN PHARM 500MG/PACKET N 205065 002 Oct 27, 2015 Aug CTEC SAPROPTERIN DIHYDROCHLORIDE AB PAR PHARM INC 500MG/PACKET A 210027 001 Aug 20, 2019 Aug CMFD TABLET;ORAL KUVAN AB +! BIOMARIN PHARM 100MG N 022181 001 Dec 13, 2007 Aug CTEC SAPROPTERIN DIHYDROCHLORIDE AB PAR PHARM INC 100MG A 207200 001 May 10, 2019 Aug CMFD

SELEGILINE HYDROCHLORIDE CAPSULE;ORAL SELEGILINE HYDROCHLORIDE @ DAVA PHARMS INC 5MG A 075352 001 Nov 30, 1998 Feb DISC TABLET;ORAL SELEGILINE HYDROCHLORIDE @ I3 PHARMS 5MG A 074672 001 Apr 01, 1997 Jul CAHN @ MLV 5MG A 074672 001 Apr 01, 1997 Mar CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -103

SELEXIPAG TABLET;ORAL UPTRAVI +! ACTELION PHARMS LTD 0.4MG N 207947 002 Dec 21, 2015 Jan CHRS + 1.6MG N 207947 008 Dec 21, 2015 Jan CHRS

SELPERCATINIB CAPSULE;ORAL RETEVMO + LOXO ONCOLOGY INC 40MG N 213246 001 May 08, 2020 May NEWA +! 80MG N 213246 002 May 08, 2020 May NEWA

SELUMETINIB SULFATE CAPSULE;ORAL KOSELUGO + ASTRAZENECA PHARMS EQ 10MG BASE N 213756 001 Apr 10, 2020 Apr NEWA +! EQ 25MG BASE N 213756 002 Apr 10, 2020 Apr NEWA

SEMAGLUTIDE SOLUTION;SUBCUTANEOUS OZEMPIC +! NOVO 4MG/3ML (1.34MG/ML) N 209637 002 Apr 09, 2019 Jan NEWA

SERTRALINE HYDROCHLORIDE CONCENTRATE;ORAL ZOLOFT AA +! UPJOHN EQ 20MG BASE/ML N 020990 001 Dec 07, 1999 Jun CAHN TABLET;ORAL SERTRALINE HYDROCHLORIDE @ SUN PHARM INDS LTD EQ 25MG BASE A 077977 001 Feb 06, 2007 Jul DISC @ EQ 50MG BASE A 077977 002 Feb 06, 2007 Jul DISC @ EQ 100MG BASE A 077977 003 Feb 06, 2007 Jul DISC @ EQ 150MG BASE A 077977 004 Feb 06, 2007 Jul DISC @ EQ 200MG BASE A 077977 005 Feb 06, 2007 Jul DISC AB VIWIT PHARM EQ 25MG BASE A 076882 001 Feb 06, 2007 Mar CAHN AB EQ 25MG BASE A 076882 001 Feb 06, 2007 Mar CAHN AB EQ 50MG BASE A 076882 002 Feb 06, 2007 Mar CAHN AB EQ 50MG BASE A 076882 002 Feb 06, 2007 Mar CAHN AB EQ 100MG BASE A 076882 003 Feb 06, 2007 Mar CAHN AB EQ 100MG BASE A 076882 003 Feb 06, 2007 Mar CAHN ZOLOFT AB + UPJOHN EQ 25MG BASE N 019839 005 Mar 06, 1996 Jun CAHN AB + EQ 50MG BASE N 019839 001 Dec 30, 1991 Jun CAHN AB +! EQ 100MG BASE N 019839 002 Dec 30, 1991 Jun CAHN + @ EQ 150MG BASE N 019839 003 Dec 30, 1991 Jun CAHN + @ EQ 200MG BASE N 019839 004 Dec 30, 1991 Jun CAHN

SEVELAMER CARBONATE TABLET;ORAL SEVELAMER CARBONATE >D> AB ANXIN 800MG A 212970 001 Apr 09, 2020 Sep DISC >A> @ 800MG A 212970 001 Apr 09, 2020 Sep DISC AB 800MG A 212970 001 Apr 09, 2020 Mar NEWA @ IMPAX LABS INC 800MG A 090975 001 Oct 23, 2017 Jul DISC >A> AB INDICUS PHARMA 800MG A 204451 001 Nov 29, 2018 Sep CAHN @ MYLAN 800MG A 201069 001 Aug 05, 2020 Aug DISC AB 800MG A 201069 001 Aug 05, 2020 Jul NEWA >D> AB WILSHIRE PHARMS INC 800MG A 204451 001 Nov 29, 2018 Sep CAHN AB ZYDUS PHARMS 800MG A 207759 001 Aug 11, 2020 Jul NEWA

SILDENAFIL CITRATE FOR SUSPENSION;ORAL REVATIO AB +! UPJOHN EQ 10MG BASE/ML N 203109 001 Aug 30, 2012 Jun CAHN SILDENAFIL CITRATE AB APTAPHARMA INC EQ 10MG BASE/ML A 213041 001 Aug 06, 2020 Jul NEWA AB TEVA PHARMS USA EQ 10MG BASE/ML A 211534 001 May 29, 2020 May NEWA SOLUTION;INTRAVENOUS REVATIO AP +! UPJOHN EQ 10MG BASE/12.5ML (EQ 0.8MG N 022473 001 Nov 18, 2009 Jun CAHN BASE/ML) RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -104

TABLET;ORAL REVATIO AB +! UPJOHN EQ 20MG BASE N 021845 001 Jun 03, 2005 Jun CAHN SILDENAFIL CITRATE AB APPCO EQ 25MG BASE A 207178 001 Mar 02, 2020 Apr CPOT AB 25MG A 207178 001 Mar 02, 2020 Feb NEWA AB EQ 50MG BASE A 207178 002 Mar 02, 2020 Apr CPOT AB 50MG A 207178 002 Mar 02, 2020 Feb NEWA AB EQ 100MG BASE A 207178 003 Mar 02, 2020 Apr CPOT AB 100MG A 207178 003 Mar 02, 2020 Feb NEWA >D> AB HEBEI CHANGSHAN EQ 20MG BASE A 202598 001 Nov 06, 2012 Sep CAHN @ PERRIGO R AND D EQ 25MG BASE A 205791 001 Apr 23, 2020 Jul DISC AB EQ 25MG BASE A 205791 001 Apr 23, 2020 Apr NEWA @ EQ 50MG BASE A 205791 002 Apr 23, 2020 Jul DISC AB EQ 50MG BASE A 205791 002 Apr 23, 2020 Apr NEWA AB REYOUNG EQ 25MG BASE A 208494 001 Jun 12, 2020 Jun NEWA AB EQ 50MG BASE A 208494 002 Jun 12, 2020 Jun NEWA AB EQ 100MG BASE A 208494 003 Jun 12, 2020 Jun NEWA AB SUNSHINE EQ 25MG BASE A 213032 001 Jun 11, 2020 Jun NEWA AB EQ 50MG BASE A 213032 002 Jun 11, 2020 Jun NEWA AB EQ 100MG BASE A 213032 003 Jun 11, 2020 Jun NEWA AB UMEDICA LABS PVT LTD EQ 50MG BASE A 209302 001 Aug 25, 2020 Aug NEWA AB EQ 100MG BASE A 209302 002 Aug 25, 2020 Aug NEWA >A> AB YILING EQ 20MG BASE A 202598 001 Nov 06, 2012 Sep CAHN VIAGRA AB + UPJOHN EQ 25MG BASE N 020895 001 Mar 27, 1998 Jun CAHN AB + EQ 50MG BASE N 020895 002 Mar 27, 1998 Jun CAHN AB +! EQ 100MG BASE N 020895 003 Mar 27, 1998 Jun CAHN

SILODOSIN CAPSULE;ORAL SILODOSIN AB HETERO LABS LTD V 4MG A 204793 001 Feb 14, 2020 Feb NEWA AB 8MG A 204793 002 Feb 14, 2020 Feb NEWA

SODIUM BENZOATE; SODIUM PHENYLACETATE SOLUTION;INTRAVENOUS AMMONUL AP +! BAUSCH 10%;10% (5GM/50ML;5GM/50ML) N 020645 001 Feb 17, 2005 Jun CAHN

SODIUM BICARBONATE INJECTABLE;INJECTION SODIUM BICARBONATE AP ! EXELA PHARMA 0.5MEQ/ML A 211091 001 Jun 20, 2019 Jul CHRS AP ! 0.9MEQ/ML A 211091 002 Jun 20, 2019 Jul CHRS AP ! 1MEQ/ML A 211091 003 Jun 20, 2019 Jul CHRS @ HOSPIRA 0.9MEQ/ML A 077394 001 Nov 09, 2005 Jul DISC @ 1MEQ/ML A 077394 002 Nov 09, 2005 Jul DISC AP HOSPIRA INC 0.5MEQ/ML A 202679 001 Mar 07, 2017 Jul CMFD

SODIUM CHLORIDE INJECTABLE;INJECTION SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER AP +! BAXTER HLTHCARE 450MG/100ML N 018016 001 Aug CHRS AP + 450MG/100ML N 018016 001 Aug CRLD SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER AP NEPHRON 9MG/ML A 211968 001 Apr 23, 2020 Apr NEWA SOLUTION;INTRAVENOUS SODIUM CHLORIDE 14.6% + HOSPIRA 2.5MEQ/ML N 018897 001 Jul 20, 1984 Jul CTNA + 2.5MEQ/ML N 018897 001 Jul 20, 1984 Jul CDFR + @ 50MEQ/20ML (2.5MEQ/ML) N 018897 001 Jul 20, 1984 Jul DISC + 50MEQ/20ML (2.5MEQ/ML) N 018897 001 Jul 20, 1984 Jul CPOT +! 100MEQ/40ML (2.5MEQ/ML) N 018897 002 Jul 20, 1984 Jul NEWA SODIUM CHLORIDE 23.4% +! HOSPIRA 400MEQ/100ML (4MEQ/ML) N 018897 003 Jun 18, 2020 Jul NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -105

SODIUM IODIDE I-123 CAPSULE;ORAL SODIUM IODIDE I 123 AA CURIUM 100uCi A 071909 001 Feb 28, 1989 Feb CAHN AA 200uCi A 071910 001 Feb 28, 1989 Feb CAHN

SODIUM IODIDE I-131 CAPSULE;ORAL SODIUM IODIDE I 131 >A> + JUBILANT 0.009-0.1mCi N 021305 006 May 19, 2005 Sep CAHN >A> @ 2-200mCi N 021305 004 Nov 18, 2004 Sep CAHN >D> + JUBILANT DRAXIMAGE 0.009-0.1mCi N 021305 006 May 19, 2005 Sep CAHN >D> @ 2-200mCi N 021305 004 Nov 18, 2004 Sep CAHN SOLUTION;ORAL HICON >A> @ JUBILANT 1-250mCi/0.25ML N 021305 002 Jan 24, 2003 Sep CAHN >A> @ 1-500mCi/0.5ML N 021305 003 Jan 24, 2003 Sep CAHN >A> @ 1-1000mCi/ML N 021305 005 Apr 04, 2006 Sep CAHN >A> AA +! 250-1000mCi N 021305 007 Dec 05, 2011 Sep CAHN >D> @ JUBILANT DRAXIMAGE 1-250mCi/0.25ML N 021305 002 Jan 24, 2003 Sep CAHN >D> @ 1-500mCi/0.5ML N 021305 003 Jan 24, 2003 Sep CAHN >D> @ 1-1000mCi/ML N 021305 005 Apr 04, 2006 Sep CAHN >D> AA +! 250-1000mCi N 021305 007 Dec 05, 2011 Sep CAHN AA +! 250-1000mCi N 021305 007 Dec 05, 2011 Jan CFTG SODIUM IODIDE I 131 AA INTL ISOTOPES 250-1000mCi A 209166 001 Feb 05, 2020 Jan NFTG

SODIUM LACTATE INJECTABLE;INJECTION SODIUM LACTATE IN PLASTIC CONTAINER + @ HOSPIRA 5MEQ/ML N 018947 001 Sep 05, 1984 Jun DISC

SODIUM NITROPRUSSIDE INJECTABLE;INJECTION SODIUM NITROPRUSSIDE @ AMPHASTAR PHARMS INC 25MG/ML A 209832 001 Dec 18, 2017 Jul DISC >D> AP CAPLIN 25MG/ML A 211016 001 Nov 29, 2019 Sep CAHN AP HAINAN POLY PHARM 25MG/ML A 214199 001 Aug 25, 2020 Aug NEWA >A> AP HONG KONG 25MG/ML A 211016 001 Nov 29, 2019 Sep CAHN

SODIUM OXYBATE SOLUTION;ORAL >D> SODIUM OXYBATE >D> AA HIKMA 0.5GM/ML A 202090 001 Jan 17, 2017 Sep DISC >A> @ 0.5GM/ML A 202090 001 Jan 17, 2017 Sep DISC AA 0.5GM/ML A 202090 001 Jan 17, 2017 Jul CPOT XYREM >D> AA +! JAZZ PHARMS 0.5GM/ML N 021196 001 Jul 17, 2002 Sep CTEC >A> +! 0.5GM/ML N 021196 001 Jul 17, 2002 Sep CTEC AA +! 0.5GM/ML N 021196 001 Jul 17, 2002 Jul CPOT

SODIUM PHENYLBUTYRATE TABLET;ORAL SODIUM PHENYLBUTYRATE @ ALVOGEN 500MG A 090910 001 Nov 18, 2011 Jan DISC

SODIUM POLYSTYRENE SULFONATE POWDER;ORAL, RECTAL SODIUM POLYSTYRENE SULFONATE >A> AA DISCOVERY THERAP 453.6GM/BOT A 090313 001 Dec 21, 2011 Sep CAHN >D> AA ECI PHARMS LLC 453.6GM/BOT A 090313 001 Dec 21, 2011 Sep CAHN SUSPENSION;ORAL, RECTAL SODIUM POLYSTYRENE SULFONATE @ HIKMA 15GM/60ML A 089049 001 Nov 17, 1986 Feb DISC

SOFOSBUVIR; VELPATASVIR TABLET;ORAL EPCLUSA + GILEAD SCIENCES INC 200MG;50MG N 208341 002 Mar 19, 2020 Mar NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -106

SOLIFENACIN SUCCINATE SUSPENSION;ORAL VESICARE LS +! ASTELLAS 1MG/ML N 209529 001 May 26, 2020 May NEWA TABLET;ORAL SOLIFENACIN SUCCINATE AB GRAVITI PHARMS 5MG A 211423 001 Dec 11, 2019 May CAHN AB 10MG A 211423 002 Dec 11, 2019 May CAHN AB RISING 5MG A 211423 001 Dec 11, 2019 Aug CAHN AB 10MG A 211423 002 Dec 11, 2019 Aug CAHN AB SUNSHINE 5MG A 213346 001 Apr 13, 2020 Mar NEWA AB 10MG A 213346 002 Apr 13, 2020 Mar NEWA

SOLRIAMFETOL HYDROCHLORIDE TABLET;ORAL SUNOSI + JAZZ EQ 75MG BASE N 211230 001 Jun 17, 2019 Jan CPOT + 75MG N 211230 001 Jun 17, 2019 Jan CAIN +! EQ 150MG BASE N 211230 002 Jun 17, 2019 Apr CHRS + EQ 150MG BASE N 211230 002 Jun 17, 2019 Jan CPOT + 150MG N 211230 002 Jun 17, 2019 Jan CAIN

SORAFENIB TOSYLATE TABLET;ORAL NEXAVAR >D> +! BAYER HLTHCARE EQ 200MG BASE N 021923 001 Dec 20, 2005 Sep CFTG >A> +! EQ 200MG BASE N 021923 001 Dec 20, 2005 Sep CTEC >A> AB +! EQ 200MG BASE N 021923 001 Dec 20, 2005 Sep CFTG SORAFENIB TOSYLATE >A> @ MYLAN EQ 200MG BASE A 207012 001 Sep 10, 2020 Sep DISC >A> AB EQ 200MG BASE A 207012 001 Sep 10, 2020 Sep NFTG

SPIRONOLACTONE TABLET;ORAL ALDACTONE AB + PFIZER 25MG N 012151 009 Dec 30, 1983 Jul CAHN AB + 50MG N 012151 008 Dec 30, 1982 Jul CAHN AB +! 100MG N 012151 010 Dec 30, 1983 Jul CAHN

STAVUDINE CAPSULE;ORAL STAVUDINE >D> AB AUROBINDO PHARMA 15MG A 077672 003 Dec 29, 2008 Sep CTEC >A> 15MG A 077672 003 Dec 29, 2008 Sep CTEC >D> AB 20MG A 077672 004 Dec 29, 2008 Sep CTEC >A> 20MG A 077672 004 Dec 29, 2008 Sep CTEC >D> AB 30MG A 077672 001 Dec 29, 2008 Sep CTEC >A> 30MG A 077672 001 Dec 29, 2008 Sep CTEC >D> AB 40MG A 077672 002 Dec 29, 2008 Sep CHRS >A> ! 40MG A 077672 002 Dec 29, 2008 Sep CTEC >A> AB ! 40MG A 077672 002 Dec 29, 2008 Sep CHRS >D> ZERIT >D> AB + BRISTOL MYERS SQUIBB 15MG N 020412 002 Jun 24, 1994 Sep DISC >D> AB + 20MG N 020412 003 Jun 24, 1994 Sep DISC >D> AB + 30MG N 020412 004 Jun 24, 1994 Sep DISC >D> AB +! 40MG N 020412 005 Jun 24, 1994 Sep DISC >A> + @ BRISTOL-MYERS SQUIBB 15MG N 020412 002 Jun 24, 1994 Sep DISC >A> + @ 20MG N 020412 003 Jun 24, 1994 Sep DISC >A> + @ 30MG N 020412 004 Jun 24, 1994 Sep DISC >A> + @ 40MG N 020412 005 Jun 24, 1994 Sep DISC

STREPTOMYCIN SULFATE INJECTABLE;INJECTION STREPTOMYCIN SULFATE ! XGEN PHARMS EQ 1GM BASE/VIAL A 064210 001 Jun 30, 1998 Feb CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -107

SUCCINYLCHOLINE CHLORIDE INJECTABLE;INJECTION QUELICIN PRESERVATIVE FREE + @ HOSPIRA 50MG/ML N 008845 002 Apr CRLD + @ 100MG/ML N 008845 004 Apr CRLD SUCCINYLCHOLINE CHLORIDE AP ACCORD HLTHCARE 20MG/ML A 213705 001 May 20, 2020 May NEWA AP AMPHASTAR PHARMS INC 20MG/ML A 213432 001 Jun 08, 2020 Jun NEWA AP ASPIRO 20MG/ML A 213810 001 May 04, 2020 Apr NEWA AP GLAND PHARMA LTD 20MG/ML A 214246 001 Jun 16, 2020 Jun NEWA AP HIKMA 20MG/ML A 213229 001 Jun 12, 2020 Jun NEWA AP INDOCO 20MG/ML A 214308 001 May 22, 2020 May NEWA AP NIVAGEN PHARMS INC 20MG/ML A 211625 001 May 19, 2020 May NEWA SUCOSTRIN + @ APOTHECON 20MG/ML N 008847 001 Apr CRLD + @ 100MG/ML N 008847 003 Apr CRLD

SUCRALFATE TABLET;ORAL SUCRALFATE AB NOSTRUM LABS INC 1GM A 074415 001 Jun 08, 1998 May CMFD

SULFACETAMIDE SODIUM LOTION;TOPICAL KLARON AB +! BAUSCH 10% N 019931 001 Dec 23, 1996 Mar CAHN

SULFAMETHOXAZOLE; TRIMETHOPRIM INJECTABLE;INJECTION SULFAMETHOXAZOLE AND TRIMETHOPRIM AP TEVA PHARMS USA 80MG/ML;16MG/ML A 073303 001 Oct 31, 1991 Mar CMFD

SULFASALAZINE TABLET;ORAL SULFASALAZINE AB NUVO PHARMS INC 500MG A 040349 001 Jan 11, 2002 Aug CAHN TABLET, DELAYED RELEASE;ORAL SULFASALAZINE AB NUVO PHARMS INC 500MG A 075339 001 Jan 11, 2002 Aug CAHN

SUMATRIPTAN SPRAY;NASAL SUMATRIPTAN >A> AB PERRIGO UK FINCO 5MG/SPRAY A 213650 001 Sep 21, 2020 Sep NEWA >A> AB 20MG/SPRAY A 213465 001 Sep 21, 2020 Sep NEWA

SUMATRIPTAN SUCCINATE TABLET;ORAL SUMATRIPTAN SUCCINATE AB COREPHARMA EQ 25MG BASE A 200263 001 Jun 19, 2012 Feb CAHN AB EQ 50MG BASE A 200263 002 Jun 19, 2012 Feb CAHN AB EQ 100MG BASE A 200263 003 Jun 19, 2012 Feb CAHN

TADALAFIL TABLET;ORAL TADALAFIL AB ACCORD HLTHCARE 10MG A 209167 003 Oct 23, 2019 Jul NEWA

TAMOXIFEN CITRATE >D> SOLUTION;ORAL >D> SOLTAMOX >D> FORTOVIA EQ 20MG BASE/10ML N 021807 001 Oct 29, 2005 Sep DISC >A> @ EQ 20MG BASE/10ML N 021807 001 Oct 29, 2005 Sep DISC TABLET;ORAL TAMOXIFEN CITRATE AB EUGIA PHARMA EQ 10MG BASE A 213358 001 Aug 14, 2020 Aug NEWA AB EQ 20MG BASE A 213358 002 Aug 14, 2020 Aug NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -108

TAMSULOSIN HYDROCHLORIDE CAPSULE;ORAL TAMSULOSIN HYDROCHLORIDE @ ANBISON LAB 0.4MG A 211885 001 Oct 17, 2019 Apr DISC

TAPENTADOL HYDROCHLORIDE SOLUTION;ORAL NUCYNTA + @ COLLEGIUM PHARM INC EQ 20MG BASE/ML N 203794 001 Oct 15, 2012 Feb CAHN TABLET;ORAL NUCYNTA + COLLEGIUM PHARM INC EQ 50MG BASE N 022304 001 Nov 20, 2008 Feb CAHN + EQ 75MG BASE N 022304 002 Nov 20, 2008 Feb CAHN +! EQ 100MG BASE N 022304 003 Nov 20, 2008 Feb CAHN TABLET, EXTENDED RELEASE;ORAL NUCYNTA ER + COLLEGIUM PHARM INC EQ 50MG BASE N 200533 001 Aug 25, 2011 Feb CAHN + EQ 100MG BASE N 200533 002 Aug 25, 2011 Feb CAHN + EQ 150MG BASE N 200533 003 Aug 25, 2011 Feb CAHN + EQ 200MG BASE N 200533 004 Aug 25, 2011 Feb CAHN +! EQ 250MG BASE N 200533 005 Aug 25, 2011 Feb CAHN

TAZEMETOSTAT HYDROBROMIDE TABLET;ORAL TAZVERIK +! EPIZYME INC EQ 200MG BASE N 211723 001 Jan 23, 2020 Jan NEWA

TECHNETIUM TC-99M DISOFENIN KIT INJECTABLE;INJECTION HEPATOLITE @ SUN PHARM INDS INC N/A N 018467 001 Mar 16, 1982 Apr CAHN

TECHNETIUM TC-99M EXAMETAZIME KIT POWDER;INTRAVENOUS DRAX EXAMETAZIME >A> JUBILANT N/A N 208870 001 Aug 17, 2017 Sep CAHN >D> JUBILANT DRAXIMAGE N/A N 208870 001 Aug 17, 2017 Sep CAHN

TECHNETIUM TC-99M MEBROFENIN KIT INJECTABLE;INJECTION TECHNETIUM TC-99M MEBROFENIN AP SUN PHARM INDS INC N/A A 078242 001 Jan 29, 2008 Apr CAHN

TECHNETIUM TC-99M MEDRONATE INJECTABLE;INJECTION DRAXIMAGE MDP-10 >A> @ JUBILANT N/A N 018035 001 Sep CAHN >D> @ JUBILANT DRAXIMAGE N/A N 018035 001 Sep CAHN DRAXIMAGE MDP-25 >A> +! JUBILANT N/A N 018035 002 Feb 27, 2004 Sep CAHN >D> +! JUBILANT DRAXIMAGE N/A N 018035 002 Feb 27, 2004 Sep CAHN

TECHNETIUM TC-99M MEDRONATE KIT INJECTABLE;INJECTION CIS-MDP SUN PHARM INDS INC N/A N 018124 001 Apr CAHN

TECHNETIUM TC-99M MERTIATIDE KIT INJECTABLE;INJECTION TECHNETIUM TC99M MERTIATIDE KIT AP SOMMER PHARMS II LLC N/A A 206489 001 Feb 06, 2020 Jan NEWA AP SUN PHARM INDS INC N/A A 208994 001 Jul 12, 2019 Apr CAHN

TECHNETIUM TC-99M PYROPHOSPHATE KIT INJECTABLE;INJECTION CIS-PYRO AP SUN PHARM INDS INC N/A N 019039 001 Jun 30, 1987 Apr CAHN RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -109

TECHNETIUM TC-99M SESTAMIBI KIT INJECTABLE;INJECTION TECHNETIUM TC 99M SESTAMIBI AP CURIUM N/A A 078098 001 Sep 22, 2008 Feb CAHN AP SUN PHARM INDS INC 10-30mCi A 079157 001 Jul 10, 2009 Apr CAHN

TECHNETIUM TC-99M SULFUR COLLOID KIT SOLUTION;INJECTION, ORAL AN-SULFUR COLLOID +! SUN PHARM INDS INC N/A N 017858 001 Apr CAHN

TELMISARTAN TABLET;ORAL TELMISARTAN @ CELLTRION 20MG A 078710 001 Jan 08, 2014 Jul CAHN @ 40MG A 078710 002 Jan 08, 2014 Jul CAHN @ 80MG A 078710 003 Jan 08, 2014 Jul CAHN @ JUBILANT GENERICS 20MG A 204164 001 Aug 22, 2016 Jan DISC @ 40MG A 204164 002 Aug 22, 2016 Jan DISC @ 80MG A 204164 003 Aug 22, 2016 Jan DISC AB MICRO LABS 20MG A 207016 001 Oct 03, 2017 Apr CMFD AB 40MG A 207016 002 Oct 03, 2017 Apr CMFD AB 80MG A 207016 003 Oct 03, 2017 Apr CMFD

TELOTRISTAT ETIPRATE TABLET;ORAL XERMELO >D> +! LEXICON PHARMS INC EQ 250MG BASE N 208794 001 Feb 28, 2017 Sep CAHN >A> +! TERSERA EQ 250MG BASE N 208794 001 Feb 28, 2017 Sep CAHN

TEMOZOLOMIDE CAPSULE;ORAL TEMOZOLOMIDE >D> AB AMERIGEN PHARMS LTD 5MG A 203490 001 Jul 13, 2016 Sep CAHN >D> AB 20MG A 203490 002 Jul 13, 2016 Sep CAHN >D> AB 100MG A 203490 003 Jul 13, 2016 Sep CAHN >D> AB 140MG A 203490 004 Jul 13, 2016 Sep CAHN >D> AB 180MG A 203490 005 Jul 13, 2016 Sep CAHN >D> AB 250MG A 203490 006 Jul 13, 2016 Sep CAHN >A> AB ANI PHARMS INC 5MG A 203490 001 Jul 13, 2016 Sep CAHN >A> AB 20MG A 203490 002 Jul 13, 2016 Sep CAHN >A> AB 100MG A 203490 003 Jul 13, 2016 Sep CAHN >A> AB 140MG A 203490 004 Jul 13, 2016 Sep CAHN >A> AB 180MG A 203490 005 Jul 13, 2016 Sep CAHN >A> AB 250MG A 203490 006 Jul 13, 2016 Sep CAHN AB CHARTWELL 5MG A 206413 001 Apr 12, 2016 Jun CAHN AB 20MG A 206413 002 Apr 12, 2016 Jun CAHN AB 100MG A 206413 003 Apr 12, 2016 Jun CAHN AB 140MG A 206413 004 Apr 12, 2016 Jun CAHN AB 180MG A 206413 005 Apr 12, 2016 Jun CAHN AB 250MG A 206413 006 Apr 12, 2016 Jun CAHN

TENAPANOR HYDROCHLORIDE TABLET;ORAL IBSRELA + @ ARDELYX INC EQ 50MG BASE N 211801 001 Sep 12, 2019 Mar DISC

TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL TENOFOVIR DISOPROXIL FUMARATE @ MYLAN 150MG A 206569 001 Nov 27, 2018 Feb DISC @ 200MG A 206569 002 Nov 27, 2018 Feb DISC @ 250MG A 206569 003 Nov 27, 2018 Feb DISC @ 300MG A 206569 004 Nov 27, 2018 Feb DISC

TERAZOSIN HYDROCHLORIDE CAPSULE;ORAL TERAZOSIN HYDROCHLORIDE >D> AB APNAR PHARMA LP EQ 1MG BASE A 074823 001 Mar 30, 1998 Sep CHRS >A> AB ! EQ 1MG BASE A 074823 001 Mar 30, 1998 Sep CHRS >D> AB ! EQ 2MG BASE A 074823 002 Mar 30, 1998 Sep CHRS RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -110

CAPSULE;ORAL TERAZOSIN HYDROCHLORIDE >A> AB EQ 2MG BASE A 074823 002 Mar 30, 1998 Sep CHRS @ HERITAGE PHARMA EQ 1MG BASE A 075614 002 Jan 30, 2001 Feb DISC @ EQ 2MG BASE A 075614 001 Jan 30, 2001 Feb DISC @ EQ 5MG BASE A 075614 003 Jan 30, 2001 Feb DISC @ EQ 10MG BASE A 075614 004 Jan 30, 2001 Feb DISC >D> AB HIKMA EQ 1MG BASE A 075498 001 Apr 12, 2001 Sep DISC >A> @ EQ 1MG BASE A 075498 001 Apr 12, 2001 Sep DISC >D> AB EQ 2MG BASE A 075498 002 Apr 12, 2001 Sep DISC >A> @ EQ 2MG BASE A 075498 002 Apr 12, 2001 Sep DISC >D> AB EQ 5MG BASE A 075498 003 Apr 12, 2001 Sep DISC >A> @ EQ 5MG BASE A 075498 003 Apr 12, 2001 Sep DISC >D> AB EQ 10MG BASE A 075498 004 Apr 12, 2001 Sep DISC >A> @ EQ 10MG BASE A 075498 004 Apr 12, 2001 Sep DISC

TERBUTALINE SULFATE TABLET;ORAL TERBUTALINE SULFATE AB TWI PHARMS 2.5MG A 211832 001 Jun 19, 2020 Jun NEWA AB 5MG A 211832 002 Jun 19, 2020 Jun NEWA

TERIFLUNOMIDE TABLET;ORAL TERIFLUNOMIDE AB IMPAX 14MG A 209677 001 Jun 17, 2020 Jun NEWA @ MYLAN 7MG A 209702 001 Feb 28, 2020 Mar DISC AB 7MG A 209702 001 Feb 28, 2020 Feb NEWA @ 14MG A 209702 002 Feb 28, 2020 Mar DISC AB 14MG A 209702 002 Feb 28, 2020 Feb NEWA

TERIPARATIDE INJECTABLE;SUBCUTANEOUS FORTEO +! LILLY 0.6MG/2.4ML (0.25MG/ML) N 021318 002 Jun 25, 2008 Jan CAIN @ 0.75MG/3ML (0.25MG/ML) N 021318 001 Nov 26, 2002 Jan CAIN SOLUTION;SUBCUTANEOUS BONSITY ALVOGEN 0.62MG/2.48ML (0.25MG/ML) N 211939 001 Oct 04, 2019 Jan CAIN FORTEO +! LILLY 0.6MG/2.4ML (0.25MG/ML) N 021318 002 Jun 25, 2008 Jan CDFR @ 0.75MG/3ML (0.25MG/ML) N 021318 001 Nov 26, 2002 Jan CDFR

TESTOSTERONE GEL, METERED;TRANSDERMAL ANDROGEL + @ ABBVIE 12.5MG/1.25GM ACTUATION N 021015 003 Sep 26, 2003 Mar DISC TESTOSTERONE BX ! ACTAVIS LABS UT INC 12.5MG/1.25GM ACTUATION A 076737 003 Mar 09, 2015 Mar CHRS BX 12.5MG/1.25GM ACTUATION A 076737 003 Mar 09, 2015 Mar CTEC AB XIROMED 1.62% (20.25MG/1.25GM ACTUATION) A 210835 001 Apr 16, 2020 Apr NEWA

TETRABENAZINE TABLET;ORAL TETRABENAZINE AB APOTEX 12.5MG A 206093 001 Mar 17, 2020 Mar NEWA AB 25MG A 206093 002 Mar 17, 2020 Mar NEWA AB PIRAMAL HLTHCARE UK 12.5MG A 213316 001 Jan 22, 2020 Jan NEWA AB 25MG A 213316 002 Jan 22, 2020 Jan NEWA

TETRACYCLINE HYDROCHLORIDE CAPSULE;ORAL TETRACYCLINE HYDROCHLORIDE >D> @ STRIDES PHARMA 250MG A 212635 001 Mar 03, 2020 Sep CMFD >A> AB 250MG A 212635 001 Mar 03, 2020 Sep CMFD @ 250MG A 212635 001 Mar 03, 2020 Jul DISC AB 250MG A 212635 001 Mar 03, 2020 Feb NEWA >D> @ 500MG A 212635 002 Mar 03, 2020 Sep CMFD >A> AB 500MG A 212635 002 Mar 03, 2020 Sep CMFD @ 500MG A 212635 002 Mar 03, 2020 Jul DISC AB 500MG A 212635 002 Mar 03, 2020 Feb NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -111

THALLOUS CHLORIDE TL-201 INJECTABLE;INTRAVENOUS THALLOUS CHLORIDE TL 201 @ CURIUM 2mCi/ML A 077698 001 Nov 09, 2006 Feb CAHN

THEOPHYLLINE TABLET, EXTENDED RELEASE;ORAL THEOPHYLLINE ALEMBIC PHARMS LTD 300MG A 090430 001 Oct 27, 2010 Jun CTEC @ HERITAGE PHARMA 300MG A 089763 001 Apr 30, 1990 Jun DISC

THIORIDAZINE HYDROCHLORIDE TABLET;ORAL THIORIDAZINE HYDROCHLORIDE AB MYLAN 10MG A 088004 002 Mar 15, 1983 Mar CTEC AB 25MG A 088004 003 Mar 15, 1983 Mar CTEC AB 50MG A 088004 004 Mar 15, 1983 Mar CTEC AB ! 100MG A 088004 001 Nov 18, 1983 Mar CTEC AB SUN PHARM INDUSTRIES 10MG A 089953 004 Aug 01, 1986 Mar CMFD AB 25MG A 089953 003 Aug 01, 1986 Mar CMFD AB 50MG A 089953 002 Aug 01, 1986 Mar CMFD AB 100MG A 089953 001 Oct 07, 1988 Mar CMFD

THIOTEPA POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL TEPADINA AP +! ADIENNE SA 15MG/VIAL N 208264 001 Jan 26, 2017 May CPOT AP +! 100MG/VIAL N 208264 002 Jan 26, 2017 May CPOT THIOTEPA AP MSN 15MG/VIAL A 213049 001 Mar 04, 2020 May CPOT AP 100MG/VIAL A 213049 002 Mar 04, 2020 May CPOT POWDER;INTRAVENOUS TEPADINA AP +! ADIENNE SA 15MG/VIAL N 208264 001 Jan 26, 2017 Feb CFTG AP +! 100MG/VIAL N 208264 002 Jan 26, 2017 Feb CFTG THIOTEPA AP MSN 15MG/VIAL A 213049 001 Mar 04, 2020 Feb NFTG AP 100MG/VIAL A 213049 002 Mar 04, 2020 Feb NFTG

TICAGRELOR TABLET;ORAL TICAGRELOR >A> @ AMNEAL 90MG A 208531 001 Jan 23, 2019 Sep CAHN >D> @ AMNEAL PHARMS CO 90MG A 208531 001 Jan 23, 2019 Sep CAHN >D> AB HEC PHARM CO LTD 90MG A 208508 001 Apr 06, 2020 Sep CAHN AB 90MG A 208508 001 Apr 06, 2020 Mar NEWA AB SIGMAPHARM LABS LLC 90MG A 208596 001 Apr 07, 2020 Mar NEWA >A> AB SUNSHINE 90MG A 208508 001 Apr 06, 2020 Sep CAHN

TIGECYCLINE POWDER;INTRAVENOUS TIGECYCLINE AP +! FRESENIUS KABI USA 50MG/VIAL N 205645 001 Dec 01, 2016 Aug CHRS AP + 50MG/VIAL N 205645 001 Dec 01, 2016 Aug CRLD

TIMOLOL MALEATE SOLUTION/DROPS;OPHTHALMIC >A> TIMOLOL MALEATE >A> AT3 AKORN INC EQ 0.5% BASE A 212291 001 Sep 11, 2020 Sep NFTG TIMOPTIC IN OCUDOSE >D> +! VALEANT PHARMS INTL EQ 0.5% BASE N 019463 002 Nov 05, 1986 Sep CFTG >A> AT3 +! EQ 0.5% BASE N 019463 002 Nov 05, 1986 Sep CFTG

TIZANIDINE HYDROCHLORIDE CAPSULE;ORAL TIZANIDINE HYDROCHLORIDE AB AUROBINDO PHARMA LTD EQ 2MG BASE A 213544 001 Mar 24, 2020 Mar NEWA AB EQ 4MG BASE A 213544 002 Mar 24, 2020 Mar NEWA AB EQ 6MG BASE A 213544 003 Mar 24, 2020 Mar NEWA AB RUBICON EQ 2MG BASE A 213798 001 May 27, 2020 May NEWA AB EQ 4MG BASE A 213798 002 May 27, 2020 May NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -112

CAPSULE;ORAL TIZANIDINE HYDROCHLORIDE AB EQ 6MG BASE A 213798 003 May 27, 2020 May NEWA

TOBRAMYCIN SOLUTION;INHALATION BETHKIS >D> +! CHIESI 300MG/4ML N 201820 001 Oct 12, 2012 Sep CTEC >A> AN +! 300MG/4ML N 201820 001 Oct 12, 2012 Sep CTEC TOBRAMYCIN @ MYLAN 300MG/5ML A 209554 001 Oct 13, 2017 Feb DISC AN TEVA PHARMS USA 300MG/4ML A 210915 001 Jun 26, 2019 Aug CMFD

TOBRAMYCIN SULFATE INJECTABLE;INJECTION TOBRAMYCIN SULFATE AP ! XGEN PHARMS EQ 1.2GM BASE/VIAL A 065013 001 Aug 17, 2001 Feb CAHN

TOFACITINIB CITRATE >A> SOLUTION;ORAL >A> Xeljanz >A> +! PFIZER EQ 1MG/ML BASE N 213082 001 Sep 25, 2020 Sep NEWA

TOLAZAMIDE TABLET;ORAL TOLAZAMIDE @ MYLAN PHARMS INC 250MG A 070259 001 Jan 02, 1986 Mar DISC @ 500MG A 070259 003 Mar 17, 1986 Mar DISC

TOLCAPONE TABLET;ORAL TOLCAPONE AB ALVOGEN 100MG A 207729 001 Jul 29, 2020 Jul NEWA

TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL DETROL LA AB + UPJOHN 2MG N 021228 001 Dec 22, 2000 Jul CAHN AB +! 4MG N 021228 002 Dec 22, 2000 Jul CAHN TOLTERODINE TARTRATE AB AJANTA PHARMA LTD 2MG A 213397 001 May 19, 2020 May NEWA AB 4MG A 213397 002 May 19, 2020 May NEWA TABLET;ORAL DETROL AB + UPJOHN 1MG N 020771 001 Mar 25, 1998 Jun CAHN AB +! 2MG N 020771 002 Mar 25, 1998 Jun CAHN TOLTERODINE TARTRATE >A> AB ATHEM 1MG A 210775 001 Dec 30, 2019 Sep CAHN >A> AB 2MG A 210775 002 Dec 30, 2019 Sep CAHN >D> AB INVATECH 1MG A 210775 001 Dec 30, 2019 Sep CAHN >D> AB 2MG A 210775 002 Dec 30, 2019 Sep CAHN @ MYLAN PHARMS INC 1MG A 202641 001 Nov 27, 2012 Jan DISC @ 2MG A 202641 002 Nov 27, 2012 Jan DISC AB UNICHEM 1MG A 205399 001 Aug 05, 2020 Jul NEWA AB 2MG A 205399 002 Aug 05, 2020 Jul NEWA AB UNIQUE PHARM LABS 1MG A 204721 001 Jan 24, 2020 Jan NEWA AB 2MG A 204721 002 Jan 24, 2020 Jan NEWA

TOLVAPTAN TABLET;ORAL SAMSCA AB +! OTSUKA AMERICA PHARM 30MG N 022275 002 May 19, 2009 May CFTG TOLVAPTAN AB ALKEM LABS LTD 30MG A 211891 001 May 19, 2020 May NEWA AB 60MG A 211891 002 May 19, 2020 May NFTG AB APOTEX 30MG A 207605 001 May 19, 2020 May NFTG RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -113

TOPIRAMATE TABLET;ORAL TOPIRAMATE AB VIWIT PHARM 25MG A 077733 001 Mar 27, 2009 Mar CAHN AB 25MG A 077733 001 Mar 27, 2009 Mar CAHN AB 50MG A 077733 002 Mar 27, 2009 Mar CAHN AB 50MG A 077733 002 Mar 27, 2009 Mar CAHN AB 100MG A 077733 003 Mar 27, 2009 Mar CAHN AB 100MG A 077733 003 Mar 27, 2009 Mar CAHN AB 200MG A 077733 004 Mar 27, 2009 Mar CAHN AB 200MG A 077733 004 Mar 27, 2009 Mar CAHN

TOREMIFENE CITRATE TABLET;ORAL TOREMIFENE CITRATE AB MSN EQ 60MG BASE A 212818 001 Aug 18, 2020 Aug NEWA

TORSEMIDE TABLET;ORAL DEMADEX + @ MYLAN SPECIALITY LP 5MG N 020136 001 Aug 23, 1993 Aug DISC + @ 10MG N 020136 002 Aug 23, 1993 Aug DISC + @ 20MG N 020136 003 Aug 23, 1993 Aug DISC + @ 100MG N 020136 004 Aug 23, 1993 Aug DISC TORSEMIDE AB COREPHARMA 5MG A 076894 001 May 31, 2005 Feb CAHN AB 10MG A 076894 002 May 31, 2005 Feb CAHN AB 20MG A 076894 003 May 31, 2005 Feb CAHN AB 100MG A 076894 004 May 31, 2005 Feb CAHN AB ! PLIVA PHARM IND 20MG A 076346 003 May 30, 2003 Aug CHRS

TRAMADOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL CONZIP + @ CIPHER PHARMS INC 150MG N 022370 004 Aug 01, 2011 Aug DISC >A> SOLUTION;ORAL >A> QDOLO >A> +! ATHENA 5MG/ML N 214044 001 Sep 01, 2020 Sep NEWA TABLET;ORAL TRAMADOL HYDROCHLORIDE @ MACLEODS PHARMS LTD 50MG A 205702 001 Sep 25, 2015 May DISC

TRANEXAMIC ACID INJECTABLE;INJECTION TRANEXAMIC ACID CA PLI N@ CAPLIN@ 100MG/ML A 212360 001 Jul 17, 2019 Jan DISC AP XGEN PHARMS 100MG/ML A 201580 001 Jun 14, 2013 Feb CAHN TABLET;ORAL TRANEXAMIC ACID @ ANI PHARMS INC 650MG A 203256 001 Jul 25, 2016 Jan CAHN

TRAZODONE HYDROCHLORIDE TABLET;ORAL TRAZODONE HYDROCHLORIDE AB AUROLIFE PHARMA LLC 50MG A 204852 001 Feb 05, 2020 Jan NEWA AB 100MG A 204852 002 Feb 05, 2020 Jan NEWA AB 150MG A 204852 003 Feb 05, 2020 Jan NEWA AB 300MG A 204852 004 Feb 05, 2020 Jan NEWA

TREPROSTINIL INJECTABLE;IV (INFUSION), SUBCUTANEOUS TREPROSTINIL AP DR REDDYS 1MG/ML A 210214 001 May 22, 2020 May NEWA AP 2.5MG/ML A 210214 002 May 22, 2020 May NEWA AP 5MG/ML A 210214 003 May 22, 2020 May NEWA AP 10MG/ML A 210214 004 May 22, 2020 May NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -114

TRIAMCINOLONE ACETONIDE LOTION;TOPICAL TRIAMCINOLONE ACETONIDE AT QUAGEN 0.025% A 213559 001 Jul 01, 2020 Jun NEWA AT 0.1% A 213559 002 Jul 01, 2020 Jun NEWA AT SAPTALIS PHARMS 0.1% A 040672 002 Dec 13, 2006 Mar CAHN OINTMENT;TOPICAL TRIAMCINOLONE ACETONIDE AT MACLEODS PHARMS LTD 0.025% A 209828 001 Nov 23, 2018 Mar CTNA AT 0.1% A 209828 002 Nov 23, 2018 Mar CTNA AT 0.5% A 209828 003 Nov 23, 2018 Mar CTNA AT STRIDES PHARMA 0.05% A 212356 001 Jun 01, 2020 May NEWA @ 0.1% A 211315 001 Mar 18, 2020 Jul DISC AT 0.1% A 211315 001 Mar 18, 2020 Mar NEWA @ 0.5% A 211315 002 Mar 18, 2020 Jul DISC AT 0.5% A 211315 002 Mar 18, 2020 Mar NEWA

TRIAZOLAM TABLET;ORAL TRIAZOLAM @ MYLAN PHARMS INC 0.125MG A 074031 001 Mar 25, 1994 Jan DISC @ 0.25MG A 074031 002 Mar 25, 1994 Jan DISC

TRIENTINE HYDROCHLORIDE CAPSULE;ORAL TRIENTINE HYDROCHLORIDE AB LUPIN LTD 250MG A 211637 001 May 21, 2020 May NEWA AB RISING 250MG A 212238 001 Feb 20, 2020 Feb NEWA

TRIFAROTENE CREAM;TOPICAL AKLIEF +! GALDERMA LABS LP 0.005% N 211527 001 Oct 04, 2019 May CAHN

TRIFLUOPERAZINE HYDROCHLORIDE TABLET;ORAL TRIFLUOPERAZINE HYDROCHLORIDE >A> @ ATHEM EQ 1MG BASE A 040153 001 Oct 25, 1996 Sep CAHN >A> @ EQ 2MG BASE A 040153 002 Oct 25, 1996 Sep CAHN >A> @ EQ 5MG BASE A 040153 003 Oct 25, 1996 Sep CAHN >A> @ EQ 10MG BASE A 040153 004 Oct 25, 1996 Sep CAHN >D> @ INVATECH EQ 1MG BASE A 040153 001 Oct 25, 1996 Sep CAHN >D> @ EQ 2MG BASE A 040153 002 Oct 25, 1996 Sep CAHN >D> @ EQ 5MG BASE A 040153 003 Oct 25, 1996 Sep CAHN >D> @ EQ 10MG BASE A 040153 004 Oct 25, 1996 Sep CAHN

TRIHEPTANOIN LIQUID;ORAL DOJOLVI +! ULTRAGENYX PHARM INC 100% w/w N 213687 001 Jun 30, 2020 Jul NEWA

TRIMETHOPRIM HYDROCHLORIDE SOLUTION;ORAL PRIMSOL + @ ALLEGIS EQ 50MG BASE/5ML N 074973 001 Jan 24, 2000 Aug DISC

TRIPTORELIN PAMOATE INJECTABLE;INTRAMUSCULAR TRELSTAR +! VERITY EQ 3.75MG BASE/VIAL N 020715 001 Jun 15, 2000 Jul CAHN +! EQ 11.25MG BASE/VIAL N 021288 001 Jun 29, 2001 Jul CAHN +! EQ 22.5MG BASE/VIAL N 022437 001 Mar 10, 2010 Jul CAHN

TROMETHAMINE SOLUTION;INJECTION THAM +! HOSPIRA 18GM/500ML (3.6GM/100ML) N 013025 002 Jun CMFD RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -115

TROSPIUM CHLORIDE CAPSULE, EXTENDED RELEASE;ORAL TROSPIUM CHLORIDE AB GRANULES PHARMS 60MG A 213185 001 Apr 23, 2020 Apr NEWA

TUCATINIB TABLET;ORAL TUKYSA + SEATTLE GENETICS 50MG N 213411 001 Apr 17, 2020 Apr NEWA +! 150MG N 213411 002 Apr 17, 2020 Apr NEWA

URSODIOL CAPSULE;ORAL URSODIOL LGM PHARMA 200MG A 205789 001 May 08, 2020 Aug CAHN 400MG A 205789 002 May 08, 2020 Aug CAHN NEXGEN PHARMA INC 200MG A 205789 001 May 08, 2020 Apr NFTG 400MG A 205789 002 May 08, 2020 Apr NFTG AB RISING 300MG A 213200 001 Feb 12, 2020 Jan NEWA AB UPSHER SMITH LABS 300MG A 213555 001 Aug 17, 2020 Aug NEWA TABLET;ORAL URSODIOL @ IMPAX LABS INC 250MG A 200826 001 Dec 23, 2011 Aug DISC @ 500MG A 200826 002 Dec 23, 2011 Aug DISC AB STRIDES PHARMA 250MG A 213504 001 Aug 20, 2020 Aug NEWA AB 500MG A 213504 002 Aug 20, 2020 Aug NEWA

VALACYCLOVIR HYDROCHLORIDE TABLET;ORAL VALACYCLOVIR HYDROCHLORIDE >D> AB HIKMA EQ 500MG BASE A 078656 001 May 24, 2010 Sep DISC >A> @ EQ 500MG BASE A 078656 001 May 24, 2010 Sep DISC >D> AB EQ 1GM BASE A 078656 002 May 24, 2010 Sep DISC >A> @ EQ 1GM BASE A 078656 002 May 24, 2010 Sep DISC @ TEVA PHARMS EQ 500MG BASE A 077655 001 May 24, 2010 Jan DISC @ EQ 1GM BASE A 077655 002 May 24, 2010 Jan DISC AB YILING EQ 500MG BASE A 209553 001 Mar 18, 2020 Mar NEWA AB EQ 1GM BASE A 209553 002 Mar 18, 2020 Mar NEWA

VALGANCICLOVIR HYDROCHLORIDE FOR SOLUTION;ORAL VALGANCICLOVIR HYDROCHLORIDE >D> AB GRANULES PHARMS 50MG/ML A 213306 001 Jan 31, 2020 Sep DISC >A> @ 50MG/ML A 213306 001 Jan 31, 2020 Sep DISC AB 50MG/ML A 213306 001 Jan 31, 2020 Jan NEWA

VALPROIC ACID CAPSULE;ORAL VALPROIC ACID >A> AB EYWA 250MG A 207611 001 Aug 05, 2019 Sep CAHN >D> AB NOVELGENIX THERAPS 250MG A 207611 001 Aug 05, 2019 Sep CAHN SYRUP;ORAL VALPROIC ACID >A> AA BIOPHARM 250MG/5ML A 090517 001 May 28, 2010 Sep CAHN >D> AA ECI PHARMS LLC 250MG/5ML A 090517 001 May 28, 2010 Sep CAHN @ NOSTRUM LABS INC 250MG/5ML A 077105 001 Jul 29, 2005 Aug CAHN >A> AA PHARMA LIFE 250MG/5ML A 090517 001 May 28, 2010 Sep CAHN

VANCOMYCIN HYDROCHLORIDE FOR SOLUTION;ORAL FIRVANQ KIT +! AZURITY EQ 25MG BASE/ML N 208910 001 Jan 26, 2018 Jun CAHN +! EQ 50MG BASE/ML N 208910 002 Jan 26, 2018 Jun CAHN VANCOCIN HYDROCHLORIDE ! ANI PHARMS INC EQ 250MG BASE/5ML A 061667 002 Jul 13, 1983 Jul CHRS INJECTABLE;INJECTION VANCOMYCIN HYDROCHLORIDE AP HAINAN POLY PHARM EQ 500MG BASE/VIAL A 212332 001 Jun 12, 2019 Jun CMFD AP EQ 1GM BASE/VIAL A 212332 002 Jun 12, 2019 Jun CMFD AP HIKMA EQ 500MG BASE/VIAL A 203300 001 Aug 11, 2020 Jul NEWA AP EQ 1GM BASE/VIAL A 203300 002 Aug 11, 2020 Jul NEWA RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -116

INJECTABLE;INJECTION VANCOMYCIN HYDROCHLORIDE ! HOSPIRA EQ 1.5GM BASE/VIAL A 062912 003 Jul 10, 2020 Jul NFTG >A> AP EQ 10GM BASE/VIAL A 063076 002 Sep 14, 2020 Sep NEWA AP ! MYLAN LABS LTD EQ 10GM BASE/VIAL A 091554 001 Sep 19, 2011 Jul CHRS AP PHARM ASSOC EQ 500MG BASE/VIAL A 065401 001 Jun 30, 2008 Jan CAHN AP EQ 1GM BASE/VIAL A 065401 002 Jun 30, 2008 Jan CAHN SOLUTION;INTRAVENOUS VANCOMYCIN HYDROCHLORIDE +! XELLIA PHARMS APS EQ 500MG BASE/100ML (EQ 5MG N 211962 001 Feb 15, 2019 May CPOT BASE/ML) +! EQ 750MG BASE/150ML (EQ 5MG N 211962 005 May 13, 2020 May NEWA BASE/ML) +! EQ 1GM BASE/200ML (EQ 5MG BASE/ML) N 211962 002 Feb 15, 2019 May CPOT +! EQ 1.25GM BASE/250ML (EQ 5MG N 211962 006 May 13, 2020 May NEWA BASE/ML) +! EQ 1.5GM BASE/300ML (EQ 5MG N 211962 003 Feb 15, 2019 May CPOT BASE/ML) +! EQ 1.75GM BASE/350ML (EQ 5MG N 211962 007 May 13, 2020 May NEWA BASE/ML) +! EQ 2GM BASE/400ML (EQ 5MG BASE/ML) N 211962 004 Feb 15, 2019 May CPOT

VARDENAFIL HYDROCHLORIDE TABLET;ORAL LEVITRA >D> + @ BAYER HLTHCARE 2.5MG N 021400 003 Aug 19, 2003 Sep CPOT >A> + @ EQ 2.5MG BASE N 021400 003 Aug 19, 2003 Sep CPOT >D> AB + 5MG N 021400 001 Aug 19, 2003 Sep CPOT >A> AB + EQ 5MG BASE N 021400 001 Aug 19, 2003 Sep CPOT >D> AB + 10MG N 021400 002 Aug 19, 2003 Sep CPOT >A> AB + EQ 10MG BASE N 021400 002 Aug 19, 2003 Sep CPOT >D> AB +! 20MG N 021400 004 Aug 19, 2003 Sep CPOT >A> AB +! EQ 20MG BASE N 021400 004 Aug 19, 2003 Sep CPOT VARDENAFIL HYDROCHLORIDE >D> AB ALEMBIC PHARMS LTD 2.5MG A 214031 001 Aug 04, 2020 Sep CPOT >A> AB EQ 2.5MG BASE A 214031 001 Aug 04, 2020 Sep CPOT AB 2.5MG A 214031 001 Aug 04, 2020 Jul NEWA >D> AB 5MG A 214031 002 Aug 04, 2020 Sep CPOT >A> AB EQ 5MG BASE A 214031 002 Aug 04, 2020 Sep CPOT AB 5MG A 214031 002 Aug 04, 2020 Jul NEWA >D> AB 10MG A 214031 003 Aug 04, 2020 Sep CPOT >A> AB EQ 10MG BASE A 214031 003 Aug 04, 2020 Sep CPOT AB 10MG A 214031 003 Aug 04, 2020 Jul NEWA >D> AB 20MG A 214031 004 Aug 04, 2020 Sep CPOT >A> AB EQ 20MG BASE A 214031 004 Aug 04, 2020 Sep CPOT AB 20MG A 214031 004 Aug 04, 2020 Jul NEWA >D> @ AMNEAL PHARMS CO 5MG A 210738 001 Oct 31, 2018 Sep CPOT >A> @ EQ 5MG BASE A 210738 001 Oct 31, 2018 Sep CPOT >D> @ 10MG A 210738 002 Oct 31, 2018 Sep CPOT >A> @ EQ 10MG BASE A 210738 002 Oct 31, 2018 Sep CPOT >D> @ 20MG A 210738 003 Oct 31, 2018 Sep CPOT >A> @ EQ 20MG BASE A 210738 003 Oct 31, 2018 Sep CPOT >D> AB CROSSMEDIKA SA 2.5MG A 209057 001 Oct 31, 2018 Sep CPOT >A> AB EQ 2.5MG BASE A 209057 001 Oct 31, 2018 Sep CPOT >D> AB 5MG A 209057 002 Oct 31, 2018 Sep CPOT >A> AB EQ 5MG BASE A 209057 002 Oct 31, 2018 Sep CPOT >D> AB 10MG A 209057 003 Oct 31, 2018 Sep CPOT >A> AB EQ 10MG BASE A 209057 003 Oct 31, 2018 Sep CPOT >D> AB 20MG A 209057 004 Oct 31, 2018 Sep CPOT >A> AB EQ 20MG BASE A 209057 004 Oct 31, 2018 Sep CPOT >D> AB MACLEODS PHARMS LTD 2.5MG A 204632 001 Oct 22, 2019 Sep CPOT >A> AB EQ 2.5MG BASE A 204632 001 Oct 22, 2019 Sep CPOT >D> AB 5MG A 204632 002 Oct 22, 2019 Sep CPOT >A> AB EQ 5MG BASE A 204632 002 Oct 22, 2019 Sep CPOT >D> AB 10MG A 204632 003 Oct 22, 2019 Sep CPOT >A> AB EQ 10MG BASE A 204632 003 Oct 22, 2019 Sep CPOT >D> AB 20MG A 204632 004 Oct 22, 2019 Sep CPOT >A> AB EQ 20MG BASE A 204632 004 Oct 22, 2019 Sep CPOT >D> AB TEVA PHARMS 2.5MG A 091347 001 May 03, 2012 Sep CPOT >A> AB EQ 2.5MG BASE A 091347 001 May 03, 2012 Sep CPOT >D> AB 5MG A 091347 002 May 03, 2012 Sep CPOT >A> AB EQ 5MG BASE A 091347 002 May 03, 2012 Sep CPOT >D> AB 10MG A 091347 003 May 03, 2012 Sep CPOT >A> AB EQ 10MG BASE A 091347 003 May 03, 2012 Sep CPOT RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -117

TABLET;ORAL VARDENAFIL HYDROCHLORIDE >D> AB 20MG A 091347 004 May 03, 2012 Sep CPOT >A> AB EQ 20MG BASE A 091347 004 May 03, 2012 Sep CPOT >D> AB ZYDUS PHARMS 2.5MG A 208960 001 Oct 31, 2018 Sep CPOT >A> AB EQ 2.5MG BASE A 208960 001 Oct 31, 2018 Sep CPOT >D> AB 5MG A 208960 002 Oct 31, 2018 Sep CPOT >A> AB EQ 5MG BASE A 208960 002 Oct 31, 2018 Sep CPOT >D> AB 10MG A 208960 003 Oct 31, 2018 Sep CPOT >A> AB EQ 10MG BASE A 208960 003 Oct 31, 2018 Sep CPOT >D> AB 20MG A 208960 004 Oct 31, 2018 Sep CPOT >A> AB EQ 20MG BASE A 208960 004 Oct 31, 2018 Sep CPOT TABLET, ORALLY DISINTEGRATING;ORAL VARDENAFIL HYDROCHLORIDE AB MACLEODS PHARMS LTD 10MG A 205988 001 Mar 10, 2020 Feb NEWA

VASOPRESSIN SOLUTION;INTRAVENOUS VASOPRESSIN +! AM REGENT 20UNITS/ML (20UNITS/ML) N 212593 001 Aug 03, 2020 Aug NEWA VASOSTRICT +! PAR STERILE PRODUCTS 40UNITS/100ML (0.4UNITS/ML) N 204485 003 Apr 15, 2020 Apr NEWA +! 60UNITS/100ML (0.6UNITS/ML) N 204485 004 Apr 15, 2020 Apr NEWA

VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EFFEXOR XR AB + UPJOHN EQ 37.5MG BASE N 020699 001 Oct 20, 1997 Jun CAHN AB + EQ 75MG BASE N 020699 002 Oct 20, 1997 Jun CAHN @ EQ 100MG BASE N 020699 003 Oct 20, 1997 Jun CAHN AB +! EQ 150MG BASE N 020699 004 Oct 20, 1997 Jun CAHN VENLAFAXINE HYDROCHLORIDE AB INVENTIA HLTHCARE EQ 37.5MG BASE A 203332 001 Mar 12, 2020 Mar NEWA AB EQ 75MG BASE A 203332 002 Mar 12, 2020 Mar NEWA AB EQ 150MG BASE A 203332 003 Mar 12, 2020 Mar NEWA

VERAPAMIL HYDROCHLORIDE INJECTABLE;INJECTION VERAPAMIL HYDROCHLORIDE >D> AUROBINDO PHARMA LTD 2.5MG/ML A 212965 001 Jul 06, 2020 Sep CHRS >A> ! 2.5MG/ML A 212965 001 Jul 06, 2020 Sep CHRS 2.5MG/ML A 212965 001 Jul 06, 2020 Jul NEWA SOLUTION;INTRAVENOUS VERAPAMIL HYDROCHLORIDE >A> AP AREVA PHARMS 5MG/2ML (2.5MG/ML) A 213352 002 Sep 16, 2020 Sep NEWA AP 10MG/4ML (2.5MG/ML) A 213352 001 Mar 17, 2020 Mar NEWA AP CAPLIN 5MG/2ML (2.5MG/ML) A 213232 001 Mar 25, 2020 Mar NEWA AP 10MG/4ML (2.5MG/ML) A 213232 002 Mar 25, 2020 Mar NEWA TABLET;ORAL CALAN @ PFIZER 40MG N 018817 003 Feb 23, 1988 Jul CAHN + @ 80MG N 018817 001 Sep 10, 1984 Jul CAHN + @ 120MG N 018817 002 Sep 10, 1984 Jul CAHN @ 160MG N 018817 004 Feb 23, 1988 Jul CAHN TABLET, EXTENDED RELEASE;ORAL COVERA-HS @ PFIZER 180MG N 020552 001 Feb 26, 1996 Aug CAHN @ 240MG N 020552 002 Feb 26, 1996 Aug CAHN

VIGABATRIN FOR SOLUTION;ORAL VIGABATRIN AA GRANULES PHARMS 500MG/PACKET A 213469 001 Apr 24, 2020 Apr NEWA

VILAZODONE HYDROCHLORIDE TABLET;ORAL VILAZODONE HYDROCHLORIDE @ TEVA PHARMS USA 10MG A 208212 001 Sep 30, 2019 Mar DISC @ 20MG A 208212 002 Sep 30, 2019 Mar DISC @ 40MG A 208212 003 Sep 30, 2019 Mar DISC RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -118

VILTOLARSEN SOLUTION;INTRAVENOUS VILTEPSO +! NIPPON SHINYAKU 250MG/5ML (50MG/ML) N 212154 001 Aug 12, 2020 Aug NEWA

VINCRISTINE SULFATE INJECTABLE;INJECTION VINCRISTINE SULFATE PFS AP ! HOSPIRA 1MG/ML A 071484 001 Apr 19, 1988 Feb CTEC AP TEVA PHARMS USA 1MG/ML A 075493 001 Sep 01, 1999 Feb CMFD

VORICONAZOLE INJECTABLE;INTRAVENOUS VORICONAZOLE AP GLAND PHARMA LTD 200MG/VIAL A 211099 001 Mar 31, 2020 Mar NEWA TABLET;ORAL VORICONAZOLE AB RISING 50MG A 206762 001 May 24, 2016 Jul CAHN AB 200MG A 206762 002 May 24, 2016 Jul CAHN

WARFARIN SODIUM TABLET;ORAL COUMADIN >D> AB + BRISTOL MYERS SQUIBB 1MG N 009218 022 Mar 01, 1990 Sep DISC >A> + @ 1MG N 009218 022 Mar 01, 1990 Sep DISC >D> AB + 2MG N 009218 013 Sep DISC >A> + @ 2MG N 009218 013 Sep DISC >D> AB + 2.5MG N 009218 018 Sep DISC >A> + @ 2.5MG N 009218 018 Sep DISC >D> AB + 3MG N 009218 025 Nov 18, 1996 Sep DISC >A> + @ 3MG N 009218 025 Nov 18, 1996 Sep DISC >D> AB + 4MG N 009218 023 Aug 24, 1993 Sep DISC >A> + @ 4MG N 009218 023 Aug 24, 1993 Sep DISC >D> AB + 5MG N 009218 007 Sep DISC >A> + @ 5MG N 009218 007 Sep DISC >D> AB + 6MG N 009218 026 Nov 18, 1996 Sep DISC >A> + @ 6MG N 009218 026 Nov 18, 1996 Sep DISC >D> AB + 7.5MG N 009218 016 Sep DISC >A> + @ 7.5MG N 009218 016 Sep DISC >D> AB +! 10MG N 009218 005 Sep DISC >A> + @ 10MG N 009218 005 Sep DISC WARFARIN SODIUM >D> AB PLIVA 10MG A 040616 008 Jul 05, 2006 Sep CHRS >A> AB ! 10MG A 040616 008 Jul 05, 2006 Sep CHRS

ZAFIRLUKAST TABLET;ORAL ZAFIRLUKAST >A> AB ANNORA PHARMA 10MG A 212475 001 Sep 10, 2020 Sep NEWA >A> AB 20MG A 212475 002 Sep 10, 2020 Sep NEWA

ZALEPLON CAPSULE;ORAL ZALEPLON >D> AB HIKMA 5MG A 078147 001 Nov 25, 2008 Sep DISC >D> AB 10MG A 078147 002 Nov 25, 2008 Sep DISC >A> @ HIKMA PHARMS 5MG A 078147 001 Nov 25, 2008 Sep DISC >A> @ 10MG A 078147 002 Nov 25, 2008 Sep DISC @ TEVA PHARMS 5MG A 077239 001 Jun 06, 2008 Mar DISC @ 10MG A 077239 002 Jun 06, 2008 Mar DISC

ZIDOVUDINE SOLUTION;ORAL RETROVIR AA +! VIIV HLTHCARE 50MG/5ML N 019910 001 Sep 28, 1989 Jul CDFR ZIDOVUDINE AA AUROBINDO 50MG/5ML A 077268 001 Sep 19, 2005 Jul CDFR AA CIPLA LTD 50MG/5ML A 077981 001 Jun 26, 2008 Jul CDFR TABLET;ORAL ZIDOVUDINE >D> AB HIKMA 300MG A 076844 001 Sep 19, 2005 Sep DISC

RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 1 -119

TABLET;ORAL ZIDOVUDINE >A> @ 300MG A 076844 001 Sep 19, 2005 Sep DISC @ MYLAN LABS LTD 100MG N 200732 001 Feb 23, 2011 Apr CAHN

ZINC SULFATE SOLUTION;INTRAVENOUS ZINC SULFATE AM REGENT EQ 10MG BASE/10ML (EQ 1MG BASE/ML) N 209377 003 Apr 15, 2020 Apr NEWA

ZIPRASIDONE HYDROCHLORIDE CAPSULE;ORAL GEODON AB +! UPJOHN EQ 20MG BASE N 020825 001 Feb 05, 2001 Jun CAHN AB + EQ 40MG BASE N 020825 002 Feb 05, 2001 Jun CAHN AB + EQ 60MG BASE N 020825 003 Feb 05, 2001 Jun CAHN AB + EQ 80MG BASE N 020825 004 Feb 05, 2001 Jun CAHN ZIPRASIDONE HYDROCHLORIDE AB CADILA EQ 20MG BASE A 208988 001 Aug 22, 2017 Mar CMFD AB EQ 40MG BASE A 208988 002 Aug 22, 2017 Mar CMFD AB EQ 60MG BASE A 208988 003 Aug 22, 2017 Mar CMFD AB EQ 80MG BASE A 208988 004 Aug 22, 2017 Mar CMFD

ZIPRASIDONE MESYLATE INJECTABLE;INTRAMUSCULAR GEODON AP +! UPJOHN EQ 20MG BASE/ML N 020919 001 Jun 21, 2002 Jun CAHN

ZOLEDRONIC ACID INJECTABLE;INTRAVENOUS ZOLEDRONIC ACID @ EMCURE PHARMS LTD EQ 5MG BASE/100ML A 201801 001 Mar 29, 2013 Apr DISC AP INGENUS PHARMS LLC EQ 4MG BASE/5ML A 208968 001 Feb 19, 2020 Feb NEWA AP PUNISKA EQ 4MG BASE/100ML A 210174 001 Oct 27, 2017 May CAHN

ZOLMITRIPTAN TABLET;ORAL ZOLMITRIPTAN AB APPCO 2.5MG A 206973 001 Jun 30, 2017 Mar CAHN AB 5MG A 206973 002 Jun 30, 2017 Mar CAHN TABLET, ORALLY DISINTEGRATING;ORAL ZOLMITRIPTAN @ MYLAN 2.5MG A 202855 001 Sep 20, 2019 Feb DISC @ 5MG A 202855 002 Sep 20, 2019 Feb DISC

ZOLPIDEM TARTRATE TABLET;ORAL ZOLPIDEM TARTRATE @ VINTAGE 5MG A 078616 001 Nov 21, 2008 Jun DISC @ 10MG A 078616 002 Nov 21, 2008 Jun DISC @ YUNG SHIN PHARM 5MG A 077990 001 Apr 23, 2007 Apr DISC @ 10MG A 077990 002 Apr 23, 2007 Apr DISC TABLET, EXTENDED RELEASE;ORAL ZOLPIDEM TARTRATE >A> AB BRECKENRIDGE 6.25MG A 213592 001 Jun 04, 2020 Sep CAHN >A> AB 12.5MG A 213592 002 Jun 04, 2020 Sep CAHN >D> AB CENTAUR PHARMS PVT 6.25MG A 213592 001 Jun 04, 2020 Sep CAHN AB 6.25MG A 213592 001 Jun 04, 2020 Jun NEWA >D> AB 12.5MG A 213592 002 Jun 04, 2020 Sep CAHN AB 12.5MG A 213592 002 Jun 04, 2020 Jun NEWA

ZONISAMIDE CAPSULE;ORAL ZONISAMIDE AB AUROBINDO PHARMA LTD 25MG A 077645 002 Sep 29, 2006 Mar CMFD AB 50MG A 077645 003 Sep 29, 2006 Mar CMFD AB 100MG A 077645 001 Dec 22, 2005 Mar CMFD OTC DRUG PRODUCT LIST - 40TH EDITION OTC DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 2 -1

ACETAMINOPHEN; IBUPROFEN TABLET;ORAL ADVIL DUAL ACTION WITH ACETAMINOPHEN +! GLAXOSMITHKLINE 250MG;125MG N 211733 001 Feb 28, 2020 Apr CAHN +! PFIZER INC 250MG;125MG N 211733 001 Feb 28, 2020 Feb NEWA

ADAPALENE GEL;TOPICAL ADAPALENE GLENMARK GENERICS 0.1% A 091314 001 Jul 01, 2010 Mar CMS1 P AND L 0.1% A 090962 001 Jun 02, 2010 Apr CMS1

CETIRIZINE HYDROCHLORIDE CAPSULE;ORAL CETIRIZINE HYDROCHLORIDE ALLERGY >A> CATALENT 10MG A 213105 001 Sep 21, 2020 Sep NEWA TABLET, ORALLY DISINTEGRATING;ORAL CETIRIZINE HYDROCHLORIDE >A> AUROBINDO PHARMA LTD 10MG A 213557 001 Sep 11, 2020 Sep NEWA

CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE PERRIGO R AND D 5MG;120MG A 210719 001 Nov 16, 2018 Mar CMFD

DICLOFENAC SODIUM GEL;TOPICAL DICLOFENAC SODIUM AMNEAL PHARMS 1% A 208077 001 Mar 18, 2016 Aug CMS1 ENCUBE 1% A 210986 001 Jan 27, 2020 Aug CMS1 MYLAN 1% A 204306 001 May 06, 2019 Aug CMS1 PERRIGO UK FINCO 1% A 211253 001 May 16, 2019 Apr CMS1 VOLTAREN ARTHRITIS PAIN +! GLAXOSMITHKLINE CONS 1% N 022122 001 Oct 17, 2007 Mar CTNA +! 1% N 022122 001 Oct 17, 2007 Mar CMS1

DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM TABLET;ORAL NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE >A> GRANULES 25MG;220MG A 213663 001 Sep 24, 2020 Sep NEWA

ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE;ORAL ESOMEPRAZOLE MAGNESIUM HETERO LABS LTD III EQ 20MG BASE A 208939 001 May 28, 2020 May NEWA EQ 20MG BASE A 212507 001 Jun 02, 2020 May NEWA SUN PHARM EQ 20MG BASE A 212866 001 May 04, 2020 Apr NEWA TABLET, DELAYED RELEASE;ORAL ESOMEPRAZOLE MAGNESIUM DR REDDYS LABS LTD EQ 20MG BASE A 211571 001 May 14, 2020 May NEWA MYLAN EQ 20MG BASE A 212088 001 Jun 25, 2020 Jun NEWA

FAMOTIDINE TABLET;ORAL FAMOTIDINE DR REDDYS LABS LTD 10MG A 077367 002 Aug 17, 2001 Jan CMS1 @ MYLAN 10MG A 075674 001 Dec 21, 2001 Jan DISC @ TEVA 10MG A 075312 001 May 31, 2001 Mar DISC

FEXOFENADINE HYDROCHLORIDE TABLET;ORAL FEXOFENADINE HYDROCHLORIDE @ L PERRIGO CO 60MG A 212971 001 Feb 24, 2020 Jul DISC 60MG A 212971 001 Feb 24, 2020 Feb NEWA @ 180MG A 212971 002 Feb 24, 2020 Jul DISC 180MG A 212971 002 Feb 24, 2020 Feb NEWA FEXOFENADINE HYDROCHLORIDE ALLERGY @ GRANULES 60MG A 211075 001 Oct 18, 2019 May DISC @ 180MG A 211075 002 Oct 18, 2019 May DISC OTC DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 2 -2

GUAIFENESIN TABLET, EXTENDED RELEASE;ORAL GUAIFENESIN GRANULES 600MG A 213420 001 May 08, 2020 Apr NEWA 1.2GM A 213420 002 May 08, 2020 Apr NEWA

GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE >D> AUROBINDO PHARMA LTD 600MG;60MG A 213203 001 Mar 25, 2020 Sep DISC >A> @ 600MG;60MG A 213203 001 Mar 25, 2020 Sep DISC 600MG;60MG A 213203 001 Mar 25, 2020 Mar NEWA >D> 1.2GM;120MG A 213203 002 Mar 25, 2020 Sep DISC >A> @ 1.2GM;120MG A 213203 002 Mar 25, 2020 Sep DISC 1.2GM;120MG A 213203 002 Mar 25, 2020 Mar NEWA SUN PHARM INDS INC 600MG;60MG A 212542 001 Apr 28, 2020 Apr NEWA 1.2GM;120MG A 212542 002 Apr 28, 2020 Apr NEWA

IBUPROFEN TABLET;ORAL ADVIL +! GLAXOSMITHKLINE 200MG N 018989 001 May 18, 1984 Aug CHRS + 200MG N 018989 001 May 18, 1984 Aug CRLD IBUPROFEN >A> SHANDONG XINHUA 200MG A 207095 002 Aug 21, 2018 Sep CMS1 @ ULTRATAB LABS INC 200MG A 209076 001 Jan 06, 2020 Jun DISC @ VINTAGE PHARMS 200MG A 071639 001 Feb 02, 1988 Jul DISC

KETOTIFEN FUMARATE SOLUTION/DROPS;OPHTHALMIC ALAWAY >A> BAUSCH EQ 0.035% BASE A 208158 001 Sep 24, 2020 Sep NEWA KETOTIFEN FUMARATE BAYSHORE PHARMS LLC EQ 0.025% BASE A 204059 001 Jun 01, 2020 May NEWA

LEVOCETIRIZINE DIHYDROCHLORIDE TABLET;ORAL LEVOCETIRIZINE DIHYDROCHLORIDE HETERO LABS LTD III 5MG A 213513 001 Apr 29, 2020 Apr NEWA PERRIGO R AND D 5MG A 211983 001 Mar 28, 2019 Feb CMFD

LEVONORGESTREL TABLET;ORAL LEVONORGESTREL APOTEX 1.5MG A 205329 001 Sep 18, 2018 Jan CMFD LABORATOIRE HRA 1.5MG A 204044 001 Jul 03, 2018 Jan CAHN @ NAARI PTE LTD 1.5MG A 207660 001 May 02, 2019 Jun CAHN XIROMED 1.5MG A 205329 001 Sep 18, 2018 Feb CAHN

LORATADINE CAPSULE;ORAL LORATADINE BIONPHARMA INC 10MG A 202538 001 Dec 21, 2018 May CMFD @ STRIDES PHARMA 10MG A 211926 001 Jan 15, 2020 Jul DISC SYRUP;ORAL LORATADINE @ TEVA 1MG/ML A 075505 001 Nov 07, 2003 Apr DISC TABLET;ORAL LORATADINE @ MYLAN 10MG A 075790 001 Nov 07, 2008 Jan DISC @ 10MG A 078447 001 Aug 12, 2011 Jan DISC TABLET, ORALLY DISINTEGRATING;ORAL ALAVERT >A> FDN CONSUMER 10MG N 021375 001 Dec 19, 2002 Sep CAHN >D> GLAXOSMITHKLINE 10MG N 021375 001 Dec 19, 2002 Sep CAHN LORATADINE @ ACTAVIS LABS FL INC 10MG A 075990 001 Nov 03, 2003 Apr DISC >A> RUBICON 10MG A 214280 001 Sep 10, 2020 Sep NEWA >A> TENSHI 5MG A 212795 001 Sep 18, 2020 Sep NEWA OTC DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 2 -3

NAPROXEN SODIUM TABLET;ORAL NAPROXEN SODIUM @ YICHANG HUMANWELL 220MG A 212033 001 Aug 30, 2019 Mar DISC

NICOTINE POLACRILEX TROCHE/LOZENGE;ORAL NICOTINE POLACRILEX DR REDDYS LABS SA EQ 2MG BASE A 212983 001 Feb 21, 2020 Feb NEWA EQ 2MG BASE A 213233 001 Aug 04, 2020 Jul NEWA EQ 4MG BASE A 212983 002 Feb 21, 2020 Feb NEWA EQ 4MG BASE A 213233 002 Aug 04, 2020 Jul NEWA P AND L EQ 2MG BASE A 212057 001 May 14, 2020 May NEWA EQ 4MG BASE A 212057 002 May 14, 2020 May NEWA

NONOXYNOL-9 SPONGE;VAGINAL TODAY + @ MAYER LABS INC 1GM N 018683 001 Apr 01, 1983 Mar DISC

OLOPATADINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC OLOPATADINE HYDROCHLORIDE APOTEX EQ 0.1% BASE A 078350 001 Dec 07, 2015 Aug CMS1 AUROBINDO PHARMA LTD EQ 0.1% BASE A 204812 001 Dec 18, 2015 Aug CMS1 EQ 0.2% BASE A 209995 001 Apr 04, 2019 Aug CMS1 GLAND PHARMA LTD EQ 0.1% BASE A 209619 001 Aug 02, 2019 Jul CMS1 EQ 0.2% BASE A 209752 001 May 20, 2020 May NFTG MICRO LABS LTD INDIA EQ 0.2% BASE A 204620 001 Jun 16, 2020 Jun NEWA PATADAY ONCE DAILY RELIEF +! ALCON LABS INC EQ 0.2% BASE N 021545 001 Dec 22, 2004 Aug CAHN +! EQ 0.7% BASE N 206276 001 Jan 30, 2015 Aug CAHN +! NOVARTIS EQ 0.2% BASE N 021545 001 Dec 22, 2004 Mar CTNA +! EQ 0.2% BASE N 021545 001 Dec 22, 2004 Mar CMS1 +! EQ 0.7% BASE N 206276 001 Jan 30, 2015 Jul CTNA +! EQ 0.7% BASE N 206276 001 Jan 30, 2015 Jul CMS1 PATADAY TWICE DAILY RELIEF +! ALCON LABS INC EQ 0.1% BASE N 020688 001 Dec 18, 1996 Aug CAHN +! NOVARTIS EQ 0.1% BASE N 020688 001 Dec 18, 1996 Mar CTNA +! EQ 0.1% BASE N 020688 001 Dec 18, 1996 Mar CMS1

OMEPRAZOLE MAGNESIUM TABLET, DELAYED RELEASE;ORAL OMEPRAZOLE MAGNESIUM HETERO LABS LTD III EQ 20MG BASE A 211732 001 Mar 25, 2020 Mar NEWA P AND L EQ 20MG BASE A 206582 001 Jun 01, 2020 May NEWA

OMEPRAZOLE; SODIUM BICARBONATE CAPSULE;ORAL OMEPRAZOLE AND SODIUM BICARBONATE >D> @ ACTAVIS ELIZABETH 20MG;1.1GM A 204137 001 Jul 15, 2016 Sep CAHN @ 20MG;1.1GM A 204137 001 Jul 15, 2016 Mar DISC >D> PAR PHARM 20MG;1.1GM A 201946 001 Jul 15, 2016 Sep DISC >A> @ 20MG;1.1GM A 201946 001 Jul 15, 2016 Sep DISC >A> @ UNICORN 20MG;1.1GM A 204137 001 Jul 15, 2016 Sep CAHN

POLYETHYLENE GLYCOL 3350 FOR SOLUTION;ORAL GLYCOLAX LANNETT CO INC 17GM/PACKET A 090600 001 Oct 06, 2009 Jan CMFD 17GM/SCOOPFUL A 090600 002 Oct 06, 2009 Jan CMFD POLYETHYLENE GLYCOL 3350 LGM PHARMA 17GM/SCOOPFUL A 090812 001 Oct 07, 2009 Aug CAHN

RANITIDINE HYDROCHLORIDE TABLET;ORAL RANITIDINE HYDROCHLORIDE @ APOTEX INC EQ 75MG BASE A 075167 001 May 04, 2000 May DISC @ EQ 150MG BASE A 200172 001 May 31, 2012 Apr DISC @ STRIDES PHARMA EQ 75MG BASE A 201745 001 Feb 29, 2012 Apr DISC @ EQ 75MG BASE A 209160 001 Mar 05, 2018 Apr DISC OTC DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020 2 -4

TABLET;ORAL RANITIDINE HYDROCHLORIDE @ EQ 150MG BASE A 200536 001 Jun 28, 2011 Apr DISC @ EQ 150MG BASE A 209161 001 Feb 22, 2018 Apr DISC

3-1

DRUG PRODUCTS WITH APPROVAL UNDER SECTION 505 OF THE ACT ADMINISTERED BY THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH LIST

CUMULATIVE SUPPLEMENT NUMBER 09 SEPTEMBER 2020

NO SEPTEMBER 2020 APPROVALS

4-1

ORPHAN PRODUCT DESIGNATIONS AND APPROVALS LIST

The list of Orphan Designations and Approvals is available at: https://www.fda.gov/industry/developing-products-rare-diseases- conditions/designating-orphan-product-drugs-and-biological-products.

5-1

DRUG PRODUCTS WHICH MUST DEMONSTRATE IN VIVO BIOAVAILABILITY ONLY IF PRODUCT FAILS TO ACHIEVE ADEQUATE DISSOLUTION

NO SEPTEMBER 2020 ADDITIONS PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST - 40TH EDITION A - 1 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

ABALOPARATIDE - TYMLOS N 208743 001 7803770 Apr 28, 2031 U-2009

ABAMETAPIR - XEGLYZE N 206966 001 10292389 Dec 17, 2034 DP U-2863 NCE Jul 31, 2025 7812163 Oct 28, 2026 DP U-2863 8212038 Jul 16, 2024 DP U-2863 9357783 Jul 16, 2024 DP 9839631 Jul 16, 2024 DS DP U-2863

ACETAMINOPHEN; BUTALBITAL - BUTALBITAL AND ACETAMINOPHEN A 213115 001 CGT Jul 28, 2020

ACETAMINOPHEN; IBUPROFEN - ADVIL DUAL ACTION WITH ACETAMINOPHEN N 211733 001 NP Feb 28, 2023

ACLIDINIUM BROMIDE - TUDORZA PRESSAIR N 202450 001 10588895 Jul 07, 2020 U-2772 M-256 Mar 29, 2022

ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE - DUAKLIR PRESSAIR N 210595 001 10588895 Jul 07, 2020 U-2772

AFATINIB DIMALEATE - GILOTRIF N 201292 001 RE43431 Jan 13, 2026 DS

AFATINIB DIMALEATE - GILOTRIF N 201292 002 RE43431 Jan 13, 2026 DS

AFATINIB DIMALEATE - GILOTRIF N 201292 003 RE43431 Jan 13, 2026 DS

ALBUTEROL SULFATE - PROAIR HFA N 021457 001 10561808 Jan 01, 2032 DP 10695512 May 18, 2031 DP

ALBUTEROL SULFATE - PROAIR RESPICLICK N 205636 001 10561808 Jan 01, 2032 DP >A> 10765820 May 19, 2025 DP

ALBUTEROL SULFATE - PROAIR DIGIHALER N 205636 002 10561808 Jan 01, 2032 DP 10569034 Aug 16, 2036 DP >A> 10765820 May 19, 2025 DP

ALCAFTADINE - LASTACAFT N 022134 001 10617695 Mar 19, 2027 DP U-1493

ALECTINIB HYDROCHLORIDE - ALECENSA N 208434 001 10350214 Apr 24, 2035 DP

AMANTADINE HYDROCHLORIDE - GOCOVRI N 208944 001 10646456 Jun 17, 2034 U-2808

AMANTADINE HYDROCHLORIDE - GOCOVRI N 208944 002 10646456 Jun 17, 2034 U-2808

AMIKACIN SULFATE - ARIKAYCE KIT N 207356 001 >A> 10751355 May 15, 2035 U-2414 A - 2 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

AMISULPRIDE - BARHEMSYS N 209510 001 10525033 Mar 10, 2031 DP NCE Feb 26, 2025 9084765 Mar 10, 2031 U-1744 9084765 Mar 10, 2031 U-2754 9545426 Mar 10, 2031 U-1744 9545426 Mar 10, 2031 U-2754 9889118 Mar 10, 2031 U-1744 9889118 Mar 10, 2031 U-2754

AMLODIPINE BENZOATE - KATERZIA N 211340 001 10695329 Oct 16, 2037 DP

AMLODIPINE BESYLATE; CELECOXIB - CONSENSI N 210045 001 >A> 9408837 Feb 28, 2030 U-2410

AMLODIPINE BESYLATE; CELECOXIB - CONSENSI N 210045 002 >A> 9408837 Feb 28, 2030 U-2410

AMLODIPINE BESYLATE; CELECOXIB - CONSENSI N 210045 003 >A> 9408837 Feb 28, 2030 U-2410

ANGIOTENSIN II ACETATE - GIAPREZA N 209360 001 10548943 Dec 16, 2029 U-2739 10548943 Dec 16, 2029 U-2740

ANGIOTENSIN II ACETATE - GIAPREZA N 209360 002 10548943 Dec 16, 2029 U-2739 10548943 Dec 16, 2029 U-2740

APOMORPHINE HYDROCHLORIDE - KYNMOBI N 210875 001 10420763 Jun 11, 2030 DP U-2825 NP May 21, 2023 10449146 Apr 19, 2036 U-2825 8414922 Dec 16, 2031 DP U-2825 8603514 Apr 03, 2024 DP 8663687 Feb 02, 2023 DP 8765167 Feb 20, 2024 DP 8846074 Dec 16, 2031 DP U-2825 9044475 Jun 11, 2030 DP 9283219 Jun 11, 2030 DP U-2825 9326981 Jun 11, 2030 U-2825 9669019 Jun 11, 2030 DP U-2825 9669021 Jun 11, 2030 U-2825 9855221 Feb 14, 2022 DP 9931305 Feb 14, 2022 DP

APOMORPHINE HYDROCHLORIDE - KYNMOBI N 210875 002 10420763 Jun 11, 2030 DP U-2825 NP May 21, 2023 10449146 Apr 19, 2036 U-2825 8414922 Dec 16, 2031 DP U-2825 8603514 Apr 03, 2024 DP 8663687 Feb 02, 2023 DP 8765167 Feb 20, 2024 DP 8846074 Dec 16, 2031 DP U-2825 9044475 Jun 11, 2030 DP 9283219 Jun 11, 2030 DP U-2825 9326981 Jun 11, 2030 U-2825 9669019 Jun 11, 2030 DP U-2825 9669021 Jun 11, 2030 U-2825 9855221 Feb 14, 2022 DP 9931305 Feb 14, 2022 DP

APOMORPHINE HYDROCHLORIDE - KYNMOBI N 210875 003 10420763 Jun 11, 2030 DP U-2825 NP May 21, 2023 10449146 Apr 19, 2036 U-2825 8414922 Dec 16, 2031 DP U-2825 8603514 Apr 03, 2024 DP A - 3 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

APOMORPHINE HYDROCHLORIDE - KYNMOBI N 210875 003 8663687 Feb 02, 2023 DP 8765167 Feb 20, 2024 DP 8846074 Dec 16, 2031 DP U-2825 9044475 Jun 11, 2030 DP 9283219 Jun 11, 2030 DP U-2825 9326981 Jun 11, 2030 U-2825 9669019 Jun 11, 2030 DP U-2825 9669021 Jun 11, 2030 U-2825 9855221 Feb 14, 2022 DP 9931305 Feb 14, 2022 DP

APOMORPHINE HYDROCHLORIDE - KYNMOBI N 210875 004 10420763 Jun 11, 2030 DP U-2825 NP May 21, 2023 10449146 Apr 19, 2036 U-2825 8414922 Dec 16, 2031 DP U-2825 8603514 Apr 03, 2024 DP 8663687 Feb 02, 2023 DP 8765167 Feb 20, 2024 DP 8846074 Dec 16, 2031 DP U-2825 9044475 Jun 11, 2030 DP 9283219 Jun 11, 2030 DP U-2825 9326981 Jun 11, 2030 U-2825 9669019 Jun 11, 2030 DP U-2825 9669021 Jun 11, 2030 U-2825 9855221 Feb 14, 2022 DP 9931305 Feb 14, 2022 DP

APOMORPHINE HYDROCHLORIDE - KYNMOBI N 210875 005 10420763 Jun 11, 2030 DP U-2825 NP May 21, 2023 10449146 Apr 19, 2036 U-2825 8414922 Dec 16, 2031 DP U-2825 8603514 Apr 03, 2024 DP 8663687 Feb 02, 2023 DP 8765167 Feb 20, 2024 DP 8846074 Dec 16, 2031 DP U-2825 9044475 Jun 11, 2030 DP 9283219 Jun 11, 2030 DP U-2825 9326981 Jun 11, 2030 U-2825 9669019 Jun 11, 2030 DP U-2825 9669021 Jun 11, 2030 U-2825 9855221 Feb 14, 2022 DP 9931305 Feb 14, 2022 DP

APREMILAST - OTEZLA N 205437 001 M-257 Apr 10, 2023

APREMILAST - OTEZLA N 205437 002 M-257 Apr 10, 2023

APREMILAST - OTEZLA N 205437 003 M-257 Apr 10, 2023

APREPITANT - CINVANTI N 209296 001 10624850 Sep 18, 2035 U-2161

ARIPIPRAZOLE - ABILIFY MAINTENA KIT N 202971 001 10525057 Mar 08, 2034 U-1632 10525057 Mar 08, 2034 U-2723 10525057 Mar 08, 2034 U-543

ARIPIPRAZOLE - ABILIFY MAINTENA KIT N 202971 002 10525057 Mar 08, 2034 U-1632 10525057 Mar 08, 2034 U-2723 10525057 Mar 08, 2034 U-543 A - 4 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

ARIPIPRAZOLE - ABILIFY MAINTENA KIT N 202971 003 10525057 Mar 08, 2034 U-1632 10525057 Mar 08, 2034 U-2723 10525057 Mar 08, 2034 U-543

ARIPIPRAZOLE - ABILIFY MAINTENA KIT N 202971 004 10525057 Mar 08, 2034 U-1632 10525057 Mar 08, 2034 U-2723 10525057 Mar 08, 2034 U-543

ARIPIPRAZOLE - ABILIFY MYCITE KIT N 207202 001 10441194 Jul 26, 2029 DP 10517507 Jun 13, 2032 DP

ARIPIPRAZOLE - ABILIFY MYCITE KIT N 207202 002 10441194 Jul 26, 2029 DP 10517507 Jun 13, 2032 DP

ARIPIPRAZOLE - ABILIFY MYCITE KIT N 207202 003 10441194 Jul 26, 2029 DP 10517507 Jun 13, 2032 DP

ARIPIPRAZOLE - ABILIFY MYCITE KIT N 207202 004 10441194 Jul 26, 2029 DP 10517507 Jun 13, 2032 DP

ARIPIPRAZOLE - ABILIFY MYCITE KIT N 207202 005 10441194 Jul 26, 2029 DP 10517507 Jun 13, 2032 DP

ARIPIPRAZOLE - ABILIFY MYCITE KIT N 207202 006 10441194 Jul 26, 2029 DP 10517507 Jun 13, 2032 DP

ARIPIPRAZOLE LAUROXIL - ARISTADA INITIO KIT N 209830 001 10688091 Aug 17, 2035 DP

ARTESUNATE - ARTESUNATE N 213036 001 NCE May 26, 2025 ODE-290 May 26, 2027

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE - PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID A 090145 001 PC Feb 27, 2021

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE - PLENVU N 209381 001 10646512 Mar 25, 2032 DP >A> 10780112 Mar 09, 2032 DP

ASENAPINE - SECUADO N 212268 001 10583121 Jul 25, 2033 DP U-2763

ASENAPINE - SECUADO N 212268 002 10583121 Jul 25, 2033 DP U-2763

ASENAPINE - SECUADO N 212268 003 10583121 Jul 25, 2033 DP U-2763

ATAZANAVIR SULFATE; COBICISTAT - EVOTAZ N 206353 001 >A> 10039718 Oct 06, 2032 DP A - 5 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

AVAPRITINIB - AYVAKIT N 212608 001 9200002 Oct 15, 2034 DS DP U-2726 NCE Jan 09, 2025 9944651 Oct 15, 2034 DS DP U-2726 9994575 Oct 15, 2034 DS DP U-2726

AVAPRITINIB - AYVAKIT N 212608 002 9200002 Oct 15, 2034 DS DP U-2726 NCE Jan 09, 2025 9944651 Oct 15, 2034 DS DP U-2726 9994575 Oct 15, 2034 DS DP U-2726

AVAPRITINIB - AYVAKIT N 212608 003 9200002 Oct 15, 2034 DS DP U-2726 NCE Jan 09, 2025 9944651 Oct 15, 2034 DS DP U-2726 9994575 Oct 15, 2034 DS DP U-2726

AVIBACTAM SODIUM; CEFTAZIDIME - AVYCAZ N 206494 001 7112592 Jan 07, 2026 DS DP U-2244 7112592 Jan 07, 2026 DS DP U-2508 7112592 Jan 07, 2026 DS DP U-282

AXITINIB - INLYTA N 202324 001 10570202 Feb 03, 2035 U-2844

AXITINIB - INLYTA N 202324 002 10570202 Feb 03, 2035 U-2844

AZACITIDINE - ONUREG N 214120 001 >A> 8846628 Jun 03, 2030 DP U-2950

AZACITIDINE - ONUREG N 214120 002 >A> 8846628 Jun 03, 2030 DP U-2950

AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE - AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE A 207712 001 PC Aug 29, 2020

BACLOFEN - OZOBAX N 208193 001 10610502 Aug 30, 2039 U-2779

BALOXAVIR MARBOXIL - XOFLUZA N 210854 001 10633397 Apr 27, 2036 U-2816

BALOXAVIR MARBOXIL - XOFLUZA N 210854 002 10633397 Apr 27, 2036 U-2816

BECLOMETHASONE DIPROPIONATE - QVAR 80 N 020911 001 10561808 Jan 01, 2032 DP 10695512 May 18, 2031 DP

BECLOMETHASONE DIPROPIONATE - QVAR 40 N 020911 002 10561808 Jan 01, 2032 DP 10695512 May 18, 2031 DP

BECLOMETHASONE DIPROPIONATE - QVAR REDIHALER N 207921 001 10561808 Jan 01, 2032 DP 10695512 May 18, 2031 DP

BECLOMETHASONE DIPROPIONATE - QVAR REDIHALER N 207921 002 10561808 Jan 01, 2032 DP 10695512 May 18, 2031 DP

BEDAQUILINE FUMARATE - SIRTURO N 204384 001 ODE-307 May 27, 2027 A - 6 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

BEDAQUILINE FUMARATE - SIRTURO N 204384 002 7498343 Dec 01, 2026 DS DP U-1321 ODE-307 May 27, 2027 8546428 Mar 19, 2029 DS DP U-1321

BEMPEDOIC ACID - NEXLETOL N 211616 001 10118881 Dec 23, 2023 U-2747 NCE Feb 21, 2025 7335799 Dec 03, 2025 DS 8497301 Dec 23, 2023 U-2747 9000041 Dec 23, 2023 U-2747 9624152 Dec 23, 2023 U-2748

BEMPEDOIC ACID; EZETIMIBE - NEXLIZET N 211617 001 10118881 Dec 23, 2023 U-2746 NCE Feb 21, 2025 7335799 Dec 03, 2025 DS NP Feb 26, 2023 8497301 Dec 23, 2023 U-2746 9000041 Dec 23, 2023 U-2746 9624152 Dec 23, 2023 U-2749

BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM - FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE N 211039 001 10293047 Nov 15, 2037 DP U-2755 10632197 Nov 15, 2037 DP U-2755

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE - ACANYA N 050819 001 10624918 Jun 03, 2029 U-916

BEPOTASTINE BESILATE - BEPREVE N 022288 001 8784789 Jan 13, 2025 DP

BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE - ENSTILAR N 207589 001 10617698 Jun 10, 2031 DP 10660908 Jun 10, 2031 DP U-2627 10682364 Jun 10, 2031 DP 10688108 Jun 10, 2031 U-2627 10716799 Jun 10, 2031 DP

BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE - WYNZORA N 213422 001 10265265 Sep 27, 2027 DP NDF Jul 20, 2023

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE - BIKTARVY N 210251 001 10548846 Nov 08, 2036 DP 7390791 Apr 17, 2025 DS DP

BIMATOPROST - DURYSTA N 211911 001 10398707 Apr 30, 2024 U-2759 NP Mar 04, 2023 10441543 Dec 19, 2026 DP 7033605 Oct 20, 2020 DP 7799336 Apr 24, 2029 DP 8206737 Apr 07, 2027 U-2759 8629185 Jul 15, 2031 DS DP 8673341 Feb 19, 2025 U-2759 9149428 Dec 19, 2026 DP 9492316 Oct 31, 2034 DP 9980974 Oct 31, 2034 U-2759

BREMELANOTIDE ACETATE - VYLEESI (AUTOINJECTOR) N 210557 001 6579968 Jun 28, 2021 DS DP 6794489 Jun 28, 2021 DS DP

BREXPIPRAZOLE - REXULTI N 205422 001 7888362 Apr 12, 2026 DS Y RE48059 Apr 12, 2026 DS A - 7 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

BREXPIPRAZOLE - REXULTI N 205422 002 7888362 Apr 12, 2026 DS Y RE48059 Apr 12, 2026 DS

BREXPIPRAZOLE - REXULTI N 205422 003 7888362 Apr 12, 2026 DS Y RE48059 Apr 12, 2026 DS

BREXPIPRAZOLE - REXULTI N 205422 004 7888362 Apr 12, 2026 DS Y RE48059 Apr 12, 2026 DS

BREXPIPRAZOLE - REXULTI N 205422 005 7888362 Apr 12, 2026 DS Y RE48059 Apr 12, 2026 DS

BREXPIPRAZOLE - REXULTI N 205422 006 7888362 Apr 12, 2026 DS Y RE48059 Apr 12, 2026 DS

BRIGATINIB - ALUNBRIG N 208772 001 10385078 Nov 10, 2035 DS DP U-2837 ODE-300 May 22, 2027 9273077 May 21, 2029 U-2837 9611283 Apr 10, 2034 U-2837

BRIGATINIB - ALUNBRIG N 208772 002 10385078 Nov 10, 2035 DS DP U-2837 ODE-300 May 22, 2027 9273077 May 21, 2029 U-2837 9611283 Apr 10, 2034 U-2837

BRIGATINIB - ALUNBRIG N 208772 003 10385078 Nov 10, 2035 DS DP U-2837 ODE-300 May 22, 2027 9273077 May 21, 2029 U-2837 9611283 Apr 10, 2034 U-2837

BRILLIANT BLUE G - TISSUEBLUE N 209569 001 NCE Dec 20, 2024 ODE-282 Dec 20, 2026

BRIVARACETAM - BRIVIACT N 205836 001 10729653 Apr 09, 2030 DP

BRIVARACETAM - BRIVIACT N 205836 002 10729653 Apr 09, 2030 DP

BRIVARACETAM - BRIVIACT N 205836 003 10729653 Apr 09, 2030 DP

BRIVARACETAM - BRIVIACT N 205836 004 10729653 Apr 09, 2030 DP

BRIVARACETAM - BRIVIACT N 205836 005 10729653 Apr 09, 2030 DP

BROMOCRIPTINE MESYLATE - CYCLOSET N 020866 001 10688094 Apr 30, 2032 U-2870 10688094 Apr 30, 2032 U-2871 10688094 Apr 30, 2032 U-2872 10688094 Apr 30, 2032 U-2873 10688094 Apr 30, 2032 U-2874 10688094 Apr 30, 2032 U-2875 10688094 Apr 30, 2032 U-2876 10688094 Apr 30, 2032 U-2877 10688094 Apr 30, 2032 U-2878 A - 8 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

BROMOCRIPTINE MESYLATE - CYCLOSET N 020866 001 10688094 Apr 30, 2032 U-2879 10688094 Apr 30, 2032 U-2880 10688094 Apr 30, 2032 U-2881 10688094 Apr 30, 2032 U-2882 10688094 Apr 30, 2032 U-2883 10688094 Apr 30, 2032 U-2884 10688094 Apr 30, 2032 U-2885 10688094 Apr 30, 2032 U-2886 10688094 Apr 30, 2032 U-2887 10688094 Apr 30, 2032 U-2888 10688155 Jun 07, 2030 U-2281 10688155 Jun 07, 2030 U-2890 10688155 Jun 07, 2030 U-2891 10688155 Jun 07, 2030 U-2892 10688155 Jun 07, 2030 U-2893 10688155 Jun 07, 2030 U-2894 10688155 Jun 07, 2030 U-2895 10688155 Jun 07, 2030 U-2896 10688155 Jun 07, 2030 U-2897 10688155 Jun 07, 2030 U-2898 10688155 Jun 07, 2030 U-2899 10688155 Jun 07, 2030 U-2900 10688155 Jun 07, 2030 U-2901 10688155 Jun 07, 2030 U-2902 10688155 Jun 07, 2030 U-2903 10688155 Jun 07, 2030 U-2904 10688155 Jun 07, 2030 U-2905 10688155 Jun 07, 2030 U-2906 10688155 Jun 07, 2030 U-2907 10688155 Jun 07, 2030 U-2908 10688155 Jun 07, 2030 U-2909 10688155 Jun 07, 2030 U-2910 10688155 Jun 07, 2030 U-2911 10688155 Jun 07, 2030 U-2912 10688155 Jun 07, 2030 U-2913 10688155 Jun 07, 2030 U-2914 10688155 Jun 07, 2030 U-2915 10688155 Jun 07, 2030 U-2916 10688155 Jun 07, 2030 U-2917 10688155 Jun 07, 2030 U-2918 10688155 Jun 07, 2030 U-2919 10688155 Jun 07, 2030 U-2920 10688155 Jun 07, 2030 U-2921 10688155 Jun 07, 2030 U-2922 10688155 Jun 07, 2030 U-2923 10688155 Jun 07, 2030 U-2924 10688155 Jun 07, 2030 U-2925 10688155 Jun 07, 2030 U-2926 10688155 Jun 07, 2030 U-2927 10688155 Jun 07, 2030 U-2928 10688155 Jun 07, 2030 U-2929 10688155 Jun 07, 2030 U-2930 10688155 Jun 07, 2030 U-2931 10688155 Jun 07, 2030 U-2932 10688155 Jun 07, 2030 U-2933 10688155 Jun 07, 2030 U-2934 10688155 Jun 07, 2030 U-2935 10688155 Jun 07, 2030 U-2936 10688155 Jun 07, 2030 U-2937

BUDESONIDE - UCERIS N 203634 001 10660858 Sep 07, 2031 DP

BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE - BREZTRI AEROSPHERE N 212122 001 10716753 May 28, 2030 DP U-2889 NC Jul 23, 2023 8324266 May 28, 2030 U-2889 8703806 May 28, 2030 U-2889 8808713 May 28, 2030 DP U-2889 A - 9 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE - BREZTRI AEROSPHERE N 212122 001 8815258 Mar 17, 2031 U-2889 9415009 May 28, 2030 U-2889 9463161 May 28, 2030 DP U-2889

BUPIVACAINE HYDROCHLORIDE - XARACOLL N 209511 001 >A> RE47826 May 20, 2029 U-2949 NP Aug 28, 2023

BUPRENORPHINE - BUPRENORPHINE A 211586 002 CGT Oct 13, 2020

BUPRENORPHINE - SUBLOCADE N 209819 001 10558394 Jun 25, 2031 DP 10592168 Jun 06, 2031 U-2489

BUPRENORPHINE - SUBLOCADE N 209819 002 10558394 Jun 25, 2031 DP 10592168 Jun 06, 2031 U-2489 10646484 Jun 22, 2038 U-2489

CABAZITAXEL - JEVTANA KIT N 201023 001 10583110 Oct 27, 2030 U-2753 10716777 Oct 27, 2030 U-2856

CALCIPOTRIENE - SORILUX N 022563 001 >A> NPP May 06, 2022 NPP Nov 05, 2022

CALCITRIOL - VECTICAL N 022087 001 >A> NPP Jul 17, 2023

CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE - XYWAV N 212690 001 10195168 Jan 11, 2033 DP NP Jul 21, 2023 10213400 Mar 15, 2033 U-2499 10675258 Jan 11, 2033 U-2938 8591922 Jan 11, 2033 DP 8731963 Dec 17, 2022 U-1110 8772306 Mar 15, 2033 U-1532 8901173 Jan 11, 2033 DP 9050302 Mar 15, 2033 U-1532 9132107 Jan 11, 2033 DP 9486426 Mar 15, 2033 U-1532

CANAGLIFLOZIN - INVOKANA N 204042 001 10617668 May 11, 2031 DP U-2441 10617668 May 11, 2031 DP U-2632 10617668 May 11, 2031 DP U-2794 10617668 May 11, 2031 DP U-2795 10617668 May 11, 2031 DP U-2796 10617668 May 11, 2031 DP U-2797 10617668 May 11, 2031 DP U-2798 10617668 May 11, 2031 DP U-2799 10617668 May 11, 2031 DP U-493

CANAGLIFLOZIN - INVOKANA N 204042 002 10617668 May 11, 2031 DP U-2441 10617668 May 11, 2031 DP U-2632 10617668 May 11, 2031 DP U-2794 10617668 May 11, 2031 DP U-2795 10617668 May 11, 2031 DP U-2796 10617668 May 11, 2031 DP U-2797 10617668 May 11, 2031 DP U-2798 10617668 May 11, 2031 DP U-2799 10617668 May 11, 2031 DP U-493 A - 10 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE - INVOKAMET N 204353 001 7943582 Feb 26, 2029 DS DP U-2441 7943582 Feb 26, 2029 DS DP U-2632 7943582 Feb 26, 2029 DS DP U-493 8222219 Apr 11, 2025 U-2441 8222219 Apr 11, 2025 U-2632 8222219 Apr 11, 2025 U-493 8513202 Dec 03, 2027 DS DP U-2441 8513202 Dec 03, 2027 DS DP U-2632 8513202 Dec 03, 2027 DS DP U-493

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE - INVOKAMET N 204353 002 7943582 Feb 26, 2029 DS DP U-2441 7943582 Feb 26, 2029 DS DP U-2632 7943582 Feb 26, 2029 DS DP U-493 8222219 Apr 11, 2025 U-2441 8222219 Apr 11, 2025 U-2632 8222219 Apr 11, 2025 U-493 8513202 Dec 03, 2027 DS DP U-2441 8513202 Dec 03, 2027 DS DP U-2632 8513202 Dec 03, 2027 DS DP U-493

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE - INVOKAMET N 204353 003 7943582 Feb 26, 2029 DS DP U-2441 7943582 Feb 26, 2029 DS DP U-2632 7943582 Feb 26, 2029 DS DP U-493 8222219 Apr 11, 2025 U-2441 8222219 Apr 11, 2025 U-2632 8222219 Apr 11, 2025 U-493 8513202 Dec 03, 2027 DS DP U-2441 8513202 Dec 03, 2027 DS DP U-2632 8513202 Dec 03, 2027 DS DP U-493

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE - INVOKAMET N 204353 004 7943582 Feb 26, 2029 DS DP U-2441 7943582 Feb 26, 2029 DS DP U-2632 7943582 Feb 26, 2029 DS DP U-493 8222219 Apr 11, 2025 U-2441 8222219 Apr 11, 2025 U-2632 8222219 Apr 11, 2025 U-493 8513202 Dec 03, 2027 DS DP U-2441 8513202 Dec 03, 2027 DS DP U-2632 8513202 Dec 03, 2027 DS DP U-493

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE - INVOKAMET XR N 205879 001 7943582 Feb 26, 2029 DS DP U-2441 7943582 Feb 26, 2029 DS DP U-2632 7943582 Feb 26, 2029 DS DP U-493 8222219 Apr 11, 2025 U-2441 8222219 Apr 11, 2025 U-2632 8222219 Apr 11, 2025 U-493 8513202 Dec 03, 2027 DS DP U-2441 8513202 Dec 03, 2027 DS DP U-2632 8513202 Dec 03, 2027 DS DP U-493

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE - INVOKAMET XR N 205879 002 7943582 Feb 26, 2029 DS DP U-2441 7943582 Feb 26, 2029 DS DP U-2632 7943582 Feb 26, 2029 DS DP U-493 8222219 Apr 11, 2025 U-2441 8222219 Apr 11, 2025 U-2632 8222219 Apr 11, 2025 U-493 8513202 Dec 03, 2027 DS DP U-2441 8513202 Dec 03, 2027 DS DP U-2632 8513202 Dec 03, 2027 DS DP U-493 A - 11 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE - INVOKAMET XR N 205879 003 7943582 Feb 26, 2029 DS DP U-2441 7943582 Feb 26, 2029 DS DP U-2632 7943582 Feb 26, 2029 DS DP U-493 8222219 Apr 11, 2025 U-2441 8222219 Apr 11, 2025 U-2632 8222219 Apr 11, 2025 U-493 8513202 Dec 03, 2027 DS DP U-2441 8513202 Dec 03, 2027 DS DP U-2632 8513202 Dec 03, 2027 DS DP U-493

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE - INVOKAMET XR N 205879 004 7943582 Feb 26, 2029 DS DP U-2441 7943582 Feb 26, 2029 DS DP U-2632 7943582 Feb 26, 2029 DS DP U-493 8222219 Apr 11, 2025 U-2441 8222219 Apr 11, 2025 U-2632 8222219 Apr 11, 2025 U-493 8513202 Dec 03, 2027 DS DP U-2441 8513202 Dec 03, 2027 DS DP U-2632 8513202 Dec 03, 2027 DS DP U-493

CANGRELOR - KENGREAL N 204958 001 8680052 Mar 09, 2033 U-1715 8680052 Mar 09, 2033 U-2869

CANNABIDIOL - EPIDIOLEX N 210365 001 10603288 Jun 17, 2035 U-2780 NPP Jul 31, 2023 10603288 Jun 17, 2035 U-2781 10603288 Jun 17, 2035 U-2782 10603288 Jun 17, 2035 U-2783 10709671 Jun 17, 2035 U-2862 10709673 Jun 17, 2035 DP 10709674 Jun 17, 2035 U-2780 10709674 Jun 17, 2035 U-2781

CAPMATINIB HYDROCHLORIDE - TABRECTA N 213591 001 10596178 Jul 22, 2035 DS DP NCE May 06, 2025 7767675 Nov 19, 2027 DS DP ODE-291 May 06, 2027 8420645 Jun 05, 2031 DS DP 8461330 Nov 19, 2027 DS DP 8901123 May 20, 2029 U-2813

CAPMATINIB HYDROCHLORIDE - TABRECTA N 213591 002 10596178 Jul 22, 2035 DS DP NCE May 06, 2025 7767675 Nov 19, 2027 DS DP ODE-291 May 06, 2027 8420645 Jun 05, 2031 DS DP 8461330 Nov 19, 2027 DS DP 8901123 May 20, 2029 U-2813

CAPSAICIN - QUTENZA N 022395 001 I-838 Jul 17, 2023

CARFILZOMIB - KYPROLIS N 202714 001 I-842 Aug 20, 2023

CARFILZOMIB - KYPROLIS N 202714 002 I-842 Aug 20, 2023

CARFILZOMIB - KYPROLIS N 202714 003 >A> 7491704 Apr 14, 2025 U-2319 I-842 Aug 20, 2023 >A> 7491704 Apr 14, 2025 U-2320 >A> 7491704 Apr 14, 2025 U-2947 >A> 8129346 Apr 14, 2025 U-2319 >A> 8129346 Apr 14, 2025 U-2320 >A> 8129346 Apr 14, 2025 U-2947 A - 12 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION DATE CODES REQUESTED CODE(S) DATE

CARFILZOMIB - KYPROLIS N 202714 003 >A> 8207127 Apr 14, 2025 U-2319 >A> 8207127 Apr 14, 2025 U-2320 >A> 8207127 Apr 14, 2025 U-2947

CEDAZURIDINE; DECITABINE - INQOVI N 212576 001 8268800 Aug 22, 2030 DS U-2864 NCE Jul 07, 2025 8268800 Aug 22, 2030 DS U-2865 8268800 Aug 22, 2030 DS U-2866 8268800 Aug 22, 2030 DS U-2867 8618075 Oct 16, 2028 U-2864 8618075 Oct 16, 2028 U-2867 9567363 Oct 16, 2028 DS

CEFTAROLINE FOSAMIL - TEFLARO N 200327 001 NPP Sep 13, 2022

CEFTAROLINE FOSAMIL - TEFLARO N 200327 002 NPP Sep 13, 2022

CELECOXIB - ELYXYB N 212157 001 10376527 May 27, 2036 DP U-2718 NP May 05, 2023 10722456 May 27, 2036 DP U-2718 9572819 May 27, 2036 DP U-2718 9795620 May 27, 2036 DP U-2718 9949990 May 27, 2036 DP U-2718

CENOBAMATE - XCOPRI N 212839 001 7598279 Oct 30, 2027 DS NCE Mar 10, 2025

CENOBAMATE - XCOPRI N 212839 002 7598279 Oct 30, 2027 DS NCE Mar 10, 2025

CENOBAMATE - XCOPRI N 212839 003 7598279 Oct 30, 2027 DS NCE Mar 10, 2025

CENOBAMATE - XCOPRI N 212839 004 7598279 Oct 30, 2027 DS NCE Mar 10, 2025

CENOBAMATE - XCOPRI N 212839 005 7598279 Oct 30, 2027 DS NCE Mar 10, 2025

CENOBAMATE - XCOPRI N 212839 006 7598279 Oct 30, 2027 DS NCE Mar 10, 2025

CERITINIB - ZYKADIA N 205755 001 7964592 Apr 29, 2028 DS DP

CERITINIB - ZYKADIA N 211225 001 7964592 Apr 29, 2028 DS DP

CILASTATIN SODIUM; IMIPENEM; RELEBACTAM - RECARBRIO N 212819 001 8487093 Nov 19, 2029 DS DP U-2586 8487093 Nov 19, 2029 DS DP U-2587 8487093 Nov 19, 2029 DS DP U-2840

CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE - PHEXXI N 208352 001 NP May 22, 2023

CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE - CLENPIQ N 209589 001 10624879 Jun 23, 2034 DP A - 13 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

CLASCOTERONE - WINLEVI N 213433 001 10159682 Aug 14, 2028 U-2942 >A> NCE Aug 26, 2025 8143240 Jan 12, 2023 U-2942 8785427 Jul 25, 2030 DP 8865690 Jul 24, 2022 U-2942 9211295 Jul 24, 2022 DP 9433628 Feb 08, 2029 DP 9486458 Jul 24, 2028 U-2942

CLOBETASOL PROPIONATE - IMPOYZ N 209483 001 10588914 Aug 31, 2030 DP U-2771

CLONIDINE - NEXICLON XR N 022500 001 8337890 Apr 17, 2027 DP 8623409 Sep 08, 2031 DP

CLONIDINE - NEXICLON XR N 022500 002 8337890 Apr 17, 2027 DP 8623409 Sep 08, 2031 DP

COBICISTAT - TYBOST N 203094 001 10039718 Oct 06, 2032 DP

COBICISTAT; DARUNAVIR - PREZCOBIX N 205395 001 10039718 Oct 06, 2032 DP >A> 8148374 Sep 03, 2029 DS DP U-1279 >A> 8148374 Sep 03, 2029 DS DP U-2939

COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE - SYMTUZA N 210455 001 10039718 Oct 06, 2032 DP 6642245 Nov 04, 2020 U-2352 6642245 Nov 04, 2020 U-2765 7390791 Apr 17, 2025 DS DP 7803788 Feb 02, 2022 U-2352 7803788 Feb 02, 2022 U-2765 8148374 Sep 03, 2029 DS DP U-2353 8148374 Sep 03, 2029 DS DP U-2364 8148374 Sep 03, 2029 DS DP U-2365 8148374 Sep 03, 2029 DS DP U-2766 8148374 Sep 03, 2029 DS DP U-2767 8148374 Sep 03, 2029 DS DP U-2768 8754065 Aug 15, 2032 DS DP U-2352 8754065 Aug 15, 2032 DS DP U-2765 9296769 Aug 15, 2032 DS DP U-2352 9296769 Aug 15, 2032 DS DP U-2765

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE - GENVOYA N 207561 001 10039718 Oct 06, 2032 DP 7390791 Apr 17, 2025 DS DP

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE - STRIBILD N 203100 001 10039718 Oct 06, 2032 DP

COBIMETINIB FUMARATE - COTELLIC N 206192 001 10590102 Jun 30, 2036 DS DP U-1776

COLCHICINE - GLOPERBA N 210942 001 10383820 Nov 22, 2036 DP U-2814 10383821 Nov 22, 2036 DP

COPPER DOTATATE CU-64 - DETECTNET N 213227 001 >A> 10159759 Aug 23, 2032 U-2951 >A> NCE Sep 03, 2025 >A> 10383961 Aug 23, 2032 U-2951 A - 14 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

CRISABOROLE - EUCRISA N 207695 001 8039451 Jun 11, 2026 DS DP NCE Dec 14, 2021 8039451*PED Dec 11, 2026 NPP Mar 23, 2023 8168614 Jan 20, 2030 U-1932 PED Jun 14, 2022 8168614*PED Jul 20, 2030 PED Sep 23, 2023 8501712 Feb 16, 2027 U-1932 8501712*PED Aug 16, 2027 9682092 Feb 16, 2027 U-1932 9682092*PED Aug 16, 2027

CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE - TRALEMENT N 209376 001 NCE Apr 30, 2024

CYSTEAMINE BITARTRATE - PROCYSBI N 203389 001 10548859 Aug 16, 2036 U-1399

CYSTEAMINE BITARTRATE - PROCYSBI N 203389 002 10548859 Aug 16, 2036 U-1399

CYSTEAMINE BITARTRATE - PROCYSBI N 213491 001 10143665 Aug 16, 2036 U-1399 M-216 Dec 22, 2020 10328037 Aug 16, 2036 U-1399 PED Jun 22, 2021 10548859 Aug 16, 2036 U-1399 8026284 Sep 22, 2027 U-1399 9173851 Jun 17, 2034 DP 9192590 Jan 26, 2027 U-1399 9198882 Jan 26, 2027 U-1399 9233077 Jun 17, 2034 DP 9925156 Jan 26, 2027 DP U-1399 9925157 Jan 26, 2027 DP U-1399 9925158 Jan 26, 2027 DP U-1399

CYSTEAMINE BITARTRATE - PROCYSBI N 213491 002 10143665 Aug 16, 2036 U-1399 M-216 Dec 22, 2020 10328037 Aug 16, 2036 U-1399 PED Jun 22, 2021 10548859 Aug 16, 2036 U-1399 8026284 Sep 22, 2027 U-1399 9173851 Jun 17, 2034 DP 9192590 Jan 26, 2027 U-1399 9198882 Jan 26, 2027 U-1399 9233077 Jun 17, 2034 DP 9925156 Jan 26, 2027 DP U-1399 9925157 Jan 26, 2027 DP U-1399 9925158 Jan 26, 2027 DP U-1399

CYSTEAMINE HYDROCHLORIDE - CYSTADROPS N 211302 001 >A> NP Aug 19, 2023

CYSTEINE HYDROCHLORIDE - ELCYS N 210660 001 10478453 Jan 15, 2039 DP U-2752 10583155 Jan 15, 2039 DP U-2752 10653719 Jan 15, 2039 DP

CYSTEINE HYDROCHLORIDE - NOURESS N 212535 001 10478453 Jan 15, 2039 DP U-2752 10493051 Mar 15, 2039 DP 10543186 Mar 15, 2039 U-2722 10583155 Jan 15, 2039 DP U-2752 10653719 Jan 15, 2039 DP 10702490 Mar 15, 2039 DP

CYTARABINE; DAUNORUBICIN - VYXEOS N 209401 001 ODE-287 Aug 03, 2024 A - 15 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

DACLATASVIR DIHYDROCHLORIDE - DAKLINZA N 206843 001 8329159 Jul 24, 2029 DS

DACLATASVIR DIHYDROCHLORIDE - DAKLINZA N 206843 002 8329159 Jul 24, 2029 DS

DAPAGLIFLOZIN - FARXIGA N 202293 001 6515117 Oct 04, 2025 DS DP U-2139 I-834 May 05, 2023 6515117 Oct 04, 2025 DS DP U-493 I-841 Oct 18, 2022

DAPAGLIFLOZIN - FARXIGA N 202293 002 6515117 Oct 04, 2025 DS DP U-2139 I-834 May 05, 2023 6515117 Oct 04, 2025 DS DP U-493 I-841 Oct 18, 2022

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE - XIGDUO XR N 205649 001 >A> 6515117 Oct 04, 2025 DS DP U-493 I-841 Oct 18, 2022

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE - XIGDUO XR N 205649 002 >A> 6515117 Oct 04, 2025 DS DP U-493 I-841 Oct 18, 2022

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE - XIGDUO XR N 205649 003 >A> 6515117 Oct 04, 2025 DS DP U-493 I-841 Oct 18, 2022

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE - XIGDUO XR N 205649 004 >A> 6515117 Oct 04, 2025 DS DP U-493 I-841 Oct 18, 2022

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE - XIGDUO XR N 205649 005 >A> 6515117 Oct 04, 2025 DS DP U-493 I-841 Oct 18, 2022

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE - QTERNMET XR N 210874 001 >A> 6515117 Oct 04, 2025 DS DP U-493

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE - QTERNMET XR N 210874 002 >A> 6515117 Oct 04, 2025 DS DP U-493

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE - QTERNMET XR N 210874 003 >A> 6515117 Oct 04, 2025 DS DP U-493

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE - QTERNMET XR N 210874 004 >A> 6515117 Oct 04, 2025 DS DP U-493

DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE - QTERN N 209091 001 >A> 6515117 Oct 04, 2025 DS DP U-493

DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE - QTERN N 209091 002 >A> 6515117 Oct 04, 2025 DS DP U-493

DAROLUTAMIDE - NUBEQA N 212099 001 10711013 Oct 27, 2030 DS DP

DEFERASIROX - EXJADE N 021882 001 M-263 Jul 23, 2023

DEFERASIROX - EXJADE N 021882 002 M-263 Jul 23, 2023

DEFERASIROX - EXJADE N 021882 003 M-263 Jul 23, 2023 A - 16 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION DATE CODES REQUESTED CODE(S) DATE

DEFERASIROX - JADENU N 206910 001 M-263 Jul 23, 2023

DEFERASIROX - JADENU N 206910 002 M-263 Jul 23, 2023

DEFERASIROX - JADENU N 206910 003 M-263 Jul 23, 2023

DEFERASIROX - JADENU SPRINKLE N 207968 001 M-263 Jul 23, 2023

DEFERASIROX - JADENU SPRINKLE N 207968 002 M-263 Jul 23, 2023

DEFERASIROX - JADENU SPRINKLE N 207968 003 M-263 Jul 23, 2023

DEFERIPRONE - FERRIPROX N 021825 002 7049328 Jun 28, 2021 U-735

DEFERIPRONE - FERRIPROX N 212269 001 7049328 Jun 28, 2021 U-735

DEGARELIX ACETATE - FIRMAGON N 022201 001 10695398 Apr 27, 2032 U-1895 10729739 Feb 10, 2029 U-1978

DEGARELIX ACETATE - FIRMAGON N 022201 002 10695398 Apr 27, 2032 U-1895 10729739 Feb 10, 2029 U-1978

DEOXYCHOLIC ACID - KYBELLA N 206333 001 10500214 Mar 02, 2030 DP

DEXAMETHASONE - OZURDEX N 022315 001 10702539 Jan 09, 2023 U-1597 10702539 Jan 09, 2023 U-2868 10702539 Jan 09, 2023 U-985

DEXAMETHASONE - DEXYCU KIT N 208912 001 10022502 Jun 22, 2034 U-2340

DEXAMETHASONE - HEMADY N 211379 001 10537585 Dec 18, 2037 DP

DIAZEPAM - VALTOCO N 211635 001 10265402 May 11, 2025 DP NP Jan 10, 2023 8895546 Mar 27, 2029 DP ODE-279 Jan 10, 2027 8927497 Jul 21, 2025 DP U-2727 9642913 May 11, 2025 DP 9763876 Mar 27, 2029 DP U-2727

DIAZEPAM - VALTOCO N 211635 002 10265402 May 11, 2025 DP NP Jan 10, 2023 8895546 Mar 27, 2029 DP ODE-279 Jan 10, 2027 8927497 Jul 21, 2025 DP U-2727 9642913 May 11, 2025 DP 9763876 Mar 27, 2029 DP U-2727

DIAZEPAM - VALTOCO N 211635 003 10265402 May 11, 2025 DP NP Jan 10, 2023 8895546 Mar 27, 2029 DP ODE-279 Jan 10, 2027 A - 17 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

DIAZEPAM - VALTOCO N 211635 003 8927497 Jul 21, 2025 DP U-2727 9642913 May 11, 2025 DP 9763876 Mar 27, 2029 DP U-2727

DICYCLOMINE HYDROCHLORIDE - DICYCLOMINE HYDROCHLORIDE A 212286 001 CGT Nov 18, 2020

DIHYDROERGOTAMINE MESYLATE - DIHYDROERGOTAMINE MESYLATE A 212907 001 CGT Nov 19, 2020

DIMETHYL FUMARATE - DIMETHYL FUMARATE A 210305 001 >A> PC Feb 14, 2021

DIMETHYL FUMARATE - DIMETHYL FUMARATE A 210305 002 >A> PC Feb 14, 2021

DIMETHYL FUMARATE - TECFIDERA N 204063 001 M-260 Feb 05, 2023

DIMETHYL FUMARATE - TECFIDERA N 204063 002 M-260 Feb 05, 2023

DOLUTEGRAVIR SODIUM - TIVICAY PD N 213983 001 8129385 Oct 05, 2027 DS DP 9242986 Dec 08, 2029 DS DP

DOLUTEGRAVIR SODIUM; LAMIVUDINE - DOVATO N 211994 001 I-839 Aug 06, 2023

DORAVIRINE - PIFELTRO N 210806 001 I-827 Sep 19, 2022

DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE - DELSTRIGO N 210807 001 10603282 Nov 29, 2036 DP

DOXEPIN HYDROCHLORIDE - SILENOR N 022036 001 10548871 Apr 11, 2028 U-620 10653660 Jul 20, 2027 U-620 10653662 May 18, 2027 U-620

DOXEPIN HYDROCHLORIDE - SILENOR N 022036 002 10548871 Apr 11, 2028 U-620 10653660 Jul 20, 2027 U-620 10653662 May 18, 2027 U-620

DROSPIRENONE - SLYND N 211367 001 10603281 Jun 08, 2031 U-2553

DULOXETINE HYDROCHLORIDE - CYMBALTA N 021427 001 NPP Apr 20, 2023

DULOXETINE HYDROCHLORIDE - CYMBALTA N 021427 002 NPP Apr 20, 2023

DULOXETINE HYDROCHLORIDE - CYMBALTA N 021427 004 NPP Apr 20, 2023

EFINACONAZOLE - JUBLIA N 203567 001 10342875 Oct 02, 2034 DP U-2720 NPP Apr 27, 2023 10478601 Apr 25, 2035 DP U-2721 A - 18 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

ELAGOLIX SODIUM - ORILISSA N 210450 001 10537572 Sep 01, 2036 U-2735 10682351 Sep 01, 2036 U-2850

ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM - ORIAHNN (COPACKAGED) N 213388 001 6872728 Jan 25, 2021 DS DP NCE Jul 23, 2023 7056927 Sep 10, 2024 DS DP NP May 29, 2023 7179815 Mar 07, 2021 U-2842 7419983 Jul 06, 2024 DS DP 7462625 Jan 25, 2021 DS DP U-2842

ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR - TRIKAFTA (COPACKAGED) N 212273 001 10646481 Aug 13, 2029 DP >A> 10758534 Oct 06, 2035 DS DP U-2645

ELUXADOLINE - VIBERZI N 206940 001 7741356 Jun 24, 2026 DS DP

ELUXADOLINE - VIBERZI N 206940 002 7741356 Jun 24, 2026 DS DP

EMPAGLIFLOZIN - JARDIANCE N 204629 001 7579449 Aug 01, 2028 DS

EMPAGLIFLOZIN - JARDIANCE N 204629 002 7579449 Aug 01, 2028 DS

EMPAGLIFLOZIN; LINAGLIPTIN - GLYXAMBI N 206073 001 7579449 Aug 01, 2028 DS M-252 Mar 30, 2023 8673927 May 04, 2027 U-1652 Y M-258 Jul 03, 2022 9173859 May 04, 2027 DP U-1772 Y

EMPAGLIFLOZIN; LINAGLIPTIN - GLYXAMBI N 206073 002 7579449 Aug 01, 2028 DS M-252 Mar 30, 2023 8673927 May 04, 2027 U-1652 Y M-258 Jul 03, 2022 9173859 May 04, 2027 DP U-1772 Y

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE - TRIJARDY XR N 212614 001 10022379 Apr 02, 2029 DP U-2732 10258637 Apr 03, 2034 U-2731 10406172 Jun 15, 2030 DP U-2733 10596120 Mar 07, 2032 DP U-2776 10596120 Mar 07, 2032 DP U-2790 6488962 Jun 20, 2020 DP 7407955 May 02, 2025 DS DP 7579449 Aug 01, 2028 DS 7713938 Apr 15, 2027 DS DP 8119648 Aug 12, 2023 U-1652 8178541 Aug 12, 2023 DP U-1652 8551957 Oct 14, 2029 DP U-2730 8883805 Nov 26, 2025 DP 9155705 May 21, 2030 DP 9415016 Apr 02, 2029 DP 9949998 Jun 11, 2034 U-2731

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE - TRIJARDY XR N 212614 002 10022379 Apr 02, 2029 DP U-2732 10258637 Apr 03, 2034 U-2731 10406172 Jun 15, 2030 DP U-2733 10596120 Mar 07, 2032 DP U-2776 10596120 Mar 07, 2032 DP U-2790 6488962 Jun 20, 2020 DP 7407955 May 02, 2025 DS DP 7579449 Aug 01, 2028 DS 7713938 Apr 15, 2027 DS DP 8119648 Aug 12, 2023 U-1652 A - 19 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE - TRIJARDY XR N 212614 002 8178541 Aug 12, 2023 DP U-1652 8551957 Oct 14, 2029 DP U-2730 8883805 Nov 26, 2025 DP 9155705 May 21, 2030 DP 9415016 Apr 02, 2029 DP 9949998 Jun 11, 2034 U-2731

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE - TRIJARDY XR N 212614 003 10022379 Apr 02, 2029 DP U-2732 10258637 Apr 03, 2034 U-2731 10406172 Jun 15, 2030 DP U-2733 10596120 Mar 07, 2032 DP U-2776 10596120 Mar 07, 2032 DP U-2790 6488962 Jun 20, 2020 DP 7407955 May 02, 2025 DS DP 7579449 Aug 01, 2028 DS 7713938 Apr 15, 2027 DS DP 8119648 Aug 12, 2023 U-1652 8178541 Aug 12, 2023 DP U-1652 8551957 Oct 14, 2029 DP U-2730 8883805 Nov 26, 2025 DP 9155705 May 21, 2030 DP 9415016 Apr 02, 2029 DP 9949998 Jun 11, 2034 U-2731

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE - TRIJARDY XR N 212614 004 10022379 Apr 02, 2029 DP U-2732 10258637 Apr 03, 2034 U-2731 10406172 Jun 15, 2030 DP U-2733 10596120 Mar 07, 2032 DP U-2776 10596120 Mar 07, 2032 DP U-2790 6488962 Jun 20, 2020 DP 7407955 May 02, 2025 DS DP 7579449 Aug 01, 2028 DS 7713938 Apr 15, 2027 DS DP 8119648 Aug 12, 2023 U-1652 8178541 Aug 12, 2023 DP U-1652 8551957 Oct 14, 2029 DP U-2730 8883805 Nov 26, 2025 DP 9155705 May 21, 2030 DP 9415016 Apr 02, 2029 DP 9949998 Jun 11, 2034 U-2731

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE - SYNJARDY N 206111 001 10610489 Sep 30, 2030 DP 7579449 Aug 01, 2028 DS

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE - SYNJARDY N 206111 002 10610489 Sep 30, 2030 DP 7579449 Aug 01, 2028 DS

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE - SYNJARDY N 206111 003 10610489 Sep 30, 2030 DP 7579449 Aug 01, 2028 DS

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE - SYNJARDY N 206111 004 10610489 Sep 30, 2030 DP 7579449 Aug 01, 2028 DS

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE - SYNJARDY XR N 208658 001 10596120 Mar 07, 2032 DP U-2775 10596120 Mar 07, 2032 DP U-2792 7579449 Aug 01, 2028 DS A - 20 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE - SYNJARDY XR N 208658 002 10596120 Mar 07, 2032 DP U-2775 10596120 Mar 07, 2032 DP U-2792 7579449 Aug 01, 2028 DS

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE - SYNJARDY XR N 208658 003 10596120 Mar 07, 2032 DP U-2775 10596120 Mar 07, 2032 DP U-2792 7579449 Aug 01, 2028 DS

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE - SYNJARDY XR N 208658 004 10596120 Mar 07, 2032 DP U-2775 10596120 Mar 07, 2032 DP U-2792 7579449 Aug 01, 2028 DS

EMTRICITABINE - EMTRICITABINE A 091168 001 >A> PC Feb 27, 2021

EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE - ODEFSEY N 208351 001 7390791 Apr 17, 2025 DS DP

EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE - DESCOVY N 208215 001 7390791 Apr 17, 2025 DS DP >A> NPP Sep 28, 2020 ODE-284 Sep 28, 2024 ODE-285 Sep 28, 2024

ENALAPRIL MALEATE - EPANED N 208686 001 >A> 10772868 Mar 25, 2036 DP

ENASIDENIB MESYLATE - IDHIFA N 209606 001 10610125 Jun 21, 2030 U-2087

ENASIDENIB MESYLATE - IDHIFA N 209606 002 10610125 Jun 21, 2030 U-2087

ENCORAFENIB - BRAFTOVI N 210496 001 I-826 Apr 08, 2023

ENCORAFENIB - BRAFTOVI N 210496 002 10005761 Aug 27, 2030 U-2335 I-826 Apr 08, 2023 10005761 Aug 27, 2030 U-2802 10005761 Aug 27, 2030 U-2803 10258622 Nov 21, 2032 U-2802 8541575 Feb 26, 2030 DS DP U-2335 8541575 Feb 26, 2030 DS DP U-2802 8541575 Feb 26, 2030 DS DP U-2803 9314464 Jul 04, 2031 U-2336 9314464 Jul 04, 2031 U-2802 9314464 Jul 04, 2031 U-2803 9474754 Aug 05, 2033 DP U-2802 9850230 Aug 27, 2030 U-2334 9850230 Aug 27, 2030 U-2802 9850230 Aug 27, 2030 U-2803

ENTRECTINIB - ROZLYTREK N 212725 001 10561651 Feb 19, 2035 U-2745 >A> ODE-313 Aug 15, 2026 >A> 10738037 May 18, 2037 DS DP U-2946

ENTRECTINIB - ROZLYTREK N 212725 002 10561651 Feb 19, 2035 U-2745 >A> ODE-313 Aug 15, 2026 >A> 10738037 May 18, 2037 DS DP U-2946 A - 21 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

ENZALUTAMIDE - XTANDI N 203415 001 8183274 Aug 24, 2026 U-1281 8183274 Aug 24, 2026 U-1588 8183274 Aug 24, 2026 U-2345 8183274 Aug 24, 2026 U-2708 9126941 May 15, 2026 U-1588 9126941 May 15, 2026 U-2345 9126941 May 15, 2026 U-2708

ENZALUTAMIDE - XTANDI N 213674 001 7709517 Aug 13, 2027 DS DP 8183274 Aug 24, 2026 U-2345 8183274 Aug 24, 2026 U-2708 9126941 May 15, 2026 U-2345 9126941 May 15, 2026 U-2708

ENZALUTAMIDE - XTANDI N 213674 002 7709517 Aug 13, 2027 DS DP 8183274 Aug 24, 2026 U-2345 8183274 Aug 24, 2026 U-2708 9126941 May 15, 2026 U-2345 9126941 May 15, 2026 U-2708

EPINEPHRINE - ADRENACLICK N 020800 003 10166334 Jan 21, 2025 DP

EPINEPHRINE - ADRENACLICK N 020800 004 10166334 Jan 21, 2025 DP

EPINEPHRINE - AUVI-Q N 201739 001 10737028 Nov 23, 2024 DP

EPINEPHRINE - AUVI-Q N 201739 002 10737028 Nov 23, 2024 DP

EPINEPHRINE - AUVI-Q N 201739 003 10737028 Nov 23, 2024 DP

ESKETAMINE HYDROCHLORIDE - SPRAVATO N 211243 001 I-840 Jul 31, 2023

ESLICARBAZEPINE ACETATE - APTIOM N 022416 001 10675287 May 06, 2025 U-2041 10675287 May 06, 2025 U-2831 10695354 May 06, 2025 U-2501 10695354 May 06, 2025 U-2831 10702536 May 06, 2025 U-2501

ESLICARBAZEPINE ACETATE - APTIOM N 022416 002 10675287 May 06, 2025 U-2041 10675287 May 06, 2025 U-2831 10695354 May 06, 2025 U-2501 10695354 May 06, 2025 U-2831 10702536 May 06, 2025 U-2501

ESLICARBAZEPINE ACETATE - APTIOM N 022416 003 10675287 May 06, 2025 U-2041 10675287 May 06, 2025 U-2831 10695354 May 06, 2025 U-2501 10695354 May 06, 2025 U-2831 10702536 May 06, 2025 U-2501 A - 22 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

ESLICARBAZEPINE ACETATE - APTIOM N 022416 004 10675287 May 06, 2025 U-2041 10675287 May 06, 2025 U-2831 10695354 May 06, 2025 U-2501 10695354 May 06, 2025 U-2831 10702536 May 06, 2025 U-2501

ESTRADIOL - IMVEXXY N 208564 001 10537581 Nov 21, 2032 DP U-2316 10537581 Nov 21, 2032 DP U-2317 10568891 Jun 18, 2033 U-2316 10568891 Jun 18, 2033 U-2317 10668082 Jun 18, 2033 U-2316 10668082 Jun 18, 2033 U-2317

ESTRADIOL - IMVEXXY N 208564 002 10537581 Nov 21, 2032 DP U-2316 10537581 Nov 21, 2032 DP U-2317 10568891 Jun 18, 2033 U-2316 10568891 Jun 18, 2033 U-2317 10668082 Jun 18, 2033 U-2316 10668082 Jun 18, 2033 U-2317

ESTRADIOL; PROGESTERONE - BIJUVA N 210132 001 10639375 Nov 21, 2032 DP 10675288 Nov 21, 2032 U-2439

ETELCALCETIDE - PARSABIV N 208325 001 8999932 Feb 07, 2031 DS DP U-2014

ETELCALCETIDE - PARSABIV N 208325 002 8999932 Feb 07, 2031 DS DP U-2014

ETELCALCETIDE - PARSABIV N 208325 003 8999932 Feb 07, 2031 DS DP U-2014

ETEPLIRSEN - EXONDYS 51 N 206488 001 10533174 May 04, 2021 DP

ETEPLIRSEN - EXONDYS 51 N 206488 002 10533174 May 04, 2021 DP

ETHINYL ESTRADIOL; LEVONORGESTREL - TWIRLA N 204017 001 7045145 Mar 14, 2021 DP U-2751 NP Feb 14, 2023 7384650 Mar 14, 2021 DP 8221784 Mar 14, 2021 DP 8221785 Mar 14, 2021 DP 8246978 Aug 26, 2028 DP 8747888 Jul 10, 2028 DP 8883196 Nov 22, 2020 DP U-2751 9050348 Jul 10, 2028 DP

ETHINYL ESTRADIOL; SEGESTERONE ACETATE - ANNOVERA N 209627 001 10632066 Feb 01, 2039 U-2786 10632066 Feb 01, 2039 U-2787 >A> 10765628 Feb 01, 2039 U-2786 >A> 10765628 Feb 01, 2039 U-2787 >A> 10780047 Feb 01, 2039 U-2786 >A> 10780047 Feb 01, 2039 U-2787

EXENATIDE SYNTHETIC - BYDUREON N 022200 001 6414126 Oct 04, 2020 DS DP U-2588 6515117 Oct 04, 2020 DS DP U-2588 6872700 Jan 14, 2020 U-2588 6872700 Jan 14, 2020 U-2589 A - 23 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

EXENATIDE SYNTHETIC - BYDUREON N 022200 001 6872700 Jan 14, 2020 U-2590 6872700 Jan 14, 2020 U-2591 6936590 Oct 04, 2020 U-2588 7456254 Jun 30, 2025 DP U-2588 7456254 Jun 30, 2025 DP U-2589 7456254 Jun 30, 2025 DP U-2590 7456254 Jun 30, 2025 DP U-2592 7612176 Apr 13, 2025 DP U-2588 7612176 Apr 13, 2025 DP U-2589 7612176 Apr 13, 2025 DP U-2590 7612176 Apr 13, 2025 DP U-2592 8329648 Aug 18, 2026 U-2588 8329648 Aug 18, 2026 U-2589 8329648 Aug 18, 2026 U-2590 8329648 Aug 18, 2026 U-2593 8329648 Aug 18, 2026 U-2594 8329648 Aug 18, 2026 U-2595 8329648 Aug 18, 2026 U-2596 8361972 Mar 21, 2028 U-2588 8431685 Apr 13, 2025 DP U-2588 8431685 Apr 13, 2025 DP U-2589 8431685 Apr 13, 2025 DP U-2590 8431685 Apr 13, 2025 DP U-2598 8461105 Apr 13, 2025 DP U-2588 8461105 Apr 13, 2025 DP U-2589 8461105 Apr 13, 2025 DP U-2590 8461105 Apr 13, 2025 DP U-2598 8501698 Jun 20, 2027 DP U-2588 8906851 Aug 18, 2026 U-2588 8906851 Aug 18, 2026 U-2589 8906851 Aug 18, 2026 U-2590 8906851 Aug 18, 2026 U-2593 9198925 Oct 04, 2020 U-2588 9238076 Apr 15, 2024 DP U-2588 9238076 Apr 15, 2024 DP U-2589 9238076 Apr 15, 2024 DP U-2590 9238076 Apr 15, 2024 DP U-2599 9884092 Aug 18, 2026 U-2588 9884092 Aug 18, 2026 U-2589 9884092 Aug 18, 2026 U-2590 9884092 Aug 18, 2026 U-2593 9884092 Aug 18, 2026 U-2594 9884092 Aug 18, 2026 U-2595 9884092 Aug 18, 2026 U-2596

EXENATIDE SYNTHETIC - BYDUREON PEN N 022200 002 6414126 Oct 04, 2020 DS DP U-2588 6515117 Oct 04, 2020 DS DP U-2588 6872700 Jan 14, 2020 U-2588 6872700 Jan 14, 2020 U-2589 6872700 Jan 14, 2020 U-2590 6872700 Jan 14, 2020 U-2591 6936590 Oct 04, 2020 U-2588 7456254 Jun 30, 2025 DP U-2588 7456254 Jun 30, 2025 DP U-2589 7456254 Jun 30, 2025 DP U-2590 7456254 Jun 30, 2025 DP U-2592 7612176 Apr 13, 2025 DP U-2588 7612176 Apr 13, 2025 DP U-2589 7612176 Apr 13, 2025 DP U-2590 7612176 Apr 13, 2025 DP U-2592 8329648 Aug 18, 2026 U-2588 8329648 Aug 18, 2026 U-2589 8329648 Aug 18, 2026 U-2590 8329648 Aug 18, 2026 U-2593 8329648 Aug 18, 2026 U-2594 8329648 Aug 18, 2026 U-2595 8329648 Aug 18, 2026 U-2596 A - 24 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

EXENATIDE SYNTHETIC - BYDUREON PEN N 022200 002 8361972 Mar 21, 2028 U-2588 8431685 Apr 13, 2025 DP U-2588 8431685 Apr 13, 2025 DP U-2589 8431685 Apr 13, 2025 DP U-2590 8431685 Apr 13, 2025 DP U-2598 8461105 Apr 13, 2025 DP U-2588 8461105 Apr 13, 2025 DP U-2589 8461105 Apr 13, 2025 DP U-2590 8461105 Apr 13, 2025 DP U-2598 8501698 Jun 20, 2027 DP U-2588 8906851 Aug 18, 2026 U-2588 8906851 Aug 18, 2026 U-2589 8906851 Aug 18, 2026 U-2590 8906851 Aug 18, 2026 U-2593 9198925 Oct 04, 2020 U-2588 9238076 Apr 15, 2024 DP U-2588 9238076 Apr 15, 2024 DP U-2589 9238076 Apr 15, 2024 DP U-2590 9238076 Apr 15, 2024 DP U-2599 9884092 Aug 18, 2026 U-2588 9884092 Aug 18, 2026 U-2589 9884092 Aug 18, 2026 U-2590 9884092 Aug 18, 2026 U-2593 9884092 Aug 18, 2026 U-2594 9884092 Aug 18, 2026 U-2595 9884092 Aug 18, 2026 U-2596

FENFLURAMINE HYDROCHLORIDE - FINTEPLA N 212102 001 10452815 Oct 22, 2039 U-2859 NP Jun 25, 2023 10478441 May 03, 2033 U-2860 >A> ODE-312 Jun 25, 2027 10478442 May 03, 2033 U-2860 10603290 Aug 02, 2037 U-2861 9549909 May 03, 2033 U-2858 9603814 May 03, 2033 U-2858 9603815 May 03, 2033 U-2858 9610260 May 03, 2033 U-2858

FENTANYL - SUBSYS N 202788 001 10610523 Jan 25, 2027 DP

FENTANYL - SUBSYS N 202788 002 10610523 Jan 25, 2027 DP

FENTANYL - SUBSYS N 202788 003 10610523 Jan 25, 2027 DP

FENTANYL - SUBSYS N 202788 004 10610523 Jan 25, 2027 DP

FENTANYL - SUBSYS N 202788 005 10610523 Jan 25, 2027 DP

FENTANYL - SUBSYS N 202788 006 10610523 Jan 25, 2027 DP

FENTANYL - SUBSYS N 202788 007 10610523 Jan 25, 2027 DP

FERRIC CARBOXYMALTOSE - INJECTAFER N 203565 001 10519252 Oct 20, 2023 DS U-2709 10519252 Oct 20, 2023 DS U-2710 10519252 Oct 20, 2023 DS U-2711 10519252 Oct 20, 2023 DS U-2712 A - 25 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

FERRIC CITRATE - AURYXIA N 205874 001 5753706 Feb 03, 2021 DP U-1577

FERRIC DERISOMALTOSE - MONOFERRIC N 208171 001 10414831 Mar 25, 2029 DS DP 8815301 Aug 14, 2029 DS DP U-2734

FERRIC PYROPHOSPHATE CITRATE - TRIFERIC AVNU N 212860 001 7816404 Apr 17, 2029 DS U-2801

FIDAXOMICIN - DIFICID N 201699 001 7906489 Mar 04, 2027 U-2741 NPP Jan 24, 2023 7906489 Mar 04, 2027 U-319 PED Jul 24, 2023 7906489*PED Sep 04, 2027 8859510 Jul 31, 2027 U-2741 8859510 Jul 31, 2027 U-319 8859510*PED Jan 31, 2028

FIDAXOMICIN - DIFICID N 213138 001 7378508 Jul 31, 2027 DS DP NP Jan 24, 2023 7378508*PED Jan 31, 2028 PED Jul 24, 2023 7863249 Jul 31, 2027 DP 7863249*PED Jan 31, 2028 7906489 Mar 04, 2027 U-2741 7906489*PED Sep 04, 2027 8586551 Jul 23, 2023 DS DP 8586551*PED Jan 23, 2024 8859510 Jul 31, 2027 U-2741 8859510*PED Jan 31, 2028 9808530 May 28, 2034 DP 9808530*PED Nov 28, 2034

FINGOLIMOD HYDROCHLORIDE - GILENYA N 022527 001 10543179 Dec 25, 2027 U-2719

FLORTAUCIPIR F-18 - TAUVID N 212123 001 8932557 May 19, 2029 DS NCE May 28, 2025

FLORTAUCIPIR F-18 - TAUVID N 212123 002 8932557 May 19, 2029 DS NCE May 28, 2025

FLUCICLOVINE F-18 - AXUMIN N 208054 001 10716868 Dec 30, 2035 U-2450

FLUOROESTRADIOL F-18 - CERIANNA N 212155 001 NCE May 20, 2025

FLUTICASONE PROPIONATE - ARMONAIR RESPICLICK N 208798 001 10561808 Jan 01, 2032 DP >A> 10765820 May 19, 2025 DP

FLUTICASONE PROPIONATE - ARMONAIR RESPICLICK N 208798 002 10561808 Jan 01, 2032 DP >A> 10765820 May 19, 2025 DP

FLUTICASONE PROPIONATE - ARMONAIR RESPICLICK N 208798 003 10561808 Jan 01, 2032 DP >A> 10765820 May 19, 2025 DP

FLUTICASONE PROPIONATE - ARMONAIR DIGIHALER N 208798 004 10022510 May 18, 2031 DP 10124131 May 18, 2031 DP 10195375 Feb 14, 2031 DP 10561808 Jan 01, 2032 DP A - 26 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

FLUTICASONE PROPIONATE - ARMONAIR DIGIHALER N 208798 004 10569034 Aug 16, 2036 DP >A> 10765820 May 19, 2025 DP 6701917 Jun 23, 2021 DP 6718972 Jun 23, 2021 DP 6748947 Jun 23, 2021 DP 6871646 Jun 23, 2021 DP 7540282 May 06, 2023 DP 8006690 Jun 23, 2021 DP 8651103 Mar 26, 2028 DP 8714149 Feb 25, 2032 DP 8978966 Jan 13, 2032 DP 9216260 Jun 28, 2031 DP 9463288 May 19, 2025 DP 9616024 Sep 01, 2024 DP 9731087 May 18, 2031 DP 9782550 Aug 28, 2035 DP 9782551 Aug 28, 2035 DP

FLUTICASONE PROPIONATE - ARMONAIR DIGIHALER N 208798 005 10022510 May 18, 2031 DP 10124131 May 18, 2031 DP 10195375 Feb 14, 2031 DP 10561808 Jan 01, 2032 DP 10569034 Aug 16, 2036 DP >A> 10765820 May 19, 2025 DP 6701917 Jun 23, 2021 DP 6718972 Jun 23, 2021 DP 6748947 Jun 23, 2021 DP 6871646 Jun 23, 2021 DP 7540282 May 06, 2023 DP 8006690 Jun 23, 2021 DP 8651103 Mar 26, 2028 DP 8714149 Feb 25, 2032 DP 8978966 Jan 13, 2032 DP 9216260 Jun 28, 2031 DP 9463288 May 19, 2025 DP 9616024 Sep 01, 2024 DP 9731087 May 18, 2031 DP 9782550 Aug 28, 2035 DP 9782551 Aug 28, 2035 DP

FLUTICASONE PROPIONATE - ARMONAIR DIGIHALER N 208798 006 10022510 May 18, 2031 DP 10124131 May 18, 2031 DP 10195375 Feb 14, 2031 DP 10561808 Jan 01, 2032 DP 10569034 Aug 16, 2036 DP >A> 10765820 May 19, 2025 DP 6701917 Jun 23, 2021 DP 6718972 Jun 23, 2021 DP 6748947 Jun 23, 2021 DP 6871646 Jun 23, 2021 DP 7540282 May 06, 2023 DP 8006690 Jun 23, 2021 DP 8651103 Mar 26, 2028 DP 8714149 Feb 25, 2032 DP 8978966 Jan 13, 2032 DP 9216260 Jun 28, 2031 DP 9463288 May 19, 2025 DP 9616024 Sep 01, 2024 DP 9731087 May 18, 2031 DP 9782550 Aug 28, 2035 DP 9782551 Aug 28, 2035 DP

FLUTICASONE PROPIONATE - XHANCE N 209022 001 >A> 6715485 Nov 03, 2020 DP 8978647 Dec 06, 2030 DP A - 27 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION DATE CODES REQUESTED CODE(S) DATE

FLUTICASONE PROPIONATE - XHANCE N 209022 001 >A> 6715485 Nov 03, 2020 DP 8978647 Dec 06, 2030 DP

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - AIRDUO RESPICLICK N 208799 001 10561808 Jan 01, 2032 DP >A> 10765820 May 19, 2025 DP

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - AIRDUO RESPICLICK N 208799 002 10561808 Jan 01, 2032 DP >A> 10765820 May 19, 2025 DP

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - AIRDUO RESPICLICK N 208799 003 10561808 Jan 01, 2032 DP >A> 10765820 May 19, 2025 DP

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - AIRDUO DIGIHALER N 208799 004 10561808 Jan 01, 2032 DP 10569034 Aug 16, 2036 DP >A> 10765820 May 19, 2025 DP

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - AIRDUO DIGIHALER N 208799 005 10561808 Jan 01, 2032 DP 10569034 Aug 16, 2036 DP >A> 10765820 May 19, 2025 DP

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - AIRDUO DIGIHALER N 208799 006 10561808 Jan 01, 2032 DP 10569034 Aug 16, 2036 DP >A> 10765820 May 19, 2025 DP

FORMOTEROL FUMARATE; GLYCOPYRROLATE - BEVESPI AEROSPHERE N 208294 001 10716753 May 28, 2030 DP U-2546

FOSFOMYCIN TROMETHAMINE - FOSFOMYCIN TROMETHAMINE A 212548 001 >A> CGT Apr 04, 2021

FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE - AKYNZEO N 210493 001 10624911 Jun 02, 2037 DP 10717721 May 23, 2032 DS

FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE - AKYNZEO N 210493 002 10208073 May 23, 2032 U-2301 NCE Apr 19, 2023 10624911 Jun 02, 2037 DP 10717721 May 23, 2032 DS 8426450 May 23, 2032 DS DP 8895586 May 23, 2032 U-2301 9186357 Nov 18, 2030 U-2301 9403772 May 23, 2032 DS U-2301 9908907 May 23, 2032 DS DP

FOSTEMSAVIR TROMETHAMINE - RUKOBIA N 212950 001 7745625 Nov 19, 2027 DS NCE Jul 02, 2025 8168615 Feb 25, 2025 DP 8461333 Feb 25, 2025 DS

GLECAPREVIR; PIBRENTASVIR - MAVYRET N 209394 001 M-259 Apr 10, 2023

GLUCAGON - GVOKE PFS N 212097 001 9649364 Apr 22, 2036 DP U-2742 A - 28 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

GLUCAGON - GVOKE PFS N 212097 002 9649364 Apr 22, 2036 DP U-2742

GLUCAGON - GVOKE HYPOPEN N 212097 003 9649364 Apr 22, 2036 DP U-2742

GLUCAGON - GVOKE HYPOPEN N 212097 004 9649364 Apr 22, 2036 DP U-2742

GLYCEROL PHENYLBUTYRATE - RAVICTI N 203284 001 10668040 Sep 22, 2030 U-1816

GLYCOPYRROLATE - LONHALA MAGNAIR KIT N 208437 001 10688518 Nov 12, 2036 DP 10744277 Dec 07, 2036 DP U-2941

GLYCOPYRRONIUM TOSYLATE - QBREXZA N 210361 001 10543192 Feb 28, 2033 DP NP Jun 28, 2021 10548875 Feb 28, 2033 DS DP U-2398

GOLODIRSEN - VYONDYS 53 N 211970 001 10533174 May 04, 2021 DP ODE-280 Dec 12, 2026

HALOBETASOL PROPIONATE - ULTRAVATE N 208183 001 NPP Aug 31, 2023

HEXAMINOLEVULINATE HYDROCHLORIDE - CYSVIEW KIT N 022555 001 10556010 Dec 19, 2036 U-2250

HYDROCODONE BITARTRATE - ZOHYDRO ER N 202880 001 10722511 Jul 25, 2033 U-1810

HYDROCODONE BITARTRATE - ZOHYDRO ER N 202880 002 10722511 Jul 25, 2033 U-1810

HYDROCODONE BITARTRATE - ZOHYDRO ER N 202880 003 10722511 Jul 25, 2033 U-1810

HYDROCODONE BITARTRATE - ZOHYDRO ER N 202880 004 10722511 Jul 25, 2033 U-1810

HYDROCODONE BITARTRATE - ZOHYDRO ER N 202880 005 10722511 Jul 25, 2033 U-1810

HYDROCODONE BITARTRATE - ZOHYDRO ER N 202880 006 10722511 Jul 25, 2033 U-1810

HYDROGEN PEROXIDE - ESKATA N 209305 001 10493103 Apr 21, 2035 DP 10729720 Apr 21, 2035 DP

IBRUTINIB - IMBRUVICA N 205552 001 10653696 Jun 03, 2031 U-1456 10695350 Oct 24, 2034 U-2846 >A> 10751342 Jun 03, 2031 U-1491 >A> 10751342 Jun 03, 2031 U-1946 >A> 10751342 Jun 03, 2031 U-2943 >A> 10751342 Jun 03, 2031 U-2944 >A> 10752634 Jun 03, 2033 DP >A> 8008309 Nov 13, 2027 DS DP A - 29 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

IBRUTINIB - IMBRUVICA N 205552 002 10653696 Jun 03, 2031 U-1456 10695350 Oct 24, 2034 U-2846 >A> 10751342 Jun 03, 2031 U-1491 >A> 10751342 Jun 03, 2031 U-1946 >A> 10751342 Jun 03, 2031 U-2943 >A> 10751342 Jun 03, 2031 U-2944 >A> 8008309 Nov 13, 2027 DS DP

IBRUTINIB - IMBRUVICA N 210563 001 10653696 Jun 03, 2031 U-1456 10695350 Oct 24, 2034 U-2846 >A> 10751342 Jun 03, 2031 U-1491 >A> 10751342 Jun 03, 2031 U-1946 >A> 10751342 Jun 03, 2031 U-2943 >A> 10751342 Jun 03, 2031 U-2944 >A> 10752634 Jun 03, 2033 DP >A> 8008309 Nov 13, 2027 DS DP

IBRUTINIB - IMBRUVICA N 210563 002 10653696 Jun 03, 2031 U-1456 10695350 Oct 24, 2034 U-2846 >A> 10751342 Jun 03, 2031 U-1491 >A> 10751342 Jun 03, 2031 U-1946 >A> 10751342 Jun 03, 2031 U-2943 >A> 10751342 Jun 03, 2031 U-2944 >A> 8008309 Nov 13, 2027 DS DP

IBRUTINIB - IMBRUVICA N 210563 003 10653696 Jun 03, 2031 U-1456 10695350 Oct 24, 2034 U-2846 >A> 10751342 Jun 03, 2031 U-1491 >A> 10751342 Jun 03, 2031 U-1946 >A> 10751342 Jun 03, 2031 U-2943 >A> 10751342 Jun 03, 2031 U-2944 >A> 8008309 Nov 13, 2027 DS DP

IBRUTINIB - IMBRUVICA N 210563 004 10653696 Jun 03, 2031 U-1456 10695350 Oct 24, 2034 U-2846 >A> 10751342 Jun 03, 2031 U-1491 >A> 10751342 Jun 03, 2031 U-1946 >A> 10751342 Jun 03, 2031 U-2943 >A> 10751342 Jun 03, 2031 U-2944 >A> 8008309 Nov 13, 2027 DS DP

ICOSAPENT ETHYL - VASCEPA N 202057 001 10555924 Jun 28, 2033 U-2743 10555925 Jun 28, 2033 U-2744 10568861 Jun 28, 2033 U-2756 10576054 Jun 28, 2033 U-2762 10668042 Jun 28, 2033 U-2841 8518929 Feb 09, 2030 U-1287 8524698 Feb 09, 2030 U-1287 8546372 Feb 09, 2030 U-1287

ICOSAPENT ETHYL - VASCEPA N 202057 002 10555924 Jun 28, 2033 U-2743 10555925 Jun 28, 2033 U-2744 10568861 Jun 28, 2033 U-2756 10576054 Jun 28, 2033 U-2762 10668042 Jun 28, 2033 U-2841 8518929 Feb 09, 2030 U-1287 8524698 Feb 09, 2030 U-1287 8546372 Feb 09, 2030 U-1287 A - 30 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

IDELALISIB - ZYDELIG N 205858 001 10730879 Mar 05, 2033 DS DP

IDELALISIB - ZYDELIG N 205858 002 10730879 Mar 05, 2033 DS DP

INDOCYANINE GREEN - SPY AGENT GREEN KIT N 211580 001 10631746 Aug 04, 2035 DP U-2815

IRINOTECAN HYDROCHLORIDE - ONIVYDE N 207793 001 10722508 May 02, 2025 DS DP

ISAVUCONAZONIUM SULFATE - CRESEMBA N 207500 001 ODE-305 Mar 06, 2022 GAIN Mar 06, 2027

ISAVUCONAZONIUM SULFATE - CRESEMBA N 207501 001 ODE-305 Mar 06, 2022 GAIN Mar 06, 2027

IVACAFTOR - KALYDECO N 203188 001 10646481 Aug 13, 2029 DP

IVACAFTOR - KALYDECO N 207925 001 10646481 Aug 13, 2029 DP

IVACAFTOR - KALYDECO N 207925 002 10646481 Aug 13, 2029 DP

IVACAFTOR - KALYDECO N 207925 003 10646481 Aug 13, 2029 DP

IVACAFTOR; IVACAFTOR, TEZACAFTOR - SYMDEKO (COPACKAGED) N 210491 001 10646481 Aug 13, 2029 DP

IVACAFTOR; IVACAFTOR, TEZACAFTOR - SYMDEKO (COPACKAGED) N 210491 002 10646481 Aug 13, 2029 DP

IVACAFTOR; LUMACAFTOR - ORKAMBI N 206038 001 10597384 Dec 04, 2028 DS DP U-2777 10646481 Aug 13, 2029 DP

IVACAFTOR; LUMACAFTOR - ORKAMBI N 206038 002 10597384 Dec 04, 2028 DS DP U-2777 10646481 Aug 13, 2029 DP

IVACAFTOR; LUMACAFTOR - ORKAMBI N 211358 001 10597384 Dec 04, 2028 DS DP U-2778 10646481 Aug 13, 2029 DP

IVACAFTOR; LUMACAFTOR - ORKAMBI N 211358 002 10597384 Dec 04, 2028 DS DP U-2778 10646481 Aug 13, 2029 DP

IVOSIDENIB - TIBSOVO N 211192 001 10610125 Jun 21, 2030 U-2784 10610125 Jun 21, 2030 U-2785

LACTITOL - PIZENSY N 211281 001 NCE Feb 12, 2025 A - 31 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

LAROTRECTINIB SULFATE - VITRAKVI N 211710 001 >A> 10668072 Apr 04, 2037 DP

LASMIDITAN SUCCINATE - REYVOW N 211280 001 7423050 Apr 06, 2025 DS DP U-1719 NCE Jan 31, 2025 8748459 Mar 27, 2023 U-1719

LASMIDITAN SUCCINATE - REYVOW N 211280 002 7423050 Apr 06, 2025 DS DP U-1719 NCE Jan 31, 2025 8748459 Mar 27, 2023 U-1719

LATANOPROST; NETARSUDIL DIMESYLATE - ROCKLATAN N 208259 001 10532993 Jul 11, 2026 U-1524 10588901 Mar 14, 2034 DS DP U-1524 10654844 Nov 10, 2030 DS DP U-1524

LEMBOREXANT - DAYVIGO N 212028 001 10188652 Oct 21, 2035 DP U-2791 NCE Apr 07, 2025 8268848 Sep 20, 2031 DS DP U-2791

LEMBOREXANT - DAYVIGO N 212028 002 10188652 Oct 21, 2035 DP U-2791 NCE Apr 07, 2025 8268848 Sep 20, 2031 DS DP U-2791

LETERMOVIR - PREVYMIS N 209939 001 RE46791 May 22, 2024 DS DP

LETERMOVIR - PREVYMIS N 209939 002 RE46791 May 22, 2024 DS DP

LETERMOVIR - PREVYMIS N 209940 001 10603384 Feb 28, 2033 DP RE46791 May 22, 2024 DS DP

LETERMOVIR - PREVYMIS N 209940 002 10603384 Feb 28, 2033 DP RE46791 May 22, 2024 DS DP

LEUPROLIDE ACETATE - FENSOLVI KIT N 213150 001 8470359 Oct 15, 2023 DS DP U-2940 I-829 May 01, 2023 9539333 Nov 13, 2020 DS DP 9914802 Nov 13, 2020 DS DP U-2940

LEVONORGESTREL - MIRENA N 021225 001 >A> 10561524 Sep 16, 2029 U-2948 >A> D-181 Aug 20, 2023

LEVONORGESTREL - SKYLA N 203159 001 >A> 10561524 Sep 16, 2029 U-2948

LEVONORGESTREL - KYLEENA N 208224 001 >A> 10561524 Sep 16, 2029 U-2948

LEVOTHYROXINE SODIUM - TIROSINT-SOL N 206977 001 10537538 Feb 28, 2037 DP

LEVOTHYROXINE SODIUM - TIROSINT-SOL N 206977 002 10537538 Feb 28, 2037 DP

LEVOTHYROXINE SODIUM - TIROSINT-SOL N 206977 003 10537538 Feb 28, 2037 DP A - 32 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION DATE CODES REQUESTED CODE(S) DATE

LEVOTHYROXINE SODIUM - TIROSINT-SOL N 206977 004 10537538 Feb 28, 2037 DP

LEVOTHYROXINE SODIUM - TIROSINT-SOL N 206977 005 10537538 Feb 28, 2037 DP

LEVOTHYROXINE SODIUM - TIROSINT-SOL N 206977 006 10537538 Feb 28, 2037 DP

LEVOTHYROXINE SODIUM - TIROSINT-SOL N 206977 007 10537538 Feb 28, 2037 DP

LEVOTHYROXINE SODIUM - TIROSINT-SOL N 206977 008 10537538 Feb 28, 2037 DP

LEVOTHYROXINE SODIUM - TIROSINT-SOL N 206977 009 10537538 Feb 28, 2037 DP

LEVOTHYROXINE SODIUM - TIROSINT-SOL N 206977 010 10537538 Feb 28, 2037 DP

LEVOTHYROXINE SODIUM - TIROSINT-SOL N 206977 011 10537538 Feb 28, 2037 DP

LEVOTHYROXINE SODIUM - TIROSINT-SOL N 206977 012 10537538 Feb 28, 2037 DP

LIDOCAINE - ZTLIDO N 207962 001 >A> 10765640 May 10, 2031 DP >A> 10765749 May 10, 2031 DP

LIDOCAINE; TETRACAINE - PLIAGLIS N 021717 001 10603293 Jan 14, 2031 DP >A> 10751305 Jan 14, 2031 DP

LINACLOTIDE - LINZESS N 202811 003 10675325 Aug 11, 2031 DP 10702576 Aug 11, 2031 U-1516

LINAGLIPTIN - TRADJENTA N 201280 001 8673927 May 04, 2027 U-1503 Y M-252 Mar 30, 2023 M-258 Jul 03, 2022

LINAGLIPTIN; METFORMIN HYDROCHLORIDE - JENTADUETO N 201281 001 8673927 May 04, 2027 U-1503 Y M-252 Mar 30, 2023 M-258 Jul 03, 2022

LINAGLIPTIN; METFORMIN HYDROCHLORIDE - JENTADUETO N 201281 002 8673927 May 04, 2027 U-1503 Y M-252 Mar 30, 2023 M-258 Jul 03, 2022

LINAGLIPTIN; METFORMIN HYDROCHLORIDE - JENTADUETO N 201281 003 8673927 May 04, 2027 U-1503 Y M-252 Mar 30, 2023 M-258 Jul 03, 2022

LINAGLIPTIN; METFORMIN HYDROCHLORIDE - JENTADUETO XR N 208026 001 8673927 May 04, 2027 U-1503 Y M-252 Mar 30, 2023 9173859 May 04, 2027 DP U-1503 Y M-258 Jul 03, 2022

LINAGLIPTIN; METFORMIN HYDROCHLORIDE - JENTADUETO XR N 208026 002 8673927 May 04, 2027 U-1503 Y M-252 Mar 30, 2023 9173859 May 04, 2027 DP U-1503 Y M-258 Jul 03, 2022 A - 33 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

LINAGLIPTIN; METFORMIN HYDROCHLORIDE - JENTADUETO XR N 208026 002 8673927 May 04, 2027 U-1503 Y M-252 Mar 30, 2023 9173859 May 04, 2027 DP U-1503 Y M-258 Jul 03, 2022

LOMITAPIDE MESYLATE - JUXTAPID N 203858 001 10555938 Mar 07, 2025 U-1316

LOMITAPIDE MESYLATE - JUXTAPID N 203858 002 10555938 Mar 07, 2025 U-1316

LOMITAPIDE MESYLATE - JUXTAPID N 203858 003 10555938 Mar 07, 2025 U-1316

LOMITAPIDE MESYLATE - JUXTAPID N 203858 004 10555938 Mar 07, 2025 U-1316

LOMITAPIDE MESYLATE - JUXTAPID N 203858 005 10555938 Mar 07, 2025 U-1316

LOMITAPIDE MESYLATE - JUXTAPID N 203858 006 10555938 Mar 07, 2025 U-1316

LOTEPREDNOL ETABONATE - LOTEMAX SM N 208219 001 10596107 Dec 23, 2036 DP U-2764

LOTEPREDNOL ETABONATE - INVELTYS N 210565 001 10646437 May 03, 2033 DP 10688045 May 03, 2033 DP

LUMATEPERONE TOSYLATE - CAPLYTA N 209500 001 10464938 Mar 12, 2028 DP NCE Dec 20, 2024 10695345 Aug 30, 2039 DP U-543 7183282 Jun 15, 2020 DS DP 8598119 Dec 28, 2029 U-543 8648077 Dec 01, 2029 DS DP 9199995 Mar 12, 2029 U-2713 9586960 Mar 12, 2029 DS DP 9616061 May 27, 2029 DP 9956227 Dec 03, 2034 U-2714 RE39680 Jun 15, 2020 DS DP U-543

LURBINECTEDIN - ZEPZELCA N 213702 001 7763615 Dec 13, 2024 DS DP U-2836 NCE Jun 15, 2025 ODE-304 Jun 15, 2027

LUTETIUM DOTATATE LU-177 - LUTATHERA N 208700 001 10596276 Jul 25, 2038 DP 10596278 Jul 25, 2038 DP

MARAVIROC - SELZENTRY N 022128 001 6667314 Aug 06, 2021 DS DP U-824 6667314*PED Feb 06, 2022 7368460 Nov 25, 2022 U-824 7368460*PED May 25, 2023 7576097 May 25, 2021 DS 7576097*PED Nov 25, 2021

MARAVIROC - SELZENTRY N 022128 002 6667314 Aug 06, 2021 DS DP U-824 6667314*PED Feb 06, 2022 7368460 Nov 25, 2022 U-824 7368460*PED May 25, 2023 7576097 May 25, 2021 DS 7576097*PED Nov 25, 2021 A - 34 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

MARAVIROC - SELZENTRY N 022128 002 6667314 Aug 06, 2021 DS DP U-824 6667314*PED Feb 06, 2022 7368460 Nov 25, 2022 U-824 7368460*PED May 25, 2023 7576097 May 25, 2021 DS 7576097*PED Nov 25, 2021

MARAVIROC - SELZENTRY N 022128 003 6667314 Aug 06, 2021 DS DP U-824 6667314*PED Feb 06, 2022 7368460 Nov 25, 2022 U-824 7368460*PED May 25, 2023 7576097 May 25, 2021 DS 7576097*PED Nov 25, 2021

MARAVIROC - SELZENTRY N 022128 004 6667314 Aug 06, 2021 DS DP U-824 6667314*PED Feb 06, 2022 7368460 Nov 25, 2022 U-824 7368460*PED May 25, 2023 7576097 May 25, 2021 DS 7576097*PED Nov 25, 2021

MARAVIROC - SELZENTRY N 208984 001 6667314 Aug 06, 2021 DS DP U-824 6667314*PED Feb 06, 2022 7368460 Nov 25, 2022 U-824 7368460*PED May 25, 2023 7576097 May 25, 2021 DS 7576097*PED Nov 25, 2021

MELOXICAM - ANJESO N 210583 001 10463673 Feb 24, 2024 DP U-2750 NP Feb 20, 2023 10471067 Feb 24, 2024 DP U-2750 10709713 May 26, 2030 U-2750 8512727 Dec 25, 2022 DP U-2750 9974746 May 26, 2030 DP

MEROPENEM; VABORBACTAM - VABOMERE N 209776 001 10561675 Aug 08, 2031 U-2490

METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET N 022044 001 M-244 Aug 12, 2022

METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET N 022044 002 M-244 Aug 12, 2022

METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET XR N 202270 001 M-244 Aug 12, 2022

METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET XR N 202270 002 M-244 Aug 12, 2022

METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET XR N 202270 003 M-244 Aug 12, 2022

METHOTREXATE - OTREXUP N 204824 001 10709844 Mar 10, 2029 DP 8814834 May 27, 2031 DP 9867949 Mar 10, 2029 DP A - 35 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

METHOTREXATE - OTREXUP N 204824 002 10709844 Mar 10, 2029 DP 8814834 May 27, 2031 DP 9867949 Mar 10, 2029 DP

METHOTREXATE - OTREXUP N 204824 003 10709844 Mar 10, 2029 DP 8814834 May 27, 2031 DP 9867949 Mar 10, 2029 DP

METHOTREXATE - OTREXUP N 204824 004 10709844 Mar 10, 2029 DP 8814834 May 27, 2031 DP 9867949 Mar 10, 2029 DP

METHOTREXATE - OTREXUP N 204824 005 10709844 Mar 10, 2029 DP 8814834 May 27, 2031 DP 9867949 Mar 10, 2029 DP

METHOTREXATE - OTREXUP N 204824 006 10709844 Mar 10, 2029 DP 8814834 May 27, 2031 DP 9867949 Mar 10, 2029 DP

METHOTREXATE - OTREXUP N 204824 007 10709844 Mar 10, 2029 DP 8814834 May 27, 2031 DP 9867949 Mar 10, 2029 DP

METHOTREXATE - OTREXUP N 204824 008 10709844 Mar 10, 2029 DP 8814834 May 27, 2031 DP 9867949 Mar 10, 2029 DP

METHOTREXATE SODIUM - XATMEP N 208400 001 10610485 Jan 02, 2033 DP

METHYLPHENIDATE HYDROCHLORIDE - JORNAY PM N 209311 001 10617651 Mar 23, 2032 U-2357

METHYLPHENIDATE HYDROCHLORIDE - JORNAY PM N 209311 002 10617651 Mar 23, 2032 U-2357

METHYLPHENIDATE HYDROCHLORIDE - JORNAY PM N 209311 003 10617651 Mar 23, 2032 U-2357

METHYLPHENIDATE HYDROCHLORIDE - JORNAY PM N 209311 004 10617651 Mar 23, 2032 U-2357

METHYLPHENIDATE HYDROCHLORIDE - JORNAY PM N 209311 005 10617651 Mar 23, 2032 U-2357

METHYLPHENIDATE HYDROCHLORIDE - ADHANSIA XR N 212038 001 10568841 Oct 30, 2035 DP U-2357 10688060 Oct 30, 2035 DP 10722473 Nov 19, 2038 U-2357

METHYLPHENIDATE HYDROCHLORIDE - ADHANSIA XR N 212038 002 10568841 Oct 30, 2035 DP U-2357 10688060 Oct 30, 2035 DP 10722473 Nov 19, 2038 U-2357 A - 36 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

METHYLPHENIDATE HYDROCHLORIDE - ADHANSIA XR N 212038 003 10568841 Oct 30, 2035 DP U-2357 10688060 Oct 30, 2035 DP 10722473 Nov 19, 2038 U-2357

METHYLPHENIDATE HYDROCHLORIDE - ADHANSIA XR N 212038 004 10568841 Oct 30, 2035 DP U-2357 10688060 Oct 30, 2035 DP 10722473 Nov 19, 2038 U-2357

METHYLPHENIDATE HYDROCHLORIDE - ADHANSIA XR N 212038 005 10568841 Oct 30, 2035 DP U-2357 10688060 Oct 30, 2035 DP 10722473 Nov 19, 2038 U-2357

METHYLPHENIDATE HYDROCHLORIDE - ADHANSIA XR N 212038 006 10568841 Oct 30, 2035 DP U-2357 10688060 Oct 30, 2035 DP 10722473 Nov 19, 2038 U-2357

METOCLOPRAMIDE HYDROCHLORIDE - GIMOTI N 209388 001 6770262 Mar 29, 2021 U-2843 8334281 May 16, 2030 DP U-2843

METRONIDAZOLE - NUVESSA N 205223 001 10596155 Jun 28, 2032 DP

METYROSINE - METYROSINE A 213734 001 CGT Jan 20, 2021

MEXILETINE HYDROCHLORIDE - MEXILETINE HYDROCHLORIDE A 213500 001 CGT Jan 18, 2021

MEXILETINE HYDROCHLORIDE - MEXILETINE HYDROCHLORIDE A 213500 002 CGT Jan 18, 2021

MEXILETINE HYDROCHLORIDE - MEXILETINE HYDROCHLORIDE A 213500 003 CGT Jan 18, 2021

MICAFUNGIN SODIUM - MICAFUNGIN SODIUM A 207344 001 PC Nov 07, 2020

MICAFUNGIN SODIUM - MICAFUNGIN SODIUM A 207344 002 PC Nov 07, 2020

MICAFUNGIN SODIUM - MYCAMINE N 021506 002 I-821 Dec 20, 2022 PED Jun 20, 2023

MICAFUNGIN SODIUM - MYCAMINE N 021506 003 I-821 Dec 20, 2022 PED Jun 20, 2023

MIFEPRISTONE - KORLYM N 202107 001 10660904 Apr 20, 2036 U-1643 >A> 10780097 Aug 22, 2038 U-1643

MIGALASTAT HYDROCHLORIDE - GALAFOLD N 208623 001 10525045 Apr 28, 2028 U-2371

MINOCYCLINE HYDROCHLORIDE - AMZEEQ N 212379 001 10517882 Oct 01, 2030 U-2647 A - 37 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

MINOCYCLINE HYDROCHLORIDE - ZILXI N 213690 001 10213512 Oct 01, 2030 DP U-1631 10265404 Oct 01, 2030 DP 10322186 Oct 01, 2030 U-1631 8865139 Oct 01, 2030 DP U-1631 8945516 Oct 01, 2030 DP 8992896 Oct 01, 2030 DP U-1631 9675700 Oct 01, 2030 DP U-1631

MITOMYCIN - JELMYTO N 211728 001 9040074 Jan 20, 2031 DP NP Apr 15, 2023 9950069 Jan 20, 2031 DP ODE-289 Apr 15, 2027

MONOMETHYL FUMARATE - BAFIERTAM N 210296 001 10098863 Feb 27, 2035 DP U-1384 10105335 Feb 27, 2035 DP 10105336 Feb 27, 2035 DP U-1384 10105337 Feb 27, 2035 DP 9326947 Feb 27, 2035 DP 9326965 Feb 27, 2035 U-1384 9511043 Feb 27, 2035 U-1384 9517209 Feb 27, 2035 DP 9566259 Feb 27, 2035 DP 9636318 Feb 27, 2035 U-1384 9636319 Feb 27, 2035 DP 9814691 Feb 27, 2035 U-1384 9814692 Feb 27, 2035 U-1384 9820960 Feb 27, 2035 DP 9820961 Feb 27, 2035 DP U-1384

NAFTIFINE HYDROCHLORIDE - NAFTIN N 204286 001 10695303 Jan 31, 2033 DP 10729667 Jan 31, 2033 DP

NALOXONE HYDROCHLORIDE - NALOXONE HYDROCHLORIDE A 213209 001 CGT Sep 14, 2020

NALOXONE HYDROCHLORIDE - EVZIO N 205787 001 10737028 Nov 23, 2024 DP

NALOXONE HYDROCHLORIDE - EVZIO (AUTOINJECTOR) N 209862 001 10737028 Nov 23, 2024 DP

NERATINIB MALEATE - NERLYNX N 208051 001 I-823 Feb 25, 2023

NETARSUDIL MESYLATE - RHOPRESSA N 208254 001 10532993 Jul 11, 2026 U-1524 10588901 Mar 14, 2034 DS DP U-1524 10654844 Nov 10, 2030 DS DP U-1524

NETUPITANT; PALONOSETRON HYDROCHLORIDE - AKYNZEO N 205718 001 10676440 Sep 25, 2035 DS DP 6297375 Mar 17, 2023 DS

NICARDIPINE HYDROCHLORIDE - CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER N 019734 002 >A> 10758616 Apr 18, 2027 DP

NICARDIPINE HYDROCHLORIDE - CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER N 019734 003 >A> 10758616 Apr 18, 2027 DP

NICARDIPINE HYDROCHLORIDE - CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER N 019734 004 >A> 10758616 Apr 18, 2027 DP A - 38 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

NIFURTIMOX - LAMPIT N 213464 001 NCE Aug 07, 2025

NIFURTIMOX - LAMPIT N 213464 002 NCE Aug 07, 2025

NIMODIPINE - NYMALIZE N 203340 002 10342787 Apr 16, 2038 DP U-2804 10576070 Apr 16, 2038 DP U-2804 7070581 Jun 23, 2023 DP 8517997 May 14, 2024 DP

NINTEDANIB ESYLATE - OFEV N 205832 001 >A> 6762180 Oct 01, 2025 DS DP I-825 Mar 09, 2023

NINTEDANIB ESYLATE - OFEV N 205832 002 >A> 6762180 Oct 01, 2025 DS DP I-825 Mar 09, 2023

NIRAPARIB TOSYLATE - ZEJULA N 208447 001 I-833 Apr 29, 2023 ODE-295 Apr 29, 2027

NITRIC OXIDE - GENOSYL N 202860 001 10213572 Feb 12, 2036 DP 10737051 Oct 20, 2035 DP 6758214 Feb 23, 2022 DP 7560076 Apr 21, 2027 DP 7618594 Oct 17, 2026 DP 9604028 Aug 13, 2029 U-2793

OBETICHOLIC ACID - OCALIVA N 207999 001 10751349 Apr 26, 2036 DP >A> 10758549 Apr 26, 2036 U-2945

OBETICHOLIC ACID - OCALIVA N 207999 002 10751349 Apr 26, 2036 DP >A> 10758549 Apr 26, 2036 U-2945

OCTREOTIDE ACETATE - MYCAPSSA N 208232 001 10238709 Feb 03, 2036 U-2857 NP Jun 26, 2023 10695397 Feb 03, 2036 U-2857 8329198 Sep 17, 2029 DP 8535695 Sep 17, 2029 U-2857 9265812 Sep 17, 2029 DP 9566246 Sep 17, 2029 DP

OCTREOTIDE ACETATE - BYNFEZIA PEN N 213224 001 10342850 May 15, 2038 DP

OLAPARIB - LYNPARZA N 208558 001 8071579 Aug 12, 2027 U-2480 I-831 May 08, 2023 8071579 Aug 12, 2027 U-2819 I-832 May 19, 2023 8071579 Aug 12, 2027 U-2820 ODE-283 Dec 27, 2026 8071579 Aug 12, 2027 U-2821 ODE-306 May 08, 2027 8071579 Aug 12, 2027 U-2822 8071579 Aug 12, 2027 U-2823 8071579 Aug 12, 2027 U-2824 8071579 Aug 12, 2027 U-2832 8071579 Aug 12, 2027 U-2833 8143241 Aug 12, 2027 U-2101 8143241 Aug 12, 2027 U-2103 8143241 Aug 12, 2027 U-2480 8143241 Aug 12, 2027 U-2481 8143241 Aug 12, 2027 U-2482 8143241 Aug 12, 2027 U-2483 A - 39 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

OLAPARIB - LYNPARZA N 208558 001 8143241 Aug 12, 2027 U-2716 8143241 Aug 12, 2027 U-2819 8143241 Aug 12, 2027 U-2820 8143241 Aug 12, 2027 U-2821 8143241 Aug 12, 2027 U-2822 8143241 Aug 12, 2027 U-2823 8143241 Aug 12, 2027 U-2824 8143241 Aug 12, 2027 U-2832 8143241 Aug 12, 2027 U-2833 8859562 Aug 04, 2031 U-2101 8859562 Aug 04, 2031 U-2480 8859562 Aug 04, 2031 U-2481 8859562 Aug 04, 2031 U-2482 8859562 Aug 04, 2031 U-2483 8859562 Aug 04, 2031 U-2716 8859562 Aug 04, 2031 U-2819 8859562 Aug 04, 2031 U-2820 8859562 Aug 04, 2031 U-2821 8859562 Aug 04, 2031 U-2822 8859562 Aug 04, 2031 U-2823 8859562 Aug 04, 2031 U-2824 8859562 Aug 04, 2031 U-2832 8912187 Mar 12, 2024 U-2101 8912187 Mar 12, 2024 U-2480 8912187 Mar 12, 2024 U-2481 8912187 Mar 12, 2024 U-2482 8912187 Mar 12, 2024 U-2483 8912187 Mar 12, 2024 U-2819 8912187 Mar 12, 2024 U-2820 8912187 Mar 12, 2024 U-2821 8912187 Mar 12, 2024 U-2822 8912187 Mar 12, 2024 U-2823 8912187 Mar 12, 2024 U-2824 9169235 Mar 12, 2024 U-2832 9169235 Mar 12, 2024 U-2833 9566276 Mar 12, 2024 U-2716

OLAPARIB - LYNPARZA N 208558 002 8071579 Aug 12, 2027 U-2480 I-831 May 08, 2023 8071579 Aug 12, 2027 U-2819 I-832 May 19, 2023 8071579 Aug 12, 2027 U-2820 ODE-283 Dec 27, 2026 8071579 Aug 12, 2027 U-2821 ODE-306 May 08, 2027 8071579 Aug 12, 2027 U-2823 8071579 Aug 12, 2027 U-2824 8071579 Aug 12, 2027 U-2832 8071579 Aug 12, 2027 U-2833 8143241 Aug 12, 2027 U-2101 8143241 Aug 12, 2027 U-2103 8143241 Aug 12, 2027 U-2480 8143241 Aug 12, 2027 U-2481 8143241 Aug 12, 2027 U-2482 8143241 Aug 12, 2027 U-2483 8143241 Aug 12, 2027 U-2716 8143241 Aug 12, 2027 U-2819 8143241 Aug 12, 2027 U-2820 8143241 Aug 12, 2027 U-2821 8143241 Aug 12, 2027 U-2822 8143241 Aug 12, 2027 U-2823 8143241 Aug 12, 2027 U-2824 8143241 Aug 12, 2027 U-2832 8143241 Aug 12, 2027 U-2833 8859562 Aug 04, 2031 U-2101 8859562 Aug 04, 2031 U-2480 8859562 Aug 04, 2031 U-2481 8859562 Aug 04, 2031 U-2482 8859562 Aug 04, 2031 U-2483 8859562 Aug 04, 2031 U-2716 8859562 Aug 04, 2031 U-2819 A - 40 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

OLAPARIB - LYNPARZA N 208558 002 8859562 Aug 04, 2031 U-2820 8859562 Aug 04, 2031 U-2821 8859562 Aug 04, 2031 U-2822 8859562 Aug 04, 2031 U-2823 8859562 Aug 04, 2031 U-2824 8859562 Aug 04, 2031 U-2832 8912187 Mar 12, 2024 U-2101 8912187 Mar 12, 2024 U-2480 8912187 Mar 12, 2024 U-2481 8912187 Mar 12, 2024 U-2482 8912187 Mar 12, 2024 U-2483 8912187 Mar 12, 2024 U-2819 8912187 Mar 12, 2024 U-2820 8912187 Mar 12, 2024 U-2821 8912187 Mar 12, 2024 U-2822 8912187 Mar 12, 2024 U-2823 8912187 Mar 12, 2024 U-2824 9169235 Mar 12, 2024 U-2832 9169235 Mar 12, 2024 U-2833 9566276 Mar 12, 2024 U-2716

OLOPATADINE HYDROCHLORIDE - PATADAY ONCE DAILY RELIEF N 206276 001 8791154 May 19, 2032 DP U-1680 9533053 May 19, 2032 DP

OPICAPONE - ONGENTYS N 212489 001 10071085 Mar 31, 2030 DP NCE Apr 24, 2025 10357468 May 27, 2035 U-2812 10583130 Mar 31, 2030 U-2811 8168793 Apr 02, 2029 DS DP U-2811 8524746 Jul 14, 2029 U-2811 8907099 May 12, 2027 DS 9550759 Jul 26, 2026 U-2811 9550759 Jul 26, 2026 U-2817 9550759 Jul 26, 2026 U-2818 9630955 Dec 12, 2032 DS DP U-2811 9745290 Oct 10, 2027 DP U-2811

OPICAPONE - ONGENTYS N 212489 002 10071085 Mar 31, 2030 DP NCE Apr 24, 2025 10357468 May 27, 2035 U-2812 10583130 Mar 31, 2030 U-2811 8168793 Apr 02, 2029 DS DP U-2811 8524746 Jul 14, 2029 U-2811 8907099 May 12, 2027 DS 9550759 Jul 26, 2026 U-2811 9550759 Jul 26, 2026 U-2817 9550759 Jul 26, 2026 U-2818 9630955 Dec 12, 2032 DS DP U-2811 9745290 Oct 10, 2027 DP U-2811

OSELTAMIVIR PHOSPHATE - TAMIFLU N 021087 001 M-251 Aug 02, 2022

OSELTAMIVIR PHOSPHATE - TAMIFLU N 021087 002 M-251 Aug 02, 2022

OSELTAMIVIR PHOSPHATE - TAMIFLU N 021087 003 M-251 Aug 02, 2022

OSELTAMIVIR PHOSPHATE - TAMIFLU N 021246 001 M-251 Aug 02, 2022 A - 41 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

OSELTAMIVIR PHOSPHATE - TAMIFLU N 021246 002 M-251 Aug 02, 2022

OSILODROSTAT PHOSPHATE - ISTURISA N 212801 001 10143680 Jul 06, 2035 DP NCE Mar 06, 2025 10709691 Oct 12, 2035 U-2770 ODE-286 Mar 06, 2027 8314097 Mar 27, 2029 DS DP 8609862 Jan 13, 2031 U-2770 8835646 Aug 23, 2026 DS DP 9434754 Jan 13, 2031 DS

OSILODROSTAT PHOSPHATE - ISTURISA N 212801 002 10143680 Jul 06, 2035 DP NCE Mar 06, 2025 10709691 Oct 12, 2035 U-2770 ODE-286 Mar 06, 2027 8314097 Mar 27, 2029 DS DP 8609862 Jan 13, 2031 U-2770 8835646 Aug 23, 2026 DS DP 9434754 Jan 13, 2031 DS

OSILODROSTAT PHOSPHATE - ISTURISA N 212801 003 10143680 Jul 06, 2035 DP NCE Mar 06, 2025 10709691 Oct 12, 2035 U-2770 ODE-286 Mar 06, 2027 8314097 Mar 27, 2029 DS DP 8609862 Jan 13, 2031 U-2770 8835646 Aug 23, 2026 DS DP 9434754 Jan 13, 2031 DS

OXYCODONE - XTAMPZA ER N 208090 001 10646485 Sep 02, 2036 DP U-1556 10668060 Dec 10, 2030 DP U-1556

OXYCODONE - XTAMPZA ER N 208090 002 10646485 Sep 02, 2036 DP U-1556 10668060 Dec 10, 2030 DP U-1556

OXYCODONE - XTAMPZA ER N 208090 003 10646485 Sep 02, 2036 DP U-1556 10668060 Dec 10, 2030 DP U-1556

OXYCODONE - XTAMPZA ER N 208090 004 10646485 Sep 02, 2036 DP U-1556 10668060 Dec 10, 2030 DP U-1556

OXYCODONE - XTAMPZA ER N 208090 005 10646485 Sep 02, 2036 DP U-1556 10668060 Dec 10, 2030 DP U-1556

OXYCODONE HYDROCHLORIDE - OXYCONTIN N 022272 001 10675278 Nov 20, 2023 DP 10696684 Mar 30, 2025 DS

OXYCODONE HYDROCHLORIDE - OXYCONTIN N 022272 002 10675278 Nov 20, 2023 DP 10696684 Mar 30, 2025 DS

OXYCODONE HYDROCHLORIDE - OXYCONTIN N 022272 003 10675278 Nov 20, 2023 DP 10696684 Mar 30, 2025 DS

OXYCODONE HYDROCHLORIDE - OXYCONTIN N 022272 004 10675278 Nov 20, 2023 DP 10696684 Mar 30, 2025 DS A - 42 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION DATE CODES REQUESTED CODE(S) DATE

OXYCODONE HYDROCHLORIDE - OXYCONTIN N 022272 005 10675278 Nov 20, 2023 DP 10696684 Mar 30, 2025 DS

OXYCODONE HYDROCHLORIDE - OXYCONTIN N 022272 006 10675278 Nov 20, 2023 DP 10696684 Mar 30, 2025 DS

OXYCODONE HYDROCHLORIDE - OXYCONTIN N 022272 007 10675278 Nov 20, 2023 DP 10696684 Mar 30, 2025 DS

OXYMETAZOLINE HYDROCHLORIDE - RHOFADE N 208552 001 10751325 Jun 11, 2035 U-2921

OXYMETAZOLINE HYDROCHLORIDE - UPNEEQ N 212520 001 8357714 Aug 26, 2031 U-2849 NP Jul 08, 2023 9867808 Aug 26, 2031 U-2849

OXYMORPHONE HYDROCHLORIDE - OPANA N 021611 001 M-14 Oct 25, 2022

OXYMORPHONE HYDROCHLORIDE - OPANA N 021611 002 M-14 Oct 25, 2022

OZANIMOD HYDROCHLORIDE - ZEPOSIA N 209899 001 8481573 May 14, 2029 DS DP U-2774 NCE Mar 25, 2025 8796318 May 14, 2029 DS DP 9382217 May 14, 2029 U-2774

OZANIMOD HYDROCHLORIDE - ZEPOSIA N 209899 002 8481573 May 14, 2029 DS DP U-2774 NCE Mar 25, 2025 8796318 May 14, 2029 DS DP 9382217 May 14, 2029 U-2774

OZANIMOD HYDROCHLORIDE - ZEPOSIA N 209899 003 8481573 May 14, 2029 DS DP U-2774 NCE Mar 25, 2025 8796318 May 14, 2029 DS DP 9382217 May 14, 2029 U-2774

OZENOXACIN - XEPI N 208945 001 6335447 Apr 06, 2021 DS

PACLITAXEL - ABRAXANE N 021660 001 >A> M-14 Dec 06, 2022 >A> PED Jun 06, 2023

PALBOCICLIB - IBRANCE N 207103 001 10723730 Feb 08, 2034 DS DP 6936612 Jan 16, 2023 DS DP 7208489 Jan 16, 2023 DS DP Y

PALBOCICLIB - IBRANCE N 207103 002 10723730 Feb 08, 2034 DS DP 6936612 Jan 16, 2023 DS DP 7208489 Jan 16, 2023 DS DP Y

PALBOCICLIB - IBRANCE N 207103 003 10723730 Feb 08, 2034 DS DP 6936612 Jan 16, 2023 DS DP 7208489 Jan 16, 2023 DS DP Y A - 43 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

PALBOCICLIB - IBRANCE N 212436 001 10723730 Feb 08, 2034 DS DP 6936612 Jan 16, 2023 DS DP

PALBOCICLIB - IBRANCE N 212436 002 10723730 Feb 08, 2034 DS DP 6936612 Jan 16, 2023 DS DP

PALBOCICLIB - IBRANCE N 212436 003 10723730 Feb 08, 2034 DS DP 6936612 Jan 16, 2023 DS DP

PALIPERIDONE PALMITATE - INVEGA SUSTENNA N 022264 001 >A> 9439906 Jan 26, 2031 U-1901 >A> 9439906 Jan 26, 2031 U-2757 >A> 9439906 Jan 26, 2031 U-2758 >A> 9439906 Jan 26, 2031 U-543

PALIPERIDONE PALMITATE - INVEGA SUSTENNA N 022264 002 >A> 9439906 Jan 26, 2031 U-1901 >A> 9439906 Jan 26, 2031 U-2757 >A> 9439906 Jan 26, 2031 U-2758 >A> 9439906 Jan 26, 2031 U-543

PALIPERIDONE PALMITATE - INVEGA SUSTENNA N 022264 003 >A> 9439906 Jan 26, 2031 U-1901 >A> 9439906 Jan 26, 2031 U-2757 >A> 9439906 Jan 26, 2031 U-2758 >A> 9439906 Jan 26, 2031 U-543

PALIPERIDONE PALMITATE - INVEGA SUSTENNA N 022264 004 >A> 9439906 Jan 26, 2031 U-1901 >A> 9439906 Jan 26, 2031 U-2757 >A> 9439906 Jan 26, 2031 U-2758 >A> 9439906 Jan 26, 2031 U-543

PALIPERIDONE PALMITATE - INVEGA SUSTENNA N 022264 005 >A> 9439906 Jan 26, 2031 U-1901 >A> 9439906 Jan 26, 2031 U-2757 >A> 9439906 Jan 26, 2031 U-2758 >A> 9439906 Jan 26, 2031 U-543

PANTOPRAZOLE SODIUM - PANTOPRAZOLE SODIUM A 213725 001 PC Feb 09, 2021

PEMETREXED - PEMFEXY N 209472 001 7772209 May 24, 2022 U-2728 7772209 May 24, 2022 U-2729 9604990 Oct 28, 2035 DS

PEMIGATINIB - PEMAZYRE N 213736 001 10131667 Jun 12, 2033 U-2809 NCE Apr 17, 2025 9611267 Jan 30, 2035 DS DP ODE-292 Apr 17, 2027

PEMIGATINIB - PEMAZYRE N 213736 002 10131667 Jun 12, 2033 U-2809 NCE Apr 17, 2025 9611267 Jan 30, 2035 DS DP ODE-292 Apr 17, 2027

PEMIGATINIB - PEMAZYRE N 213736 003 10131667 Jun 12, 2033 U-2809 NCE Apr 17, 2025 9611267 Jan 30, 2035 DS DP ODE-292 Apr 17, 2027 A - 44 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

PERFLUTREN - DEFINITY N 021064 001 10583207 Dec 28, 2035 U-665 10583208 Mar 16, 2037 U-665 10588988 May 04, 2037 U-665

PEXIDARTINIB HYDROCHLORIDE - TURALIO N 211810 001 10730876 May 05, 2036 DS

PIMAVANSERIN TARTRATE - NUPLAZID N 210793 001 10646480 Aug 27, 2038 DP

PITOLISANT HYDROCHLORIDE - WAKIX N 211150 001 8354430 Feb 06, 2026 U-1101

PITOLISANT HYDROCHLORIDE - WAKIX N 211150 002 8354430 Feb 06, 2026 U-1101

PLECANATIDE - TRULANCE N 208745 001 7041786 Jan 30, 2028 DS

POMALIDOMIDE - POMALYST N 204026 001 10555939 May 19, 2030 DP ODE-296 May 14, 2027 ODE-297 May 14, 2027

POMALIDOMIDE - POMALYST N 204026 002 10555939 May 19, 2030 DP ODE-296 May 14, 2027 ODE-297 May 14, 2027

POMALIDOMIDE - POMALYST N 204026 003 10555939 May 19, 2030 DP ODE-296 May 14, 2027 ODE-297 May 14, 2027

POMALIDOMIDE - POMALYST N 204026 004 10555939 May 19, 2030 DP ODE-296 May 14, 2027 ODE-297 May 14, 2027

POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC - POTASSIUM PHOSPHATES N 212121 001 10632150 Apr 19, 2039 DP U-2789

PRALSETINIB - GAVRETO N 213721 001 >A> 10030005 Nov 01, 2036 DS DP U-2952 >A> NCE Sep 08, 2025

PROGESTERONE - MILPROSA N 201110 001 10537584 Feb 03, 2029 DP NP Apr 29, 2023 10548904 Feb 03, 2029 U-2810 8580293 Jan 21, 2030 U-2810

REMIMAZOLAM BESYLATE - BYFAVO N 212295 001 NCE Jul 02, 2025

REVEFENACIN - YUPELRI N 210598 001 10550081 Jul 14, 2030 DS

RIFAXIMIN - XIFAXAN N 021361 001 10703763 Feb 27, 2026 U-1708 10703763 Feb 27, 2026 U-2847 10703763 Feb 27, 2026 U-2848

RIFAXIMIN - XIFAXAN N 022554 001 10314828 Jul 24, 2029 U-1481 10335397 Jul 24, 2029 U-2579 10703763 Feb 27, 2026 U-1708 10703763 Feb 27, 2026 U-2847 A - 45 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

RIFAXIMIN - XIFAXAN N 022554 001 10703763 Feb 27, 2026 U-2848 10709694 Jul 24, 2029 U-2579 9421195 Jul 24, 2029 U-1481

RILUZOLE - EXSERVAN N 212640 001 8603514 Apr 03, 2024 DP 8765167 Feb 20, 2024 DP

RIMEGEPANT SULFATE - NURTEC ODT N 212728 001 8314117 Feb 22, 2031 DS DP U-2718 NCE Feb 27, 2025 8759372 Feb 25, 2033 DS DP

RIOCIGUAT - ADEMPAS N 204819 001 10662188 Feb 18, 2034 DS DP U-2834 10662188 Feb 18, 2034 DS DP U-2835

RIOCIGUAT - ADEMPAS N 204819 002 10662188 Feb 18, 2034 DS DP U-2834 10662188 Feb 18, 2034 DS DP U-2835

RIOCIGUAT - ADEMPAS N 204819 003 10662188 Feb 18, 2034 DS DP U-2834 10662188 Feb 18, 2034 DS DP U-2835

RIOCIGUAT - ADEMPAS N 204819 004 10662188 Feb 18, 2034 DS DP U-2834 10662188 Feb 18, 2034 DS DP U-2835

RIOCIGUAT - ADEMPAS N 204819 005 10662188 Feb 18, 2034 DS DP U-2834 10662188 Feb 18, 2034 DS DP U-2835

RIPRETINIB - QINLOCK N 213973 001 8188113 Jul 27, 2030 DS DP NCE May 15, 2025 8461179 Jun 07, 2032 DS DP ODE-298 May 15, 2027 8940756 Jun 07, 2032 U-2829

RISDIPLAM - EVRYSDI N 213535 001 >A> 9586955 Feb 08, 2033 DS DP NCE Aug 07, 2025 >A> 9969754 May 11, 2035 DS DP U-1943

RIVAROXABAN - XARELTO N 022406 001 9415053 Nov 13, 2024 DP U-1167 9415053 Nov 13, 2024 DP U-2142 9415053 Nov 13, 2024 DP U-2640 9539218 Feb 17, 2034 U-1957 9539218 Feb 17, 2034 U-2143 9539218 Feb 17, 2034 U-2641

RIVAROXABAN - XARELTO N 022406 002 9415053 Nov 13, 2024 DP U-1200 9415053 Nov 13, 2024 DP U-1301 9415053 Nov 13, 2024 DP U-1302 9539218 Feb 17, 2034 U-1953

RIVAROXABAN - XARELTO N 022406 003 9415053 Nov 13, 2024 DP U-1200 9415053 Nov 13, 2024 DP U-1301 9415053 Nov 13, 2024 DP U-1302 9539218 Feb 17, 2034 U-1953 9539218 Feb 17, 2034 U-1954 9539218 Feb 17, 2034 U-1955 A - 46 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

RIVAROXABAN - XARELTO N 022406 004 I-824 Oct 11, 2021

RUCAPARIB CAMSYLATE - RUBRACA N 209115 001 10130636 Aug 17, 2035 U-2012 I-830 May 15, 2023 10130636 Aug 17, 2035 U-2101 10130636 Aug 17, 2035 U-2273 10130636 Aug 17, 2035 U-2830 7351701 Jul 23, 2024 U-2012 7351701 Jul 23, 2024 U-2101 7351701 Jul 23, 2024 U-2273 7351701 Jul 23, 2024 U-2830 7531530 Jul 23, 2024 U-2012 7531530 Jul 23, 2024 U-2101 7531530 Jul 23, 2024 U-2273 7531530 Jul 23, 2024 U-2830 8071579 Aug 12, 2027 U-2012 8071579 Aug 12, 2027 U-2101 8071579 Aug 12, 2027 U-2273 8071579 Aug 12, 2027 U-2830 8143241 Aug 12, 2027 U-2012 8143241 Aug 12, 2027 U-2101 8143241 Aug 12, 2027 U-2273 8143241 Aug 12, 2027 U-2830 8859562 Aug 04, 2031 U-2012 8859562 Aug 04, 2031 U-2101 8859562 Aug 04, 2031 U-2273 8859562 Aug 04, 2031 U-2830

RUCAPARIB CAMSYLATE - RUBRACA N 209115 002 10130636 Aug 17, 2035 U-2012 I-830 May 15, 2023 10130636 Aug 17, 2035 U-2101 10130636 Aug 17, 2035 U-2273 10130636 Aug 17, 2035 U-2830 7351701 Jul 23, 2024 U-2012 7351701 Jul 23, 2024 U-2101 7351701 Jul 23, 2024 U-2273 7351701 Jul 23, 2024 U-2830 7531530 Jul 23, 2024 U-2012 7531530 Jul 23, 2024 U-2101 7531530 Jul 23, 2024 U-2273 7531530 Jul 23, 2024 U-2830 8071579 Aug 12, 2027 U-2012 8071579 Aug 12, 2027 U-2101 8071579 Aug 12, 2027 U-2273 8071579 Aug 12, 2027 U-2830 8143241 Aug 12, 2027 U-2012 8143241 Aug 12, 2027 U-2101 8143241 Aug 12, 2027 U-2273 8143241 Aug 12, 2027 U-2830 8859562 Aug 04, 2031 U-2012 8859562 Aug 04, 2031 U-2101 8859562 Aug 04, 2031 U-2273 8859562 Aug 04, 2031 U-2830

RUCAPARIB CAMSYLATE - RUBRACA N 209115 003 10130636 Aug 17, 2035 U-2012 I-830 May 15, 2023 10130636 Aug 17, 2035 U-2101 10130636 Aug 17, 2035 U-2273 10130636 Aug 17, 2035 U-2830 7351701 Jul 23, 2024 U-2012 7351701 Jul 23, 2024 U-2101 7351701 Jul 23, 2024 U-2273 7351701 Jul 23, 2024 U-2830 7531530 Jul 23, 2024 U-2012 7531530 Jul 23, 2024 U-2101 7531530 Jul 23, 2024 U-2273 7531530 Jul 23, 2024 U-2830 A - 47 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

RUCAPARIB CAMSYLATE - RUBRACA N 209115 003 8071579 Aug 12, 2027 U-2012 8071579 Aug 12, 2027 U-2101 8071579 Aug 12, 2027 U-2273 8071579 Aug 12, 2027 U-2830 8143241 Aug 12, 2027 U-2012 8143241 Aug 12, 2027 U-2101 8143241 Aug 12, 2027 U-2273 8143241 Aug 12, 2027 U-2830 8859562 Aug 04, 2031 U-2012 8859562 Aug 04, 2031 U-2101 8859562 Aug 04, 2031 U-2273 8859562 Aug 04, 2031 U-2830

SECNIDAZOLE - SOLOSEC N 209363 001 10682338 Sep 04, 2035 U-2583

SELINEXOR - XPOVIO N 212306 001 10519139 Aug 14, 2035 DS DP U-2584 I-837 Jun 22, 2023 10519139 Aug 14, 2035 DS DP U-2855 >A> ODE-310 Jun 22, 2027 10544108 Jul 26, 2032 U-2584 9079865 Jul 26, 2032 U-2584 9079865 Jul 26, 2032 U-2855

SELPERCATINIB - RETEVMO N 213246 001 10112942 Oct 10, 2037 DS DP NCE May 08, 2025 10137124 Oct 10, 2037 U-2826 ODE-301 May 08, 2027 10137124 Oct 10, 2037 U-2827 ODE-302 May 08, 2027 10137124 Oct 10, 2037 U-2828 ODE-303 May 08, 2027 10172851 Oct 10, 2037 U-2826 10172851 Oct 10, 2037 U-2827 10172851 Oct 10, 2037 U-2828 10584124 Oct 10, 2038 DS U-2826 10584124 Oct 10, 2038 DS U-2827 10584124 Oct 10, 2038 DS U-2828

SELPERCATINIB - RETEVMO N 213246 002 10112942 Oct 10, 2037 DS DP NCE May 08, 2025 10137124 Oct 10, 2037 U-2826 ODE-301 May 08, 2027 10137124 Oct 10, 2037 U-2827 ODE-302 May 08, 2027 10137124 Oct 10, 2037 U-2828 ODE-303 May 08, 2027 10172851 Oct 10, 2037 U-2826 10172851 Oct 10, 2037 U-2827 10172851 Oct 10, 2037 U-2828 10584124 Oct 10, 2038 DS U-2826 10584124 Oct 10, 2038 DS U-2827 10584124 Oct 10, 2038 DS U-2828

SELUMETINIB SULFATE - KOSELUGO N 213756 001 7425637 Apr 11, 2024 DS NCE Apr 10, 2025 8178693 Mar 13, 2023 DS DP ODE-288 Apr 10, 2027 9156795 Dec 12, 2026 DS DP 9562017 Dec 12, 2026 DS U-2800

SELUMETINIB SULFATE - KOSELUGO N 213756 002 7425637 Apr 11, 2024 DS NCE Apr 10, 2025 8178693 Mar 13, 2023 DS DP ODE-288 Apr 10, 2027 9156795 Dec 12, 2026 DS DP 9562017 Dec 12, 2026 DS U-2800

SEMAGLUTIDE - OZEMPIC N 209637 001 I-822 Jan 16, 2023

SEMAGLUTIDE - OZEMPIC N 209637 002 >A> 10335462 Jun 21, 2033 U-2580 I-822 Jan 16, 2023 >A> 8114833 Aug 13, 2025 DP A - 48 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

SEMAGLUTIDE - OZEMPIC N 209637 002 >A> 8129343 Jan 29, 2029 DS DP U-2202 >A> 8536122 Mar 20, 2026 DS DP U-2202

SEMAGLUTIDE - RYBELSUS N 213051 001 M-252 Jan 16, 2023

SEMAGLUTIDE - RYBELSUS N 213051 002 M-252 Jan 16, 2023

SEMAGLUTIDE - RYBELSUS N 213051 003 M-252 Jan 16, 2023

SODIUM OXYBATE - XYREM N 021196 001 ODE-231 Oct 26, 2025 PED Apr 26, 2026

SODIUM ZIRCONIUM CYCLOSILICATE - LOKELMA N 207078 001 10695365 Oct 22, 2033 DS M-261 Apr 24, 2023

SODIUM ZIRCONIUM CYCLOSILICATE - LOKELMA N 207078 002 10695365 Oct 22, 2033 DS M-261 Apr 24, 2023

SOFOSBUVIR; VELPATASVIR - EPCLUSA N 208341 001 NPP Mar 19, 2023 ODE-293 Mar 19, 2027

SOFOSBUVIR; VELPATASVIR - EPCLUSA N 208341 002 10086011 Jan 30, 2034 U-1470 NS Mar 19, 2023 7964580 Mar 26, 2029 DS DP U-1470 ODE-293 Mar 19, 2027 8334270 Mar 21, 2028 DS DP U-1470 8575135 Nov 16, 2032 DS DP U-1470 8580765 Mar 21, 2028 DS DP U-1470 8618076 Dec 11, 2030 DS DP U-1470 8633309 Mar 26, 2029 DS DP U-1470 8735372 Mar 21, 2028 U-1470 8889159 Mar 26, 2029 DP U-1470 8921341 Nov 16, 2032 DS DP U-1470 8940718 Nov 16, 2032 DS DP U-1470 9085573 Mar 21, 2028 DS DP U-1470 9284342 Sep 13, 2030 DS DP U-1470 9757406 Jan 30, 2034 DP

SOLIFENACIN SUCCINATE - VESICARE LS N 209529 001 NP May 26, 2023 PED Nov 26, 2023

SOLRIAMFETOL HYDROCHLORIDE - SUNOSI N 211230 001 10512609 Sep 05, 2037 U-2548

SOLRIAMFETOL HYDROCHLORIDE - SUNOSI N 211230 002 10512609 Sep 05, 2037 U-2548

SOTALOL HYDROCHLORIDE - SOTALOL HYDROCHLORIDE N 022306 001 10512620 Aug 18, 2038 U-2769

SPIRONOLACTONE - CAROSPIR N 209478 001 10624906 Oct 28, 2036 DP 10660907 Oct 28, 2036 DP

SUCROFERRIC OXYHYDROXIDE - VELPHORO N 205109 001 10624855 Nov 26, 2034 DP 10682376 Nov 13, 2028 DP 10695367 Nov 13, 2028 DP A - 49 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

SUCROFERRIC OXYHYDROXIDE - VELPHORO N 205109 001 10624855 Nov 26, 2034 DP 10682376 Nov 13, 2028 DP 10695367 Nov 13, 2028 DP

SUGAMMADEX SODIUM - BRIDION N 022225 001 RE44733 Jan 27, 2026 DS DP U-1794 M-262 Jun 09, 2023

SUGAMMADEX SODIUM - BRIDION N 022225 002 RE44733 Jan 27, 2026 DS DP U-1794 M-262 Jun 09, 2023

SUMATRIPTAN - TOSYMRA N 210884 001 10603305 Jun 16, 2030 DP U-1719

SUMATRIPTAN SUCCINATE - ONZETRA XSAIL N 206099 001 10722667 Dec 30, 2028 DP

SUMATRIPTAN SUCCINATE - ZEMBRACE SYMTOUCH N 208223 001 10537554 Jan 29, 2036 U-72

SUVOREXANT - BELSOMRA N 204569 001 M-253 Jan 29, 2023

SUVOREXANT - BELSOMRA N 204569 002 M-253 Jan 29, 2023

SUVOREXANT - BELSOMRA N 204569 003 M-253 Jan 29, 2023

SUVOREXANT - BELSOMRA N 204569 004 M-253 Jan 29, 2023

TACROLIMUS - PROGRAF N 050708 001 ODE-294 May 24, 2025

TACROLIMUS - PROGRAF N 050708 002 ODE-294 May 24, 2025

TACROLIMUS - PROGRAF N 050708 003 ODE-294 May 24, 2025

TACROLIMUS - PROGRAF N 050709 001 ODE-294 May 24, 2025

TACROLIMUS - ENVARSUS XR N 206406 001 10548880 Aug 30, 2024 U-2677 10548880 Aug 30, 2024 U-2678 8664239 Aug 30, 2028 U-1752 8664239 Aug 30, 2028 U-2677 8664239 Aug 30, 2028 U-2678

TACROLIMUS - ENVARSUS XR N 206406 002 10548880 Aug 30, 2024 U-2677 10548880 Aug 30, 2024 U-2678 8664239 Aug 30, 2028 U-1752 8664239 Aug 30, 2028 U-2677 8664239 Aug 30, 2028 U-2678

TACROLIMUS - ENVARSUS XR N 206406 003 10548880 Aug 30, 2024 U-2677 10548880 Aug 30, 2024 U-2678 8664239 Aug 30, 2028 U-1752 8664239 Aug 30, 2028 U-2677 A - 50 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

TACROLIMUS - ENVARSUS XR N 206406 003 8664239 Aug 30, 2028 U-2678

TASIMELTEON - HETLIOZ N 205677 001 10610510 Jan 25, 2033 U-2805 10610511 Oct 10, 2034 U-2806

TAZAROTENE - FABIOR N 202428 001 10568859 Feb 24, 2030 DP U-2760 10688071 Feb 24, 2030 DP U-2760

TAZEMETOSTAT HYDROBROMIDE - TAZVERIK N 211723 001 10155002 Apr 13, 2032 U-2736 I-835 Jun 18, 2023 10245269 Apr 11, 2033 U-2737 I-836 Jun 18, 2023 10245269 Apr 11, 2033 U-2851 NCE Jan 23, 2025 10245269 Apr 11, 2033 U-2854 ODE-299 Jan 23, 2027 10369155 Oct 16, 2035 U-2736 >A> ODE-314 Jun 18, 2027 10369155 Oct 16, 2035 U-2852 10369155 Oct 16, 2035 U-2853 10420775 Apr 13, 2032 U-2736 10420775 Apr 13, 2032 U-2852 10420775 Apr 13, 2032 U-2853 8410088 Apr 13, 2032 DS DP 8691507 Sep 12, 2031 U-2852 8765732 Apr 13, 2032 U-2852 8765732 Apr 13, 2032 U-2853 8895245 Sep 12, 2031 U-2852 9090562 Apr 13, 2032 DS DP 9175331 Sep 12, 2031 U-2852 9333217 Sep 12, 2031 U-2852 9334527 Sep 12, 2031 U-2852 9394283 Apr 11, 2033 DS DP U-2852 9394283 Apr 11, 2033 DS DP U-2853 9522152 Apr 13, 2032 U-2738 9549931 Apr 13, 2032 U-2736 9549931 Apr 13, 2032 U-2852 9549931 Apr 13, 2032 U-2853 9688665 Aug 22, 2034 U-2736 9855275 Apr 13, 2032 U-2736 9872862 Apr 11, 2033 U-2738 9889138 Oct 16, 2035 U-2736 9889138 Oct 16, 2035 U-2852 9889138 Oct 16, 2035 U-2853 9949999 Sep 12, 2031 U-2851

TECHNETIUM TC-99M TILMANOCEPT - LYMPHOSEEK KIT N 202207 001 6409990 May 12, 2025 DS

TEDIZOLID PHOSPHATE - SIVEXTRO N 205435 001 7816379 Jun 20, 2028 DS DP U-2507 NPP Jun 19, 2023

TEDIZOLID PHOSPHATE - SIVEXTRO N 205436 001 7816379 Jun 20, 2028 DS DP U-2507 NPP Jun 19, 2023

TENOFOVIR ALAFENAMIDE FUMARATE - VEMLIDY N 208464 001 7390791 Apr 17, 2025 DS DP M-255 Feb 04, 2023

TESTOSTERONE ENANTHATE - XYOSTED (AUTOINJECTOR) N 209863 001 10238662 Feb 19, 2035 DP U-2418 10279131 Jul 31, 2031 DP 10357609 Aug 21, 2031 DP 10478560 Jan 24, 2026 DP 10646495 Aug 30, 2038 DP A - 51 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

TESTOSTERONE ENANTHATE - XYOSTED (AUTOINJECTOR) N 209863 002 10238662 Feb 19, 2035 DP U-2418 10279131 Jul 31, 2031 DP 10357609 Aug 21, 2031 DP 10478560 Jan 24, 2026 DP 10646495 Aug 30, 2038 DP

TESTOSTERONE ENANTHATE - XYOSTED (AUTOINJECTOR) N 209863 003 10238662 Feb 19, 2035 DP U-2418 10279131 Jul 31, 2031 DP 10357609 Aug 21, 2031 DP 10478560 Jan 24, 2026 DP 10646495 Aug 30, 2038 DP

TESTOSTERONE UNDECANOATE - AVEED N 022219 001 >A> 8338395 May 08, 2027 U-1500

TESTOSTERONE UNDECANOATE - JATENZO N 206089 001 10543219 Apr 12, 2030 U-2506 10617696 Apr 12, 2030 DS DP

TESTOSTERONE UNDECANOATE - JATENZO N 206089 002 10543219 Apr 12, 2030 U-2506 10617696 Apr 12, 2030 DS DP

TESTOSTERONE UNDECANOATE - JATENZO N 206089 003 10543219 Apr 12, 2030 U-2506 10617696 Apr 12, 2030 DS DP

TICAGRELOR - BRILINTA N 022433 001 RE46276 Oct 30, 2024 DS DP U-1935 RE46276 Oct 30, 2024 DS DP U-1936 RE46276 Oct 30, 2024 DS DP U-1937 RE46276 Oct 30, 2024 DS DP U-1938 RE46276 Oct 30, 2024 DS DP U-2838 RE46276 Oct 30, 2024 DS DP U-2839

TICAGRELOR - BRILINTA N 022433 002 RE46276 Oct 30, 2024 DS DP U-1935 RE46276 Oct 30, 2024 DS DP U-1936 RE46276 Oct 30, 2024 DS DP U-1937 RE46276 Oct 30, 2024 DS DP U-1938 RE46276 Oct 30, 2024 DS DP U-2838 RE46276 Oct 30, 2024 DS DP U-2839

TIGECYCLINE - TYGACIL N 021821 001 10588975 Mar 13, 2026 DP

TOBRAMYCIN - TOBI PODHALER N 201688 001 RE47526 Apr 09, 2024 DP

TOFACITINIB CITRATE - XELJANZ N 203214 002 7301023 Dec 08, 2020 DS

TOFACITINIB CITRATE - XELJANZ XR N 208246 001 7301023 Dec 08, 2020 DS

TOFACITINIB CITRATE - XELJANZ XR N 208246 002 10639309 Mar 14, 2034 DP 7301023 Dec 08, 2020 DS

TREPROSTINIL - REMODULIN N 021272 001 10695308 Dec 16, 2024 U-2845 A - 52 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

TREPROSTINIL - REMODULIN N 021272 002 10695308 Dec 16, 2024 U-2845

TREPROSTINIL - REMODULIN N 021272 003 10695308 Dec 16, 2024 U-2845

TREPROSTINIL - REMODULIN N 021272 004 10695308 Dec 16, 2024 U-2845

TREPROSTINIL - TYVASO N 022387 001 10376525 May 14, 2027 U-1849 10716793 May 14, 2027 U-1849

TREPROSTINIL DIOLAMINE - ORENITRAM N 203496 001 8747897 Aug 11, 2031 DP U-2724 ODE-308 Dec 20, 2020 8747897 Aug 11, 2031 DP U-2725

TREPROSTINIL DIOLAMINE - ORENITRAM N 203496 002 8747897 Aug 11, 2031 DP U-2724 ODE-308 Dec 20, 2020 8747897 Aug 11, 2031 DP U-2725

TREPROSTINIL DIOLAMINE - ORENITRAM N 203496 003 8747897 Aug 11, 2031 DP U-2724 ODE-308 Dec 20, 2020 8747897 Aug 11, 2031 DP U-2725

TREPROSTINIL DIOLAMINE - ORENITRAM N 203496 004 8747897 Aug 11, 2031 DP U-2724 ODE-308 Dec 20, 2020 8747897 Aug 11, 2031 DP U-2725

TREPROSTINIL DIOLAMINE - ORENITRAM N 203496 005 8747897 Aug 11, 2031 DP U-2724 ODE-308 Dec 20, 2020 8747897 Aug 11, 2031 DP U-2725

TRETINOIN - ALTRENO N 209353 001 10653656 Aug 22, 2038 DP U-2368

TRIHEPTANOIN - DOJOLVI N 213687 001 >A> 8697748 Oct 03, 2025 DP NCE Jun 30, 2025 >A> 9186344 Jul 01, 2025 DP >A> ODE-311 Jun 30, 2027

TRIPTORELIN PAMOATE - TRELSTAR N 022437 001 10166181 Jun 30, 2029 DP

TRIPTORELIN PAMOATE - TRIPTODUR KIT N 208956 001 10166181 Jun 30, 2029 DP

TUCATINIB - TUKYSA N 213411 001 7452895 Nov 16, 2024 DS DP U-2788 NCE Apr 17, 2025 8648087 Apr 12, 2031 DS DP >A> ODE-309 Apr 17, 2027 9457093 Oct 12, 2032 DP U-2788 9693989 May 09, 2027 DP U-2788

TUCATINIB - TUKYSA N 213411 002 7452895 Nov 16, 2024 DS DP U-2788 NCE Apr 17, 2025 8648087 Apr 12, 2031 DS DP >A> ODE-309 Apr 17, 2027 9457093 Oct 12, 2032 DP U-2788 9693989 May 09, 2027 DP U-2788

UBROGEPANT - UBRELVY N 211765 001 10117836 Jan 30, 2035 DP 8754096 Jul 19, 2032 DS DP U-2717 8912210 Nov 10, 2031 DS DP 9499545 Nov 10, 2031 DS DP U-2718 9833448 Nov 10, 2031 U-2718 A - 53 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

UBROGEPANT - UBRELVY N 211765 001 10117836 Jan 30, 2035 DP 8754096 Jul 19, 2032 DS DP U-2717 8912210 Nov 10, 2031 DS DP 9499545 Nov 10, 2031 DS DP U-2718 9833448 Nov 10, 2031 U-2718

UBROGEPANT - UBRELVY N 211765 002 10117836 Jan 30, 2035 DP 8754096 Jul 19, 2032 DS DP U-2717 8912210 Nov 10, 2031 DS DP 9499545 Nov 10, 2031 DS DP U-2718 9833448 Nov 10, 2031 U-2718

UMECLIDINIUM BROMIDE - INCRUSE ELLIPTA N 205382 001 M-245 Jun 09, 2022

UPADACITINIB - RINVOQ N 211675 001 10519164 Oct 17, 2036 DP 10597400 Oct 17, 2036 U-2616

VANCOMYCIN HYDROCHLORIDE - FIRVANQ KIT N 208910 001 10688046 Mar 13, 2035 DP

VANCOMYCIN HYDROCHLORIDE - FIRVANQ KIT N 208910 002 10688046 Mar 13, 2035 DP

VANCOMYCIN HYDROCHLORIDE - VANCOMYCIN HYDROCHLORIDE N 211962 005 10039804 Nov 06, 2035 DP U-282 10188697 Nov 06, 2035 DP U-282

VANCOMYCIN HYDROCHLORIDE - VANCOMYCIN HYDROCHLORIDE N 211962 006 10039804 Nov 06, 2035 DP U-282 10188697 Nov 06, 2035 DP U-282

VANCOMYCIN HYDROCHLORIDE - VANCOMYCIN HYDROCHLORIDE N 211962 007 10039804 Nov 06, 2035 DP U-282 10188697 Nov 06, 2035 DP U-282

VASOPRESSIN - VASOSTRICT N 204485 003 10010575 Jan 30, 2035 U-1857 9919026 Jan 30, 2035 DP 9925233 Jan 30, 2035 U-1857 9925234 Jan 30, 2035 U-1857 9962422 Jan 30, 2035 U-1857 9968649 Jan 30, 2035 U-1857 9974827 Jan 30, 2035 U-1857 9981006 Jan 30, 2035 U-1857

VASOPRESSIN - VASOSTRICT N 204485 004 10010575 Jan 30, 2035 U-1857 9919026 Jan 30, 2035 DP 9925233 Jan 30, 2035 U-1857 9925234 Jan 30, 2035 U-1857 9962422 Jan 30, 2035 U-1857 9968649 Jan 30, 2035 U-1857 9974827 Jan 30, 2035 U-1857 9981006 Jan 30, 2035 U-1857

VENETOCLAX - VENCLEXTA N 208573 001 10730873 Nov 21, 2031 DS 8722657 Jan 29, 2032 DS A - 54 PATENT AND EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 09 - September 2020

APPL/PROD PATENT PATENT EXCLUSIVITY

NO PATENT NO EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION

DATE CODES REQUESTED CODE(S) DATE

VENETOCLAX - VENCLEXTA N 208573 002 10730873 Nov 21, 2031 DS 8722657 Jan 29, 2032 DS

VENETOCLAX - VENCLEXTA N 208573 003 10730873 Nov 21, 2031 DS 8722657 Jan 29, 2032 DS

VILAZODONE HYDROCHLORIDE - VIIBRYD N 022567 001 7834020 Jun 05, 2022 DS DP U-839 M-254 Jan 31, 2023 7834020*PED Dec 05, 2022 PED Jul 31, 2023 8193195 Jun 05, 2022 U-839 8193195*PED Dec 05, 2022 8236804 Jun 05, 2022 U-839 8236804*PED Dec 05, 2022 8673921 Jun 05, 2022 DS DP 8673921*PED Dec 05, 2022

VILAZODONE HYDROCHLORIDE - VIIBRYD N 022567 002 7834020 Jun 05, 2022 DS DP U-839 M-254 Jan 31, 2023 7834020*PED Dec 05, 2022 PED Jul 31, 2023 8193195 Jun 05, 2022 U-839 8193195*PED Dec 05, 2022 8236804 Jun 05, 2022 U-839 8236804*PED Dec 05, 2022 8673921 Jun 05, 2022 DS DP 8673921*PED Dec 05, 2022

VILAZODONE HYDROCHLORIDE - VIIBRYD N 022567 003 7834020 Jun 05, 2022 DS DP U-839 M-254 Jan 31, 2023 7834020*PED Dec 05, 2022 PED Jul 31, 2023 8193195 Jun 05, 2022 U-839 8193195*PED Dec 05, 2022 8236804 Jun 05, 2022 U-839 8236804*PED Dec 05, 2022 8673921 Jun 05, 2022 DS DP 8673921*PED Dec 05, 2022

VILTOLARSEN - VILTEPSO N 212154 001 9079934 Aug 31, 2031 DS DP NCE Aug 12, 2025

VOXELOTOR - OXBRYTA N 213137 001 10017491 Dec 28, 2032 DP ODE-281 Nov 25, 2026 10034879 Dec 28, 2032 DS DP 10493035 Oct 12, 2037 DP 10722502 Feb 06, 2035 DP 9018210 Dec 28, 2032 DS DP 9248199 Jan 29, 2034 U-2676 9248199 Jan 29, 2034 U-2715 9447071 Feb 06, 2035 DS DP

B-1

PATENT AND EXCLUSIVITY TERMS

Due to space limitations in the patent and exclusivity columns, abbreviations and references have been developed. Refer to the APPROVED DRUG th PRODUCTS WITH THERAPEUTIC EQUIVALENCE EVALUATIONS, 40 Edition for a full listing of patent and exclusivity terms (Abbreviations, Dosing Schedule, Indications, and Patent Use Codes).

The current complete list of patent terms is available at http://www.accessdata.fda.gov/scripts/cder/ob/results_patent.cfm

The current complete list of exclusivity terms is available at http://www.accessdata.fda.gov/scripts/cder/ob/results_exclusivity.cfm